Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABL2	"ABLL, ARG"	ENSG00000143322	"ABL proto-oncogene 2, non-receptor tyrosine kinase"	P42684	1	179099330-179229684	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 166.8;Langerhans cells: 188.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 73.5;TIME: 70.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001866, CAB017106, HPA072754"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Vesicles	"CAB017106: , HPA001866: AB_1078082, HPA072754: AB_2732212"	"unprognostic (3.05e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (1.07e-1)"	"unprognostic (4.71e-2)"	"unprognostic (9.45e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.91e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (1.78e-7)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (8.40e-4)"	9.3	3.2	5.9	4.9	6.7	2.7	5.7	6.1	6.1	5.4	2.0	4.6	2.8	3.7	2.7	2.5	3.2	11.8	3.9	7.4	5.0	3.6	2.7	6.5	2.7	3.8	4.4	3.5	5.7	4.2	3.8	4.1	3.9	3.5	3.3	9.2	3.5	2.6	3.1	4.2	3.2	4.5	3.0	2.7	3.7	4.4	5.6	4.1	3.8	4.2	2.5	6.4	4.0	4.8	24.2	13.1	8.7	5.8	7.3	16.8	5.3	26.3	21.6	31.9	23.1	9.9	7.2	13.7	18.9	19.2	21.7	11.0	12.6	9.1	44.6	8.5	11.4	6.7	12.4	4.9	13.3	7.5	2.1	15.6	11.6	45.3	73.5	13.9	36.2	7.0	16.1	3.8	42.6	6.5	5.9	4.0	8.3	5.0	4.3	8.6	14.4	6.5	10.8	4.0	5.2	11.9	22.0	7.0	53.8	13.2	6.2	6.4	70.7	33.3	24.5	15.7	42.8	7.0	9.3	14.1	15.6	4.0	32.4	1.4	0.3	0.0	0.5	0.1	0.2	0.5	0.3	0.3	0.2	0.7	0.4	0.5	0.6	0.5	0.1	0.5	0.2	0.1	5.9	6.7	6.1	6.1	7.4	5.0	3.8	4.4	3.9	3.0	5.6	4.8	33.5	22.4	24.0	44.1	14.4	46.9	43.6	16.3	12.5	40.0	18.7	9.5	8.9	22.8	10.8	11.0	166.8	9.3	7.7	15.5	11.7	14.3	15.6	12.3	23.4	67.2	27.0	9.9	81.6	13.9	8.2	67.6	10.2	21.5	17.1	19.5	31.1	15.3	22.9	25.2	62.0	11.0	10.2	34.9	188.1	32.2	15.2	67.7	69.4	45.0	13.9	11.3	8.2	72.4	57.1	45.5	16.0	13.5	10.3	42.6	9.9	9.4	11.0	35.7	6.6	32.3	30.5	17.8	30.5	11.5	38.4	10.4	12.4	11.6	14.9	25.3
ACOD1	"CAD, IRG1"	ENSG00000102794	"Aconitate decarboxylase 1"	A6NK06	13	76948511-76958638	"Enzymes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"	"Antimicrobial, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.4"	"Cell type enhanced"	"Detected in single"		"Distal tubular cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA040143	Uncertain					NA	NA				"Cluster 16: Immune cells - Immune response"		"Cluster 41: Macrophages - Immune response"			"HPA040143: AB_10793916"	"unprognostic (2.39e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.37e-1)"			"unprognostic (3.54e-2)"		"unprognostic (3.09e-1)"	"unprognostic (8.30e-2)"	"unprognostic (4.30e-2)"			"unprognostic (1.64e-5)"	"unprognostic (7.70e-2)"	"unprognostic (3.68e-2)"		"unprognostic (6.51e-3)"	0.2	0.0	0.0	1.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADA2	"ADGF, CECR1, IDGFL"	ENSG00000093072	"Adenosine deaminase 2"	Q9NZK5	22	17178790-17258235	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Heparin-binding, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 106.3"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 27.6;Glandular and luminal cells: 22.0;Hofbauer cells: 57.6;Macrophages: 62.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 23.7;EFO-21: 21.4;HUVEC TERT2: 24.0;Karpas-707: 44.9;MOLT-4: 38.9;U-266/70: 23.8;U-937: 39.6"					"Low region specificity"	"Detected in all"			HPA007888	Uncertain				"Secreted to blood"	NA	NA		58000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA007888: AB_1078495"	"unprognostic (1.03e-3)"	"unprognostic (2.00e-3)"	"unprognostic (6.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.01e-3)"	"unprognostic (4.48e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.80e-2)"	"prognostic favorable (9.26e-4)"	"prognostic favorable (8.91e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.86e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.51e-1)"	14.0	11.3	8.3	39.4	9.9	22.8	17.6	10.6	7.9	22.0	20.5	28.3	18.1	19.9	2.7	12.0	51.5	32.1	39.6	7.8	10.9	14.5	21.1	54.9	47.3	16.3	11.4	12.1	13.9	5.4	22.5	15.2	14.7	15.4	34.3	11.0	15.6	17.1	3.4	4.7	26.1	23.4	13.7	106.3	19.6	18.4	12.9	53.7	16.9	4.3	60.7	34.7	6.5	21.1	0.0	0.0	6.4	0.0	0.2	0.8	0.3	2.3	0.1	0.0	0.0	0.0	23.7	6.0	21.4	7.2	0.0	0.5	0.2	0.0	0.0	0.1	0.0	1.1	0.0	0.1	4.0	0.3	0.3	11.3	0.1	0.0	0.1	0.1	24.0	9.0	0.1	44.9	0.9	0.0	38.9	1.1	17.8	0.0	0.1	1.2	0.0	6.5	0.0	9.3	10.9	0.1	0.1	0.0	0.0	19.1	0.2	9.7	3.0	0.1	0.2	0.0	0.0	23.8	2.3	1.7	0.0	39.6	0.0	17.5	212.9	11.3	34.6	204.9	26.8	25.8	27.4	34.1	139.1	19.7	31.6	32.4	10.5	44.9	176.1	57.4	17.2	170.7	8.3	9.9	10.6	7.9	7.8	10.9	16.3	11.4	14.7	13.7	12.9	21.1	8.7	0.0	16.8	0.0	7.2	0.0	0.0	0.0	0.0	0.0	5.1	4.2	0.0	0.0	11.2	5.5	0.0	0.4	13.7	0.0	7.9	1.7	0.0	27.6	6.6	2.2	0.0	0.0	0.0	5.2	0.9	2.1	0.0	22.0	5.1	12.6	0.0	0.0	57.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	12.4	0.0	0.0	3.1	15.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.8	8.2	3.1	0.0	0.0
ADAM17	"CD156B, cSVP, TACE"	ENSG00000151694	"ADAM metallopeptidase domain 17"	P78536	2	9488486-9556732	"CD markers, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 154.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010738, HPA051575"	Approved		Supported	Cytosol		NA	NA		300000	"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA010738: AB_1078100, HPA051575: AB_2681539"	"unprognostic (2.28e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.82e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (4.23e-5)"	10.3	5.5	8.7	9.1	8.6	5.8	10.4	7.8	10.6	8.7	9.5	5.4	4.1	7.2	11.4	10.0	6.5	9.0	6.7	8.6	9.4	4.7	4.6	14.6	8.5	9.7	8.3	8.9	4.1	7.9	4.2	20.1	9.4	4.0	6.8	4.5	6.2	6.3	6.9	11.1	6.1	8.6	8.3	9.3	5.1	9.9	9.1	9.6	6.6	6.8	12.7	10.4	7.1	10.4	10.0	18.2	23.2	25.9	45.9	34.7	45.4	8.6	25.4	16.1	24.6	19.2	31.6	33.4	18.1	18.8	42.1	21.9	16.4	29.4	22.6	8.4	12.1	15.8	14.7	13.9	68.0	20.7	17.8	41.2	32.2	25.1	47.5	26.6	46.0	8.7	30.0	12.3	17.3	8.7	8.5	23.4	19.2	13.7	4.6	14.3	21.6	20.5	25.8	18.7	11.7	28.6	14.9	16.5	30.1	27.0	6.6	19.4	29.0	25.5	12.0	19.1	22.1	15.1	17.5	29.6	20.2	11.1	31.1	5.0	3.7	2.8	1.0	3.7	1.9	1.7	0.9	1.1	2.3	0.9	0.9	1.0	5.5	1.2	2.5	0.7	1.1	0.9	8.7	8.6	7.8	10.6	8.6	9.4	9.7	8.3	9.4	8.3	9.1	10.4	53.8	48.1	66.9	19.6	34.5	130.0	48.2	37.0	19.9	25.2	40.8	26.4	3.6	27.1	38.8	31.3	54.2	29.8	37.7	20.7	5.9	23.7	72.1	30.0	32.0	45.1	19.7	16.8	66.7	19.4	45.1	44.1	13.7	51.5	30.9	31.3	41.4	13.5	34.6	10.1	46.2	13.8	12.2	80.4	84.5	16.0	19.0	76.9	40.9	42.2	40.3	12.9	16.5	26.7	41.5	20.9	18.3	16.1	23.2	57.2	12.9	7.0	37.2	41.4	39.5	79.4	27.3	35.7	35.2	33.7	154.7	56.0	30.1	17.7	15.4	104.3
AHR	bHLHe76	ENSG00000106546	"Aryl hydrocarbon receptor"	P35869	7	16916359-17346152	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Cancer-related genes, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 262.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 71.0;hTERT-HME1: 73.8;OE19: 61.2;RT4: 63.2"									"CAB005072, HPA029722, HPA029723"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Cytosol	Nucleoplasm	"CAB005072: AB_633731, HPA029722: AB_10599189, HPA029723: AB_10599025"	"unprognostic (1.29e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.32e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.25e-2)"	"unprognostic (9.45e-2)"	22.3	15.0	1.4	25.8	2.7	44.1	19.5	1.4	2.8	14.5	2.3	13.7	16.4	8.8	7.0	17.4	10.5	33.7	9.5	1.9	1.3	7.1	45.0	37.6	15.4	5.4	1.9	6.9	5.8	6.6	3.0	17.7	3.9	11.0	16.3	4.0	10.5	11.2	2.2	22.0	14.5	15.2	2.8	18.7	25.2	2.9	2.7	9.7	12.7	6.5	19.8	49.5	15.0	5.8	8.2	6.6	2.6	0.0	19.2	13.1	1.2	16.5	23.9	7.5	10.8	8.2	17.5	0.0	5.0	24.4	29.7	21.8	1.6	15.1	19.7	0.4	3.6	4.8	8.1	7.3	35.5	8.1	11.5	18.1	71.0	28.8	73.8	33.8	25.3	0.0	0.7	0.2	34.3	4.2	0.0	12.6	2.1	61.2	10.3	0.0	0.0	0.3	23.5	63.2	2.4	0.0	12.4	13.0	12.5	19.0	9.4	2.7	4.3	3.1	0.1	40.7	0.0	3.3	0.1	0.0	51.6	30.6	51.9	0.8	5.6	4.2	0.5	2.6	0.7	0.6	1.7	1.0	6.9	0.7	0.9	0.7	0.6	2.1	1.0	1.6	2.1	1.7	1.4	2.7	1.4	2.8	1.9	1.3	5.4	1.9	3.9	2.8	2.7	5.8	78.3	150.6	76.2	1.6	15.2	75.3	47.6	67.9	104.2	37.0	23.4	30.0	14.7	34.3	84.9	7.3	8.4	3.3	13.6	23.9	0.0	19.3	6.2	39.1	8.4	78.1	5.4	8.6	18.0	15.7	1.8	57.0	56.1	78.8	133.1	0.6	52.1	48.3	24.4	43.7	39.2	12.9	30.5	88.4	262.6	3.2	3.7	107.1	71.2	8.4	70.1	0.9	5.2	1.5	40.6	33.3	19.8	2.6	16.7	48.6	9.9	6.8	51.3	6.1	6.6	14.8	37.8	2.8	2.2	38.3	89.2	21.5	54.7	3.3	19.3	116.1
AIDA	"C1orf80, FLJ12806"	ENSG00000186063	"Axin interactor, dorsalization associated"	Q96BJ3	1	222668013-222713210	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027935	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	No			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 41: Macrophages - Immune response"	Cytosol	"Microtubules, Cytokinetic bridge"	"HPA027935: AB_10602226"	"unprognostic (2.33e-1)"	"prognostic unfavorable (7.08e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.70e-2)"	72.3	36.1	53.6	39.1	63.8	21.9	40.2	57.1	66.5	47.8	47.1	50.0	25.3	36.1	56.1	45.2	31.3	40.8	45.8	51.7	62.0	39.3	49.0	46.2	51.2	63.0	58.4	40.6	32.5	32.5	21.4	47.8	62.8	35.1	36.1	19.4	28.0	42.1	28.4	26.6	28.9	54.2	58.9	37.4	28.2	44.3	58.5	33.8	37.5	49.7	52.9	47.2	31.2	69.6	74.3	56.2	65.5	70.4	181.2	169.9	71.4	135.7	145.0	95.1	87.0	64.3	62.0	39.5	67.2	161.7	73.4	44.8	81.4	89.9	115.4	59.6	30.0	50.4	64.2	61.9	95.2	62.5	28.4	104.0	78.9	113.4	108.9	102.4	117.8	49.6	77.1	54.3	180.8	27.6	40.9	38.4	163.6	83.9	118.8	43.8	183.9	57.9	110.9	49.7	43.1	72.1	91.0	53.4	83.8	100.3	43.5	38.5	94.1	127.4	62.9	124.9	162.7	40.3	80.4	35.2	118.1	38.7	128.0	5.7	2.8	2.9	5.7	4.4	4.8	14.2	7.2	6.2	2.5	13.8	7.4	5.8	1.6	3.5	5.0	7.2	10.2	4.1	53.6	63.8	57.1	66.5	51.7	62.0	63.0	58.4	62.8	58.9	58.5	69.6	80.2	22.4	49.9	6.5	57.9	32.5	36.2	19.8	20.5	18.8	20.8	18.0	8.6	27.1	18.7	33.1	33.3	20.6	46.5	19.0	29.4	38.6	20.4	27.1	48.9	52.4	36.1	46.7	8.9	37.9	55.0	52.6	12.8	46.6	3.8	32.4	43.9	36.9	31.5	23.5	11.1	22.4	22.4	37.8	40.2	23.8	60.3	42.5	37.4	30.9	58.9	32.1	38.1	10.6	10.0	51.1	19.8	50.8	32.1	61.2	24.4	54.4	32.8	13.8	32.9	66.1	43.9	35.3	17.9	26.6	30.3	9.0	28.0	32.0	17.8	33.7
AKIRIN2	"C6orf166, dJ486L4.2, FLJ10342"	ENSG00000135334	"Akirin 2"	Q53H80	6	87674860-87702233	"Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA064239			Supported	Nucleoplasm		No	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA064239: AB_2685222"	"unprognostic (9.65e-2)"	"unprognostic (2.56e-1)"	"unprognostic (8.25e-2)"	"unprognostic (8.09e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.62e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.02e-1)"	32.9	37.1	29.0	23.8	32.5	70.5	26.0	26.5	37.6	22.7	27.8	19.8	12.7	24.6	23.7	33.2	22.6	15.3	30.9	34.0	34.0	20.8	31.2	33.2	28.4	26.9	28.8	25.6	13.2	17.8	23.4	18.5	26.4	17.0	12.5	29.7	24.5	11.7	97.4	22.9	22.9	16.4	29.5	49.0	16.8	24.1	35.7	31.2	17.2	42.6	30.3	23.2	25.0	30.9	23.9	24.7	71.0	40.1	43.1	29.6	41.4	41.1	25.7	33.2	32.3	39.7	18.0	62.2	44.1	42.1	55.1	36.2	39.1	29.6	37.9	79.2	48.5	36.3	21.8	89.7	47.1	31.4	30.2	34.6	29.9	41.0	40.2	32.5	36.6	24.3	71.2	42.2	43.5	30.7	9.9	64.9	51.0	20.3	38.1	38.7	50.2	25.7	41.7	20.8	53.0	50.3	24.9	14.8	44.2	40.1	17.9	73.9	47.6	27.5	18.8	23.5	54.6	40.9	48.4	38.8	30.4	40.2	45.1	76.1	57.8	64.8	28.1	73.2	29.2	41.6	27.4	27.6	55.0	32.6	21.4	23.1	144.4	36.6	75.6	75.1	39.1	35.0	29.0	32.5	26.5	37.6	34.0	34.0	26.9	28.8	26.4	29.5	35.7	30.9	49.9	25.6	19.8	10.4	88.2	96.5	192.2	101.9	80.8	13.0	31.8	28.8	22.5	35.8	43.7	18.4	8.4	45.1	94.4	17.1	45.0	30.9	58.0	44.9	34.3	45.6	12.1	45.4	15.6	14.7	71.0	51.1	16.3	39.9	33.6	47.2	44.6	29.9	77.0	11.8	14.8	10.9	69.2	104.4	167.0	100.9	35.8	142.8	74.7	19.7	46.7	80.5	33.0	17.6	15.1	29.6	21.7	28.2	69.4	119.7	19.0	53.5	17.9	17.0	6.6	62.2	39.9	70.6	63.0	92.6	92.9	136.5	99.5	54.2	12.6	191.0
AMPD2	SPG63	ENSG00000116337	"Adenosine monophosphate deaminase 2"	Q01433	1	109616104-109632051	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 62.6;Horizontal cells: 52.2;Macrophages: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 19.4;eosinophil: 19.2;intermediate monocyte: 40.7;myeloid DC: 18.9;neutrophil: 61.1;non-classical monocyte: 44.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 18.9;granulocytes: 61.1;monocytes: 44.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027137, HPA045760"	Approved		Enhanced	Cytosol		NA	NA		230000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA027137: AB_2672129, HPA045760: AB_2679443"	"unprognostic (2.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.78e-10)"	"unprognostic (9.16e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	9.3	17.5	31.2	12.0	41.6	28.6	7.4	22.9	34.7	13.1	36.6	7.5	10.7	11.5	4.1	7.2	13.1	8.8	7.2	34.8	37.0	10.5	16.2	13.4	7.6	34.7	31.7	17.5	10.0	9.4	45.8	7.6	33.6	10.8	4.1	10.5	9.2	12.0	3.3	8.5	10.8	7.1	27.9	19.0	8.6	4.3	39.3	4.9	10.6	1.5	5.9	7.5	11.4	29.0	20.6	22.5	20.5	20.1	18.0	18.7	8.6	25.6	57.2	24.9	25.0	19.1	7.0	10.5	21.8	39.1	16.0	11.3	15.8	20.0	13.4	13.0	20.7	46.0	15.6	19.3	24.9	15.7	45.7	23.3	13.2	32.5	24.1	28.2	26.7	17.0	17.4	13.0	16.0	23.2	26.7	29.0	20.6	17.1	22.9	18.6	15.8	17.3	24.2	8.7	19.3	22.4	17.4	19.8	24.6	5.7	10.4	16.2	16.7	27.7	39.0	33.7	25.4	48.4	28.4	12.1	50.8	25.9	35.1	0.5	19.4	19.2	5.3	40.7	8.0	5.3	5.2	4.9	18.9	2.7	6.4	5.1	61.1	4.3	44.6	2.6	4.0	12.3	31.2	41.6	22.9	34.7	34.8	37.0	34.7	31.7	33.6	27.9	39.3	29.0	3.6	3.2	5.5	13.7	9.4	8.9	5.4	5.0	9.1	41.0	8.8	11.4	3.2	12.8	5.4	0.0	62.6	4.9	10.0	4.2	7.9	9.8	3.5	4.4	9.4	7.1	17.5	5.0	13.3	11.2	8.6	12.6	14.3	5.5	3.8	11.0	6.1	20.5	10.8	52.2	17.6	9.6	2.0	42.1	42.0	1.3	13.1	52.5	5.4	6.5	16.1	10.5	6.2	12.1	10.6	10.3	3.0	21.4	11.1	11.1	6.1	4.5	4.2	7.2	13.1	8.8	10.6	4.2	3.8	7.9	8.1	2.6	15.4	8.5	10.7	4.0
ANKRD20A3P	ANKRD20A3	ENSG00000276203	"Ankyrin repeat domain 20 family member A3, pseudogene"	Q5VUR7	9	66106815-66179474	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"testis: 2.0"	"Cell type enriched"	"Detected in single"	15	"Cardiomyocytes: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Karpas-707: 9.5;U-266/84: 3.7"									"HPA043239, HPA047112, HPA047167, HPA047766, HPA051753"	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592"					"unprognostic (4.27e-2)"													0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.7	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.4	0.2	0.1	0.0	0.1	0.1	0.0	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APAF1	"APAF-1, CED4"	ENSG00000120868	"Apoptotic peptidase activating factor 1"	O14727	12	98645290-98735433	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 32.0"	"Cell type enhanced"	"Detected in many"		"monocytes: 54.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 71.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031373, CAB069399"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"CAB069399: AB_1611908, HPA031373: AB_10602230"	"unprognostic (1.32e-1)"	"unprognostic (5.12e-2)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.21e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (5.63e-2)"	"unprognostic (6.04e-2)"	"unprognostic (9.93e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.07e-2)"	4.5	2.8	2.4	8.9	2.8	32.0	5.0	2.5	2.7	5.5	1.2	8.5	5.1	5.5	3.5	3.2	4.0	7.3	2.6	2.8	1.3	3.7	4.7	6.7	9.4	2.3	1.2	7.7	4.0	2.8	3.1	7.6	2.2	3.9	9.6	5.8	4.6	3.4	3.4	5.7	7.1	5.0	1.9	9.7	6.6	3.1	2.2	7.7	4.7	3.1	8.8	5.8	3.9	4.3	6.8	8.7	30.3	11.6	9.4	18.2	8.3	17.3	12.1	11.7	11.6	6.3	4.8	9.8	4.5	12.7	4.4	11.3	20.2	11.4	13.9	7.3	8.0	18.5	9.6	7.7	3.5	18.6	22.7	7.5	3.5	12.1	5.5	14.1	19.6	7.3	9.1	5.2	18.7	1.8	9.4	19.0	8.1	7.5	5.8	11.9	22.8	3.1	7.1	11.5	4.1	7.4	13.5	5.3	4.6	18.6	9.2	25.7	17.7	7.5	6.6	9.0	5.4	3.5	7.1	11.5	3.3	25.4	11.5	16.8	18.1	17.0	4.0	8.0	3.1	5.5	2.8	2.3	14.3	6.2	2.9	1.9	71.1	2.9	8.5	10.4	2.1	3.9	2.4	2.8	2.5	2.7	2.8	1.3	2.3	1.2	2.2	1.9	2.2	4.3	11.7	12.8	8.2	10.4	13.8	3.8	5.7	8.7	8.6	5.8	6.4	6.5	1.5	1.5	7.8	7.3	14.6	3.8	21.4	22.3	0.0	9.4	0.7	5.9	11.6	11.1	12.0	7.6	12.8	8.0	8.0	9.1	14.8	8.7	6.3	18.6	13.2	6.7	12.3	5.0	13.8	18.9	4.1	34.7	25.3	1.3	5.9	34.1	10.6	30.9	54.6	2.7	20.6	14.1	11.2	19.7	20.3	5.3	8.9	8.7	9.2	2.7	8.9	9.8	0.0	6.9	8.1	6.9	10.0	8.7	3.3	1.9	14.6	4.3	13.3	15.0
AQP9	"HsT17287, SSC1"	ENSG00000103569	"Aquaporin 9"	O43315	15	58138169-58185911	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"liver: 702.7"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 313.9;Macrophages: 82.1"	"Cancer enriched"	"Detected in many"	30	"liver cancer: 132.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 14.4"	"Immune cell enriched"	"Detected in many"	20	"neutrophil: 1161.4"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 1161.4"	"Cell line enriched"	"Detected in some"	29	"U-87 MG: 29.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA074762, CAB075684"	Enhanced					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"			"CAB075684: , HPA074762: AB_2732267"	"unprognostic (1.91e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.28e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.80e-3)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (5.72e-11)"	"unprognostic (8.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.39e-2)"	18.2	0.8	0.8	72.9	0.9	67.5	2.4	0.9	14.4	1.3	0.8	0.9	0.2	1.2	43.4	1.2	7.1	5.3	1.7	3.2	0.5	0.9	702.7	22.2	0.6	0.7	1.0	0.5	1.6	5.6	0.3	6.2	4.0	0.9	0.3	0.4	1.1	0.7	0.5	22.0	0.9	6.4	0.6	42.7	1.5	0.3	6.9	1.8	0.6	7.5	0.8	32.6	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	29.7	0.1	0.0	0.2	58.4	1.2	0.1	17.5	0.1	0.5	0.1	0.0	1.8	0.1	0.1	0.0	1161.4	0.3	23.0	0.6	0.3	18.9	0.8	0.9	0.9	14.4	3.2	0.5	0.7	1.0	4.0	0.6	6.9	0.8	0.7	0.0	12.2	0.3	2.3	0.4	0.2	0.0	0.0	0.0	0.1	0.0	1.1	5.7	3.1	0.0	0.0	0.3	0.5	0.0	0.0	0.1	2.1	0.3	0.1	0.7	0.0	13.9	2.4	0.2	0.9	1.9	0.0	1.8	7.6	0.0	7.9	313.9	40.8	0.0	0.8	0.0	0.0	28.5	6.2	1.9	0.3	82.1	0.0	0.0	18.9	0.0	1.0	0.5	0.2	0.5	0.0	0.0	0.7	0.2	0.0	0.3	1.5	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.6	0.8	1.5	0.0	0.0	0.1
AREG	"AREGB, SDGF"	ENSG00000109321	Amphiregulin	P15514	4	74445136-74455005	"Cancer-related genes, Human disease related genes, Predicted membrane proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 129.9;placenta: 328.8;urinary bladder: 145.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1119.1;Basal prostatic cells: 1254.3;Macrophages: 1271.1;Paneth cells: 909.8;Urothelial cells: 2102.9"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 67.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"basophil: 11.0;eosinophil: 11.8;NK-cell: 3.8"	"Group enriched"	"Detected in many"	10	"granulocytes: 11.8;NK-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 379.0;HBEC3-KT: 648.1;hTCEpi: 644.0;hTERT-HME1: 1365.7;MCF7: 416.8"	"Region enriched"	"Detected in single"	4	"olfactory bulb: 1.2"	"Low region specificity"	"Detected in many"			"HPA008720, CAB023519"	Approved		Approved	Mitochondria		NA	NA	1520000		"Cluster 2: Granulocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB023519: AB_2060673, HPA008720: AB_1844978"	"unprognostic (1.44e-2)"	"unprognostic (1.84e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.90e-1)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (8.32e-5)"	"unprognostic (2.56e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.40e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.83e-3)"	48.1	4.6	0.1	36.7	0.1	129.9	61.6	0.1	0.8	19.2	1.8	18.7	3.3	3.7	0.2	43.4	13.2	74.1	20.5	0.3	0.1	2.5	4.0	36.1	1.9	0.3	0.2	12.4	4.5	1.5	9.5	328.8	0.8	6.5	18.9	0.1	11.7	0.7	18.4	15.3	10.2	6.5	0.2	10.0	20.2	9.3	0.4	7.1	5.4	0.8	3.0	145.6	13.8	0.4	15.9	107.3	0.0	0.0	0.9	1.4	0.0	3.2	5.0	0.7	2.9	379.0	59.8	0.0	8.0	0.0	0.0	17.4	0.1	648.1	6.5	0.1	0.0	0.4	2.8	18.0	191.9	2.3	0.4	5.9	644.0	37.8	1365.7	0.9	0.2	0.4	1.6	0.7	14.4	416.8	0.2	0.0	0.0	78.6	42.8	0.0	0.1	0.1	36.4	2.9	0.5	0.2	22.2	1.2	0.0	0.4	11.6	0.1	1.0	0.0	15.3	5.3	0.1	0.9	0.0	0.1	0.0	0.0	1.7	11.0	0.0	11.8	0.0	0.0	0.0	0.2	0.4	0.0	0.8	0.3	0.2	0.0	0.1	3.8	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.3	0.1	0.3	0.2	0.8	0.2	0.4	0.4	670.0	198.7	301.9	0.0	190.7	1119.1	1254.3	73.0	303.9	0.0	801.5	460.2	49.0	62.9	183.9	51.5	0.0	1.8	836.1	878.0	0.0	61.8	70.4	167.7	12.3	32.2	41.6	18.5	0.0	10.2	1.5	80.8	254.9	193.1	680.5	0.9	10.8	4.2	32.2	0.0	0.5	393.5	8.2	250.4	196.4	12.1	0.3	1271.1	33.8	0.0	1.7	0.8	20.6	0.0	0.0	497.1	909.8	1.2	352.1	115.3	55.7	0.7	53.3	0.2	19.7	10.3	20.2	68.3	51.1	194.5	342.4	1.1	473.6	1.2	308.9	2102.9
ARL8B	"ARL10C, FLJ10702, Gie1"	ENSG00000134108	"ADP ribosylation factor like GTPase 8B"	Q9NVJ2	3	5122249-5180911	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 249.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038759, HPA040515, HPA045924"	Approved					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA038759: AB_2676193, HPA040515: AB_2677017, HPA045924: AB_2679500"	"unprognostic (1.37e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.90e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.08e-1)"	"prognostic unfavorable (3.68e-6)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.96e-1)"	"prognostic favorable (4.84e-6)"	"unprognostic (5.90e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.95e-2)"	41.7	51.1	53.6	36.1	58.4	59.7	42.4	55.4	73.2	39.5	38.3	33.8	30.7	45.1	39.8	65.8	31.1	38.7	55.2	59.7	58.6	53.8	43.9	43.6	38.7	57.2	54.3	38.9	27.5	48.1	0.1	49.8	59.2	45.0	34.8	34.3	28.6	41.8	50.7	54.8	34.3	47.0	60.3	33.9	34.1	32.2	59.5	35.8	62.1	59.9	47.5	49.7	0.3	61.7	49.5	44.1	38.5	20.7	118.4	103.8	71.7	67.8	75.5	64.0	75.8	33.6	44.9	52.6	29.4	65.7	141.4	30.6	61.9	60.1	73.2	58.3	35.8	86.2	34.3	48.4	162.5	73.9	97.0	96.7	179.5	80.9	56.2	67.4	72.2	47.2	76.6	55.0	96.2	45.1	63.0	56.1	36.2	44.6	65.2	43.5	52.2	46.7	63.9	73.8	22.1	41.9	57.7	112.5	96.2	42.7	66.0	219.7	61.6	66.5	55.8	91.9	62.3	50.8	88.0	143.9	94.4	102.7	54.9	42.9	37.8	24.5	18.8	33.0	22.4	19.8	19.6	18.8	31.7	16.7	20.0	20.0	17.0	22.1	27.4	14.2	20.3	27.7	53.6	58.4	55.4	73.2	59.7	58.6	57.2	54.3	59.2	60.3	59.5	61.7	35.8	80.1	63.7	52.9	42.9	128.1	60.5	40.4	74.6	23.3	44.4	31.4	55.6	31.5	45.2	35.0	10.4	42.4	30.4	38.9	19.6	37.2	33.7	45.9	39.8	35.9	13.1	35.1	61.6	37.6	80.1	48.7	33.6	88.5	56.4	25.3	19.2	42.4	97.8	8.4	68.3	19.5	24.4	68.3	249.6	42.0	23.0	109.3	55.2	47.8	103.3	37.2	23.7	47.7	86.0	61.5	26.7	33.8	45.4	71.5	23.2	46.1	40.6	22.7	72.3	31.7	45.7	34.5	24.0	109.5	164.7	173.1	36.8	23.8	16.6	123.3
ARRDC2	"CLONE24945, PP2703"	ENSG00000105643	"Arrestin domain containing 2"	Q8TBH0	19	18001132-18014102	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 204.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 114.2;B-cells: 80.3;Cholangiocytes: 64.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 57.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053788, HPA074216"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA053788: AB_2682262, HPA074216: "	"unprognostic (8.10e-2)"	"prognostic favorable (5.93e-4)"	"unprognostic (2.20e-3)"	"unprognostic (8.67e-2)"	"unprognostic (4.81e-3)"	"unprognostic (4.26e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.40e-2)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (1.16e-1)"	"unprognostic (8.37e-2)"	"unprognostic (4.87e-3)"	"unprognostic (7.26e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (6.91e-4)"	"prognostic favorable (2.92e-4)"	65.8	10.7	50.9	23.7	61.3	80.0	49.8	52.9	67.2	31.7	34.2	30.8	12.2	22.8	7.7	22.1	27.7	22.8	34.4	43.2	48.4	32.9	20.4	75.0	38.7	64.7	61.1	13.7	16.5	71.6	17.2	14.4	58.0	33.6	12.1	1.3	44.2	18.8	204.8	30.7	43.4	11.1	50.4	58.4	27.7	5.2	53.1	24.8	44.0	49.3	35.0	32.6	32.0	81.3	12.1	21.2	0.4	10.6	8.5	7.8	8.4	6.8	19.3	5.6	5.5	4.8	22.9	22.1	18.9	5.8	9.1	7.9	8.4	6.2	4.4	14.5	12.3	16.8	18.0	6.8	7.8	12.9	24.0	8.4	9.6	6.5	9.9	10.5	9.6	13.9	19.7	0.6	5.4	18.4	9.8	35.6	2.7	26.4	34.9	57.7	0.2	16.8	8.1	11.0	5.0	5.2	11.1	11.0	11.5	1.7	6.7	32.5	21.1	9.7	7.5	32.9	8.6	1.6	0.1	24.8	15.5	48.6	7.7	3.7	5.8	3.6	3.6	4.8	2.5	3.4	6.1	4.6	3.0	5.3	14.1	7.5	2.3	6.6	5.7	1.8	5.1	4.4	50.9	61.3	52.9	67.2	43.2	48.4	64.7	61.1	58.0	50.4	53.1	81.3	114.2	16.0	15.5	1.6	80.3	6.4	19.8	14.0	13.1	0.4	16.7	11.0	7.3	64.3	15.8	9.2	0.0	0.7	47.7	12.7	1.9	10.8	0.8	10.7	13.0	29.9	18.5	44.6	3.8	6.2	7.8	9.2	23.4	29.8	26.6	3.3	17.2	7.0	17.9	0.0	0.5	12.3	16.2	31.0	58.7	1.2	4.7	50.3	5.4	9.4	14.5	1.1	13.4	0.5	20.0	15.4	9.4	7.5	13.6	24.9	3.5	0.5	15.9	0.4	13.1	14.0	15.9	0.5	3.9	7.6	7.1	1.2	38.6	5.0	5.6	26.7
ARRDC3	"KIAA1376, TLIMP"	ENSG00000113369	"Arrestin domain containing 3"	Q96B67	5	91368631-91383317	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 394.2;Syncytiotrophoblasts: 339.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 115.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"				"unprognostic (2.28e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.25e-8)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.15e-1)"	36.8	80.1	16.9	26.8	22.6	167.4	94.6	23.7	32.5	44.8	24.0	19.9	9.9	40.5	27.1	38.7	24.9	39.0	24.7	16.3	20.1	52.7	75.9	44.5	29.3	27.8	20.2	93.2	20.8	54.3	21.5	76.8	22.3	30.3	27.5	75.1	63.9	24.3	34.2	41.3	16.8	33.0	23.8	37.1	25.7	16.6	18.1	28.0	84.0	44.9	28.2	57.0	42.0	41.9	6.6	10.7	12.1	16.6	18.4	31.0	40.2	15.8	14.7	9.3	16.2	5.2	26.9	7.9	13.0	16.2	26.1	14.6	13.4	13.3	8.5	8.2	1.4	3.9	43.3	8.5	14.3	27.9	1.6	13.3	21.2	8.1	20.9	56.4	26.1	7.6	11.5	37.7	14.4	3.7	29.9	4.1	4.3	2.8	11.3	24.8	15.2	41.5	60.4	11.9	21.1	14.0	48.2	3.7	2.9	30.2	17.9	13.1	28.3	7.7	11.2	12.4	9.6	28.6	40.9	16.1	45.8	16.4	8.7	28.7	15.2	20.4	29.1	13.1	21.1	12.3	18.3	22.8	9.3	9.4	24.0	37.7	115.3	14.9	22.2	2.2	21.9	19.9	16.9	22.6	23.7	32.5	16.3	20.1	27.8	20.2	22.3	23.8	18.1	41.9	53.8	51.3	166.5	6.5	47.0	112.0	17.6	51.2	9.1	30.9	89.5	48.5	34.5	20.0	72.4	97.5	31.3	89.9	110.2	21.2	154.6	72.6	27.1	28.9	43.1	143.3	73.0	37.1	10.5	79.5	81.6	95.7	38.7	51.4	37.3	36.4	37.5	155.1	48.7	32.0	15.5	32.4	10.2	106.9	394.2	22.3	21.1	100.3	120.9	14.0	56.6	97.0	50.4	13.6	28.3	41.2	16.1	15.1	58.8	31.2	9.3	57.3	28.5	67.2	19.7	32.1	54.9	8.1	9.6	55.6	118.3	339.4	66.3	23.4	20.2	22.7
ASCL4	"bHLHa44, HASH4"	ENSG00000187855	"Achaete-scute family bHLH transcription factor 4"	Q6XD76	12	107774385-107776644	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Langerhans cells: 3.1"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA036116	Uncertain					NA	NA						"Cluster 41: Macrophages - Immune response"			"HPA036116: AB_10671833"	"unprognostic (2.20e-1)"	"unprognostic (1.53e-4)"			"unprognostic (1.86e-2)"	"unprognostic (8.88e-4)"		"unprognostic (2.09e-5)"	"unprognostic (1.40e-1)"		"unprognostic (1.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.90e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATF6	ATF6A	ENSG00000118217	"Activating transcription factor 6"	P18850	1	161766298-161977574	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005935	Approved					NA	NA		46000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"			"HPA005935: AB_2667472"	"unprognostic (1.31e-1)"	"unprognostic (5.15e-3)"	"unprognostic (3.18e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.59e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.38e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.57e-3)"	13.6	10.1	7.2	13.9	8.4	12.6	11.5	8.3	7.5	8.4	13.6	9.9	9.9	10.6	18.9	11.0	8.9	11.3	9.4	7.2	9.9	14.6	22.0	11.4	10.6	10.2	9.4	9.0	34.4	18.9	7.1	18.0	10.5	10.7	11.2	16.7	13.3	10.3	8.9	11.2	9.4	12.8	10.0	11.3	11.2	10.1	8.0	8.4	15.1	9.5	11.1	13.7	7.9	11.9	23.3	17.9	15.1	22.4	18.6	17.7	26.7	27.8	25.3	17.7	19.2	11.6	38.2	16.9	39.6	34.6	19.9	34.0	15.1	18.6	17.6	23.2	12.9	15.9	22.6	12.7	40.3	29.7	40.6	18.3	29.0	18.2	53.3	23.8	40.3	22.7	37.9	19.2	19.3	23.0	15.9	17.3	12.2	24.5	23.1	13.7	21.4	39.2	19.3	11.1	9.1	13.8	33.3	19.8	41.0	32.9	24.5	39.2	54.4	23.2	21.9	8.7	31.5	28.0	29.2	20.4	28.2	5.1	29.0	9.7	17.8	12.0	9.2	18.3	9.0	8.7	8.3	7.7	12.8	9.5	9.5	9.7	33.2	7.4	24.4	5.7	9.6	10.6	7.2	8.4	8.3	7.5	7.2	9.9	10.2	9.4	10.5	10.0	8.0	11.9	40.5	102.5	85.1	41.8	31.4	34.8	45.4	28.4	18.2	38.6	38.0	25.4	21.6	25.8	67.0	51.5	50.1	49.2	23.2	30.5	7.9	45.9	13.0	27.1	25.3	49.8	37.1	17.9	79.9	37.6	43.1	46.2	23.9	40.2	54.3	24.0	37.5	53.5	50.3	26.9	69.7	28.2	30.5	59.5	59.4	10.8	23.0	66.6	26.6	103.0	62.0	34.1	21.6	60.3	105.8	35.9	15.6	24.5	53.9	43.3	22.3	18.8	61.7	29.9	6.6	61.3	31.8	43.1	30.5	22.7	47.7	103.0	29.0	22.1	22.9	44.1
ATP13A3	AFURS1	ENSG00000133657	"ATPase 13A3"	Q9H7F0	3	194402672-194498364	"Predicted membrane proteins"		Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 384.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029471	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoli	"Plasma membrane, Cytosol"	"HPA029471: AB_10600784"	"unprognostic (5.07e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.77e-1)"	38.0	22.5	8.5	32.0	9.3	36.9	22.8	12.2	14.8	17.0	18.4	21.2	20.2	18.9	17.0	18.0	17.4	24.2	55.7	10.4	9.3	36.2	87.0	35.5	20.8	9.7	8.4	15.9	16.4	50.3	15.3	54.8	9.1	15.5	22.0	11.6	21.8	15.2	17.0	11.5	16.6	16.9	9.5	16.9	24.4	9.6	12.8	16.3	46.0	14.4	19.4	40.1	16.3	10.1	184.6	19.3	33.0	35.2	49.7	64.9	96.8	62.7	75.4	74.9	132.5	114.1	45.2	74.2	161.1	89.4	197.9	64.2	37.5	66.9	171.4	175.5	31.4	43.1	24.8	31.7	77.1	139.7	91.6	32.6	36.8	127.8	89.0	105.0	38.0	34.9	46.2	139.1	90.7	41.0	53.9	34.8	41.1	64.5	33.5	40.0	77.1	48.8	71.6	53.4	52.4	30.5	64.1	77.9	52.9	31.2	127.7	92.4	37.1	81.2	64.2	162.1	116.5	93.4	141.2	116.6	149.3	80.6	55.7	0.2	0.4	0.4	0.4	0.6	0.5	0.4	0.4	0.7	0.6	0.2	0.5	0.5	0.0	0.6	0.2	0.3	1.0	0.2	8.5	9.3	12.2	14.8	10.4	9.3	9.7	8.4	9.1	9.5	12.8	10.1	56.6	51.3	34.1	51.6	22.3	82.5	49.1	42.1	21.1	25.9	32.1	16.6	50.0	78.6	35.9	49.7	20.9	29.6	26.6	43.7	3.9	66.6	2.0	52.3	65.4	50.5	30.6	23.5	61.8	71.4	19.0	53.2	42.8	181.8	8.8	27.9	68.9	153.2	37.2	15.2	80.6	24.1	26.4	31.1	384.4	2.3	10.2	110.1	62.2	76.8	27.0	8.4	18.6	64.3	49.6	87.8	23.7	13.2	37.8	94.3	11.6	41.4	31.7	13.6	13.1	35.8	42.4	15.2	6.8	36.5	71.2	64.6	24.4	14.1	24.7	69.9
ATP1B3	"CD298, FLJ29027"	ENSG00000069849	"ATPase Na+/K+ transporting subunit beta 3"	P54709	3	141876124-141926549	"CD markers, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 982.6;Late spermatids: 930.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020697, HPA048963"	Enhanced		Supported	"Plasma membrane"		NA	NA		33000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB020697: , HPA048963: AB_2680574"	"unprognostic (2.31e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.75e-1)"	"prognostic favorable (5.19e-5)"	"unprognostic (2.60e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (8.11e-3)"	"unprognostic (6.99e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.29e-5)"	"unprognostic (5.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.19e-3)"	"unprognostic (6.15e-2)"	229.4	349.6	62.2	81.0	62.8	63.0	87.0	78.5	78.8	98.4	100.5	146.7	112.7	75.7	37.6	182.3	96.2	55.4	102.8	63.6	74.7	128.4	24.5	191.0	41.3	71.1	66.6	180.0	36.7	20.3	168.7	96.7	76.5	102.0	168.0	43.6	85.8	46.2	26.7	259.3	125.0	71.4	68.7	65.7	66.3	75.8	70.6	51.4	75.8	16.0	57.1	101.0	161.2	62.2	280.8	170.1	155.5	145.6	411.7	118.0	354.7	322.2	287.6	224.2	252.1	253.7	136.5	223.3	278.2	243.5	328.4	595.8	157.0	152.2	253.4	120.4	190.0	195.7	161.4	156.8	161.7	164.9	149.1	126.5	355.1	179.1	169.7	162.4	245.7	156.3	135.9	193.7	233.8	114.6	165.6	275.0	213.6	384.5	76.1	225.0	116.4	227.1	191.1	186.7	127.6	86.0	413.2	188.5	455.9	270.7	145.6	197.2	170.7	196.4	76.3	298.8	189.8	138.0	197.6	367.5	259.5	176.5	165.2	69.7	104.1	35.4	70.4	174.3	51.7	39.7	56.3	74.8	103.3	30.4	32.6	59.6	6.7	32.0	260.4	64.8	68.4	103.7	62.2	62.8	78.5	78.8	63.6	74.7	71.1	66.6	76.5	68.7	70.6	62.2	114.7	57.7	41.9	38.2	143.4	492.8	428.3	535.9	326.7	35.9	53.0	46.4	19.7	17.2	177.6	220.7	25.0	281.3	464.5	982.6	41.1	73.9	465.9	86.0	72.2	199.2	56.1	147.1	107.5	60.6	226.8	164.1	24.5	127.2	130.7	94.3	100.6	9.0	305.9	25.2	91.2	65.2	164.8	148.0	678.3	930.5	84.8	455.3	222.3	37.5	364.8	46.3	75.2	46.3	54.7	70.6	321.1	68.4	153.1	396.5	413.3	41.5	33.3	28.4	124.9	99.5	265.2	69.0	200.2	178.4	414.4	391.4	216.1	122.2	134.9	370.2
ATP2B1	PMCA1	ENSG00000070961	"ATPase plasma membrane Ca2+ transporting 1"	P20020	12	89588049-89709300	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 106.8"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 781.6;Langerhans cells: 435.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 314.6;LHCN-M2: 501.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005605, HPA011166, HPA012945"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB005605: AB_2061563, HPA011166: AB_1855484, HPA012945: AB_1855483"	"unprognostic (6.78e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (7.74e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.82e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	18.5	11.2	33.0	25.6	92.0	106.8	19.6	14.0	59.1	18.8	0.0	33.1	40.8	18.2	12.1	14.7	18.6	25.2	11.0	52.7	4.9	16.4	22.7	21.3	29.2	0.0	14.4	13.1	17.1	21.5	11.0	27.3	0.0	13.9	32.3	71.2	11.5	14.9	24.4	26.0	30.1	19.7	0.0	30.7	29.0	23.0	10.9	18.4	14.4	24.1	28.8	37.0	10.6	34.9	24.0	117.8	45.5	22.1	64.5	102.2	20.9	71.2	232.6	67.5	106.8	47.7	21.6	46.8	4.9	99.3	77.6	21.0	40.3	19.7	187.5	16.2	46.9	16.6	39.8	41.9	209.6	70.7	26.6	85.0	36.9	210.8	314.6	78.9	17.5	17.6	27.9	16.6	501.1	37.6	22.1	30.1	35.6	32.9	55.6	31.1	146.4	19.7	64.4	108.5	42.9	23.4	82.6	22.9	20.2	91.7	33.9	7.8	12.5	181.8	29.4	67.6	78.9	12.7	21.2	49.1	82.6	19.6	41.0	9.4	39.4	22.3	20.9	42.5	26.4	84.5	36.3	26.8	51.3	84.4	13.2	16.8	127.1	27.0	86.1	9.0	53.7	21.8	33.0	92.0	14.0	59.1	52.7	4.9	0.0	14.4	0.0	0.0	10.9	34.9	46.0	44.8	46.0	90.8	226.4	201.6	71.0	29.3	76.2	370.9	30.9	109.7	20.3	45.8	30.0	53.3	154.3	176.8	139.8	181.5	1.9	27.6	2.3	29.3	61.0	63.6	91.6	31.5	781.6	28.5	42.1	91.6	44.9	59.4	31.6	45.5	49.6	39.5	193.5	302.9	279.1	30.7	16.2	116.0	435.1	9.6	29.2	285.4	55.2	126.5	157.1	96.4	50.4	193.5	91.9	25.5	80.6	32.0	133.9	54.7	75.0	22.1	20.6	113.3	32.9	97.0	69.5	44.5	130.7	30.4	204.7	228.8	125.1	76.0	65.9	90.2
AZIN1	"OAZI, OAZIN, ODC1L"	ENSG00000155096	"Antizyme inhibitor 1"	O14977	8	102826308-102893864	"Predicted intracellular proteins"	"Polyamine biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 261.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027948	Approved		Approved	Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA027948: AB_10602391"	"unprognostic (1.16e-2)"	"unprognostic (4.81e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.07e-3)"	"unprognostic (4.33e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.68e-1)"	61.7	48.1	45.7	48.1	50.3	141.1	57.8	44.8	51.2	55.3	43.5	49.1	66.6	44.4	30.3	52.7	64.0	43.6	51.5	51.9	50.5	39.4	78.0	40.1	58.1	48.1	48.2	38.7	136.6	38.3	31.6	82.8	48.1	52.5	53.6	57.8	47.7	49.5	41.9	32.7	80.8	44.5	53.8	35.9	52.2	35.7	46.7	58.6	67.5	30.9	60.6	62.3	27.3	60.0	320.4	81.7	129.0	92.6	122.7	83.3	77.6	145.4	168.5	103.5	106.8	87.1	217.5	148.0	111.0	121.9	64.3	119.5	113.8	114.5	165.8	244.7	57.4	147.4	30.1	72.3	156.0	81.0	120.7	58.9	136.1	72.5	182.4	92.2	72.8	86.0	112.6	124.0	165.2	92.6	201.8	59.3	144.9	239.3	123.0	87.3	136.5	84.2	108.2	146.7	208.2	327.3	49.1	100.0	144.3	209.9	131.7	84.7	85.9	83.2	83.9	135.7	118.6	122.3	104.2	207.4	98.3	120.1	117.0	73.3	57.7	68.0	31.2	64.1	36.7	43.7	40.8	29.9	55.9	27.5	33.1	32.1	68.5	40.1	64.5	44.3	50.0	65.7	45.7	50.3	44.8	51.2	51.9	50.5	48.1	48.2	48.1	53.8	46.7	60.0	56.3	60.9	27.7	30.0	59.6	93.8	121.1	52.8	93.4	31.5	64.0	39.8	46.3	28.6	52.8	42.3	37.5	148.7	54.0	48.4	52.8	39.6	62.6	95.1	37.9	34.9	84.9	62.7	35.9	50.5	55.0	55.5	59.1	85.4	68.5	31.9	33.5	65.0	54.7	23.5	31.9	77.3	63.1	72.8	127.2	107.9	49.7	86.0	64.0	23.4	53.0	50.4	32.0	30.2	23.7	66.6	44.0	32.4	97.6	106.7	114.6	52.6	167.6	42.3	19.7	36.0	57.1	34.5	30.7	90.8	82.3	261.9	71.6	26.2	66.0	117.0
BACH1	"BACH-1, BTBD24"	ENSG00000156273	"BTB domain and CNC homolog 1"	O14867	21	29194071-29630751	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 89.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 164.4;Late spermatids: 422.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 150.2"	"Group enriched"	"Detected in all"	4	"granulocytes: 150.2;monocytes: 51.1"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 129.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034949	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA034949: AB_2674376"	"unprognostic (1.57e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.99e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.79e-3)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.19e-2)"	"unprognostic (8.70e-2)"	15.8	12.1	12.3	27.8	13.3	89.4	13.3	27.6	16.0	18.1	9.9	13.4	17.4	19.8	9.7	23.0	9.1	26.1	13.2	10.5	19.5	16.0	30.5	21.4	16.9	23.0	28.4	11.6	17.2	8.3	3.3	50.6	31.0	13.3	13.2	12.0	17.4	8.6	26.3	23.3	17.4	15.9	14.2	20.7	13.5	27.3	16.6	14.2	12.6	12.8	14.8	29.8	13.1	12.3	21.5	8.6	26.1	6.8	20.2	57.7	16.3	23.0	55.0	21.8	24.3	18.1	28.9	25.5	18.0	21.1	22.7	11.1	15.7	30.9	38.6	21.3	13.3	78.7	18.9	18.6	26.8	22.8	28.1	30.3	46.4	42.8	63.4	25.7	11.7	13.9	40.6	129.7	30.2	7.6	19.5	13.0	40.3	8.4	8.9	19.8	61.8	33.1	11.5	16.8	10.8	12.2	12.6	23.5	29.0	26.0	17.1	27.1	29.6	21.3	29.4	23.1	11.8	74.9	51.9	26.9	17.3	27.8	64.9	72.4	51.1	38.6	5.0	40.1	4.1	10.3	8.3	4.3	24.9	13.7	11.9	6.0	150.2	7.1	46.0	6.0	14.8	15.3	12.3	13.3	27.6	16.0	10.5	19.5	23.0	28.4	31.0	14.2	16.6	12.3	31.9	28.9	15.3	12.1	90.6	59.0	53.2	17.9	19.4	16.6	18.3	15.1	20.7	15.7	23.1	14.7	18.8	13.7	33.0	30.7	7.9	19.8	164.4	32.2	45.9	26.0	30.9	33.0	5.1	16.6	15.7	31.3	30.5	64.1	48.6	13.6	22.1	20.9	22.0	13.5	36.9	24.7	12.2	57.1	113.8	422.4	13.4	113.8	21.4	68.4	109.1	10.2	24.7	33.7	25.0	28.2	38.2	14.3	87.8	50.7	25.5	12.8	15.7	12.6	32.9	54.7	36.6	31.5	28.4	34.7	58.1	39.7	31.3	17.4	11.7	48.4
BASP1	"CAP-23, CAP23, NAP-22, NAP22"	ENSG00000176788	"Brain abundant membrane attached signal protein 1"	P80723	5	17065598-17276843	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 486.3;epididymis: 303.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 345.6;Extravillous trophoblasts: 362.9;Langerhans cells: 489.4;Muller glia cells: 796.9;Syncytiotrophoblasts: 738.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 128.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 128.5"	"Cell line enhanced"	"Detected in many"		"GAMG: 467.0;HeLa: 800.8;SiHa: 830.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045218, HPA050333"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		63000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"HPA045218: AB_2679263, HPA050333: AB_2681090"	"unprognostic (3.35e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (5.25e-11)"	"unprognostic (1.95e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.70e-1)"	35.3	13.8	235.9	73.6	257.0	87.6	14.0	103.0	486.3	56.9	79.9	12.5	7.3	37.3	303.3	10.9	11.4	29.2	13.9	247.3	210.9	15.1	17.2	36.5	80.9	134.7	153.1	36.6	3.7	3.4	21.2	92.1	184.3	79.7	10.8	74.3	13.2	21.6	2.3	22.0	22.2	33.4	107.7	76.5	22.7	2.9	157.1	24.1	11.3	6.8	91.5	57.9	27.3	281.8	0.1	125.6	152.7	0.2	71.7	76.1	227.1	161.7	50.9	127.9	135.0	6.1	0.1	51.3	22.4	112.0	467.0	10.6	98.2	109.2	164.8	21.3	57.9	0.4	800.8	0.3	158.9	101.3	1.4	131.2	132.7	145.6	121.0	163.9	140.1	0.2	0.4	0.5	138.2	183.7	0.3	92.5	115.7	0.3	39.6	0.1	0.5	28.0	46.5	31.3	99.3	21.3	830.7	72.3	0.2	336.5	0.3	101.9	187.7	169.3	0.6	14.2	26.1	1.7	0.2	27.1	171.2	123.0	23.1	25.0	3.1	25.3	0.0	1.5	0.0	5.4	0.0	0.0	4.9	7.9	0.0	0.0	128.5	1.8	2.1	0.5	0.3	0.8	235.9	257.0	103.0	486.3	247.3	210.9	134.7	153.1	184.3	107.7	157.1	281.8	8.0	9.6	4.8	22.2	158.7	215.9	88.0	21.3	58.1	54.8	9.8	10.2	1.6	0.0	15.8	9.2	12.5	155.0	3.8	0.6	0.0	0.6	0.9	98.4	345.6	30.2	0.0	18.1	254.0	3.4	362.9	102.6	23.4	156.4	27.3	18.1	35.7	2.5	53.8	244.0	125.3	0.7	12.2	227.9	489.4	0.0	0.6	298.5	28.4	53.4	275.1	796.9	1.0	115.1	23.7	1.0	0.2	0.0	173.0	121.0	0.0	0.3	93.5	58.4	0.0	2.0	66.2	0.4	3.4	21.0	58.8	738.5	11.9	8.3	1.8	13.2
BATF3	"JDP1, JUNDM1, SNFT"	ENSG00000123685	"Basic leucine zipper ATF-like transcription factor 3"	Q9NR55	1	212686417-212699840	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 9.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 41.0;Langerhans cells: 50.4;Macrophages: 24.4;monocytes: 65.7;Smooth muscle cells: 20.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 65.9;myeloid DC: 55.3;non-classical monocyte: 99.3"	"Group enriched"	"Detected in many"	34	"dendritic cells: 55.3;monocytes: 99.3"	"Cell line enriched"	"Detected in many"	11	"HDLM-2: 497.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA075858			Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA075858: "	"unprognostic (3.87e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.29e-2)"	"unprognostic (6.85e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.84e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.43e-10)"	"unprognostic (9.88e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.08e-2)"	5.9	1.1	1.9	3.6	2.9	3.0	3.0	1.4	2.8	1.8	9.1	1.7	0.6	1.3	0.0	1.1	2.0	2.0	2.1	2.2	1.9	5.1	1.1	5.8	5.9	1.8	1.8	0.6	1.7	0.4	0.9	2.5	1.9	1.8	0.6	0.0	0.9	0.4	0.5	0.9	2.3	1.8	2.3	7.3	1.5	0.5	1.7	4.2	1.6	0.6	2.6	4.9	1.4	2.0	2.4	6.6	0.7	0.0	0.2	3.1	4.3	2.3	7.4	6.5	7.0	0.0	1.7	0.0	0.9	0.4	10.6	0.0	7.0	1.1	4.5	497.4	12.5	0.1	1.9	0.0	1.2	22.6	3.9	0.5	0.0	12.5	1.8	1.0	0.1	43.5	1.1	6.5	1.3	0.0	17.8	9.3	2.7	0.0	8.4	3.5	2.4	0.3	6.0	0.0	1.4	0.9	1.6	0.0	0.5	2.3	0.0	17.8	0.0	2.7	11.1	0.5	13.4	0.5	1.4	2.7	8.7	21.3	6.2	0.0	13.6	0.0	0.0	65.9	0.0	0.7	0.2	0.3	55.3	0.0	0.0	0.0	2.2	1.5	99.3	0.2	1.8	8.8	1.9	2.9	1.4	2.8	2.2	1.9	1.8	1.8	1.9	2.3	1.7	2.0	9.6	3.2	0.6	0.3	2.4	5.7	2.3	0.9	0.0	0.2	5.2	5.5	0.5	0.0	1.6	0.0	0.0	2.1	0.7	0.0	0.0	0.7	0.7	1.5	3.1	8.2	0.0	0.4	4.5	0.4	41.0	6.8	0.0	2.3	5.1	1.0	6.1	0.4	5.8	0.0	0.6	0.1	0.0	14.4	50.4	0.8	0.9	24.4	1.8	7.5	65.7	0.1	0.0	0.5	0.9	1.1	0.0	0.0	0.0	18.9	0.0	0.4	2.7	0.4	0.0	5.2	20.0	1.0	4.1	0.1	2.8	4.5	1.9	0.1	0.0	1.4
BCL2A1	"ACC-1, ACC-2, ACC1, ACC2, BCL2L5, BFL1, GRS, HBPA1"	ENSG00000140379	"BCL2 related protein A1"	Q16548	15	79960892-79971196	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"bone marrow: 617.3"	"Group enriched"	"Detected in many"	5	"B-cells: 177.4;granulocytes: 220.7;Hofbauer cells: 214.9;Langerhans cells: 508.2;Macrophages: 604.2;monocytes: 386.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 39.4"	"Group enriched"	"Detected in all"	4	"cerebral cortex: 39.7;pons: 12.5"	"Group enriched"	"Detected in all"	5	"eosinophil: 284.0;intermediate monocyte: 195.8;neutrophil: 534.0;non-classical monocyte: 378.9"	"Group enriched"	"Detected in all"	7	"granulocytes: 534.0;monocytes: 378.9"	"Cell line enriched"	"Detected in many"	5	"SK-MEL-30: 525.0"					"Low region specificity"	"Detected in single"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"				"unprognostic (3.19e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.54e-3)"	"unprognostic (9.65e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-2)"	"unprognostic (4.01e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.87e-1)"	28.6	1.7	2.5	105.1	2.7	617.3	4.3	2.8	39.7	4.3	4.3	5.9	4.6	2.8	1.5	2.4	8.4	17.4	4.6	2.4	2.7	3.4	14.7	59.0	72.0	4.9	3.9	0.9	4.7	0.9	1.3	20.4	12.5	2.3	5.9	0.6	4.4	0.9	0.9	1.7	8.0	13.5	3.4	57.9	5.6	0.4	6.3	17.2	2.4	10.8	56.7	52.1	1.7	5.8	0.4	1.4	0.0	0.1	0.6	0.9	0.0	0.0	6.9	0.0	0.6	0.0	0.1	3.0	0.2	0.0	0.2	0.0	0.0	14.3	4.1	1.5	0.0	0.6	0.0	1.4	2.2	3.7	111.4	2.0	0.1	8.2	0.0	0.2	0.7	0.6	0.0	0.4	0.2	0.0	0.1	19.3	0.1	0.0	3.5	0.2	0.1	0.2	0.6	0.1	0.0	0.1	0.0	0.0	525.0	0.0	0.0	5.0	0.0	51.8	4.9	0.2	1.1	0.5	0.3	4.3	2.3	40.3	27.4	24.2	42.3	284.0	24.5	195.8	13.9	64.4	31.3	32.4	25.2	44.2	38.1	35.1	534.0	21.5	378.9	5.0	8.0	49.1	2.5	2.7	2.8	39.7	2.4	2.7	4.9	3.9	12.5	3.4	6.3	5.8	7.6	22.4	57.3	0.0	177.4	11.0	0.8	50.9	0.6	0.1	2.9	3.7	4.3	0.0	38.0	1.8	0.0	1.9	33.9	0.3	1.9	2.2	1.3	12.0	4.2	6.2	0.0	1.3	0.1	1.6	2.3	8.4	2.0	41.1	220.7	0.2	1.4	1.6	214.9	0.0	0.1	0.1	2.0	60.5	508.2	1.5	0.0	604.2	33.8	0.0	386.0	0.3	13.4	0.0	0.0	6.5	0.1	0.0	14.6	1.4	0.1	0.8	13.8	0.2	0.0	1.3	4.8	0.3	0.2	0.5	10.2	4.5	53.3	0.1	0.2	1.8
C1orf54	FLJ23221	ENSG00000118292	"Chromosome 1 open reading frame 54"	Q8WWF1	1	150268200-150280916	"Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.7;Endothelial cells: 101.3;Kupffer cells: 145.7;Langerhans cells: 282.7;Leydig cells: 95.1;Peritubular cells: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"myeloid DC: 103.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 103.5"	"Cell line enhanced"	"Detected in many"		"AF22: 77.8;AN3-CA: 110.5;ASC diff: 86.1;ASC TERT1: 141.3;HSkMC: 102.1;HUVEC TERT2: 108.4;U-87 MG: 68.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA026518, HPA043874"	Approved		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"HPA026518: AB_1845647, HPA043874: AB_2732511"	"unprognostic (4.64e-3)"	"unprognostic (6.81e-3)"	"unprognostic (4.01e-3)"	"unprognostic (5.69e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.48e-2)"	37.6	19.1	59.8	26.4	60.7	11.9	30.7	62.0	96.2	27.6	56.2	25.9	13.3	30.1	39.1	17.9	33.2	46.4	34.6	57.6	62.2	28.4	29.7	29.2	62.6	61.9	61.8	7.9	5.1	14.5	10.5	59.2	62.0	28.7	25.9	16.2	8.4	75.6	24.6	11.1	15.0	60.3	63.5	69.4	12.7	13.9	64.2	30.8	13.9	48.3	27.9	36.2	18.2	62.4	1.6	0.3	77.8	110.5	86.1	141.3	2.2	14.0	20.5	3.8	12.0	0.9	1.9	0.6	4.1	12.3	1.5	2.7	0.2	0.5	5.6	1.4	12.2	1.9	2.0	1.3	17.7	3.9	2.6	102.1	5.9	24.8	1.9	13.2	108.4	1.8	1.8	12.2	15.0	4.2	0.7	24.0	5.7	0.1	3.9	18.8	1.7	1.4	1.1	6.1	1.5	1.3	1.4	0.8	7.5	16.4	1.4	58.0	0.7	28.1	2.1	0.8	0.9	5.0	4.8	1.2	68.3	3.1	0.7	0.1	21.2	0.8	0.6	20.8	2.5	0.9	3.8	1.7	103.5	0.7	3.5	2.0	1.0	0.8	5.6	2.1	1.9	6.4	59.8	60.7	62.0	96.2	57.6	62.2	61.9	61.8	62.0	63.5	64.2	62.4	115.7	3.2	4.5	19.6	3.3	6.4	2.2	2.4	1.8	0.8	2.3	3.7	10.6	2.8	2.5	22.0	0.0	1.3	1.5	2.0	76.3	0.7	9.4	3.1	37.6	101.3	1.2	0.4	4.1	2.3	0.8	29.3	5.1	3.1	1.3	0.7	51.8	1.3	45.3	0.0	3.8	1.3	0.0	145.7	282.7	19.6	95.1	65.6	12.4	16.9	24.9	23.4	1.0	0.5	0.3	2.0	1.5	104.2	3.0	4.9	2.7	4.9	0.5	1.6	32.9	7.5	70.4	16.6	1.9	7.5	5.1	3.6	3.3	5.2	1.4	8.4
C5AR1	"C5A, C5AR, C5R1, CD88"	ENSG00000197405	"Complement C5a receptor 1"	P21730	19	47290023-47322066	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 125.5;lymphoid tissue: 84.8"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 130.9;Kupffer cells: 228.3;Langerhans cells: 122.4;Macrophages: 446.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 394.0"	"Group enriched"	"Detected in many"	42	"granulocytes: 394.0;monocytes: 115.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.9;CAPAN-2: 4.1;HMC-1: 4.7;U-87 MG: 6.2;U-937: 6.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB002720, HPA014520, HPA048012"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Vesicles	"CAB002720: , HPA014520: AB_1846337, HPA048012: "	"unprognostic (5.95e-2)"	"prognostic favorable (4.71e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (9.55e-4)"	"unprognostic (2.02e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.54e-2)"	72.7	18.2	3.3	84.8	3.1	125.5	8.5	2.4	9.0	11.8	21.6	9.8	2.5	7.5	1.4	8.3	23.9	38.8	11.7	3.9	8.2	9.7	18.0	43.1	11.5	8.9	6.9	5.0	8.9	4.8	51.8	31.8	8.4	5.3	4.2	4.4	5.1	2.5	1.9	2.3	5.8	28.1	5.7	38.2	7.2	2.6	10.5	7.1	3.6	5.8	4.3	37.1	4.6	11.6	1.0	3.9	0.1	0.1	0.7	0.2	0.6	0.7	0.5	0.2	0.1	0.2	4.1	0.3	0.7	0.9	0.4	1.4	0.2	0.5	0.2	0.7	0.5	0.1	3.8	0.6	0.4	1.5	4.7	0.3	2.2	0.4	0.3	0.6	0.0	0.2	0.2	1.7	0.1	1.1	0.2	2.5	1.2	0.2	0.3	0.2	0.1	0.3	1.3	0.9	0.0	0.0	0.3	0.3	0.6	0.5	0.2	2.2	0.0	0.1	2.1	0.3	0.1	0.2	0.3	0.3	6.2	6.5	0.2	41.6	53.8	38.8	0.4	80.4	0.3	0.4	0.3	0.2	6.1	0.6	0.3	0.3	394.0	0.5	115.9	1.1	0.3	19.3	3.3	3.1	2.4	9.0	3.9	8.2	8.9	6.9	8.4	5.7	10.5	11.6	4.4	3.2	20.8	0.0	5.1	5.1	1.0	3.4	2.8	1.0	2.1	4.4	2.9	1.5	15.3	1.8	2.1	0.8	1.5	1.6	3.9	0.0	1.3	17.3	1.8	6.3	0.0	0.4	1.5	0.0	1.5	5.3	1.1	4.6	25.2	0.1	2.9	8.3	130.9	0.0	0.6	0.8	4.1	228.3	122.4	1.3	0.6	446.7	5.4	5.6	56.3	0.2	0.0	1.0	0.3	0.1	0.1	0.0	4.9	0.5	0.7	1.3	40.7	4.3	13.1	4.1	2.8	0.5	0.9	1.4	3.0	1.5	3.3	0.0	1.3	0.5
C5AR2	"C5L2, GPR77"	ENSG00000134830	"Complement component 5a receptor 2"	Q9P296	19	47332175-47347329	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 14.4;Hepatic stellate cells: 23.9;Kupffer cells: 48.6;Macrophages: 34.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 3.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 17.8;eosinophil: 11.9;neutrophil: 33.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 33.0"	"Group enriched"	"Detected in some"	4	"MCF7: 20.7;T-47d: 24.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA016629	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 6: T47d - Mammary gland"	"Cluster 41: Macrophages - Immune response"			"HPA016629: AB_1849312"	"unprognostic (5.00e-2)"	"unprognostic (2.31e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.00e-6)"	"unprognostic (2.88e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.73e-5)"	"unprognostic (1.16e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.88e-3)"	4.2	1.2	1.1	4.1	0.8	5.8	2.2	1.2	2.9	1.2	1.8	1.3	0.4	0.7	0.4	0.6	2.3	0.7	2.1	2.4	0.5	1.2	1.9	6.5	0.9	1.3	0.7	0.6	0.8	0.1	0.9	2.2	0.7	0.4	0.4	0.4	1.2	0.3	0.3	1.4	1.5	1.0	0.5	14.1	1.1	3.1	0.8	0.3	0.9	0.4	3.2	1.2	1.3	1.3	0.1	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.7	0.4	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.1	5.2	0.1	0.0	0.8	1.5	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.4	0.0	20.7	0.1	2.4	0.2	0.0	0.1	0.3	0.1	2.7	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.1	24.8	0.3	0.2	0.8	0.2	0.5	0.1	0.3	0.3	0.9	0.8	1.4	0.1	17.8	2.7	11.9	0.3	2.3	0.4	0.3	0.2	0.2	0.6	0.4	0.2	0.2	33.0	0.3	4.4	0.3	0.6	0.7	1.1	0.8	1.2	2.9	2.4	0.5	1.3	0.7	0.7	0.5	0.8	1.3	0.6	3.2	1.9	0.3	1.1	0.4	2.8	0.1	0.0	1.3	4.7	2.8	1.6	2.8	2.6	1.8	2.1	0.1	1.7	0.0	0.0	0.0	14.4	0.5	0.5	1.7	0.0	3.2	0.6	0.0	0.2	2.1	0.0	1.1	1.3	6.1	23.9	1.2	8.3	0.0	0.1	0.0	0.0	48.6	4.6	3.0	0.0	34.5	0.0	1.0	8.3	0.3	1.0	0.0	0.1	0.0	0.0	0.4	1.3	2.0	0.0	0.3	0.8	4.2	0.0	4.0	1.0	0.2	0.4	0.1	0.9	0.1	1.3	4.1	0.0	1.9
C9orf72	"DENND9, DENNL72, MGC23980"	ENSG00000147894	"C9orf72-SMCR8 complex subunit"	Q96LT7	9	27535640-27573866	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Autophagy	"Guanine-nucleotide releasing factor"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 127.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 24.3;classical monocyte: 32.0;intermediate monocyte: 44.7;myeloid DC: 25.2;neutrophil: 34.3;non-classical monocyte: 36.9"	"Group enriched"	"Detected in all"	8	"dendritic cells: 25.2;granulocytes: 34.3;monocytes: 44.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023873	Uncertain		Supported	"Vesicles,Midbody ring,Cytosol"	"Intracellular and membrane"	Yes	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Cytosol"	"Midbody ring"	"HPA023873: AB_1845834"	"unprognostic (1.78e-2)"	"unprognostic (5.01e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.89e-2)"	"unprognostic (9.13e-2)"	11.7	12.1	9.5	16.6	9.5	25.3	9.4	21.0	12.5	9.8	12.4	8.8	6.8	12.0	11.3	7.6	16.0	10.2	9.3	9.7	13.5	7.0	16.0	17.7	9.2	14.6	11.9	24.2	9.6	6.9	16.2	12.1	12.5	14.2	7.8	31.3	6.7	5.8	14.9	8.8	8.3	8.6	12.4	16.8	7.8	17.6	11.3	11.1	13.1	9.9	8.8	9.2	8.5	14.5	4.4	3.7	28.7	4.4	5.7	7.0	4.4	5.9	4.9	3.5	1.8	0.4	1.4	10.2	3.7	5.3	7.5	3.1	9.4	7.2	2.5	19.8	3.6	4.9	11.0	3.0	8.9	3.4	5.2	7.3	8.6	0.8	16.1	3.5	7.6	11.1	9.8	18.6	4.3	0.8	6.6	5.0	14.2	6.8	16.0	2.4	9.5	5.1	2.8	3.3	9.9	24.4	4.0	4.4	3.7	10.9	3.7	2.9	6.6	0.0	14.5	8.6	4.0	4.8	15.8	6.8	11.4	11.0	3.8	24.3	32.0	2.4	1.9	44.7	3.3	3.4	2.7	2.5	25.2	2.5	4.6	2.9	34.3	4.3	36.9	3.9	4.0	10.0	9.5	9.5	21.0	12.5	9.7	13.5	14.6	11.9	12.5	12.4	11.3	14.5	15.4	16.0	14.7	19.2	43.2	35.9	50.7	15.0	26.2	22.1	7.2	6.6	15.6	4.3	15.2	7.3	20.9	21.2	11.7	5.0	1.9	8.4	2.6	94.4	11.8	15.0	11.4	3.0	53.0	9.3	7.3	18.7	16.8	57.6	16.5	18.4	8.2	9.3	25.8	11.8	58.9	12.5	10.2	71.9	127.8	4.2	6.2	94.8	19.6	42.2	58.2	45.2	3.1	30.2	60.9	8.6	11.1	3.8	10.7	30.0	4.1	5.4	80.7	27.5	0.0	17.5	20.6	29.2	20.9	15.2	29.1	34.6	18.2	7.9	5.1	37.6
CASP9	"APAF-3, ICE-LAP6, MCH6, PPP1R56"	ENSG00000132906	"Caspase 9"	P55211	1	15490832-15526534	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001473, CAB004348, HPA046488"	Approved		Approved	Mitochondria		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB004348: AB_673489, HPA001473: AB_1078401, HPA046488: AB_2679670"	"prognostic favorable (5.91e-4)"	"unprognostic (2.42e-1)"	"unprognostic (8.94e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.90e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.21e-2)"	"unprognostic (5.48e-2)"	"prognostic favorable (1.67e-5)"	12.0	50.8	14.1	7.0	14.5	11.5	8.9	16.1	18.8	19.3	13.3	11.8	6.4	14.4	12.5	14.1	22.5	9.4	16.4	14.2	13.0	20.7	14.8	10.8	6.9	14.8	14.2	57.6	37.8	12.0	32.4	7.1	14.1	19.2	5.3	12.3	8.9	9.8	12.7	5.5	11.0	6.6	13.6	10.6	12.4	25.9	14.6	8.7	25.9	9.4	7.9	12.9	12.8	17.1	10.4	17.8	4.6	8.9	11.0	5.4	5.3	7.5	9.9	11.1	12.7	12.5	10.1	13.4	16.2	7.5	13.1	4.2	10.5	8.2	11.7	5.9	11.6	9.8	32.8	10.8	10.8	10.6	11.5	9.7	11.5	15.3	3.8	8.3	8.7	13.3	20.4	13.4	5.8	5.2	3.3	8.6	5.9	11.3	8.2	7.4	13.4	16.4	12.3	6.7	4.4	9.0	9.6	1.8	15.6	12.1	5.7	7.9	4.8	13.8	5.8	15.6	5.1	13.3	21.5	16.3	8.9	9.9	5.0	54.2	24.7	54.8	11.0	17.4	8.2	21.3	6.6	7.6	25.1	30.0	3.1	4.8	36.3	29.3	18.9	11.4	6.9	15.0	14.1	14.5	16.1	18.8	14.2	13.0	14.8	14.2	14.1	13.6	14.6	17.1	2.8	3.2	3.7	18.3	17.1	2.9	8.2	5.0	4.6	3.2	7.0	4.7	9.3	11.5	7.3	18.4	6.2	17.0	8.0	7.0	1.9	7.5	12.6	10.9	5.2	3.3	3.0	5.7	7.9	9.1	10.8	5.6	12.8	7.6	1.3	5.7	4.2	4.7	9.5	5.0	9.9	6.3	6.1	4.8	12.9	5.5	2.1	12.9	0.0	6.5	4.8	7.5	10.3	9.5	8.8	8.4	7.3	3.8	9.9	4.0	9.8	7.2	8.9	6.3	0.0	5.3	9.7	16.4	7.1	6.0	2.4	35.7	6.4	7.9	5.6	7.4
CCDC6	"D10S170, H4, PTC, TPC, TST1"	ENSG00000108091	"Coiled-coil domain containing 6"	Q16204	10	59788747-59906556	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019049, HPA019051"	Enhanced		Supported	Cytosol		No	No		12000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA019049: AB_1846163, HPA019051: AB_1846164"	"unprognostic (1.88e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.98e-3)"	"prognostic favorable (5.48e-4)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.39e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (4.08e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.19e-2)"	11.9	12.2	21.1	13.9	23.4	16.8	22.4	10.2	20.0	23.4	8.5	23.5	22.8	24.9	16.7	34.1	25.3	16.7	10.0	24.9	21.4	21.2	12.1	17.3	21.4	12.4	15.8	15.7	25.2	17.9	11.5	13.2	17.4	19.4	19.8	18.3	29.0	14.3	17.3	28.6	16.2	30.8	11.9	14.7	18.6	11.4	20.8	12.1	18.3	12.2	21.6	17.3	23.1	12.6	42.9	38.0	18.7	41.9	27.8	41.6	37.9	20.6	27.2	20.2	23.7	74.4	81.8	36.5	30.2	34.6	11.7	61.7	37.7	37.5	30.0	55.1	18.7	29.8	29.1	45.5	33.5	34.5	26.9	30.3	48.7	33.7	81.8	28.3	30.2	20.4	22.6	22.7	26.6	57.6	14.5	19.8	29.9	40.1	25.6	19.2	30.5	23.0	33.9	36.2	19.0	16.6	26.1	107.8	23.1	24.1	68.7	18.4	31.1	18.8	33.9	29.3	34.9	12.0	14.9	16.3	29.6	64.6	11.9	0.0	2.0	0.0	1.0	2.3	1.1	4.3	1.5	1.3	5.0	4.9	1.3	1.0	0.1	0.8	1.3	1.3	1.4	1.0	21.1	23.4	10.2	20.0	24.9	21.4	12.4	15.8	17.4	11.9	20.8	12.6	24.0	99.3	25.9	45.1	41.6	95.0	51.7	25.3	70.0	15.1	51.2	38.7	16.5	28.6	46.3	25.8	41.7	37.8	31.4	42.6	29.4	50.2	27.6	105.2	54.6	22.4	27.0	25.7	83.2	65.3	18.8	27.8	39.8	134.5	29.1	45.2	17.2	20.1	23.1	16.8	58.4	38.9	30.5	40.7	35.3	80.6	24.5	36.4	16.0	32.8	23.0	11.5	13.4	55.3	34.2	50.2	25.0	19.5	26.4	52.2	47.1	48.4	28.1	49.8	19.7	31.4	27.0	2.3	22.4	92.3	80.1	27.0	24.3	32.5	46.3	46.1
CCL13	"CKb10, MCP-4, MGC17134, NCC-1, SCYA13, SCYL1"	ENSG00000181374	"C-C motif chemokine ligand 13"	Q99616	17	34356480-34358610	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 30.4;urinary bladder: 30.4"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 48.7;Langerhans cells: 81.2;Melanocytes: 17.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.8;BJ hTERT+: 1.7;BJ hTERT+ SV40 Large T+ RasG12V: 1.0;HMC-1: 1.3;HSkMC: 1.7"														"Secreted to blood"	NA	NA	336000			"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"				"unprognostic (2.22e-2)"	"unprognostic (3.56e-2)"	"unprognostic (8.41e-3)"	"unprognostic (1.49e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.58e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.98e-2)"	"unprognostic (8.63e-8)"	"unprognostic (2.26e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.71e-2)"	24.0	4.5	0.0	7.0	0.0	0.3	18.4	0.0	0.5	3.2	0.0	30.4	21.3	0.6	0.3	11.9	4.4	2.7	11.8	0.0	0.0	1.7	0.2	22.5	3.2	0.0	0.0	0.3	0.7	1.6	0.1	9.7	0.0	1.6	25.1	0.0	2.6	0.8	0.6	4.5	27.0	9.0	0.0	0.1	2.9	2.4	0.0	8.7	1.8	5.8	1.8	30.4	3.2	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.2	1.7	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.0	0.0	0.0	8.8	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.4	7.0	0.0	0.0	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	0.0	0.0	81.2	0.3	0.0	6.6	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.0	0.0	0.1	4.7	0.3	1.0	0.0	0.0	0.1
CCRL2	"ACKR5, CKRX, CRAM-A, CRAM-B, HCR"	ENSG00000121797	"C-C motif chemokine receptor like 2"	O00421	3	46407166-46412997	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 35.0;Erythroid cells: 26.5;Hofbauer cells: 42.7;Kupffer cells: 22.1;Langerhans cells: 36.5;Macrophages: 56.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 21.0;OE19: 8.4;PC-3: 15.3;RT4: 8.3;TIME: 15.4;U-266/84: 8.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043238	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"			"HPA043238: AB_10794924"	"unprognostic (3.94e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (9.67e-5)"	11.7	1.6	2.1	11.4	2.1	9.0	8.4	2.2	3.7	2.3	2.2	11.5	11.7	1.2	0.6	0.9	1.1	5.5	2.7	2.1	2.2	2.2	4.4	12.4	4.9	2.8	2.3	0.5	1.5	0.8	0.8	5.1	3.1	0.8	10.4	0.2	0.9	0.8	1.1	0.7	12.1	2.5	2.6	8.5	5.5	0.3	2.9	7.7	1.3	1.1	3.8	6.0	1.1	3.3	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	1.2	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.3	0.7	4.6	0.0	21.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	5.0	0.2	0.0	7.2	4.2	2.8	0.1	5.0	0.0	1.6	2.6	0.0	8.4	15.3	0.4	0.3	0.0	0.0	8.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	15.4	0.6	0.3	0.7	0.3	0.0	8.6	0.2	7.5	6.5	0.0	8.7	15.4	4.3	2.8	22.1	3.4	1.7	1.6	4.7	9.9	3.9	1.0	2.5	2.6	6.7	10.1	3.0	4.7	5.0	2.1	2.1	2.2	3.7	2.1	2.2	2.8	2.3	3.1	2.6	2.9	3.3	35.0	0.0	4.7	0.0	4.4	2.0	0.2	0.2	0.0	0.0	0.4	0.4	1.1	1.5	1.2	0.0	0.0	0.3	4.5	19.5	0.0	0.6	0.1	0.1	0.2	12.1	0.0	26.5	0.0	8.8	1.2	1.4	4.6	0.1	9.5	0.1	6.4	0.4	42.7	0.0	0.0	16.6	0.0	22.1	36.5	0.0	0.0	56.2	1.8	1.9	6.7	0.0	0.0	0.0	0.0	9.8	12.4	0.0	4.2	0.2	17.2	0.2	0.6	0.0	0.0	0.6	0.5	0.0	0.0	0.0	1.1	2.5	6.4	0.4	9.2	1.1
CD1A	CD1	ENSG00000158477	"CD1a molecule"	P06126	1	158254424-158258269	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"lymphoid tissue: 318.0"	"Cell type enriched"	"Detected in some"	20	"Langerhans cells: 151.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"classical monocyte: 6.4;intermediate monocyte: 4.2;memory B-cell: 10.1;myeloid DC: 11.4;naive B-cell: 5.3"	"Group enriched"	"Detected in many"	37	"B-cells: 10.1;dendritic cells: 11.4;monocytes: 6.4"	"Group enriched"	"Detected in some"	81	"JURKAT: 41.4;MOLT-4: 66.4"					"Not detected"	"Not detected"			"CAB000009, HPA010734"	Enhanced					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"			"CAB000009: AB_2073290, HPA010734: AB_1078452"	"unprognostic (7.21e-5)"	"prognostic favorable (6.37e-4)"	"unprognostic (1.37e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-2)"	"unprognostic (9.93e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.86e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.12e-2)"	"unprognostic (5.49e-5)"	"unprognostic (5.58e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.81e-2)"	0.1	0.0	0.0	1.6	0.0	0.0	1.4	0.0	0.0	0.4	0.0	0.3	0.2	0.0	0.0	10.4	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.4	0.0	0.1	27.1	0.2	0.0	0.0	1.3	0.8	0.1	0.0	318.0	0.2	0.0	3.9	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	41.4	0.0	0.0	0.0	0.0	66.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.4	0.0	0.0	4.2	0.2	10.1	0.0	0.0	11.4	5.3	0.1	0.0	0.0	0.0	0.2	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2	151.7	0.0	0.0	4.0	1.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	7.0	0.0	0.2	0.0	0.0	0.0
CD1B	CD1	ENSG00000158485	"CD1b molecule"	P29016	1	158327951-158331531	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	157	"lymphoid tissue: 528.9"	"Cell type enriched"	"Detected in some"	21	"Langerhans cells: 153.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"myeloid DC: 19.2"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 19.2"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 587.9"									HPA021824	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus, Vesicles"	Cytosol	"HPA021824: AB_1846262"	"unprognostic (7.72e-3)"	"unprognostic (1.55e-4)"	"unprognostic (1.66e-5)"	"unprognostic (1.04e-2)"		"unprognostic (1.06e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.89e-4)"	"unprognostic (2.27e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.53e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.53e-2)"	0.1	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.6	0.0	0.7	0.1	0.0	0.0	0.1	0.2	1.0	2.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	3.3	0.2	0.1	0.0	1.0	0.7	0.0	0.0	528.9	0.3	0.1	1.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	118.6	0.0	0.0	0.0	0.0	587.9	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	2.8	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.9	153.1	0.2	0.0	7.0	1.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0
CD1C	CD1	ENSG00000158481	"CD1c molecule"	P29017	1	158289923-158294774	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"lymphoid tissue: 130.4"	"Cell type enriched"	"Detected in some"	6	"Langerhans cells: 551.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"memory B-cell: 84.1;myeloid DC: 324.9"	"Group enriched"	"Detected in many"	8	"B-cells: 84.1;dendritic cells: 324.9"	"Group enriched"	"Detected in some"	10	"JURKAT: 14.8;MOLT-4: 49.4"									HPA068359			Approved	"Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA		200000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus, Vesicles"	"Endoplasmic reticulum"	"HPA068359: "	"unprognostic (2.55e-3)"	"prognostic favorable (1.79e-5)"	"unprognostic (1.75e-5)"	"unprognostic (3.09e-5)"	"unprognostic (3.12e-2)"	"unprognostic (8.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (3.80e-3)"	"unprognostic (7.11e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.99e-1)"	2.7	0.8	0.0	17.3	0.0	1.1	5.0	0.0	0.2	2.3	0.0	3.4	2.0	2.4	0.6	4.5	1.8	7.7	2.0	0.0	0.0	1.2	4.1	6.5	26.2	0.0	0.0	0.9	0.7	0.6	0.2	0.1	0.0	1.8	9.4	0.0	2.8	1.3	1.0	12.2	12.0	3.1	0.0	23.0	3.7	0.9	0.0	130.4	0.7	1.1	38.2	4.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	49.4	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.9	0.0	0.6	26.8	0.1	0.1	24.7	0.3	84.1	0.1	0.0	324.9	49.1	0.2	0.0	1.1	4.1	3.7	1.5	0.5	15.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.2	0.0	26.6	13.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	4.1	0.0	0.1	1.5	0.0	0.8	0.0	0.0	0.1	1.4	0.0	0.0	3.8	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	7.1	551.4	4.5	0.0	91.2	19.6	0.0	11.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	1.5	0.0	0.0	0.2	0.4	0.1	0.3	0.0	7.4	0.0	1.9	0.0	0.0	0.0
CD1E		ENSG00000158488	"CD1e molecule"	P15812	1	158353696-158357553	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	69	"lymphoid tissue: 962.6"	"Cell type enriched"	"Detected in some"	13	"Langerhans cells: 549.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	14	"myeloid DC: 62.5"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 62.5"	"Cell line enriched"	"Detected in some"	43	"MOLT-4: 1276.2"					"Not detected"	"Not detected"			"HPA057769, HPA070634"	Uncertain		Supported	"Nucleoli,Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Nucleoli	"HPA057769: AB_2683522, HPA070634: "	"unprognostic (7.94e-3)"	"unprognostic (1.85e-5)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.45e-1)"	0.7	0.5	0.0	4.4	0.0	0.0	1.8	0.0	0.0	2.1	0.0	2.1	2.2	1.1	0.4	7.9	0.9	4.8	1.0	0.0	0.0	0.8	1.5	3.1	6.4	0.0	0.0	0.6	0.3	0.5	0.1	0.0	0.0	1.1	5.6	0.0	1.5	0.6	0.4	13.9	2.8	0.9	0.0	5.1	4.7	0.5	0.0	962.6	0.8	0.2	9.9	2.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	29.8	0.1	0.0	0.0	0.5	1276.2	0.0	0.3	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	2.5	0.2	0.0	0.0	0.0	62.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.5	0.0	0.8	8.4	0.0	0.0	0.6	0.0	0.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	1.3	0.0	0.0	0.0	0.7	0.0	0.0	1.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	4.8	549.5	0.0	0.0	41.7	8.8	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	7.1	0.1	0.7	0.0	0.0	0.0
CD55	"CR, CROM, DAF, TC"	ENSG00000196352	"CD55 molecule (Cromer blood group)"	P08174	1	207321532-207386804	"Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Blood group antigen, Host cell receptor for virus entry, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 2227.6;Syncytiotrophoblasts: 847.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 662.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 472.3;HMC-1: 665.7;PC-3: 395.0;U-2197: 405.3"					"Low region specificity"	"Detected in many"			"HPA002190, CAB010454, HPA024386"	Enhanced				"Secreted to blood"	NA	No	32300000	360000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"			"CAB010454: AB_2075970, HPA002190: AB_1078472, HPA024386: AB_1846319"	"unprognostic (4.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (9.36e-4)"	"unprognostic (3.41e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.33e-2)"	64.9	161.5	13.8	99.6	23.3	134.0	59.0	15.8	28.3	103.3	19.0	47.7	47.7	58.3	17.3	58.3	28.0	49.4	48.4	15.7	29.4	20.5	28.0	224.1	26.7	21.1	20.0	67.7	24.5	28.9	26.3	92.5	26.2	16.1	42.9	9.2	126.1	18.1	108.9	85.9	50.7	46.6	15.2	43.1	44.0	36.0	20.8	15.8	47.6	59.5	41.3	183.2	41.8	34.4	33.2	43.6	0.1	14.6	54.2	55.1	220.7	62.5	100.1	31.3	33.1	139.5	44.3	60.8	50.3	35.8	123.3	17.4	65.2	12.9	29.1	29.0	26.4	79.9	472.3	23.3	162.3	50.5	665.7	25.9	150.5	40.8	171.8	133.8	169.7	9.6	89.6	29.3	19.4	35.6	5.3	37.8	43.2	78.9	395.0	7.4	42.3	50.7	54.3	30.7	17.7	0.4	321.2	64.3	53.9	95.1	54.4	41.5	80.4	17.6	33.2	405.3	23.8	24.7	31.4	42.7	44.8	19.6	78.9	317.7	181.2	247.6	35.0	174.4	51.8	108.2	46.0	36.4	121.7	115.2	102.6	101.9	662.2	134.5	223.7	64.8	34.6	159.3	13.8	23.3	15.8	28.3	15.7	29.4	21.1	20.0	26.2	15.2	20.8	34.4	95.9	2227.6	405.3	2.3	529.8	705.1	214.1	143.6	59.2	3.1	69.9	53.8	72.7	7.2	542.6	23.9	0.0	217.5	201.7	196.1	3.9	98.6	324.6	345.6	101.9	143.4	17.3	79.8	7.6	180.2	411.7	244.7	387.9	709.3	146.9	88.9	46.8	9.1	70.0	1.7	10.7	155.7	77.3	177.5	449.2	66.3	32.6	377.3	160.1	7.5	122.6	4.8	69.0	6.0	54.3	388.9	241.2	9.1	305.4	334.9	138.4	3.2	259.5	3.3	6.6	56.1	98.0	8.9	13.7	273.4	765.9	847.7	215.4	281.5	145.1	578.6
CD74	DHLAG	ENSG00000019582	"CD74 molecule"	P04233	5	150400041-150412969	"Cancer-related genes, CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 5258.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 10167.0;Kupffer cells: 5201.6;Langerhans cells: 23363.4;Macrophages: 7290.2;monocytes: 10305.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 11041.2;intermediate monocyte: 15961.1;memory B-cell: 26889.3;myeloid DC: 23750.6;naive B-cell: 27930.3;non-classical monocyte: 8003.3;plasmacytoid DC: 16940.0"	"Group enriched"	"Detected in all"	6	"B-cells: 27930.3;dendritic cells: 23750.6;monocytes: 15961.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 2171.7;Daudi: 3523.2;HDLM-2: 4787.6;REH: 3026.0;RPMI-8226: 2014.2;U-266/70: 1443.4;U-698: 1978.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002506, HPA010592, CAB079994"	Enhanced		Supported	"Golgi apparatus"		NA	NA		210000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"CAB002506: AB_563630, CAB079994: , HPA010592: AB_1078482"	"prognostic favorable (1.06e-4)"	"unprognostic (1.48e-2)"	"unprognostic (4.80e-3)"	"prognostic favorable (6.53e-6)"	"unprognostic (1.41e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.64e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.24e-2)"	1512.1	976.5	338.1	2741.2	301.9	984.3	1157.2	365.5	474.4	1562.8	429.1	992.3	1826.2	593.6	490.6	618.8	1139.0	1477.9	604.0	306.7	506.8	1271.1	1142.0	3786.3	4995.6	598.7	431.8	464.3	392.4	390.6	469.3	305.7	533.4	556.7	1155.8	58.1	1999.3	911.8	307.2	682.4	2438.8	1014.2	514.2	4897.4	1511.5	207.5	514.4	2160.2	853.5	374.2	5258.9	1557.5	483.5	771.8	35.7	0.3	1.5	2.4	2.3	2.5	11.0	0.0	0.0	0.7	0.6	443.0	2171.7	3523.2	124.2	0.0	9.2	9.4	0.0	0.0	0.1	4787.6	0.0	109.1	1.2	250.2	6.6	9.2	6.5	24.5	0.0	0.8	0.0	0.6	0.0	0.0	8.0	1270.7	0.4	0.0	4.2	14.0	5.3	0.0	0.1	3026.0	5.2	2014.2	9.0	133.5	5.1	8.2	5.5	4.7	94.9	19.2	81.2	414.4	5.6	10.3	9.9	9.0	4.5	1443.4	170.7	1978.6	745.9	154.2	678.6	410.8	11041.2	3996.9	808.7	15961.1	899.9	26889.3	688.4	1188.4	23750.6	27930.3	378.9	646.6	839.6	2378.1	8003.3	16940.0	2157.2	17779.7	338.1	301.9	365.5	474.4	306.7	506.8	598.7	431.8	533.4	514.2	514.4	771.8	2080.4	419.9	2160.4	0.7	10167.0	715.9	154.0	762.2	398.4	1.7	220.3	437.5	69.6	401.7	1063.3	502.1	0.0	28.3	3199.0	139.7	117.4	1264.4	10.4	111.3	11.5	1787.6	242.9	562.5	0.7	527.5	32.6	278.6	538.2	85.5	417.2	113.4	514.7	52.5	4361.8	1.7	0.6	475.7	390.6	5201.6	23363.4	31.3	117.1	7290.2	1197.1	137.7	10305.9	16.8	403.7	0.5	1.4	384.2	487.3	17.7	2068.3	174.9	5034.4	815.8	1153.1	10.0	164.3	45.1	146.7	2.8	12.6	170.9	575.8	41.6	790.7	12.9	450.7	743.4
CD83	"BL11, HB15"	ENSG00000112149	"CD83 molecule"	Q01151	6	14117256-14136918	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 209.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 668.5;Langerhans cells: 1390.2;Macrophages: 539.4;monocytes: 513.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 79.1;HDLM-2: 71.9;U-698: 121.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002509, HPA041454, HPA073595"	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles	"Golgi apparatus"	"CAB002509: AB_563641, HPA041454: AB_2677489, HPA073595: "	"unprognostic (2.22e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.39e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.05e-3)"	"unprognostic (9.05e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.37e-2)"	"unprognostic (6.68e-2)"	"prognostic favorable (3.49e-4)"	"unprognostic (2.30e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.46e-2)"	10.2	19.9	14.7	34.9	13.9	209.6	7.0	16.1	17.9	26.2	23.0	5.2	4.6	7.3	4.0	4.5	5.1	17.0	4.8	15.6	19.2	18.7	14.9	39.9	51.3	20.2	16.6	16.5	4.2	6.6	7.2	9.2	21.0	8.3	9.2	5.0	19.5	13.8	1.3	5.0	11.5	6.9	16.7	20.1	5.7	5.2	21.0	38.0	5.3	2.9	70.2	15.5	15.4	21.6	18.1	0.8	12.7	17.7	18.2	4.2	0.4	5.1	17.6	8.3	14.4	1.3	11.6	79.1	14.6	1.3	16.8	2.0	4.8	5.5	27.0	71.9	7.6	10.6	21.4	2.1	0.6	15.8	16.5	4.8	2.3	8.0	2.6	2.5	0.2	26.4	2.4	0.0	0.8	6.5	12.6	29.7	5.3	3.2	3.7	12.1	28.1	10.9	6.0	17.2	2.8	5.2	1.0	0.6	13.5	7.3	3.0	12.3	0.4	12.8	8.1	1.9	12.0	0.7	0.2	121.5	2.8	21.6	19.7	0.0	3.1	2.0	4.4	19.0	4.8	19.7	4.0	3.7	9.0	31.0	2.8	3.3	2.2	5.0	29.3	3.2	6.2	4.4	14.7	13.9	16.1	17.9	15.6	19.2	20.2	16.6	21.0	16.7	21.0	21.6	41.3	19.2	77.9	5.2	668.5	49.5	16.0	10.0	41.5	4.2	26.5	46.4	30.9	2.8	8.2	11.0	6.2	1.5	100.4	5.4	3.9	0.9	0.9	29.0	24.1	39.1	24.0	3.0	5.6	1.6	2.4	31.1	11.2	74.8	238.8	8.1	2.9	1.1	145.6	1.7	6.1	7.3	4.1	83.0	1390.2	1.9	0.3	539.4	44.4	13.1	513.6	3.5	1.0	2.5	1.3	2.1	0.4	0.0	20.4	26.2	1.7	17.7	4.9	2.7	0.0	17.2	17.0	2.1	10.2	17.2	38.5	2.7	69.2	21.0	11.6	3.5
CDC42EP2	"BORG1, CEP2"	ENSG00000149798	"CDC42 effector protein 2"	O14613	11	65314866-65322417	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 50.5;Langerhans cells: 77.7;Pancreatic endocrine cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"classical monocyte: 50.4;intermediate monocyte: 118.8;neutrophil: 171.5;non-classical monocyte: 88.5"	"Group enriched"	"Detected in many"	15	"granulocytes: 171.5;monocytes: 118.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 51.5;PC-3: 61.0;U-2197: 55.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038562	Approved		Supported	Microtubules,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Microtubules, Cytosol"		"HPA038562: AB_10671745"	"unprognostic (1.69e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.73e-3)"	"prognostic unfavorable (2.89e-5)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (1.01e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.57e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-2)"	42.1	5.7	15.4	7.7	25.1	0.4	23.1	20.7	20.0	13.9	5.8	15.4	9.1	16.6	1.7	7.7	15.3	15.2	22.4	15.7	17.0	15.3	4.1	19.1	1.8	24.9	23.6	10.8	5.8	0.6	5.0	11.6	22.3	10.2	1.6	1.9	4.9	4.5	6.6	5.6	13.0	6.8	17.5	18.4	14.5	2.1	21.4	0.4	16.8	5.6	1.2	18.6	9.4	44.3	7.1	6.6	0.9	4.3	14.6	26.4	1.3	7.4	28.8	5.5	6.2	19.8	16.7	0.5	20.9	19.9	2.0	8.9	2.5	26.0	1.2	1.0	3.8	1.3	12.8	14.8	51.5	0.4	0.5	11.5	2.7	20.3	28.8	4.5	22.4	1.0	2.6	4.3	7.1	10.7	0.8	1.6	3.7	18.5	61.0	0.8	0.7	0.5	19.5	4.9	0.5	1.7	18.0	14.7	1.1	0.7	2.5	0.4	30.6	6.7	5.6	55.9	3.1	0.1	1.7	0.6	11.2	0.3	2.7	0.0	50.4	2.1	0.1	118.8	0.1	1.2	0.0	0.1	9.9	0.0	0.1	0.0	171.5	0.0	88.5	0.4	0.0	17.8	15.4	25.1	20.7	20.0	15.7	17.0	24.9	23.6	22.3	17.5	21.4	44.3	25.8	0.0	0.0	0.0	1.5	12.7	11.0	25.8	6.8	15.3	12.1	6.3	6.3	2.8	17.0	12.9	0.0	0.5	1.6	10.0	3.9	50.5	0.5	6.0	11.6	36.4	1.8	2.7	0.6	40.3	3.5	32.3	9.7	11.1	5.7	1.5	26.7	0.9	1.3	3.3	0.4	8.0	8.2	18.7	77.7	1.9	18.6	33.3	12.4	1.0	18.3	1.0	0.0	0.0	10.6	65.1	15.6	13.5	1.8	7.4	21.2	3.7	6.3	5.3	39.5	16.6	16.2	1.7	3.4	4.8	10.1	1.6	1.4	1.8	8.4	36.4
CEBPB	"C/EBP-beta, CRP2, IL6DBP, LAP, NFIL6, TCF5"	ENSG00000172216	"CCAAT enhancer binding protein beta"	P17676	20	50190830-50192668	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 765.6;Suprabasal keratinocytes: 800.1;Syncytiotrophoblasts: 1409.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 16.7"	"Group enriched"	"Detected in many"	8	"granulocytes: 16.7;monocytes: 7.7"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 169.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB004213, HPA061355, HPA062267"	Supported		Enhanced	Nucleoplasm		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB004213: AB_626772, HPA061355: AB_2684487, HPA062267: AB_2684731"	"unprognostic (2.30e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.85e-3)"	"unprognostic (9.26e-3)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (2.44e-12)"	"unprognostic (7.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-2)"	"unprognostic (7.63e-2)"	160.7	125.5	26.6	63.9	29.4	43.2	86.5	24.4	29.8	95.5	36.7	60.0	13.1	72.4	5.8	43.2	94.9	27.6	59.3	29.7	32.4	39.3	228.7	139.5	11.2	34.8	36.4	89.6	35.6	10.8	28.4	37.8	29.2	60.3	7.1	4.6	49.1	12.3	202.2	99.1	43.4	15.5	35.7	93.1	57.7	9.0	33.3	6.3	57.5	44.3	7.3	64.9	67.2	31.5	26.4	11.8	1.3	13.9	63.7	24.9	112.7	34.9	54.6	23.5	20.7	12.0	23.9	17.1	64.5	14.5	115.4	35.3	3.7	34.2	15.9	12.5	8.3	5.2	15.0	17.8	78.3	8.7	32.9	26.7	88.5	29.9	52.9	49.0	3.3	17.4	25.4	31.0	15.0	9.9	4.1	19.0	7.3	24.8	33.6	12.3	3.4	20.1	7.9	6.3	6.7	4.4	28.9	70.7	169.6	7.4	18.8	48.1	4.5	48.6	37.2	42.1	34.0	64.6	29.5	15.9	88.7	19.6	21.6	8.6	3.5	12.5	0.5	6.8	0.1	0.6	0.4	0.6	1.5	0.3	0.4	0.2	16.7	0.5	7.7	0.0	0.3	0.8	26.6	29.4	24.4	29.8	29.7	32.4	34.8	36.4	29.2	35.7	33.3	31.5	83.3	35.3	67.6	16.3	64.2	724.2	371.8	48.3	241.9	3.9	244.6	244.5	48.7	130.1	35.6	46.0	0.0	185.0	208.1	83.4	31.3	32.9	9.9	305.3	417.4	74.9	66.7	33.9	18.4	13.2	681.2	605.1	102.4	410.5	51.4	10.8	94.9	402.7	345.7	3.3	8.6	102.5	24.4	500.4	438.5	10.6	129.5	765.6	217.1	37.5	159.0	87.6	61.8	0.5	1.8	19.2	60.9	96.3	102.7	346.5	61.9	74.2	29.8	5.6	157.8	466.2	356.7	1.1	13.3	162.1	800.1	1409.9	159.3	68.2	63.4	359.6
CEBPD	"C/EBP-delta, CELF, CRP3, NF-IL6-beta"	ENSG00000221869	"CCAAT enhancer binding protein delta"	P49716	8	47736913-47738164	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 1541.7;Basal prostatic cells: 1435.6;Basal squamous epithelial cells: 2487.0;Prostatic glandular cells: 1668.5;Skeletal myocytes: 1386.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 54.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 54.9;monocytes: 19.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 51.9;HHSteC: 66.8;HSkMC: 66.7;NB-4: 148.7;SiHa: 58.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA067581			Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA067581: AB_2685865"	"prognostic favorable (2.28e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.87e-7)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.40e-2)"	251.6	72.0	33.4	62.1	35.2	34.3	168.0	37.2	42.0	99.7	43.9	143.5	26.7	82.8	2.7	85.4	192.0	14.7	136.9	35.8	63.6	106.9	207.8	157.5	8.7	81.5	49.3	265.3	81.9	7.6	117.4	50.0	49.5	151.1	12.1	16.9	89.3	19.4	133.0	106.9	79.6	21.6	46.5	109.7	116.3	14.3	47.4	18.5	103.5	21.6	6.6	168.1	139.9	44.6	9.5	7.4	0.3	0.1	41.5	43.2	51.9	24.1	18.7	6.8	14.4	14.8	14.8	0.1	17.3	6.6	5.8	9.9	1.7	12.9	2.1	0.1	3.9	0.5	6.0	6.3	66.8	4.1	0.0	66.7	33.7	1.6	16.0	4.3	1.4	0.4	4.1	7.3	2.5	2.9	0.1	148.7	2.8	6.2	2.5	0.1	5.1	0.5	20.6	7.8	2.8	1.0	58.7	7.7	6.3	2.6	6.4	33.5	6.2	1.5	3.9	15.6	1.5	0.1	0.1	0.1	7.9	0.1	0.3	2.3	19.9	10.6	2.1	8.4	6.2	0.1	0.3	1.2	7.4	0.6	0.0	0.0	54.9	3.7	3.2	0.2	0.3	2.8	33.4	35.2	37.2	42.0	35.8	63.6	81.5	49.3	49.5	46.5	47.4	44.6	1541.7	102.5	196.3	31.3	14.9	663.5	1435.6	98.7	2487.0	6.0	551.3	617.1	79.2	185.8	76.5	224.3	6.2	189.8	152.8	59.2	217.2	50.7	3.5	287.0	418.9	547.9	23.4	30.3	12.5	77.2	457.9	1377.3	387.3	621.0	5.1	96.4	269.5	157.7	220.3	1.7	2.5	44.3	42.7	520.1	502.0	21.5	435.5	912.6	268.6	29.0	163.5	321.9	150.4	6.0	0.5	53.2	58.4	144.8	34.9	1668.5	127.1	353.4	54.9	17.3	466.8	1386.3	1290.5	3.7	13.9	940.2	817.5	351.9	122.7	85.9	73.2	814.5
CFLAR	"c-FLIP, CASH, CASP8AP1, Casper, cFLIP, CLARP, FLAME, FLIP, I-FLICE, MRIT"	ENSG00000003402	"CASP8 and FADD like apoptosis regulator"	O15519	2	201116154-201176687	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 609.9;Urothelial cells: 521.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 392.6"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 392.6"	"Cell line enhanced"	"Detected in all"		"U-266/70: 214.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019044, CAB022157, CAB025216"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	Yes			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Plasma membrane, Cytosol"	"Nuclear bodies"	"CAB022157: , CAB025216: , HPA019044: AB_10696204"	"unprognostic (4.61e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.95e-2)"	"prognostic favorable (2.79e-4)"	"unprognostic (7.46e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.08e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.83e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.24e-2)"	122.4	50.6	38.8	103.9	40.9	247.6	83.1	54.1	47.4	57.0	75.6	86.0	59.2	57.9	60.6	68.0	66.6	71.6	184.8	39.4	32.7	57.5	59.2	174.6	91.1	46.5	40.5	38.3	40.7	31.8	29.4	94.0	42.1	65.6	56.4	12.4	58.0	63.2	222.8	51.0	64.8	58.8	36.6	98.1	56.5	25.3	51.9	54.1	78.8	89.2	107.3	78.7	61.7	46.1	21.5	42.9	30.0	17.9	92.3	71.0	37.5	53.6	92.1	34.3	41.6	50.4	78.4	5.8	49.6	62.5	41.6	15.5	9.8	40.3	53.9	160.7	29.9	32.3	38.4	82.2	63.6	24.2	102.2	76.8	39.6	58.2	50.3	41.7	176.7	7.3	110.8	131.2	63.1	17.9	11.3	96.3	10.2	17.2	32.7	11.7	7.2	46.5	42.5	44.0	6.6	11.8	35.7	31.2	43.2	19.6	22.1	44.8	193.6	71.0	29.5	26.7	26.1	214.6	76.2	35.9	50.6	19.5	36.3	91.8	60.3	70.3	54.4	61.8	48.4	25.6	46.5	52.1	33.4	20.9	29.5	38.3	392.6	45.2	68.5	23.0	60.7	42.0	38.8	40.9	54.1	47.4	39.4	32.7	46.5	40.5	42.1	36.6	51.9	46.1	191.3	451.9	234.9	30.3	126.4	54.8	229.6	164.9	29.0	10.9	38.9	30.0	205.8	102.9	206.7	69.9	31.3	77.2	166.2	132.5	74.3	148.8	83.3	202.8	75.0	261.0	95.1	59.1	6.9	72.5	34.8	89.5	73.4	219.2	81.6	93.4	201.0	97.5	68.6	13.5	16.8	76.8	40.7	123.2	609.9	44.8	51.9	278.0	97.8	146.1	247.0	23.4	276.0	29.7	56.8	166.4	155.6	49.7	317.8	386.0	116.7	101.5	276.1	30.7	39.5	113.2	77.9	14.4	12.2	33.2	86.1	70.1	168.3	56.1	50.9	521.3
CH25H		ENSG00000138135	"Cholesterol 25-hydroxylase"	O95992	10	89205629-89207317	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 125.9;Basal squamous epithelial cells: 224.3;Macrophages: 47.3;Microglial cells: 40.3;Smooth muscle cells: 59.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 8.8;ASC TERT1: 4.4;fHDF/TERT166: 32.8;HSkMC: 8.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"spinal cord: 6.3"							NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"				"unprognostic (6.07e-3)"	"unprognostic (2.96e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.54e-1)"	"unprognostic (8.65e-3)"	"unprognostic (7.74e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.62e-5)"	"unprognostic (2.47e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.29e-2)"	21.5	5.1	4.3	7.0	5.0	3.1	7.4	6.5	6.6	3.5	4.4	3.6	3.2	1.3	12.6	14.7	6.0	14.6	4.5	4.2	8.4	7.8	3.6	17.2	4.0	18.4	9.5	2.1	1.6	1.1	9.0	4.2	11.4	4.1	5.5	0.4	2.1	1.3	1.8	3.0	5.6	5.5	8.6	2.0	5.8	0.1	6.0	35.3	2.8	1.0	3.7	18.5	2.1	8.2	0.0	0.0	0.0	0.0	8.8	4.4	0.0	0.1	3.1	0.8	0.9	0.0	0.0	0.0	1.1	32.8	0.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.8	0.0	0.0	8.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	4.2	0.0	0.2	0.0	0.1	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	5.0	6.5	6.6	4.2	8.4	18.4	9.5	11.4	8.6	6.0	8.2	125.9	3.2	3.4	0.3	1.8	6.9	4.4	11.7	224.3	0.0	6.4	1.0	0.6	0.0	10.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	1.5	0.9	23.6	0.0	0.0	2.9	0.0	0.2	33.4	2.0	3.1	1.3	0.0	2.5	0.0	10.2	1.7	0.5	0.0	2.0	12.9	8.2	0.0	0.3	47.3	7.2	40.3	0.0	0.6	0.0	0.0	0.4	0.1	0.0	0.7	4.4	1.0	0.0	0.0	4.5	0.5	6.6	3.6	59.3	0.0	0.0	30.8	6.7	0.1	11.6	0.5	0.0	6.2
CHD1		ENSG00000153922	"Chromodomain helicase DNA binding protein 1"	O14646	5	98853985-98929007	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 69.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022236	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA022236: AB_2670915"	"unprognostic (2.63e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.15e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (7.25e-6)"	"unprognostic (2.69e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.17e-1)"	14.7	10.3	6.9	17.8	7.3	69.6	9.2	17.9	14.1	8.0	8.8	10.5	9.8	12.7	7.0	7.9	8.1	15.0	5.4	6.1	8.3	8.3	13.2	9.4	13.7	9.7	7.7	14.1	10.0	9.4	4.8	14.2	8.8	8.2	10.3	14.9	5.4	7.1	9.7	6.2	9.5	9.0	7.4	15.7	8.2	18.1	7.3	49.6	8.8	9.0	13.8	12.4	5.9	9.3	23.0	20.7	47.5	32.3	15.7	16.1	41.3	23.2	15.1	18.4	23.8	25.9	17.3	19.3	22.0	13.5	29.8	18.6	37.6	25.6	38.2	30.5	28.2	34.2	25.8	19.8	17.3	33.3	25.5	14.0	10.2	32.0	32.2	12.5	22.6	62.0	42.0	28.9	18.7	18.5	66.4	14.4	32.0	7.2	24.8	55.7	33.2	29.2	16.0	21.6	22.1	18.9	29.8	15.4	37.9	24.6	15.0	22.6	25.7	39.3	21.2	24.9	41.6	20.0	22.6	40.0	21.5	32.6	24.2	13.1	7.1	10.1	5.4	6.6	6.9	9.4	5.1	5.3	6.5	8.3	7.0	5.6	14.4	7.4	6.8	4.7	5.9	2.0	6.9	7.3	17.9	14.1	6.1	8.3	9.7	7.7	8.8	7.4	7.3	9.3	87.2	48.1	72.2	35.3	145.3	155.5	99.0	26.6	115.5	39.3	85.9	56.1	29.9	22.8	57.4	36.8	43.8	53.9	203.6	64.0	7.9	36.5	101.0	84.3	114.3	79.5	31.8	40.8	50.9	32.0	38.4	104.6	50.0	107.3	89.2	45.2	40.0	30.6	35.6	33.7	59.8	31.2	16.2	65.8	145.9	19.8	32.3	169.7	67.6	90.9	89.1	20.5	59.8	66.4	72.1	35.3	51.4	19.2	121.0	82.6	28.1	15.5	45.3	49.5	46.0	173.8	113.5	67.1	54.6	74.1	188.5	90.3	148.2	49.9	39.4	75.4
CHMP1B	"C18orf2, CHMP1.5, Vps46B"	ENSG00000255112	"Charged multivesicular body protein 1B"	Q7LBR1	18	11851413-11854444	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 361.4"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 514.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA061997, HPA062896"	Supported		Approved	Nucleoplasm,Midbody		Yes	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Midbody	Nucleoplasm	"HPA061997: AB_2684653, HPA062896: AB_2684898"	"unprognostic (6.73e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.90e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.37e-3)"	"unprognostic (9.20e-2)"	"prognostic favorable (7.37e-8)"	"unprognostic (1.88e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.92e-1)"	43.3	35.7	24.5	36.2	25.9	61.2	29.0	19.6	25.4	25.6	30.0	39.1	38.7	28.3	26.2	39.1	24.8	39.3	40.7	25.9	25.6	33.1	31.1	29.7	29.9	21.9	23.2	29.6	24.8	39.9	29.3	27.8	22.6	27.8	37.5	17.6	29.5	35.0	361.4	40.4	48.8	23.6	20.3	30.2	30.5	14.0	24.0	46.0	52.2	53.2	24.8	49.5	23.8	23.6	30.0	28.8	36.5	31.1	46.9	32.7	52.9	31.4	52.6	21.0	27.9	37.5	29.4	18.5	45.9	34.2	35.0	25.0	16.8	43.7	18.5	17.2	20.8	13.5	43.6	31.1	34.6	51.7	22.3	47.7	92.5	23.5	53.9	46.8	30.7	41.6	23.1	23.4	33.3	37.3	36.1	39.6	15.3	94.9	14.3	18.4	18.8	32.1	56.5	40.5	35.5	35.5	53.1	24.7	50.5	33.9	20.2	47.2	45.2	46.7	24.5	37.3	34.0	27.8	34.3	23.5	43.3	23.8	22.7	32.5	38.8	66.7	15.4	35.7	14.3	14.7	14.3	18.5	30.2	14.7	17.6	16.4	77.9	18.3	36.6	26.7	21.5	29.2	24.5	25.9	19.6	25.4	25.9	25.6	21.9	23.2	22.6	20.3	24.0	23.6	71.2	67.3	47.0	0.0	152.9	419.6	141.8	291.8	216.9	30.5	71.3	59.4	21.7	52.9	157.7	132.4	8.4	135.9	171.0	281.4	60.7	123.0	80.4	146.6	110.2	69.9	143.8	40.4	0.0	80.3	144.4	99.3	70.8	298.3	149.9	38.4	52.8	44.1	118.0	28.6	0.0	104.6	111.9	139.9	440.8	42.6	37.9	354.5	158.3	0.0	102.1	32.2	78.2	0.0	0.0	134.0	393.7	37.2	21.8	93.9	179.2	139.1	84.8	16.8	78.9	61.2	94.5	16.0	21.1	177.1	514.7	253.2	135.5	43.9	96.8	252.2
CHSY1	"CSS1, KIAA0990"	ENSG00000131873	"Chondroitin sulfate synthase 1"	Q86X52	15	101175727-101252048	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 216.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"				"unprognostic (7.28e-2)"	"unprognostic (6.39e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.60e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (6.33e-5)"	"unprognostic (3.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	27.5	18.6	10.3	18.5	9.8	23.0	21.7	9.0	11.8	19.5	14.4	7.7	6.0	17.3	9.5	10.8	14.9	22.7	20.1	9.2	10.3	13.7	10.0	23.6	11.6	14.2	13.8	19.7	7.3	7.4	8.5	46.7	11.9	14.4	8.2	7.0	10.1	11.4	6.5	15.0	7.7	20.0	11.5	13.9	10.4	8.7	12.5	10.5	10.0	7.4	10.3	34.8	14.0	9.8	9.1	11.2	36.8	18.7	18.9	25.0	24.5	21.8	19.2	25.8	26.2	9.7	7.1	22.0	12.7	36.3	16.8	24.7	24.5	27.7	28.2	24.6	12.4	43.4	12.2	11.4	23.3	66.9	42.9	23.2	22.8	22.3	20.1	29.3	30.8	9.7	16.2	216.3	19.7	7.9	9.2	46.3	42.5	17.7	7.9	20.6	36.9	32.8	18.1	17.7	6.4	34.6	23.0	11.1	40.8	29.8	12.6	81.6	26.2	41.9	24.1	20.0	46.5	38.2	94.5	12.7	32.5	62.2	32.0	0.0	1.3	2.9	1.5	0.8	1.7	0.9	0.9	1.6	0.8	1.0	0.5	1.0	4.9	0.7	0.9	0.5	1.8	0.6	10.3	9.8	9.0	11.8	9.2	10.3	14.2	13.8	11.9	11.5	12.5	9.8	55.0	0.0	15.7	27.7	11.4	57.9	20.7	10.1	20.5	10.7	41.9	29.8	9.3	5.7	9.4	16.5	6.2	6.1	14.6	1.6	1.9	5.3	1.2	10.0	33.4	45.8	3.0	12.0	34.2	2.2	28.8	40.0	5.1	13.8	25.9	51.9	60.0	5.4	16.6	38.7	36.1	3.6	10.2	17.8	37.1	2.5	55.0	41.2	26.6	59.0	10.2	9.2	10.3	21.1	24.2	5.5	2.5	47.0	9.3	19.3	1.2	2.4	8.1	7.5	46.0	47.9	53.5	3.9	7.5	10.5	62.5	13.8	15.2	23.0	3.9	10.2
CIITA	"C2TA, MHC2TA, NLRA"	ENSG00000179583	"Class II major histocompatibility complex transactivator"	P33076	16	10866222-10943021	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Kinase, Transferase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 57.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 48.8;Langerhans cells: 51.8;Macrophages: 43.8;Microglial cells: 42.2;monocytes: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 29.1;eosinophil: 17.5;intermediate monocyte: 23.5;memory B-cell: 47.3;myeloid DC: 46.2;naive B-cell: 63.3;non-classical monocyte: 29.0;plasmacytoid DC: 48.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 51.1;REH: 89.5;U-266/70: 18.0;U-698: 25.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016084, HPA054757"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB016084: AB_627261, HPA054757: "	"unprognostic (1.45e-3)"	"unprognostic (1.38e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-2)"	9.4	6.5	6.4	39.2	5.9	9.2	7.8	7.3	7.9	10.7	8.9	6.7	20.5	7.3	2.6	5.5	7.4	15.0	5.4	5.4	11.5	7.2	4.7	24.1	57.3	15.0	8.3	3.6	3.9	2.6	3.0	2.6	11.9	4.8	8.2	1.4	12.1	6.9	5.0	8.7	24.8	7.3	11.5	51.2	12.9	2.1	13.0	15.9	5.2	2.4	57.0	9.0	4.1	16.4	0.4	0.4	0.7	0.6	0.1	0.0	0.5	0.2	0.0	0.3	0.4	0.6	12.0	11.2	1.6	0.0	1.7	1.8	0.0	0.0	0.2	51.1	0.6	6.3	2.6	1.3	0.0	0.9	0.9	2.1	0.0	0.2	0.0	1.8	0.0	0.7	0.8	4.1	0.2	0.7	0.6	1.0	0.3	0.4	0.3	89.5	0.6	7.9	0.1	3.6	1.8	0.3	2.1	0.6	2.1	0.6	1.0	3.8	0.5	4.3	0.7	1.2	0.5	18.0	1.4	25.8	16.0	1.1	14.7	0.7	29.1	17.5	0.8	23.5	0.4	47.3	0.3	1.4	46.2	63.3	0.2	0.4	6.8	1.8	29.0	48.3	1.2	5.4	6.4	5.9	7.3	7.9	5.4	11.5	15.0	8.3	11.9	11.5	13.0	16.4	14.5	6.4	19.5	0.3	48.8	2.3	0.3	1.3	1.2	0.8	1.7	2.0	5.3	1.5	1.5	3.7	0.0	0.2	17.9	2.0	0.0	5.5	0.8	1.5	0.4	7.3	2.4	6.9	1.4	2.0	0.3	1.2	4.6	1.4	10.8	7.7	1.4	0.7	8.7	0.0	1.8	1.9	0.0	16.1	51.8	0.0	0.6	43.8	7.2	42.2	51.8	0.2	2.1	0.0	0.3	1.1	0.1	0.0	1.1	0.4	12.3	4.8	5.6	1.6	0.0	1.0	1.2	0.0	0.0	1.0	2.8	0.1	3.0	0.4	1.5	0.5
CLEC10A	"CD301, CLECSF13, CLECSF14, HML, HML2"	ENSG00000132514	"C-type lectin domain containing 10A"	Q8IUN9	17	7074537-7080307	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Endocytosis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.4"	"Group enriched"	"Detected in some"	6	"Langerhans cells: 805.4;Macrophages: 213.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in many"	12	"myeloid DC: 465.9"	"Lineage enriched"	"Detected in many"	12	"dendritic cells: 465.9"	"Not detected"	"Not detected"											HPA021937	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"		"Cluster 41: Macrophages - Immune response"			"HPA021937: AB_1846905"	"unprognostic (3.96e-3)"	"unprognostic (1.71e-3)"	"unprognostic (2.95e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.54e-2)"	"prognostic favorable (1.26e-5)"	"unprognostic (1.07e-1)"	"prognostic favorable (9.24e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (3.23e-1)"	"unprognostic (3.65e-1)"	20.9	3.3	0.3	29.4	0.4	2.5	8.5	0.3	0.6	4.1	1.6	13.6	15.8	3.8	1.2	10.4	4.5	18.8	6.4	0.3	0.4	2.7	6.9	12.3	19.8	0.4	0.5	2.1	2.8	1.3	1.3	0.7	1.2	3.0	18.2	0.0	4.3	4.7	3.0	10.0	25.5	18.9	0.3	18.5	7.7	2.5	0.6	7.8	2.6	3.1	13.6	19.9	3.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	29.9	0.1	0.0	39.0	0.2	0.0	0.2	0.1	465.9	0.3	0.1	0.0	2.1	2.2	0.3	9.2	0.3	20.5	0.3	0.4	0.3	0.6	0.3	0.4	0.4	0.5	1.2	0.3	0.6	0.5	1.1	3.2	3.9	0.0	3.6	13.3	0.0	0.0	1.2	0.0	0.2	0.5	1.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.4	0.1	0.1	1.5	0.0	3.0	0.2	0.0	0.2	2.0	0.0	0.1	1.3	0.0	0.4	1.1	18.4	0.0	0.0	0.1	0.0	77.9	805.4	1.2	0.3	213.9	21.4	0.0	26.9	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.9	0.0	0.0	0.2	0.0	0.0	6.6	0.5	1.7	0.0	2.3	0.4	11.8	0.1	1.6	0.0	0.0	0.0
CLEC4E	"CLECSF9, mincle"	ENSG00000166523	"C-type lectin domain family 4 member E"	Q9ULY5	12	8533305-8540905	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 75.7;lymphoid tissue: 52.3"	"Cell type enhanced"	"Detected in some"		"Glandular and luminal cells: 31.9;Kupffer cells: 158.0;Macrophages: 115.2;monocytes: 109.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"classical monocyte: 128.8;neutrophil: 448.8"	"Group enriched"	"Detected in many"	17	"granulocytes: 448.8;monocytes: 128.8"	"Group enriched"	"Detected in some"	4	"NB-4: 4.3;RPTEC TERT1: 12.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004935	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA004935: AB_2667299"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.91e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.29e-1)"	13.3	5.4	2.3	37.5	2.1	75.7	4.5	1.8	4.4	5.8	2.2	2.2	0.4	2.3	0.4	3.2	5.5	11.8	2.5	2.3	2.9	3.6	6.6	22.4	7.6	1.3	1.3	1.7	6.2	1.7	1.9	2.1	1.2	2.3	1.0	1.3	1.4	1.2	0.7	0.9	3.1	5.7	0.7	52.3	2.5	1.1	2.0	2.2	10.5	5.0	2.3	9.6	1.7	2.9	0.1	0.4	0.4	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	1.5	0.1	0.1	2.0	0.0	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.2	0.1	0.5	0.1	0.0	1.5	0.0	0.5	0.2	0.2	0.2	0.2	0.0	0.1	0.0	4.3	0.3	0.0	0.0	0.0	0.2	0.1	12.4	0.1	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.4	1.0	0.5	0.1	1.0	0.1	0.2	0.1	0.1	1.3	0.4	0.1	0.2	128.8	0.5	0.1	18.1	0.3	0.1	0.1	0.1	16.9	0.1	0.0	0.1	448.8	0.0	0.7	0.7	0.0	30.3	2.3	2.1	1.8	4.4	2.3	2.9	1.3	1.3	1.2	0.7	2.0	2.9	6.2	0.0	4.7	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	5.7	1.8	1.8	0.0	0.0	0.3	0.0	0.0	9.0	0.3	2.1	4.4	3.5	0.0	0.0	0.0	0.0	0.1	1.4	0.0	31.9	0.0	0.0	7.1	2.1	5.6	0.0	0.0	0.0	0.0	158.0	9.0	2.9	0.9	115.2	0.0	0.0	109.5	0.0	4.1	0.0	0.0	0.4	0.0	0.4	1.3	0.0	0.0	0.2	0.7	0.0	13.1	0.2	0.4	0.2	0.5	0.1	0.0	0.1	1.1	0.0	0.0	0.1
CLEC7A	"CD369, CLECSF12, dectin-1, hDectin-1, SCARE2"	ENSG00000172243	"C-type lectin domain containing 7A"	Q9BXN2	12	10116777-10130258	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 84.0;lung: 30.9;lymphoid tissue: 44.5"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 87.2;Kupffer cells: 415.2;Langerhans cells: 291.5;Macrophages: 255.5;monocytes: 186.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 249.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"Karpas-707: 192.2;U-266/84: 168.1"					"Low region specificity"	"Detected in all"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"				"unprognostic (1.79e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.83e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.14e-1)"	9.9	5.9	2.2	44.5	2.0	84.0	4.5	2.6	3.7	3.5	3.3	7.5	5.6	3.2	3.7	9.7	5.8	11.1	5.7	1.9	3.3	3.5	11.0	30.9	14.4	5.0	2.7	2.4	2.9	2.0	2.7	7.3	4.0	3.3	7.3	1.7	7.3	3.2	1.3	3.8	8.6	8.7	3.6	34.2	4.6	1.5	3.8	10.0	2.6	2.0	11.9	9.1	4.8	6.1	0.3	0.4	0.1	0.2	0.0	0.0	1.1	0.0	0.5	0.2	0.1	0.1	0.4	0.1	0.1	0.0	1.1	0.6	0.0	0.0	0.0	0.1	0.0	0.4	0.5	0.0	0.0	0.9	0.7	0.1	0.8	0.1	0.0	0.2	0.1	0.2	0.0	192.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.1	4.3	0.0	5.2	0.3	0.2	0.3	0.6	0.0	1.4	0.4	0.1	0.3	0.1	0.2	0.2	0.2	11.4	168.1	0.1	0.3	1.0	0.2	1.4	122.9	2.2	0.3	137.2	0.5	0.3	0.3	0.2	60.6	0.3	0.3	0.2	249.6	0.4	148.1	1.0	0.4	40.4	2.2	2.0	2.6	3.7	1.9	3.3	5.0	2.7	4.0	3.6	3.8	6.1	2.0	12.8	15.1	0.3	5.9	3.7	0.2	0.9	8.6	0.0	3.1	2.8	0.9	0.0	9.7	0.0	0.0	1.5	2.1	0.2	0.0	0.1	1.7	0.2	0.1	9.3	0.0	0.0	0.1	0.0	14.1	2.4	0.0	0.1	6.3	0.0	6.1	2.1	87.2	0.0	0.1	0.0	4.1	415.2	291.5	2.2	0.3	255.5	3.6	27.2	186.1	0.0	8.2	0.0	0.0	0.0	1.1	0.0	1.1	0.1	0.0	1.3	2.4	0.4	13.1	1.1	1.0	0.1	0.5	13.2	3.0	5.3	4.1	0.0	0.0	0.5
CLEC9A	"CD370, DNGR-1, HEEE9341, UNQ9341"	ENSG00000197992	"C-type lectin domain containing 9A"	Q6UXN8	12	10030678-10066031	"CD markers, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 7.5"	"Group enriched"	"Detected in some"	5	"Langerhans cells: 30.2;Macrophages: 19.5;Microglial cells: 15.9;Spermatocytes: 9.4"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 2.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	96	"myeloid DC: 22.0;neutrophil: 7.9"	"Group enriched"	"Detected in many"	96	"dendritic cells: 22.0;granulocytes: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"		"Cluster 41: Macrophages - Immune response"				"unprognostic (1.13e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.00e-3)"	"unprognostic (7.85e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.56e-5)"	"unprognostic (6.58e-4)"	"unprognostic (4.73e-3)"	"unprognostic (9.65e-2)"	"unprognostic (7.45e-3)"	"unprognostic (8.15e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.45e-5)"	"unprognostic (2.17e-1)"	0.3	0.2	1.3	1.5	1.4	0.5	0.6	2.0	1.8	0.3	1.1	0.7	0.8	0.5	0.2	0.2	0.2	0.9	0.2	1.6	2.1	0.3	0.8	0.6	7.5	2.7	1.8	0.7	0.3	0.2	0.3	0.2	2.1	0.6	0.6	0.1	1.1	0.4	0.1	0.3	1.5	0.7	2.2	4.8	0.4	3.0	1.9	4.9	0.2	0.2	2.2	1.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	7.9	0.1	0.0	0.0	0.0	0.4	1.3	1.4	2.0	1.8	1.6	2.1	2.7	1.8	2.1	2.2	1.9	2.6	0.8	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.5	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.7	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	3.2	30.2	1.8	0.0	19.5	0.0	15.9	2.1	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.4	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CLIC2	"CLCNL2, XAP121"	ENSG00000155962	"Chloride intracellular channel 2"	O15247	X	155276211-155334657	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 51.2;Alveolar cells type 1: 89.8;Alveolar cells type 2: 54.9;Endothelial cells: 60.4;Erythroid cells: 70.7;Kupffer cells: 73.5;Langerhans cells: 135.0;monocytes: 71.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 18.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 18.6;myeloid DC: 47.9;non-classical monocyte: 14.2"	"Group enriched"	"Detected in many"	16	"dendritic cells: 47.9;monocytes: 18.6"	"Group enriched"	"Detected in some"	5	"HDLM-2: 103.3;K-562: 60.4;Karpas-707: 53.4;RPMI-8226: 92.2"					"Low region specificity"	"Detected in all"			"HPA047381, HPA060101"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		150000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA047381: AB_2680022, HPA060101: AB_2684204"	"unprognostic (3.27e-2)"	"unprognostic (5.21e-3)"	"unprognostic (9.70e-2)"	"unprognostic (7.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-1)"	23.1	7.1	6.9	16.7	7.8	9.8	16.7	6.9	18.1	20.1	7.6	10.9	8.7	22.6	7.8	9.4	12.5	19.0	14.6	7.1	7.0	5.8	12.8	30.6	30.2	7.7	6.9	21.6	3.5	4.6	4.5	9.3	7.4	4.6	13.6	2.4	6.2	6.3	4.4	6.1	10.3	17.7	7.7	50.1	8.5	3.2	8.5	14.5	31.8	14.3	25.6	15.9	10.7	7.8	0.7	0.0	1.0	0.9	1.0	4.7	0.0	0.2	2.8	0.0	0.4	0.0	0.2	0.1	0.4	0.0	0.2	0.1	0.3	0.0	0.0	103.3	0.5	16.4	0.3	0.0	0.0	0.4	0.6	1.4	0.0	0.0	0.1	0.5	0.1	0.5	60.4	53.4	0.3	0.2	0.1	1.3	0.2	0.1	0.4	0.4	0.0	92.2	0.2	0.2	0.7	0.9	0.0	0.1	0.4	0.2	0.0	1.0	0.0	5.3	1.6	2.0	0.9	3.3	4.6	0.0	2.7	2.6	1.7	0.0	3.5	0.2	0.0	18.6	0.3	0.0	0.1	0.1	47.9	0.0	0.0	0.0	1.4	2.0	14.2	5.2	0.0	2.1	6.9	7.8	6.9	18.1	7.1	7.0	7.7	6.9	7.4	7.7	8.5	7.8	51.2	89.8	54.9	3.9	1.1	13.3	0.8	0.2	2.2	1.2	0.7	1.3	3.2	0.0	5.8	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.5	11.3	60.4	1.2	70.7	8.6	0.2	0.1	25.6	0.5	0.4	3.8	0.5	27.1	1.2	4.7	0.0	7.0	0.6	0.0	73.5	135.0	1.1	13.7	34.5	17.8	8.4	71.4	0.2	0.0	3.0	2.4	0.1	0.0	9.4	2.0	0.5	0.0	0.6	1.5	0.3	6.6	2.5	4.6	0.3	0.3	0.4	13.8	0.0	2.6	5.2	0.1	1.9
CLNK	MIST	ENSG00000109684	"Cytokine dependent hematopoietic cell linker"	Q7Z7G1	4	10486395-10684768	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 6.2"	"Cell type enriched"	"Detected in many"	5	"Ionocytes: 73.2"	"Cancer enriched"	"Detected in single"	13	"renal cancer: 3.3"	"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HDLM-2: 4.1;U-937: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035671, HPA035672"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA035671: AB_10669673, HPA035672: AB_10669775"	"unprognostic (2.47e-3)"	"unprognostic (4.74e-4)"	"unprognostic (1.99e-4)"	"unprognostic (2.24e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.23e-6)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	"unprognostic (9.87e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.99e-2)"	0.3	0.2	0.5	0.9	0.4	0.4	0.6	1.5	0.7	0.2	0.5	0.3	0.6	0.4	1.2	0.4	0.2	0.5	0.2	0.5	0.5	6.2	0.9	0.6	3.0	0.4	0.2	0.4	0.1	0.1	1.3	1.0	0.5	0.4	0.4	0.3	0.5	0.3	0.2	0.8	0.9	0.1	0.1	1.5	1.1	0.8	0.5	1.4	0.3	0.0	2.0	0.3	0.0	0.9	0.0	0.2	0.2	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	4.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.2	0.3	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.2	2.2	0.1	0.5	0.1	0.2	0.2	0.1	0.1	1.4	0.4	0.1	2.6	1.1	0.1	0.1	0.4	2.0	0.0	0.6	1.8	0.2	0.5	0.4	1.5	0.7	0.5	0.5	0.4	0.2	0.5	0.1	0.5	0.9	0.1	3.2	3.0	1.0	12.9	0.8	0.8	0.0	0.0	1.3	0.3	0.3	0.7	0.0	0.9	0.0	2.1	0.3	4.6	0.1	13.7	0.0	5.3	0.7	0.2	0.4	0.0	5.3	1.7	0.0	2.2	0.5	0.5	0.9	11.4	0.2	0.7	0.3	0.3	0.0	1.6	0.2	73.2	1.9	5.5	5.4	0.3	3.5	1.8	1.9	0.5	0.4	0.0	1.0	0.7	0.1	0.0	2.2	1.1	0.7	0.0	0.2	0.2	1.0	0.0	1.1	0.5	1.9	0.8	0.0	0.4	0.1	6.0	1.3	0.0	0.7
CMTM6	"CKLFSF6, FLJ20396"	ENSG00000091317	"CKLF like MARVEL transmembrane domain containing 6"	Q9NX76	3	32481312-32502852	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 815.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026980, HPA063491"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA026980: AB_10602801, HPA063491: "	"unprognostic (1.32e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.81e-2)"	"unprognostic (7.25e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.04e-3)"	"unprognostic (6.79e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.23e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.55e-3)"	40.3	26.2	11.6	69.0	11.4	97.3	54.4	11.7	13.5	50.4	24.8	47.7	26.7	46.3	41.0	40.3	176.6	50.3	18.5	10.8	13.4	40.0	132.4	54.3	53.9	14.5	12.5	18.6	23.5	41.6	9.2	70.1	14.3	48.6	58.4	13.0	33.2	39.9	5.0	49.4	29.5	41.6	14.5	55.4	46.9	40.4	13.5	47.8	61.7	13.6	78.3	79.0	18.9	14.7	107.4	34.2	66.5	50.1	112.1	111.0	292.4	77.5	110.4	79.7	91.5	36.6	174.4	63.5	86.1	104.6	53.8	67.6	47.0	128.9	108.2	285.4	57.3	80.4	22.8	54.5	79.6	135.3	153.0	110.5	81.3	92.0	68.6	128.2	130.3	60.9	39.8	116.0	103.0	33.4	81.9	70.0	59.3	88.6	50.0	68.6	51.7	49.9	111.1	147.9	15.3	44.3	70.5	39.5	76.1	66.9	58.3	133.5	117.8	88.0	57.9	86.7	94.1	59.6	63.9	58.6	61.4	116.8	112.1	176.8	84.4	208.0	29.1	133.4	32.8	54.4	38.1	28.3	72.7	42.2	22.0	24.7	313.4	65.1	210.2	38.6	46.3	108.6	11.6	11.4	11.7	13.5	10.8	13.4	14.5	12.5	14.3	14.5	13.5	14.7	57.0	35.3	49.9	12.4	243.7	96.0	82.4	159.3	55.2	13.9	233.0	57.5	5.8	60.1	112.0	95.6	12.5	253.6	122.5	88.0	33.2	113.8	12.3	129.1	68.3	70.7	132.1	41.2	14.2	83.0	101.7	74.9	63.2	180.9	126.8	186.5	124.9	305.2	156.5	50.5	19.2	117.6	118.0	310.1	815.8	8.4	39.4	326.0	81.8	30.0	425.8	130.1	71.1	18.1	9.4	136.7	46.1	42.9	104.7	147.1	23.8	63.4	183.0	17.3	39.5	32.9	74.3	36.1	20.2	89.7	126.6	261.7	120.9	50.3	64.6	110.3
CNEP1R1	"C16orf69, FLJ38101, NEP1-R1, TMEM188"	ENSG00000205423	"CTD nuclear envelope phosphatase 1 regulatory subunit 1"	Q8N9A8	16	50024410-50037088	"Predicted membrane proteins"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042815, HPA077906"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 14: REH - Unknown function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA042815: AB_10794765, HPA077906: AB_2686868"	"unprognostic (4.11e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.53e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.37e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.78e-2)"	9.6	8.4	6.4	14.4	7.3	23.8	7.9	8.0	7.1	8.4	5.9	9.4	8.9	9.2	12.9	12.0	7.6	10.7	9.0	6.7	6.6	7.1	10.6	9.5	14.3	6.6	5.9	9.8	7.1	8.6	8.4	15.6	6.6	8.3	13.4	9.6	8.3	8.2	10.1	11.6	9.2	11.0	6.7	13.4	9.8	18.0	6.7	9.5	5.4	7.3	15.3	10.0	9.0	7.9	11.2	10.2	12.4	13.9	23.5	23.1	17.4	22.5	17.1	21.4	12.5	11.0	15.3	12.4	16.3	18.7	14.6	17.0	10.0	10.9	27.1	9.1	11.7	6.1	6.7	17.8	16.7	8.1	18.1	17.0	18.2	13.9	10.8	16.6	14.8	15.5	7.6	6.9	27.4	3.4	16.0	21.0	9.0	4.9	13.8	19.3	16.4	12.8	15.9	7.4	9.3	11.1	21.3	8.5	9.0	10.7	7.4	10.0	19.3	20.7	15.9	19.7	8.0	11.4	11.3	14.5	12.0	8.1	17.4	16.6	21.0	16.3	16.0	29.2	15.1	9.4	12.4	11.9	17.5	8.7	12.4	14.5	51.0	12.7	36.4	6.9	13.4	14.5	6.4	7.3	8.0	7.1	6.7	6.6	6.6	5.9	6.6	6.7	6.7	7.9	8.2	3.2	7.8	8.8	10.1	10.6	3.4	6.5	5.7	5.8	5.9	3.9	11.4	8.6	6.9	7.3	4.2	17.7	10.6	7.7	3.9	5.2	4.6	5.9	8.6	8.6	4.8	7.8	13.7	5.4	25.1	9.7	8.6	6.8	12.7	5.6	10.0	6.9	14.8	6.7	13.2	3.7	2.0	20.0	20.8	3.9	5.9	18.2	16.0	6.5	15.4	12.2	12.3	8.5	12.5	5.8	6.4	7.9	7.7	4.2	5.0	5.5	4.5	10.0	6.6	9.4	8.4	26.4	18.8	5.5	9.8	14.4	13.3	5.7	5.6	3.8
COMMD5	"FLJ13008, HCaRG, HT002"	ENSG00000170619	"COMM domain containing 5"	Q9GZQ3	8	144841042-144853736	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046905			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"		"HPA046905: AB_2732535"	"unprognostic (2.95e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.13e-2)"	"unprognostic (5.05e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.24e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.25e-2)"	"unprognostic (8.58e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.73e-3)"	17.0	22.9	16.6	11.9	17.0	21.2	15.7	18.1	19.7	14.9	15.6	15.6	12.1	16.1	9.7	20.1	14.2	11.3	18.9	16.2	16.3	18.7	23.2	15.1	16.2	18.1	16.9	12.8	16.7	14.5	17.7	11.0	17.5	16.4	6.8	3.8	15.5	10.7	18.2	16.8	14.9	8.8	17.3	21.9	16.4	11.2	17.2	11.3	16.4	11.4	10.6	15.9	14.3	18.7	32.8	38.3	17.9	24.2	21.8	17.4	16.0	18.5	19.7	30.9	24.2	23.0	25.1	22.3	40.4	22.6	17.9	21.7	22.5	30.6	13.2	29.6	31.7	47.1	35.3	38.8	28.8	16.0	39.6	23.1	27.6	21.2	15.7	15.0	24.2	7.9	34.2	39.8	25.2	59.4	14.6	16.8	27.1	45.6	75.3	18.8	20.4	34.8	30.2	28.3	41.6	36.6	30.9	18.5	27.4	11.9	36.3	29.7	22.4	23.1	45.9	33.3	36.8	16.6	19.2	21.3	32.5	29.7	30.5	66.1	84.3	76.6	55.8	72.4	49.8	60.7	42.4	54.9	74.2	54.1	41.6	46.7	52.3	69.2	47.0	26.8	71.2	70.1	16.6	17.0	18.1	19.7	16.2	16.3	18.1	16.9	17.5	17.3	17.2	18.7	27.8	12.8	15.0	8.5	27.5	27.8	20.4	46.4	11.4	12.3	22.8	23.9	10.9	21.5	25.0	16.5	12.5	35.8	39.0	26.4	39.2	46.4	3.5	19.6	16.4	27.6	19.9	14.1	6.2	40.1	23.8	22.7	13.7	18.6	24.8	15.6	25.7	19.0	70.0	11.8	7.7	16.8	34.6	31.4	27.6	2.5	18.6	34.2	26.6	5.6	37.2	22.3	38.1	6.6	9.5	50.0	18.4	23.3	20.3	42.7	29.8	44.6	28.2	15.2	13.1	16.0	24.6	12.1	17.2	18.4	30.0	33.1	27.0	28.7	18.9	28.5
CPNE3		ENSG00000085719	"Copine 3"	O75131	8	86514435-86561498	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 249.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029552	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		71000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"		"HPA029552: AB_10600703"	"unprognostic (5.63e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.92e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.64e-3)"	"unprognostic (2.77e-1)"	"prognostic favorable (5.07e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.13e-2)"	35.4	29.3	14.6	22.4	17.4	76.6	42.3	23.0	15.0	40.7	24.3	35.0	32.1	33.2	21.4	73.6	32.0	30.1	52.4	15.5	19.2	51.5	46.2	33.8	39.5	15.3	17.6	39.2	29.7	52.1	11.8	25.5	17.3	41.2	34.2	18.2	37.1	29.9	17.5	36.3	30.8	31.7	16.4	28.4	30.1	8.3	16.2	38.5	60.9	26.4	46.5	34.9	25.5	21.8	135.1	46.8	30.9	40.9	116.9	92.1	24.6	63.3	93.3	51.9	58.2	30.4	44.5	36.7	40.6	77.6	31.6	101.2	68.7	67.5	92.5	39.5	52.1	6.0	27.2	34.7	41.0	2.3	1.5	63.0	71.2	57.6	76.0	83.1	64.6	17.6	33.2	68.4	65.0	51.6	65.9	1.8	10.5	110.6	64.4	30.7	28.9	174.4	67.4	92.2	66.2	51.5	55.4	249.3	39.6	35.7	95.0	10.3	69.3	44.5	44.1	61.3	49.4	47.0	63.3	9.9	66.0	12.6	42.9	28.6	32.6	54.3	33.2	38.1	26.2	26.4	27.5	23.8	63.1	26.9	23.8	26.1	46.5	27.6	52.5	62.2	20.9	32.0	14.6	17.4	23.0	15.0	15.5	19.2	15.3	17.6	17.3	16.4	16.2	21.8	84.1	137.8	103.9	23.2	52.0	81.8	110.6	111.8	96.2	16.2	80.2	73.9	120.2	75.8	89.3	69.9	14.6	73.0	85.4	49.4	99.7	77.9	1.6	66.9	73.5	66.3	50.2	28.4	37.0	83.7	55.1	92.6	48.9	83.5	8.2	44.7	66.4	103.9	50.4	45.4	39.9	55.3	81.4	71.0	93.8	4.5	85.7	64.0	53.4	13.1	75.0	75.6	36.0	58.3	24.5	59.3	51.7	87.6	49.4	112.5	53.3	126.1	78.8	17.4	59.2	102.1	77.4	3.2	8.8	183.2	91.1	78.0	55.2	71.4	75.1	91.8
CPVL		ENSG00000106066	"Carboxypeptidase vitellogenic like"	Q9H3G5	7	28995235-29195451	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 219.0"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 306.1;Kupffer cells: 290.3;Langerhans cells: 531.0;Macrophages: 266.2;monocytes: 176.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 61.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 1136.9;intermediate monocyte: 953.5;myeloid DC: 1319.5"	"Group enriched"	"Detected in all"	52	"dendritic cells: 1319.5;monocytes: 1136.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 190.8;RPTEC TERT1: 801.1;U-266/84: 205.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003697, HPA045715, HPA056466"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		760000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"		"CAB003697: AB_425990, HPA045715: AB_2679429, HPA056466: AB_2683140"	"unprognostic (4.72e-2)"	"unprognostic (7.08e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.49e-2)"	"unprognostic (6.85e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.07e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.46e-3)"	"prognostic unfavorable (4.99e-4)"	44.0	23.5	7.5	66.3	8.7	59.8	24.9	48.9	12.0	28.5	39.6	28.9	32.8	17.1	34.6	25.4	19.8	42.1	79.3	6.8	9.9	96.7	52.9	57.6	92.9	15.2	11.4	18.1	7.9	5.4	10.1	84.9	15.4	17.9	25.7	0.9	5.3	21.3	12.5	19.3	46.5	34.1	11.8	219.0	15.5	34.4	8.8	66.7	128.4	8.3	35.8	50.6	15.8	23.4	1.5	0.2	20.3	0.1	0.1	0.0	190.8	0.0	0.0	1.9	0.4	59.8	0.1	0.0	90.3	0.8	94.4	3.2	51.8	4.2	0.6	0.4	47.9	67.0	1.2	144.5	0.0	0.0	0.3	0.3	5.9	0.7	1.6	0.0	0.6	27.5	45.5	0.1	1.6	0.0	63.4	0.4	31.6	0.1	16.0	0.3	0.0	0.6	801.1	22.8	11.9	9.4	53.6	125.5	101.7	97.0	15.1	49.6	0.0	0.4	0.8	0.5	12.0	17.5	205.5	1.0	0.2	25.0	20.8	19.5	1136.9	5.7	2.6	953.5	3.4	1.8	1.3	1.9	1319.5	1.2	1.2	1.2	23.4	5.8	327.8	34.8	1.5	1142.7	7.5	8.7	48.9	12.0	6.8	9.9	15.2	11.4	15.4	11.8	8.8	23.4	12.3	6.4	16.0	3.3	7.2	12.5	1.3	0.7	5.7	0.0	2.6	3.4	69.1	10.0	2.5	71.7	0.0	138.0	2.1	0.2	35.2	0.5	24.7	3.7	0.3	21.1	1.8	34.1	3.7	15.6	118.3	29.4	1.1	0.6	5.1	2.3	6.8	1.1	306.1	0.0	1.7	1.2	0.0	290.3	531.0	7.6	9.3	266.2	10.6	45.9	176.8	0.2	2.1	2.0	1.3	0.8	0.4	3.0	2.9	0.5	0.4	30.6	1.5	0.4	0.0	31.0	3.0	27.1	92.8	27.2	8.8	118.5	3.3	3.6	1.2	0.9
CSGALNACT2	"GALNACT-2, GALNACT2, MGC40204, PRO0082"	ENSG00000169826	"Chondroitin sulfate N-acetylgalactosaminyltransferase 2"	Q8N6G5	10	43138445-43185302	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 133.9"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 121.6;Macrophages: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031540	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"		"HPA031540: AB_10599943"	"unprognostic (1.65e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.28e-3)"	"unprognostic (2.85e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.43e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (3.53e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.05e-3)"	19.7	10.6	8.8	24.1	10.8	133.9	12.9	15.1	13.3	15.1	12.6	15.1	9.2	19.5	8.4	10.5	15.5	25.4	12.8	8.5	10.8	8.8	13.9	26.8	22.5	10.7	9.7	17.0	7.8	8.0	11.6	26.4	11.1	13.4	11.6	9.8	7.9	10.9	14.6	11.0	11.5	20.8	9.4	26.5	10.1	9.2	9.9	27.9	9.9	17.2	17.4	24.0	12.1	13.5	12.6	8.2	15.1	14.4	23.0	38.5	3.7	44.7	59.8	19.3	30.0	2.9	12.7	20.8	10.8	40.6	9.2	11.4	12.6	16.8	31.3	24.9	9.3	10.8	7.9	8.6	50.0	25.3	21.8	38.6	18.1	43.1	89.3	24.3	25.0	30.7	4.6	60.1	39.9	6.5	19.3	15.1	6.5	4.2	10.7	11.9	15.0	8.8	17.1	6.6	13.6	26.8	11.6	11.9	28.8	13.0	15.7	20.5	37.3	16.5	26.2	52.3	30.4	15.4	23.2	10.9	35.1	60.8	7.9	14.7	11.9	19.4	7.3	14.2	6.4	3.0	5.5	5.7	14.4	3.0	6.4	5.4	11.2	11.3	21.8	4.1	7.1	6.9	8.8	10.8	15.1	13.3	8.5	10.8	10.7	9.7	11.1	9.4	9.9	13.5	16.3	16.0	18.7	23.8	20.5	17.7	13.3	7.0	6.2	13.1	10.7	8.5	10.9	5.7	9.6	11.0	10.4	2.1	47.8	1.7	0.0	5.9	2.1	12.0	22.0	16.8	9.0	18.5	42.5	6.9	6.1	31.4	4.6	11.3	48.1	23.5	11.4	11.9	16.4	8.4	41.1	1.6	4.1	68.6	121.6	1.4	17.1	82.6	8.8	16.9	41.5	4.1	35.0	45.2	54.5	13.7	3.1	12.4	33.8	12.7	1.5	4.4	5.8	8.5	26.3	27.7	25.3	17.8	18.3	3.6	12.1	1.5	37.4	7.2	1.6	7.0
CST3		ENSG00000101439	"Cystatin C"	P01034	20	23626706-23638473	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Age-related macular degeneration, Amyloidosis, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 4217.6"	"Cell type enriched"	"Detected in all"	4	"Langerhans cells: 18746.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 4967.5;intermediate monocyte: 6424.5;myeloid DC: 7959.0;non-classical monocyte: 4297.7;plasmacytoid DC: 4427.4"	"Group enriched"	"Detected in all"	9	"dendritic cells: 7959.0;monocytes: 6424.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1733.4;ASC TERT1: 1179.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000118, HPA013143"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1040000000	2800000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus, Vesicles"		"CAB000118: , HPA013143: AB_1847417"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (8.53e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.01e-2)"	"prognostic favorable (8.77e-4)"	1046.2	707.6	3041.2	262.3	3117.9	170.8	900.3	2823.3	4217.6	587.8	3094.8	788.7	389.6	708.3	875.9	557.1	802.7	583.0	1275.3	2976.3	2707.6	517.4	833.6	595.8	463.5	3258.4	3096.2	575.8	944.1	320.0	670.1	165.9	2939.3	773.9	416.9	46.9	2008.0	441.5	749.0	497.1	800.3	367.6	3028.1	723.7	979.9	761.3	3302.7	418.9	658.8	517.4	208.1	703.0	618.4	2883.1	155.2	328.2	75.4	175.8	1733.4	1179.8	145.3	261.4	350.7	170.3	137.7	625.1	219.7	0.8	241.0	345.2	221.3	496.2	69.6	499.9	51.9	0.9	253.5	157.6	61.1	1082.9	621.2	7.5	251.0	919.0	415.9	226.6	241.5	352.5	268.5	18.5	147.6	4.0	239.5	234.4	1.5	162.2	103.5	461.9	752.2	5.7	96.4	215.2	708.0	328.3	84.7	98.2	191.1	54.6	343.3	107.7	156.5	548.2	702.0	163.4	119.0	231.6	97.7	157.1	6.2	1.8	138.0	339.5	184.0	48.1	4967.5	33.2	66.9	6424.5	25.5	23.1	18.3	45.8	7959.0	13.6	16.9	31.1	809.3	191.4	4297.7	4427.4	13.6	4250.8	3041.2	3117.9	2823.3	4217.6	2976.3	2707.6	3258.4	3096.2	2939.3	3028.1	3302.7	2883.1	662.4	115.4	168.8	849.5	93.8	942.9	571.1	568.2	213.9	152.4	660.2	512.1	240.7	1361.2	514.5	641.9	29.2	476.8	603.3	1889.9	414.8	489.9	46.2	441.1	795.0	728.2	882.1	252.1	4.5	783.6	308.7	3026.2	981.7	631.0	359.9	687.0	491.9	2563.0	1816.7	48.8	11.2	1360.6	691.7	4301.1	18746.6	184.3	2132.6	4542.6	1563.5	87.1	2025.6	248.7	99.9	263.9	6.0	1458.5	2342.1	1790.4	67.9	786.0	4301.1	1098.6	364.4	36.3	2195.7	1417.0	846.2	125.5	400.6	461.5	822.0	469.0	117.4	208.1	1039.4	1079.7
CTNNB1	"armadillo, beta-catenin, CTNNB"	ENSG00000168036	"Catenin beta 1"	P35222	3	41194741-41260096	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation, Wnt signaling pathway"	Activator	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 539.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000108, CAB001950, HPA029159, HPA029160"	Supported		Enhanced	"Plasma membrane"		NA	NA		2000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 37: Intestine - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB000108: , CAB001950: , HPA029159: AB_10599619, HPA029160: AB_10600996"	"unprognostic (2.47e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (7.54e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.20e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.79e-2)"	130.8	112.2	106.7	98.7	85.3	162.4	194.3	147.8	87.5	179.4	94.7	141.2	136.9	149.4	84.4	113.7	131.0	121.8	109.9	88.1	105.3	106.5	147.9	132.9	81.9	101.3	112.9	173.9	93.3	137.2	84.7	200.0	94.0	132.3	134.5	88.8	110.9	126.3	87.3	99.0	142.9	178.4	104.9	92.5	81.8	59.5	129.4	95.6	140.6	89.9	99.5	158.3	109.3	108.4	161.6	210.0	423.6	242.8	226.9	184.7	333.8	179.6	249.7	288.2	284.3	146.3	224.0	131.7	157.8	314.1	129.0	119.6	315.8	510.0	306.2	123.3	215.7	215.5	261.0	523.7	169.5	121.8	99.1	271.6	226.7	345.5	208.7	235.7	258.1	63.0	153.7	80.3	324.1	161.8	87.3	68.3	397.2	211.0	159.3	64.9	281.9	88.3	177.9	494.8	102.9	172.4	296.2	147.1	809.4	509.8	242.1	248.6	340.8	217.1	163.6	139.3	264.0	50.7	82.7	138.4	221.5	150.5	369.7	4.7	7.3	6.4	9.2	12.3	10.9	7.7	8.6	10.1	11.8	8.0	8.6	9.4	6.6	9.6	12.6	10.0	10.8	5.6	106.7	85.3	147.8	87.5	88.1	105.3	101.3	112.9	94.0	104.9	129.4	108.4	171.7	137.8	179.5	58.1	71.7	213.5	130.1	75.3	116.1	40.7	232.5	168.1	84.7	90.1	119.2	62.5	33.3	318.9	99.0	251.6	35.2	132.2	11.0	90.3	125.9	187.3	93.8	43.8	50.9	78.5	115.6	116.8	53.0	95.5	116.6	137.0	139.2	172.5	115.1	13.5	82.4	145.9	42.7	154.6	228.1	9.5	59.7	161.1	202.7	124.6	98.3	89.2	49.4	70.9	62.9	139.8	249.5	86.9	55.5	128.3	160.3	93.2	96.1	62.0	46.0	175.6	137.3	78.4	40.1	70.9	174.9	539.5	77.0	245.6	189.6	127.9
CTSZ	CTSX	ENSG00000101160	"Cathepsin Z"	Q9UBR2	20	58985686-59008238	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 1078.9;Langerhans cells: 983.5;Macrophages: 652.3;monocytes: 723.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 542.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025114, HPA049876, HPA053504"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA		88000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Vesicles		"CAB025114: , HPA049876: AB_2680927, HPA053504: AB_2682172"	"unprognostic (7.30e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.25e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (1.96e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	178.1	117.8	18.9	208.8	21.8	99.8	137.0	20.5	32.0	92.1	59.6	173.8	215.4	87.3	13.4	53.1	88.9	89.4	152.6	15.3	33.9	125.6	356.4	233.3	271.5	31.6	23.5	71.0	89.4	91.8	112.5	118.7	27.9	87.8	77.1	4.1	181.0	66.3	58.7	58.5	226.0	97.9	26.2	234.4	88.2	24.6	47.2	57.1	122.3	54.6	91.3	146.3	69.0	45.4	205.4	139.8	1.1	1.1	114.2	124.2	106.5	291.0	225.4	187.4	152.3	231.6	324.6	96.5	213.9	542.1	0.5	160.1	51.4	257.5	30.2	362.1	13.6	80.3	169.0	0.8	137.3	9.0	331.0	130.9	127.8	83.1	62.4	34.8	281.3	1.1	74.0	48.7	90.0	1.1	1.3	70.6	11.5	43.5	158.2	2.9	0.4	135.7	86.3	25.5	2.7	1.7	222.4	258.4	0.8	19.5	131.9	148.4	420.5	1.4	161.8	209.0	2.0	253.7	172.0	18.2	2.8	207.9	0.4	1.2	1.5	1.6	0.6	1.4	0.4	1.1	0.6	0.4	1.1	1.4	0.7	0.8	1.6	0.5	2.9	1.8	0.3	0.7	18.9	21.8	20.5	32.0	15.3	33.9	31.6	23.5	27.9	26.2	47.2	45.4	132.1	16.0	5.3	5.9	119.8	50.3	64.5	33.8	24.5	6.7	67.4	99.6	21.7	62.9	14.1	71.7	0.0	38.2	104.8	303.6	23.5	176.0	3.5	52.9	47.7	82.2	27.1	63.3	5.3	42.4	104.8	71.5	19.4	71.3	10.8	68.4	62.8	363.0	1078.9	11.8	3.0	56.6	26.4	334.0	983.5	6.0	13.1	652.3	101.4	23.4	723.6	58.6	21.6	2.5	2.5	82.6	217.5	13.9	96.3	50.6	339.8	90.0	18.8	5.0	46.0	67.5	74.5	3.7	4.8	14.5	41.5	41.3	33.4	3.3	99.7	52.7
CTTNBP2NL	DKFZp547A023	ENSG00000143079	"CTTNBP2 N-terminal like"	Q9P2B4	1	112396214-112463456	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 131.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 8.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 68.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007301	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center, Cytosol"		"HPA007301: AB_1847693"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (4.21e-3)"	"unprognostic (4.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (8.08e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.99e-2)"	"unprognostic (5.12e-2)"	14.5	4.8	5.6	10.3	4.6	0.5	11.3	4.4	6.1	11.8	3.1	15.5	7.5	15.2	4.7	19.5	8.4	16.5	6.3	4.4	7.6	9.1	5.6	13.0	6.2	7.3	6.6	9.4	4.6	7.4	3.5	20.2	7.1	8.9	14.8	8.2	7.0	9.2	3.0	15.4	10.5	13.5	5.7	10.6	8.6	5.8	5.9	4.3	8.3	6.9	8.2	15.6	11.8	7.6	21.8	7.9	25.7	12.2	17.0	22.3	8.6	33.6	31.4	21.4	21.1	6.1	10.7	3.4	13.2	25.4	10.5	17.4	16.9	23.2	24.9	7.1	8.1	4.6	13.1	4.9	19.7	1.6	7.8	26.4	14.0	26.5	23.0	24.5	52.7	5.7	4.2	3.0	29.9	6.4	3.0	0.6	16.6	6.1	12.3	5.3	24.0	0.0	32.6	15.9	12.6	13.2	26.0	5.3	13.3	24.5	4.3	1.8	68.5	21.3	24.9	22.0	15.8	0.4	3.1	0.1	22.1	2.0	57.0	0.0	2.6	0.0	0.0	2.1	0.0	0.1	0.0	0.0	8.6	0.3	0.0	0.0	0.1	0.0	0.4	3.7	2.0	0.4	5.6	4.6	4.4	6.1	4.4	7.6	7.3	6.6	7.1	5.7	5.9	7.6	100.4	57.7	22.4	17.6	4.4	38.7	30.2	32.0	24.5	10.2	12.3	9.5	9.7	7.2	41.4	22.0	6.2	17.6	4.6	64.0	3.9	39.1	3.3	29.1	30.7	71.6	8.3	3.6	44.1	21.6	12.8	24.2	14.8	58.5	19.0	17.8	41.7	1.6	13.5	5.0	31.2	27.4	30.5	29.7	131.7	4.0	10.5	40.8	16.0	81.5	30.5	11.0	0.0	30.2	25.1	47.7	52.7	11.3	0.7	25.4	21.7	22.6	17.5	7.9	19.7	20.1	29.2	16.8	16.7	25.0	60.7	25.4	2.7	9.1	24.4	69.3
CXCL10	"C7, crg-2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10"	ENSG00000169245	"C-X-C motif chemokine ligand 10"	P02778	4	76021118-76023497	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 95.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 52.7;Glandular and luminal cells: 23.5;Kupffer cells: 41.1;Langerhans cells: 21.4;Macrophages: 45.7;Plasma cells: 22.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"classical monocyte: 21.5;intermediate monocyte: 52.4;non-classical monocyte: 36.9"	"Lineage enriched"	"Detected in many"	15	"monocytes: 52.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.1;BJ hTERT+ SV40 Large T+: 2.2;BJ hTERT+ SV40 Large T+ RasG12V: 2.2;GAMG: 5.1;RPMI-8226: 4.3;RT4: 2.4;THP-1: 3.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	253000		"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 41: Macrophages - Immune response"				"unprognostic (1.94e-1)"	"unprognostic (5.32e-2)"	"unprognostic (9.98e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.59e-2)"	"prognostic favorable (1.12e-5)"	"prognostic unfavorable (4.61e-4)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (1.03e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-2)"	4.0	5.9	1.4	95.5	1.5	1.2	20.7	0.9	2.6	13.2	1.2	10.7	11.2	7.1	0.7	8.0	4.1	10.6	4.4	1.2	1.0	7.8	29.0	35.1	68.0	7.4	1.2	3.0	0.9	17.1	2.1	10.3	10.8	43.9	15.9	0.4	20.1	1.8	1.2	2.0	11.2	15.8	3.4	20.3	19.2	3.0	2.6	35.2	3.7	1.1	17.3	45.1	3.7	1.5	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	6.1	2.2	2.2	0.2	0.1	2.0	0.2	0.0	5.1	0.0	0.0	0.1	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	4.3	0.1	2.4	0.0	0.0	0.0	0.4	1.3	0.0	0.1	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.6	0.0	0.0	21.5	0.0	0.0	52.4	0.0	1.4	0.3	0.0	3.5	0.1	0.0	0.0	1.1	0.0	36.9	0.0	0.0	7.6	1.4	1.5	0.9	2.6	1.2	1.0	7.4	1.2	10.8	3.4	2.6	1.5	3.8	0.0	2.2	0.0	2.2	0.9	9.4	52.7	0.6	0.0	2.6	7.0	0.3	1.5	2.8	0.0	0.0	0.1	0.0	2.7	0.0	5.9	2.6	12.5	10.9	8.0	0.0	0.0	0.0	0.0	0.0	6.9	3.1	23.5	1.3	0.0	0.0	0.1	17.3	0.0	0.0	1.0	10.2	41.1	21.4	4.0	0.3	45.7	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	11.4	6.4	2.6	1.3	0.0	0.0	1.3	12.4	0.0	0.0	0.8	0.0	0.0	1.8	0.0	0.9	1.4
CXCL9	"CMK, crg-10, Humig, MIG, SCYB9"	ENSG00000138755	"C-X-C motif chemokine ligand 9"	Q07325	4	76001275-76007509	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 309.9"	"Cell type enhanced"	"Detected in some"		"Hepatic stellate cells: 5.0;Hofbauer cells: 6.2;Kupffer cells: 10.3;Macrophages: 12.6;Spermatogonia: 8.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"RPMI-8226: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	902000		"Cluster 14: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"				"prognostic favorable (6.36e-4)"	"unprognostic (6.86e-3)"	"unprognostic (1.25e-2)"	"prognostic favorable (2.07e-4)"	"unprognostic (2.97e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.46e-2)"	"prognostic favorable (8.06e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (5.15e-6)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.54e-2)"	5.5	2.0	0.1	65.1	0.2	0.2	17.5	0.1	0.6	4.9	0.3	10.2	3.0	4.8	0.7	5.3	2.8	8.5	5.9	0.1	0.1	8.7	19.1	31.8	309.9	1.8	0.2	3.8	1.4	1.5	1.0	1.7	1.6	3.7	25.3	0.0	19.0	0.7	1.5	2.9	6.0	3.2	0.3	31.2	17.5	6.0	0.2	32.8	7.1	2.5	30.6	11.1	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.2	0.1	0.6	0.1	0.1	1.8	0.2	1.6	0.3	0.2	0.3	3.4	0.0	1.7	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.7	0.0	0.0	1.8	0.0	0.0	0.2	0.4	0.0	0.2	1.3	0.1	1.1	2.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	5.0	1.8	6.2	0.0	0.0	0.0	0.0	10.3	3.6	1.3	0.6	12.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	3.5	1.7	8.0	0.0	0.3	0.1	0.5	0.0	0.1	0.4
CYP2S1		ENSG00000167600	"Cytochrome P450 family 2 subfamily S member 1"	Q96SQ9	19	41193210-41207539	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 101.3;stomach 1: 120.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 31.0;Gastric mucus-secreting cells: 110.6;Intestinal goblet cells: 29.2;Langerhans cells: 73.0;Proximal enterocytes: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"classical monocyte: 24.7;myeloid DC: 84.4"	"Group enriched"	"Detected in many"	131	"dendritic cells: 84.4;monocytes: 24.7"	"Cell line enhanced"	"Detected in many"		"A549: 99.4;CACO-2: 49.8;HaCaT: 50.3;NTERA-2: 69.6;OE19: 158.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049227, HPA069248"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"		"HPA049227: AB_2680681, HPA069248: AB_2732128"	"unprognostic (1.49e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.45e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.60e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.66e-2)"	1.8	1.1	1.4	6.7	1.4	1.8	0.9	3.1	1.5	2.7	1.2	26.7	101.3	0.5	0.2	14.5	6.3	5.5	0.5	1.3	4.1	1.1	1.4	7.1	1.7	6.3	10.0	0.3	0.6	0.7	1.2	1.6	6.1	1.3	18.6	0.2	5.0	0.9	0.2	3.7	65.3	1.7	2.2	6.1	120.4	0.8	3.6	3.2	0.6	0.2	13.2	3.6	4.0	2.5	3.8	99.4	0.0	0.1	0.0	0.0	4.5	0.6	0.8	1.0	0.2	49.8	13.6	0.2	10.4	0.7	0.1	50.3	16.6	25.0	0.4	0.0	0.3	12.9	5.1	19.1	19.4	0.0	0.4	0.8	1.4	1.4	0.8	0.2	0.8	4.3	5.8	0.2	0.0	2.0	0.3	0.2	69.6	158.6	12.5	0.2	0.0	0.9	1.5	20.4	0.1	0.6	9.1	0.0	0.0	27.8	12.2	4.7	10.6	0.1	4.0	1.7	0.0	0.5	0.0	0.0	0.5	2.1	0.1	0.0	24.7	0.0	0.0	5.9	0.4	0.0	0.0	0.1	84.4	0.0	0.0	0.0	0.2	0.1	3.7	3.2	0.0	11.4	1.4	1.4	3.1	1.5	1.3	4.1	6.3	10.0	6.1	2.2	3.6	2.5	0.3	0.0	6.9	1.0	0.7	2.5	2.0	18.2	23.3	0.0	0.1	0.3	1.2	0.0	7.6	1.8	0.0	24.9	0.1	31.0	0.0	0.7	0.3	7.4	0.3	0.4	0.0	0.0	0.4	1.0	1.1	0.8	110.6	0.3	1.3	0.1	0.4	0.0	14.5	0.0	0.5	29.2	0.0	5.7	73.0	0.0	0.0	16.0	0.0	1.0	7.2	0.0	0.0	0.5	0.1	23.7	22.3	0.0	0.4	0.5	50.7	0.2	10.8	0.0	0.0	0.3	0.9	0.1	0.4	4.0	2.8	10.3	0.3	0.0	14.1	0.5
CYRIA	"CYRI-A, DKFZP566A1524, FAM49A, FLJ11080"	ENSG00000197872	"CYFIP related Rac1 interactor A"	Q9H0Q0	2	16549459-16666331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 46.4;Extravillous trophoblasts: 102.6;Hofbauer cells: 37.1;Macrophages: 24.0;Syncytiotrophoblasts: 150.0"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 18.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 53.1;HUVEC TERT2: 43.1;RH-30: 95.6;SK-BR-3: 28.2;TIME: 34.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017847, HPA060398"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB017847: , HPA060398: AB_2684275"	"unprognostic (3.45e-1)"	"unprognostic (1.83e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.78e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.74e-2)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (1.32e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (4.46e-4)"	13.9	11.0	29.8	21.1	34.2	23.2	8.8	4.6	37.9	15.8	2.5	7.9	3.4	10.1	2.2	5.1	9.1	10.9	4.1	37.2	18.3	1.9	7.6	13.0	19.2	9.9	20.6	11.9	2.8	1.1	6.4	20.0	13.2	8.2	6.3	6.4	4.1	8.6	8.4	3.6	6.5	10.7	14.5	27.8	4.2	1.9	24.1	5.0	40.9	7.3	18.1	10.3	9.4	19.6	0.5	0.0	6.1	0.3	6.2	1.8	18.0	0.0	0.1	0.0	0.0	0.1	0.0	2.9	1.0	0.0	4.2	3.7	1.5	2.4	0.0	6.8	0.2	3.8	0.1	0.0	3.3	0.1	53.1	3.1	2.3	0.5	0.0	4.9	43.1	0.1	0.4	4.8	3.8	0.4	0.1	12.9	2.7	0.3	0.0	2.1	95.6	0.4	5.1	24.4	1.0	3.6	0.0	28.2	0.0	7.4	1.1	1.7	34.1	0.4	5.4	0.0	0.2	2.8	0.1	3.4	13.9	2.8	2.0	0.2	100.1	140.5	21.6	129.7	2.5	37.2	1.0	11.3	66.4	32.3	0.8	8.1	195.4	58.1	159.2	33.0	0.4	43.2	29.8	34.2	4.6	37.9	37.2	18.3	9.9	20.6	13.2	14.5	24.1	19.6	12.2	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	46.4	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	102.6	4.7	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	150.0	0.7	0.0	0.0	0.0
CYSLTR2	"CysLT(2), CYSLT2R"	ENSG00000152207	"Cysteinyl leukotriene receptor 2"	Q9NS75	13	48653711-48711226	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 25.8;seminal vesicle: 17.5"	"Cell type enhanced"	"Detected in some"		"Hepatic stellate cells: 9.3;Macrophages: 13.1;Melanocytes: 5.4;monocytes: 4.8;NK-cells: 5.2;Sertoli cells: 13.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.6;thyroid cancer: 7.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	13	"eosinophil: 100.6"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 100.6"	"Cell line enriched"	"Detected in some"	47	"HDLM-2: 89.9"									HPA046528	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA046528: AB_2679687"	"unprognostic (9.83e-3)"	"unprognostic (2.72e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.41e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.88e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.18e-2)"	2.4	7.2	3.1	3.0	3.0	1.1	1.1	2.6	4.0	0.8	2.3	1.2	2.4	1.5	1.3	0.8	3.8	1.8	10.0	3.1	3.9	1.9	1.3	1.8	4.7	3.7	3.2	1.8	0.5	0.6	1.3	25.8	3.7	0.8	1.2	1.0	0.3	17.5	0.4	1.3	2.9	0.8	2.4	8.3	1.3	0.9	3.4	1.8	1.3	0.0	1.8	0.9	0.5	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	89.9	0.0	0.1	0.6	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	7.8	2.5	100.6	0.6	8.0	0.0	0.0	1.1	0.2	2.5	0.0	1.1	0.4	0.3	1.1	5.8	0.0	0.9	1.0	3.1	3.0	2.6	4.0	3.1	3.9	3.7	3.2	3.7	2.4	3.4	2.9	0.3	0.0	1.1	0.0	0.6	0.5	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	3.7	0.0	0.4	3.4	0.0	0.0	0.0	0.3	0.0	0.1	2.0	0.0	0.8	0.0	0.0	1.5	3.8	0.0	0.1	1.3	0.3	9.3	0.0	0.6	0.0	0.0	0.0	0.0	4.7	0.8	0.4	0.3	13.1	5.4	0.0	4.8	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.1	13.1	0.0	3.7	0.0	0.2	0.0	0.0	2.9	2.9	0.1	0.0	0.0
DAPP1	BAM32	ENSG00000070190	"Dual adaptor of phosphotyrosine and 3-phosphoinositides 1"	Q9UN19	4	99816827-99870190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.2;lymphoid tissue: 38.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 92.0;Langerhans cells: 188.5;monocytes: 235.5;Respiratory ciliated cells: 88.6;Urothelial cells: 221.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 61.2;RPMI-8226: 70.2;SK-BR-3: 30.6;U-698: 46.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB033822, HPA046074"	Approved					NA	NA		56000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"			"CAB033822: AB_2245677, HPA046074: AB_2679525"	"unprognostic (9.30e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (9.09e-2)"	"unprognostic (4.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.45e-5)"	"unprognostic (2.88e-1)"	"unprognostic (3.91e-2)"	"unprognostic (9.32e-2)"	"unprognostic (4.60e-2)"	1.6	1.0	0.5	22.6	0.9	15.5	3.7	0.4	0.5	6.9	0.6	3.1	2.1	8.4	1.0	29.2	5.2	11.9	0.5	0.5	0.6	0.7	1.5	6.3	34.6	1.0	1.0	0.4	0.4	0.2	0.2	6.8	1.1	2.8	3.2	0.1	8.6	0.8	0.9	13.7	6.3	13.5	0.8	16.6	6.5	0.4	0.7	10.2	0.6	1.3	38.5	14.9	12.9	1.5	22.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	22.5	23.8	0.3	0.0	0.1	12.8	0.0	25.3	0.0	61.2	0.0	24.3	0.0	0.0	0.0	9.4	1.0	0.0	11.3	0.0	7.5	0.0	0.0	1.0	1.2	21.7	0.0	0.2	0.1	6.7	0.0	0.0	0.4	0.1	0.1	70.2	4.6	16.3	0.1	0.0	0.0	30.6	0.0	0.2	0.4	10.1	0.0	0.0	0.4	0.0	0.1	8.3	3.2	46.4	0.1	6.5	0.0	25.0	70.2	71.0	2.3	62.6	2.5	90.9	11.4	4.0	75.9	98.7	12.5	4.5	138.1	17.8	57.3	32.4	25.2	65.3	0.5	0.9	0.4	0.5	0.5	0.6	1.0	1.0	1.1	0.8	0.7	1.5	0.3	3.2	3.0	0.0	92.0	61.8	30.2	51.4	16.5	0.1	10.1	5.0	0.8	2.8	43.2	9.2	0.0	2.6	13.3	8.4	0.0	6.2	0.3	37.1	0.8	1.2	1.2	9.4	0.4	3.1	14.1	1.4	14.8	9.0	8.2	0.2	0.7	0.7	25.1	0.0	0.1	1.8	22.4	32.0	188.5	0.9	0.0	86.0	12.4	5.6	235.5	0.0	7.2	0.0	0.1	18.9	17.6	0.0	60.2	24.3	0.2	0.1	88.6	0.2	0.0	0.9	4.2	0.2	0.5	40.4	70.3	3.4	17.2	0.1	2.2	221.2
DNMBP	"ARHGEF36, KIAA1010, Tuba"	ENSG00000107554	"Dynamin binding protein"	Q6XZF7	10	99875577-100009947	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037878, HPA058216"	Uncertain		Approved	"Nucleoli,Nuclear bodies,Golgi apparatus,Cytosol"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Nucleoli, Golgi apparatus, Cytosol"	"Nuclear bodies"	"HPA037878: AB_10675622, HPA058216: AB_2683640"	"unprognostic (3.25e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.95e-6)"	"unprognostic (3.92e-2)"	"unprognostic (4.13e-1)"	"unprognostic (9.79e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.67e-3)"	"unprognostic (4.03e-2)"	"unprognostic (5.07e-3)"	"unprognostic (6.52e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.28e-1)"	"prognostic favorable (6.15e-4)"	13.6	6.0	3.6	5.5	3.7	10.3	10.2	6.2	5.3	15.8	8.6	17.7	22.5	9.6	12.5	10.2	11.3	11.0	7.5	4.7	4.2	20.6	13.1	8.4	4.6	3.7	3.6	11.5	17.6	31.7	3.9	10.5	3.8	8.9	20.7	15.8	8.4	12.8	13.4	27.4	27.2	8.8	3.0	7.7	23.8	6.9	5.2	20.1	8.1	11.1	5.2	19.8	17.7	3.1	25.7	20.7	18.4	29.2	32.9	27.4	4.4	45.2	43.6	21.5	20.7	14.2	38.0	26.6	18.9	34.9	11.8	19.9	21.6	26.1	29.9	1.4	6.7	3.8	23.7	10.0	17.1	2.6	1.8	13.0	5.7	26.6	23.4	75.5	52.1	8.5	3.6	0.0	44.1	3.2	4.5	5.1	17.7	18.0	12.3	5.5	18.7	1.4	36.6	21.9	3.1	4.2	7.4	1.9	5.7	25.3	1.5	2.4	63.4	16.0	15.3	13.1	29.8	2.1	1.7	36.3	15.2	8.4	12.2	0.0	0.8	0.2	0.7	1.2	0.7	1.2	0.1	0.4	0.3	1.9	0.1	0.3	0.7	2.1	1.2	0.3	0.0	0.6	3.6	3.7	6.2	5.3	4.7	4.2	3.7	3.6	3.8	3.0	5.2	3.1	6.8	9.6	11.0	11.1	14.8	35.1	7.2	5.0	5.2	6.3	9.3	6.3	6.1	12.8	11.2	12.9	35.5	7.7	4.4	36.7	3.9	7.5	1.0	27.0	11.0	12.6	3.6	0.0	15.9	14.3	1.4	17.6	26.0	43.9	2.5	4.1	11.4	12.8	4.7	13.5	24.8	25.0	6.1	10.7	9.6	3.2	13.7	20.5	3.6	23.4	3.3	4.3	0.0	10.6	2.6	19.3	23.6	9.1	6.1	4.0	36.5	3.7	19.9	26.6	0.0	4.3	6.9	4.2	9.3	9.0	45.6	3.7	4.3	15.0	28.4	21.8
DRGX	"DRG11, PRRXL1"	ENSG00000165606	"Dorsal root ganglia homeobox"	A6NNA5	10	49364066-49396089	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	19	"adrenal gland: 5.4;brain: 10.4"	"Cell type enhanced"	"Detected in some"		"Langerhans cells: 1.2;Melanocytes: 1.8"	"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in some"	12	"medulla oblongata: 10.1;pons: 10.4;spinal cord: 8.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"RH-30: 11.6;SH-SY5Y: 46.2;U-2197: 17.7"	"Region enriched"	"Detected in single"	6	"pons and medulla: 3.9"	"Group enriched"	"Detected in some"	10	"cerebral cortex: 4.0;hippocampal formation: 1.6;medulla oblongata: 2.4;spinal cord: 3.7"	HPA043978	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA043978: AB_10961154"		"unprognostic (1.42e-2)"	"unprognostic (5.68e-2)"		"unprognostic (3.92e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.58e-1)"		"unprognostic (4.54e-2)"	"unprognostic (3.74e-2)"			"unprognostic (8.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.09e-2)"		0.1	5.4	0.0	0.2	0.1	0.1	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	10.1	0.7	0.0	0.0	0.0	0.2	0.0	10.4	0.0	0.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	8.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	17.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.1	0.3	10.1	0.7	10.4	8.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.8	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0
DUSP1	"CL100, HVH1, MKP-1, PTPN10"	ENSG00000120129	"Dual specificity phosphatase 1"	P28562	5	172768096-172771195	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 2357.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 7426.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 7426.8"	"Cell line enhanced"	"Detected in all"		"HHSteC: 201.0;hTCEpi: 359.3;REH: 202.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069577			Approved	Nucleoli,Cytosol		NA	Yes			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Nucleoli	Cytosol	"HPA069577: AB_2686156"	"unprognostic (1.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.73e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.58e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (2.69e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-3)"	922.6	515.4	84.9	364.9	85.8	692.4	586.1	134.8	121.1	501.3	134.7	336.1	66.0	382.3	42.0	526.6	677.4	570.5	395.3	79.4	114.6	281.2	721.3	719.9	178.6	132.0	90.3	541.2	240.1	116.5	319.5	297.3	104.1	438.5	228.5	202.7	350.3	356.9	251.8	1054.1	170.3	452.7	123.7	304.7	396.0	68.1	115.4	131.3	612.9	451.3	56.2	778.1	610.0	121.2	10.7	26.5	8.2	11.5	175.6	102.2	14.0	170.3	49.3	111.9	45.0	29.2	12.4	3.5	48.6	120.4	128.1	4.7	8.1	42.3	52.1	95.8	22.4	2.3	63.1	12.6	201.0	1.2	3.8	98.1	359.3	50.9	82.1	58.2	35.6	7.4	9.0	66.1	73.1	12.6	5.7	5.0	7.4	8.2	7.7	202.2	15.3	32.3	80.2	5.4	35.5	14.9	46.2	76.9	6.3	34.1	6.7	1.9	94.1	79.1	39.8	77.8	13.4	13.6	8.4	3.1	70.3	1.8	3.3	931.4	584.5	1640.7	85.0	589.2	212.6	57.6	75.6	88.6	263.4	54.1	35.9	40.7	7426.8	114.5	791.6	14.3	68.1	409.9	84.9	85.8	134.8	121.1	79.4	114.6	132.0	90.3	104.1	123.7	115.4	121.2	1856.5	410.3	341.0	23.8	918.4	1279.8	1140.5	456.9	1810.4	73.0	464.2	567.7	211.3	739.2	243.1	211.5	27.1	316.2	618.9	633.7	56.7	335.9	71.6	531.6	990.9	870.4	715.5	193.5	11.9	88.7	407.2	1367.4	597.3	1013.7	301.1	175.8	781.4	345.7	1043.0	48.8	13.4	891.8	207.5	1525.5	2357.3	40.3	384.9	1965.5	542.5	66.5	173.3	1159.3	33.0	6.6	4.1	226.3	683.3	311.1	952.2	685.7	736.1	35.5	218.0	190.5	769.2	720.7	671.9	12.9	24.6	1996.9	1956.6	582.0	1015.2	223.4	415.8	676.6
DUSP4	"HVH2, MKP-2, TYP"	ENSG00000120875	"Dual specificity phosphatase 4"	Q13115	8	29333064-29350684	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 32.2;stomach 1: 32.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 155.5;Ionocytes: 126.1;Pancreatic endocrine cells: 195.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.9"	"Region enhanced"	"Detected in many"		"hippocampal formation: 20.9"	"Immune cell enriched"	"Detected in single"	9	"T-reg: 6.7"	"Lineage enriched"	"Detected in single"	20	"T-cells: 6.7"	"Cell line enhanced"	"Detected in many"		"A549: 100.0;OE19: 91.7;SK-MEL-30: 157.2;WM-115: 122.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061967			Supported	Nucleoplasm		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA061967: AB_2684648"	"unprognostic (1.92e-1)"	"unprognostic (5.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.66e-3)"	"unprognostic (7.30e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.73e-3)"	"unprognostic (9.60e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (6.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.07e-2)"	15.2	5.2	2.3	5.4	1.4	6.2	23.7	5.0	9.0	6.0	0.4	1.2	1.2	4.5	0.1	2.5	1.9	11.3	2.3	20.9	1.2	2.8	0.7	5.7	2.6	1.6	1.1	0.4	32.2	0.6	5.3	7.5	1.1	5.2	1.4	5.9	16.1	10.1	4.2	5.6	2.0	1.2	0.3	1.0	32.4	2.8	2.9	4.2	1.2	0.9	2.7	13.8	2.8	1.1	38.0	100.0	57.9	2.8	7.2	0.0	4.9	7.7	42.0	22.8	10.1	1.1	18.8	0.0	20.5	3.6	16.0	12.0	0.7	25.7	13.5	1.0	1.9	0.3	3.7	0.7	0.2	0.5	47.3	4.6	16.7	7.1	42.1	49.7	18.9	0.4	0.3	4.5	46.0	42.9	0.1	7.1	10.1	91.7	60.5	1.2	1.9	8.1	52.3	19.7	0.4	32.0	10.8	49.5	157.2	1.1	10.7	1.1	53.3	16.7	0.3	0.0	5.7	11.6	1.4	0.1	50.2	8.9	122.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	6.7	0.0	2.3	1.4	5.0	9.0	20.9	1.2	1.6	1.1	1.1	0.3	2.9	1.1	11.1	0.0	2.8	0.0	33.5	12.1	98.3	27.3	4.0	43.2	80.4	62.2	2.6	51.5	51.1	0.0	12.5	3.2	24.0	1.9	0.0	74.3	7.6	64.7	13.3	16.3	97.8	0.0	3.8	78.6	40.9	9.6	121.8	155.5	6.3	0.0	21.8	0.3	25.0	43.7	8.2	8.5	126.1	4.0	102.8	25.6	0.3	47.4	65.8	0.0	75.6	0.8	0.0	1.5	0.3	195.2	0.0	0.0	31.0	30.9	0.4	0.2	43.6	3.4	13.1	18.9	17.8	1.4	8.2	2.3	11.9	17.8	115.6	0.1	4.6	102.7
EDEM1	"EDEM, KIAA0212"	ENSG00000134109	"ER degradation enhancing alpha-mannosidase like protein 1"	Q92611	3	5187646-5219958	"Plasma proteins, Predicted intracellular proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 79.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 100.7;Langerhans cells: 194.0;Plasma cells: 135.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 184.4;U-698: 162.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029565	Uncertain		Enhanced	"Endoplasmic reticulum,Aggresome"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"	Aggresome	"HPA029565: AB_10602032"	"unprognostic (3.03e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.57e-3)"	"unprognostic (4.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	11.2	11.3	5.5	31.3	6.6	66.5	14.4	3.7	6.2	11.6	4.4	15.6	14.1	11.9	12.6	16.7	10.7	12.2	7.2	5.2	5.6	12.5	59.3	29.8	41.4	6.5	5.2	13.1	24.9	17.2	9.4	14.0	4.9	12.4	16.9	5.6	13.3	10.7	5.7	17.2	18.7	12.5	5.4	24.4	17.7	10.5	6.7	79.1	17.6	5.4	42.5	16.7	13.2	6.4	18.0	17.8	11.1	11.1	14.3	31.6	35.1	28.8	38.8	19.5	25.5	8.2	23.4	95.9	15.2	28.6	42.3	13.9	12.1	39.8	29.6	184.4	7.1	32.7	16.9	18.7	66.2	39.0	91.8	28.7	47.4	41.6	45.5	26.4	39.2	122.1	8.7	128.2	24.4	10.6	78.9	14.9	5.6	8.2	13.4	113.2	19.6	90.0	22.4	37.0	1.4	14.5	20.8	29.6	44.4	9.8	15.2	123.3	38.7	37.2	25.7	32.1	33.6	75.1	49.4	162.3	61.8	37.1	31.8	2.9	2.6	3.1	4.0	3.7	5.7	6.7	5.9	4.4	3.3	4.4	5.2	4.1	3.0	2.1	4.6	7.5	6.7	2.0	5.5	6.6	3.7	6.2	5.2	5.6	6.5	5.2	4.9	5.4	6.7	6.4	11.8	60.9	100.7	10.7	51.1	20.6	7.0	15.5	10.2	5.3	17.2	11.0	3.1	20.0	19.9	16.5	10.4	10.0	29.1	23.8	0.0	7.0	14.4	11.4	14.8	12.6	8.4	12.6	17.4	12.2	32.8	11.3	20.9	20.0	23.5	8.1	12.8	76.2	17.0	1.7	15.4	26.4	14.2	32.9	194.0	63.1	8.4	44.3	16.0	14.0	43.1	3.3	12.3	11.1	10.3	15.2	4.7	9.1	135.5	12.5	16.1	8.5	11.0	4.0	0.0	9.4	13.6	7.8	5.5	23.1	27.3	40.9	25.5	5.1	12.3	20.7
ELF2	"EU32, NERF, NERF-1A, NERF-1B, NERF-2"	ENSG00000109381	"E74 like ETS transcription factor 2"	Q15723	4	139028112-139177218	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 279.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006057, HPA071166"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nuclear bodies"	"HPA006057: AB_1078733, HPA071166: AB_2686351"	"unprognostic (7.21e-2)"	"unprognostic (3.84e-2)"	"unprognostic (7.41e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.97e-3)"	23.7	14.2	12.1	15.2	17.3	47.3	24.5	19.2	16.1	21.8	9.6	24.6	15.0	24.7	18.5	17.3	20.7	17.8	20.1	11.1	15.6	15.5	20.4	19.0	19.9	15.6	14.9	28.2	16.7	20.0	22.6	26.8	15.9	21.5	19.2	30.7	21.4	21.7	36.0	23.2	17.6	23.0	13.2	19.6	17.4	37.4	14.5	32.8	23.0	33.6	21.4	19.2	18.4	20.2	15.9	11.3	27.9	21.4	28.2	31.7	26.9	18.4	31.8	19.6	21.8	22.2	31.2	32.3	18.5	25.7	10.4	16.8	41.2	26.3	20.5	20.2	18.6	28.5	26.4	20.0	20.7	32.1	22.1	31.1	24.8	19.3	23.3	25.7	29.5	18.0	46.8	18.4	17.7	27.8	37.8	28.6	17.0	36.4	13.1	36.0	36.8	30.1	25.1	27.2	28.4	32.6	23.1	28.5	17.6	32.4	19.7	38.5	25.0	18.3	15.9	16.7	12.4	40.8	48.6	28.3	13.5	32.4	17.2	13.3	8.3	14.1	12.0	7.2	13.2	17.5	11.8	10.8	9.9	19.3	14.6	13.5	9.1	12.9	7.9	18.0	9.4	5.3	12.1	17.3	19.2	16.1	11.1	15.6	15.6	14.9	15.9	13.2	14.5	20.2	103.0	48.1	22.5	64.0	57.6	53.2	41.1	36.1	120.1	42.0	50.3	40.4	37.0	40.0	39.1	40.5	75.0	32.6	71.9	31.0	43.0	26.4	26.0	60.0	54.3	67.1	47.3	43.5	73.6	24.2	32.3	63.7	35.7	56.3	34.8	44.0	53.2	46.9	22.2	67.3	75.3	38.1	42.7	52.2	40.1	24.6	52.5	59.5	30.2	98.4	49.2	37.3	77.2	83.9	279.4	24.1	33.5	38.0	51.0	52.6	35.9	23.1	48.2	57.7	39.5	81.4	59.2	59.7	42.0	79.0	47.6	23.7	50.7	33.6	27.7	39.6
ELL2	MRCCAT1	ENSG00000118985	"Elongation factor for RNA polymerase II 2"	O00472	5	95885098-95961851	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 382.9;Plasma cells: 430.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 322.3;HDLM-2: 291.4;U-266/84: 216.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013569			Supported	Nucleoplasm		No	No			"Cluster 10: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA013569: AB_2668853"	"unprognostic (1.18e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.82e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.31e-4)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.74e-2)"	49.0	19.5	13.5	28.6	32.3	48.3	37.3	22.9	26.8	24.0	6.8	13.5	14.5	9.1	5.7	61.2	16.0	35.6	39.9	18.4	32.0	16.5	86.8	35.8	14.6	51.1	28.5	24.8	94.3	15.6	25.1	25.3	33.7	39.1	13.1	3.7	96.5	23.0	33.5	58.9	14.5	11.4	21.3	18.0	44.3	15.2	41.4	8.1	17.1	10.7	21.8	33.2	35.7	55.8	31.7	12.3	3.8	0.5	45.0	56.1	4.6	322.3	56.2	105.4	89.7	23.7	7.2	1.4	6.7	173.7	24.6	40.0	10.0	103.5	129.3	291.4	7.6	20.5	53.5	52.3	29.0	4.5	33.3	55.1	70.1	64.0	191.4	63.2	17.0	3.8	11.5	120.3	100.6	3.3	0.1	5.6	4.9	5.0	16.8	3.1	19.2	25.3	20.3	30.0	6.4	2.1	118.6	6.2	7.3	15.1	3.6	3.7	35.5	137.6	27.4	32.0	59.4	84.0	216.0	1.5	71.9	2.1	9.4	7.0	0.8	5.7	0.6	1.0	1.0	3.5	0.8	0.9	0.4	1.7	0.6	0.5	1.8	1.6	0.8	0.3	1.1	0.6	13.5	32.3	22.9	26.8	18.4	32.0	51.1	28.5	33.7	21.3	41.4	55.8	30.9	28.9	94.9	28.1	93.2	183.2	137.3	47.1	134.9	0.6	56.0	37.6	31.6	14.3	61.5	18.4	0.0	2.0	98.6	19.4	5.9	24.6	2.5	46.2	32.4	33.4	107.8	25.7	138.6	91.9	14.8	64.4	85.6	88.6	172.4	11.2	18.5	141.1	36.7	0.0	87.5	18.1	12.2	64.4	52.0	4.3	7.8	126.5	46.2	83.4	25.3	1.2	2.1	49.8	382.9	70.8	14.7	7.2	430.1	134.7	12.7	15.8	35.2	0.5	13.1	213.2	76.8	17.2	9.2	185.8	171.5	25.9	72.4	2.4	14.3	88.8
EMILIN2	"FLJ33200, FOAP-10"	ENSG00000132205	"Elastin microfibril interfacer 2"	Q9BXX0	18	2847006-2916003	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 76.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 98.0;Hofbauer cells: 61.1;Kupffer cells: 52.9;Langerhans cells: 99.7;Macrophages: 97.5;monocytes: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 48.2;BEWO: 37.8;HL-60: 37.8;HMC-1: 60.6;HSkMC: 26.1;SuSa: 25.7;THP-1: 36.7;U-2197: 46.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 25.7"	HPA064576	Supported				"Secreted to extracellular matrix"	NA	NA		840000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA064576: AB_2732717"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.91e-3)"	"prognostic unfavorable (6.30e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.96e-1)"	13.0	1.3	1.2	17.2	2.2	11.3	5.1	4.8	1.7	5.3	2.2	2.8	1.6	6.4	0.8	2.4	4.7	5.9	6.8	0.7	1.2	1.1	1.5	11.9	2.4	8.1	4.4	5.9	1.4	76.0	0.4	21.9	5.8	1.0	3.3	0.1	2.3	1.2	0.8	2.7	2.2	8.4	6.6	3.9	1.6	1.8	7.4	2.9	1.6	2.4	2.0	8.0	4.0	10.6	0.2	0.4	2.9	0.0	48.2	19.9	37.8	7.9	0.0	1.4	2.4	5.6	0.1	0.0	0.6	19.3	0.5	0.1	1.0	0.0	2.6	0.0	2.6	0.5	0.2	0.4	1.6	37.8	60.6	26.1	0.0	1.5	0.0	0.0	0.2	0.6	0.1	0.1	0.0	0.0	0.1	10.4	4.9	0.4	0.1	0.1	2.5	0.0	0.1	0.2	0.4	0.2	0.2	0.3	1.4	25.7	0.0	36.7	0.4	0.0	5.2	46.7	0.4	0.0	0.0	0.0	3.1	9.1	1.0	5.5	1.1	0.3	0.4	0.8	0.3	0.2	0.4	0.3	1.1	0.3	0.2	0.4	1.1	1.5	0.7	0.7	0.3	0.4	1.2	2.2	4.8	1.7	0.7	1.2	8.1	4.4	5.8	6.6	7.4	10.6	6.8	3.2	6.7	0.0	13.7	5.7	3.3	0.5	0.6	0.1	2.8	3.0	15.7	1.5	5.3	3.7	0.0	4.7	14.5	2.8	1.9	2.7	2.3	19.3	98.0	8.8	3.0	6.7	0.5	1.1	11.9	31.4	5.6	46.0	46.3	5.7	2.9	0.5	61.1	0.0	1.2	4.9	0.0	52.9	99.7	2.3	15.2	97.5	5.4	2.8	51.0	0.0	7.2	11.1	9.1	2.4	7.9	1.2	2.7	3.5	1.5	1.7	4.0	0.2	0.0	2.3	8.7	4.9	5.5	0.4	4.0	2.9	9.6	14.7	5.1	2.8
EMP3	YMP	ENSG00000142227	"Epithelial membrane protein 3"	P54852	19	48321509-48330553	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 2037.4;Macrophages: 699.2;Melanocytes: 1117.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 195.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 1472.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062030			Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Plasma membrane"		"HPA062030: "	"unprognostic (5.06e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.33e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.31e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.31e-7)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.90e-3)"	107.7	85.6	37.6	115.8	37.4	325.1	68.8	37.9	41.0	149.6	36.9	166.7	36.9	143.9	60.7	37.1	96.2	72.5	100.9	38.6	53.8	51.8	29.1	141.0	86.1	52.1	43.9	110.8	18.4	17.1	21.4	67.1	46.9	61.3	65.5	9.2	41.8	90.1	21.7	61.6	81.6	202.9	44.2	91.8	65.3	33.5	43.7	45.2	43.2	43.7	94.7	132.8	106.9	48.4	73.8	739.3	44.9	127.1	691.3	1081.5	1.2	490.7	898.0	627.6	560.7	73.5	265.0	6.9	107.5	1101.0	296.4	12.1	45.5	54.6	390.4	241.3	20.5	335.0	192.0	43.3	572.4	160.2	338.9	586.1	12.2	635.3	436.3	455.5	277.9	66.1	237.4	616.1	1019.5	10.1	25.1	1472.4	55.4	12.1	196.9	22.1	150.1	355.7	554.6	0.4	1.8	2.0	225.2	1.2	131.2	77.2	2.7	253.1	456.6	574.7	236.5	435.8	388.1	287.6	426.6	20.1	339.2	232.5	402.5	2401.3	980.4	1402.3	1324.0	1173.0	1117.1	570.1	1425.3	1327.0	688.7	467.9	818.8	948.4	1094.0	854.5	1148.4	516.9	1631.4	1971.4	37.6	37.4	37.9	41.0	38.6	53.8	52.1	43.9	46.9	44.2	43.7	48.4	66.5	0.0	4.5	5.5	338.0	278.0	75.4	161.0	48.3	2.3	14.7	22.9	5.4	21.5	21.8	33.1	0.0	14.9	375.9	1.5	5.9	72.0	6.5	18.9	255.1	118.6	6.0	94.8	0.2	11.2	26.0	371.3	23.0	15.1	257.0	8.5	128.2	7.2	589.0	0.0	0.3	4.1	42.7	458.8	2037.4	21.3	335.5	699.2	1117.1	6.5	444.5	64.6	565.4	0.0	0.7	114.3	28.2	217.0	334.9	285.5	1.7	9.3	14.6	5.0	105.2	193.0	278.7	16.2	6.7	10.6	189.9	20.2	441.4	29.1	4.9	44.4
ENTPD1	"ATPDase, CD39, NTPDase-1, SPG64"	ENSG00000138185	"Ectonucleoside triphosphate diphosphohydrolase 1"	P49961	10	95711779-95877266	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 74.1;Kupffer cells: 110.4;Langerhans cells: 161.3;Microglial cells: 217.4;monocytes: 112.2;Plasma cells: 80.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 17.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 102.2"	"Group enriched"	"Detected in all"	4	"dendritic cells: 31.9;granulocytes: 102.2;monocytes: 41.0"	"Group enriched"	"Detected in many"	7	"HDLM-2: 147.5;Karpas-707: 135.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002494, HPA014067, CAB079986"	Enhanced		Uncertain	Microtubules		NA	NA		19000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Microtubules		"CAB002494: AB_563557, CAB079986: , HPA014067: AB_1848178"	"unprognostic (1.14e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.67e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.31e-2)"	"unprognostic (5.26e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (5.33e-5)"	"unprognostic (9.79e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (7.89e-4)"	"unprognostic (5.09e-2)"	11.8	8.3	5.9	24.7	5.5	27.5	10.8	5.0	6.3	17.5	5.0	14.3	9.3	28.0	19.3	19.2	14.0	27.7	8.5	5.3	6.3	7.6	5.4	16.1	20.2	7.1	6.5	5.5	2.8	3.4	3.9	11.4	7.7	11.2	12.8	6.8	6.0	18.1	4.0	6.3	11.7	49.7	6.2	21.5	7.3	4.5	7.5	6.8	20.0	8.7	25.6	30.6	11.0	6.3	1.4	2.7	5.4	7.1	0.1	0.1	5.0	4.5	1.2	0.0	0.0	4.0	1.6	8.2	3.1	0.0	5.3	2.2	0.0	0.0	0.0	147.5	5.2	7.2	4.0	4.3	0.0	12.5	4.1	0.1	0.0	0.6	0.0	2.4	18.2	2.0	5.3	135.4	0.1	4.4	4.7	5.8	5.9	3.6	2.8	15.3	2.4	4.4	1.7	2.2	5.1	6.2	3.6	3.7	3.9	3.6	5.5	5.9	3.9	3.9	2.8	3.8	5.3	21.6	7.2	0.6	4.3	13.9	2.7	0.7	41.0	102.2	0.6	27.2	1.1	13.7	1.6	1.1	31.9	11.4	0.6	0.6	49.4	1.5	6.7	2.1	13.1	15.5	5.9	5.5	5.0	6.3	5.3	6.3	7.1	6.5	7.7	6.2	7.5	6.3	19.6	0.0	1.1	74.1	40.9	8.9	0.3	0.0	0.6	1.4	0.8	1.5	10.1	0.0	0.7	1.8	2.1	0.6	3.7	0.3	1.9	0.0	10.3	0.6	3.6	60.6	0.0	4.4	2.8	2.0	1.9	15.7	6.1	0.6	3.8	0.3	31.4	0.8	26.6	0.0	5.2	0.1	0.0	110.4	161.3	7.3	0.6	62.1	16.0	217.4	112.2	0.4	0.0	20.6	5.0	0.2	1.2	3.0	80.1	0.5	0.1	0.3	0.8	0.8	6.6	1.0	22.7	10.1	4.4	0.8	11.2	15.7	26.9	15.1	1.0	0.5
EREG	ER	ENSG00000124882	Epiregulin	O14944	4	74365145-74388749	"Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"bone marrow: 129.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 179.1;Kupffer cells: 133.9;Langerhans cells: 171.1;Macrophages: 570.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 270.0;CAPAN-2: 76.7;hTEC/SVTERT24-B: 83.7;U-2197: 181.4;U-87 MG: 307.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054373			Approved	Vesicles	"Secreted to blood"	NA	NA	46000			"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA054373: "	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.67e-7)"	"unprognostic (4.56e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (1.07e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (6.57e-5)"	"unprognostic (2.94e-1)"	"unprognostic (1.70e-6)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.59e-3)"	"unprognostic (3.16e-3)"	4.5	0.0	0.3	10.3	0.3	129.0	2.5	0.2	0.5	1.9	0.2	2.0	0.2	0.2	0.2	12.6	0.8	5.7	0.7	0.3	0.1	0.1	0.2	2.7	0.1	0.2	0.1	0.1	0.3	0.0	0.0	0.6	0.4	0.1	3.4	0.1	1.3	0.0	0.2	9.3	1.6	3.0	0.0	0.5	0.2	0.1	0.6	0.1	0.1	0.0	1.0	4.9	4.0	0.3	1.4	41.1	0.0	0.0	3.8	6.6	0.1	9.2	270.0	2.6	1.6	32.5	76.7	0.0	44.1	0.0	20.1	2.4	0.0	59.3	2.7	0.0	0.0	1.2	1.6	1.2	1.1	0.1	0.1	3.9	20.2	83.7	43.5	0.0	0.0	0.0	0.1	0.5	0.2	0.4	0.1	0.1	0.1	0.2	0.6	0.1	0.0	0.1	0.6	1.6	0.0	0.0	27.0	0.2	0.0	0.0	0.1	0.0	0.0	1.6	0.6	181.4	0.0	0.0	0.0	0.2	307.0	0.0	0.2	0.4	0.2	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.5	0.3	0.1	0.2	0.1	0.4	0.0	0.6	0.3	4.9	6.4	7.2	0.0	5.7	5.4	5.6	179.1	4.0	0.0	24.4	2.3	18.2	5.7	82.4	0.0	0.0	0.4	2.2	56.3	0.0	1.8	3.7	2.4	0.7	2.5	3.6	17.0	0.1	0.2	0.7	4.4	0.5	3.9	7.0	0.1	0.4	1.9	26.8	0.0	1.8	38.2	16.2	133.9	171.1	1.0	0.3	570.7	7.2	0.0	23.2	0.0	0.0	0.0	0.0	0.8	27.1	0.0	11.7	2.5	32.4	0.2	41.9	0.0	0.0	2.5	3.1	0.5	0.3	3.8	9.2	0.7	3.3	0.2	33.1	7.4
ETS2		ENSG00000157557	"ETS proto-oncogene 2, transcription factor"	P15036	21	38805183-38824955	"Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 701.0;Basal squamous epithelial cells: 863.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 33.6;granulocytes: 37.0;monocytes: 32.4"	"Cell line enhanced"	"Detected in many"		"HEL: 309.0;hTCEpi: 269.6;hTERT-HME1: 210.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003176			Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003176: AB_2666824"	"unprognostic (2.06e-1)"	"unprognostic (5.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (5.33e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.88e-3)"	"unprognostic (7.36e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.10e-2)"	109.9	29.7	51.4	95.5	43.3	167.1	87.7	31.6	72.5	89.6	61.4	119.3	131.3	77.5	27.9	90.6	72.5	132.1	68.0	50.9	43.2	66.1	230.7	185.5	38.0	50.0	39.9	65.7	37.5	61.9	56.6	73.6	45.0	80.1	146.5	7.5	50.3	45.7	149.7	248.3	179.7	78.0	47.9	201.0	72.7	7.6	54.0	43.7	62.5	42.8	34.8	210.2	103.6	44.4	120.1	26.2	16.6	5.6	18.8	61.3	49.2	27.4	154.1	36.2	46.5	23.0	35.1	24.7	13.3	25.0	48.5	35.7	28.0	71.2	63.8	24.5	12.0	309.0	152.6	62.2	196.9	18.4	28.2	39.8	269.6	49.6	210.2	22.0	28.3	17.2	31.3	0.2	14.4	20.1	54.1	22.2	56.0	39.3	18.2	189.6	10.2	25.2	50.2	74.4	14.2	18.4	78.4	32.8	6.2	5.7	1.9	36.3	30.8	83.0	13.0	55.3	60.5	0.5	0.3	25.2	20.7	69.4	70.8	21.0	19.5	7.0	3.2	24.9	3.9	0.4	3.0	4.7	33.6	0.4	3.2	3.2	37.0	0.3	32.4	8.1	0.3	8.9	51.4	43.3	31.6	72.5	50.9	43.2	50.0	39.9	45.0	47.9	54.0	44.4	253.0	51.3	156.6	6.2	10.8	427.4	701.0	150.8	863.4	2.1	84.2	69.7	25.6	51.5	141.9	51.5	0.0	58.4	17.5	150.7	11.7	73.7	4.0	241.1	127.4	312.7	91.8	36.4	39.6	108.5	109.3	98.7	161.1	497.9	51.3	0.9	242.0	262.4	62.1	0.0	10.7	266.0	79.3	150.8	291.7	2.0	18.0	253.4	67.6	74.0	41.0	1.5	3.1	4.0	3.1	127.6	175.1	24.8	21.0	184.0	162.2	47.2	107.9	1.6	52.6	81.8	108.8	0.6	3.3	522.6	486.4	177.6	28.8	8.2	243.3	338.7
ETV3	PE-1	ENSG00000117036	"ETS variant transcription factor 3"	P41162	1	157121191-157138474	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 361.2;monocytes: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004794, HPA073211"	Supported		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Vesicles	"HPA004794: AB_1078761, HPA073211: "	"unprognostic (1.65e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.02e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.97e-2)"	"unprognostic (6.65e-2)"	13.7	7.7	6.6	11.1	6.6	24.0	12.1	7.9	20.1	8.3	5.3	8.7	15.1	9.3	7.5	15.6	7.8	12.7	7.4	8.3	8.1	6.6	6.6	12.6	10.1	7.7	6.5	11.5	6.4	23.9	5.0	12.8	7.0	10.2	9.5	5.7	9.2	8.5	9.4	31.5	14.6	10.1	7.1	10.0	10.0	9.4	7.4	10.8	7.9	8.8	12.5	17.6	11.4	7.1	11.9	11.4	11.6	10.1	17.3	11.3	9.9	10.9	11.4	10.5	9.7	12.2	11.6	14.2	13.4	13.4	5.6	18.0	12.8	16.7	13.8	31.0	8.1	11.9	12.2	6.7	10.3	19.0	18.1	12.5	19.2	15.7	13.3	8.5	11.1	8.8	13.9	10.2	12.0	15.7	5.8	10.7	38.6	16.9	8.7	8.7	13.8	16.3	8.1	43.9	9.8	19.0	11.9	28.1	29.5	20.7	14.4	20.7	18.8	13.5	11.9	13.2	13.7	24.6	13.5	16.7	15.5	10.9	45.2	6.3	4.6	3.3	4.5	4.2	6.2	2.1	3.9	4.5	4.5	2.4	3.9	3.5	5.4	4.2	4.2	1.2	3.3	2.6	6.6	6.6	7.9	20.1	8.3	8.1	7.7	6.5	7.0	7.1	7.4	7.1	22.9	35.3	16.2	3.6	20.4	70.4	18.4	20.2	71.7	2.3	18.2	14.4	9.4	5.7	24.3	12.9	10.4	7.5	37.2	22.1	0.0	6.4	9.4	18.1	18.0	19.4	10.7	5.9	8.1	6.3	9.0	16.3	15.3	29.5	22.2	6.4	15.4	8.3	8.7	1.7	6.9	12.5	10.2	13.2	361.2	7.3	4.1	69.0	16.0	5.6	97.0	3.9	10.3	6.0	4.4	10.4	13.4	4.5	25.3	16.5	16.0	3.2	29.7	6.3	13.1	16.4	15.4	10.2	9.4	64.2	78.7	14.9	40.4	6.0	14.4	51.4
FAM102B	"DKFZp779B126, SYM-3B"	ENSG00000162636	"Family with sequence similarity 102 member B"	Q5T8I3	1	108560089-108644900	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 54.9;Langerhans cells: 43.2;Microglial cells: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028451	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Nucleoli, Cytosol"		"HPA028451: AB_10602497"	"unprognostic (1.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.87e-3)"	"unprognostic (3.10e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.47e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.86e-1)"	9.1	3.9	8.1	10.5	9.7	21.2	10.7	5.1	9.2	7.4	0.1	13.3	11.0	6.5	4.2	6.0	5.1	14.7	6.6	9.4	8.6	3.2	4.9	7.8	9.0	4.1	6.8	5.3	3.8	7.5	3.8	5.9	8.1	6.3	14.6	3.6	13.7	7.8	1.3	3.7	11.2	8.8	3.0	8.8	7.6	8.6	5.6	8.7	3.5	6.0	8.2	16.4	4.4	5.0	6.9	4.9	9.7	5.2	17.0	10.2	6.4	4.0	5.4	6.1	10.3	1.8	6.8	7.6	3.6	10.4	6.3	13.1	33.2	1.4	7.8	5.1	4.8	10.6	35.8	0.8	4.3	14.0	19.8	5.5	1.4	9.0	0.5	12.3	4.0	12.5	26.3	41.2	14.4	28.4	9.0	10.0	7.6	16.2	24.6	20.8	24.5	1.6	1.7	7.9	31.4	9.3	15.9	27.4	8.3	6.8	5.8	22.5	0.7	9.8	18.4	8.6	15.5	7.6	1.9	7.1	14.4	10.8	5.3	2.9	0.4	0.4	0.3	0.9	0.2	0.3	0.3	0.4	1.0	0.3	0.2	0.2	0.3	0.2	0.3	0.2	0.3	0.1	8.1	9.7	5.1	9.2	9.4	8.6	4.1	6.8	8.1	3.0	5.6	5.0	5.9	0.0	2.2	12.1	6.1	6.1	2.3	1.0	4.6	3.9	10.1	7.2	1.9	10.0	2.2	1.8	0.0	2.4	17.2	15.6	1.9	2.7	15.3	2.1	7.8	5.5	7.2	3.8	54.9	6.1	2.7	16.3	6.6	5.2	7.6	3.6	8.2	1.2	9.7	0.0	27.9	8.1	0.0	25.1	43.2	6.9	14.3	27.5	5.4	52.5	15.2	1.2	11.3	25.1	7.2	4.5	10.5	20.7	11.9	1.9	4.5	1.0	1.8	1.1	0.0	3.2	6.5	4.4	6.4	6.5	3.7	3.4	16.4	36.2	13.8	4.6
FAM117B	"ALS2CR13, FLJ38771"	ENSG00000138439	"Family with sequence similarity 117 member B"	Q6P1L5	2	202634969-202769757	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 45.8;Inhibitory neurons: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003229, HPA028746"	Uncertain		Approved	Nucleoplasm,Centrosome		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Centrosome	"HPA003229: AB_2246696, HPA028746: AB_2672760"	"unprognostic (1.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.55e-2)"	"unprognostic (4.84e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.40e-3)"	"unprognostic (5.75e-1)"	"unprognostic (6.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.37e-3)"	3.1	7.5	5.1	4.5	5.4	2.9	3.3	7.0	7.1	2.7	0.7	4.9	4.3	2.9	2.9	5.4	3.8	3.0	1.8	5.0	6.3	4.9	1.9	2.9	7.2	3.1	3.8	5.1	4.6	7.3	3.5	6.9	3.6	5.1	4.7	2.6	3.3	3.0	1.5	5.0	3.7	2.0	3.3	5.4	4.1	5.8	6.4	9.6	2.8	1.8	7.4	3.8	3.2	4.1	2.0	2.4	10.5	7.2	3.5	1.9	10.2	0.6	0.9	0.6	1.1	3.1	4.2	8.2	6.5	1.2	1.6	1.9	9.0	4.6	1.7	0.2	7.2	6.9	4.3	11.6	2.8	5.9	3.0	2.6	6.3	1.3	1.9	4.7	2.8	10.8	10.1	1.6	0.6	3.9	16.1	12.1	10.7	5.8	4.5	12.5	2.1	9.8	5.5	5.2	17.7	15.4	8.0	5.3	3.9	8.7	2.2	8.1	1.7	1.2	2.4	1.9	1.1	5.9	3.6	10.8	2.4	4.5	1.3	0.4	3.9	1.5	1.3	8.2	3.4	8.1	3.0	2.7	4.5	7.7	8.2	5.7	2.2	4.4	9.1	1.5	1.2	3.1	5.1	5.4	7.0	7.1	5.0	6.3	3.1	3.8	3.6	3.3	6.4	4.1	9.7	3.2	7.5	13.1	21.5	17.2	2.9	3.0	12.0	4.9	8.1	4.3	4.9	12.8	2.6	18.4	4.2	8.4	8.8	11.7	0.0	10.2	2.2	8.6	6.5	4.9	25.8	3.0	45.8	6.4	6.3	6.1	7.1	10.1	5.7	15.3	8.2	2.2	2.8	6.7	49.7	11.8	2.0	27.4	13.9	1.4	13.1	17.1	3.6	23.4	17.1	1.7	3.1	29.1	29.4	5.8	9.7	23.7	5.2	6.7	4.9	5.9	3.0	2.7	6.6	2.0	4.1	5.0	16.3	29.2	19.9	2.7	10.1	11.1	13.8	6.0
FAM210A	"C18orf19, HsT2329, MGC24180"	ENSG00000177150	"Family with sequence similarity 210 member A"	Q96ND0	18	13663347-13726663	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 33.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA014324, HPA051564"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Mitochondria"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Golgi apparatus, Mitochondria"		"HPA014324: AB_2668972, HPA051564: AB_2681536"	"unprognostic (1.32e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.18e-3)"	"unprognostic (4.13e-2)"	"prognostic unfavorable (8.14e-4)"	"unprognostic (2.23e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.26e-1)"	"unprognostic (5.53e-3)"	"unprognostic (6.79e-3)"	"unprognostic (2.98e-2)"	"unprognostic (3.27e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.82e-2)"	6.1	4.7	4.7	5.5	4.5	3.5	4.8	5.8	7.1	4.2	8.0	6.9	9.3	3.9	2.9	8.8	4.2	4.0	21.8	4.6	5.3	9.4	13.2	4.0	6.4	5.2	7.0	5.6	3.3	6.4	2.6	7.5	5.6	4.4	6.4	11.5	5.1	4.6	25.5	3.3	6.2	6.2	5.1	3.7	4.7	8.4	6.3	5.3	6.3	33.1	7.3	6.3	5.0	5.7	24.6	13.6	9.4	8.8	10.9	11.2	13.6	16.5	15.3	18.2	21.1	18.4	11.6	24.9	20.2	11.8	33.6	11.5	18.2	20.6	29.5	17.4	8.4	17.7	9.7	13.0	12.9	30.3	15.9	9.7	15.9	17.5	61.6	12.7	11.9	14.8	24.2	13.4	21.2	16.8	18.7	19.5	10.6	47.7	13.5	15.2	22.3	29.1	15.1	15.3	6.0	10.1	14.5	21.1	40.0	13.4	10.8	14.2	13.2	46.4	45.7	29.1	20.6	15.1	20.1	28.8	24.6	15.6	18.9	3.5	5.3	3.3	6.2	8.0	6.8	5.7	5.2	5.4	6.4	6.3	6.4	6.2	0.8	6.0	4.2	4.0	5.4	3.8	4.7	4.5	5.8	7.1	4.6	5.3	5.2	7.0	5.6	5.1	6.3	5.7	14.9	9.6	8.3	13.7	29.8	55.3	14.8	28.3	12.5	63.2	11.0	11.2	66.4	12.8	14.6	7.3	20.9	20.6	11.6	9.1	21.5	18.6	20.5	16.7	21.6	18.3	11.4	5.9	18.0	8.8	39.0	17.4	10.2	32.7	7.0	36.7	6.8	20.7	20.0	30.3	23.5	10.0	10.2	9.5	43.4	6.1	9.3	26.5	8.8	15.0	11.4	19.0	15.5	18.6	24.8	12.6	4.1	10.1	14.2	19.9	12.1	29.8	5.0	29.9	6.6	16.3	15.4	31.4	32.3	20.6	57.3	25.7	16.8	45.6	20.5	14.8
FCER1A	FCE1A	ENSG00000179639	"Fc fragment of IgE receptor Ia"	P12319	1	159289714-159308224	"FDA approved drug targets, Predicted membrane proteins"		"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 33.6"	"Cell type enriched"	"Detected in many"	7	"Langerhans cells: 1962.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	8	"basophil: 21557.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 21557.7"	"Cell line enriched"	"Detected in some"	99	"HEL: 447.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB022102, HPA036051, CAB055526"	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"			"CAB022102: , CAB055526: , HPA036051: AB_2674919"	"unprognostic (1.78e-2)"	"unprognostic (2.26e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.44e-1)"	"unprognostic (7.20e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.20e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.39e-2)"	3.9	1.7	0.4	5.7	0.4	14.2	17.3	0.5	0.8	10.6	0.5	7.0	7.1	7.1	5.4	23.0	2.9	14.9	3.2	0.4	0.6	4.7	4.4	14.5	2.5	0.6	0.5	0.7	1.2	2.6	0.8	0.2	0.7	5.9	10.7	0.1	4.0	9.1	2.8	33.6	8.8	7.4	0.4	8.0	3.5	2.3	0.6	4.8	1.2	3.9	10.9	11.9	2.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	447.9	0.0	0.0	0.0	0.5	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21557.7	14.4	36.4	0.4	4.1	4.4	2.8	4.4	1.5	2645.6	3.1	2.3	3.4	17.2	14.6	11.0	361.0	2.8	132.1	0.4	0.4	0.5	0.8	0.4	0.6	0.6	0.5	0.7	0.4	0.6	0.5	1.6	6.4	33.1	0.3	5.5	37.7	0.1	0.0	0.6	0.0	0.6	1.8	0.6	0.0	1.8	0.0	0.0	0.0	76.8	0.0	0.0	0.0	0.3	0.1	0.0	3.4	0.0	37.8	0.0	0.0	0.1	4.2	0.0	0.1	270.7	0.0	0.0	0.0	6.4	0.0	0.1	0.0	0.0	4.0	1962.9	1.1	0.0	169.1	46.2	0.0	46.8	0.0	3.1	0.0	0.0	0.0	0.1	0.0	1.3	0.1	0.0	0.0	1.5	0.0	13.1	0.1	2.6	0.1	0.3	0.2	34.1	0.0	6.8	0.0	0.0	0.0
FGD4	"CMT4H, frabin, FRABP, ZFYVE6"	ENSG00000139132	"FYVE, RhoGEF and PH domain containing 4"	Q96M96	12	32399558-32646050	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Actin-binding, Guanine-nucleotide releasing factor"	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 232.5;Early spermatids: 196.3;Late spermatids: 250.1;Microglial cells: 203.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 14.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 3.6;granulocytes: 8.4;monocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039235	Approved		Approved	"Actin filaments"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Actin filaments"		"HPA039235: AB_10673420"	"unprognostic (6.73e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.45e-2)"	"unprognostic (8.61e-3)"	"unprognostic (3.91e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (7.16e-5)"	"unprognostic (9.50e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.41e-3)"	12.6	4.3	8.1	5.6	10.3	12.1	8.0	11.4	6.7	6.1	13.8	9.4	8.8	2.3	2.9	7.4	4.9	10.3	5.3	7.4	10.3	10.8	17.7	8.1	1.8	12.3	10.1	24.6	9.4	14.8	3.1	10.4	12.4	4.6	10.1	23.6	6.7	4.0	10.8	7.4	8.2	3.4	9.2	5.2	28.9	12.1	9.5	1.7	6.3	10.8	2.7	4.0	5.9	13.7	5.4	2.6	6.6	2.0	24.1	14.8	8.1	4.5	22.5	1.2	0.4	8.1	8.3	0.8	2.5	0.3	2.8	5.1	5.3	7.5	0.7	0.7	2.6	4.7	2.7	2.5	4.3	0.9	0.0	8.8	10.3	6.0	12.9	3.3	11.6	1.1	0.5	5.4	15.6	1.9	0.0	1.7	17.4	5.3	0.2	0.4	6.9	16.2	8.0	5.3	7.2	8.5	4.7	4.4	6.6	11.8	7.0	0.3	13.1	0.1	1.5	18.8	0.7	1.9	4.6	2.9	0.0	2.8	5.2	3.6	3.8	8.4	0.2	5.7	0.2	0.6	0.3	0.2	3.6	1.4	0.2	0.3	5.5	0.7	5.1	0.4	0.2	1.3	8.1	10.3	11.4	6.7	7.4	10.3	12.3	10.1	12.4	9.2	9.5	13.7	84.3	48.1	31.4	232.5	5.6	8.4	11.3	12.1	8.6	23.8	10.7	7.5	19.2	54.3	18.3	22.0	118.9	1.3	0.5	57.8	13.7	16.8	196.3	36.0	8.1	24.8	19.2	4.4	40.5	20.7	16.8	19.9	78.5	65.7	2.5	34.1	9.3	37.7	11.8	70.7	55.1	31.2	26.4	71.7	22.3	250.1	4.7	92.9	14.2	203.3	39.9	79.3	1.0	25.1	95.1	33.5	29.3	1.5	16.4	16.4	54.8	15.0	15.3	114.5	52.6	16.5	41.3	10.4	7.4	25.0	12.6	1.4	3.1	25.6	30.5	20.2
FGF20		ENSG00000078579	"Fibroblast growth factor 20"	Q9NP95	8	16992181-17002345	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.5"	"Cell type enriched"	"Detected in some"	7	"Microglial cells: 8.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 2.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 1.6;CAPAN-2: 5.3;OE19: 1.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.8"						"Secreted in other tissues"	NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"				"unprognostic (1.93e-2)"		"unprognostic (2.19e-1)"	"unprognostic (5.57e-3)"	"unprognostic (3.95e-2)"			"unprognostic (1.59e-3)"		"unprognostic (1.40e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.32e-2)"	"unprognostic (9.95e-2)"	"unprognostic (3.92e-1)"	"unprognostic (4.08e-2)"		0.1	0.6	0.8	0.0	0.8	0.0	0.2	2.5	1.4	0.9	0.5	0.0	0.1	0.0	0.6	0.0	0.2	0.3	0.1	0.8	1.2	0.0	0.0	0.1	0.1	1.1	1.2	0.6	0.1	0.0	0.4	0.1	1.4	0.2	0.0	0.1	1.1	0.1	0.0	0.0	0.1	0.0	1.1	1.0	0.6	0.2	1.4	0.2	0.2	0.0	0.4	0.1	0.1	1.6	0.0	0.0	0.1	0.0	0.4	0.6	0.0	0.6	1.6	0.2	0.8	0.0	5.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	2.5	1.4	0.8	1.2	1.1	1.2	1.4	1.1	1.4	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.0	0.0	0.0	0.0	1.2	0.0	8.4	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0
FGL2	"pT49, T49"	ENSG00000127951	"Fibrinogen like 2"	Q14314	7	77193369-77199848	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 162.5"	"Group enriched"	"Detected in many"	4	"Kupffer cells: 466.3;Langerhans cells: 571.0;Macrophages: 430.3;monocytes: 463.1;Skeletal myocytes: 166.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	45	"classical monocyte: 256.5;eosinophil: 226.3;intermediate monocyte: 380.6;myeloid DC: 160.0;neutrophil: 294.7;non-classical monocyte: 379.8"	"Group enriched"	"Detected in all"	59	"dendritic cells: 160.0;granulocytes: 294.7;monocytes: 380.6"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.0;LHCN-M2: 2.9;NB-4: 2.9;RPTEC TERT1: 5.0;THP-1: 2.1;U-937: 5.0;WM-115: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021011, HPA026682"	Enhanced				"Secreted to blood"	NA	NA	38800000	7800000	"Cluster 14: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"			"HPA021011: AB_1848532, HPA026682: AB_1848533"	"unprognostic (9.80e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.01e-2)"	48.5	24.4	3.3	89.4	2.7	5.8	35.1	5.3	3.5	17.2	6.1	44.9	43.7	17.8	7.6	38.5	22.1	45.4	21.6	2.4	5.4	44.9	43.5	32.7	56.5	7.7	5.9	10.9	8.3	5.2	7.9	21.6	6.7	10.5	57.2	0.8	14.8	11.7	8.8	13.9	69.8	45.7	6.2	162.5	23.5	6.2	3.9	30.1	18.8	24.6	27.5	73.3	7.1	9.8	0.0	0.0	0.0	0.0	1.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.9	0.0	0.0	2.9	0.1	0.0	0.0	0.1	0.2	0.3	5.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	5.0	5.7	2.8	256.5	226.3	3.9	380.6	1.2	4.3	2.5	3.4	160.0	2.0	1.8	3.0	294.7	2.5	379.8	6.2	4.7	174.0	3.3	2.7	5.3	3.5	2.4	5.4	7.7	5.9	6.7	6.2	3.9	9.8	102.0	6.4	12.1	0.0	26.2	38.1	1.1	0.1	3.4	1.1	1.4	3.0	4.4	0.0	5.0	88.3	10.4	1.3	60.3	17.3	5.9	1.9	7.5	2.6	0.7	50.6	0.0	7.0	0.3	0.0	1.4	102.8	2.0	5.0	10.1	0.6	45.3	5.2	36.2	1.7	0.4	0.3	0.0	466.3	571.0	9.4	27.7	430.3	49.8	33.7	463.1	13.6	39.1	0.0	0.9	0.1	10.9	19.5	82.6	1.1	42.5	5.9	2.2	7.4	0.0	166.2	8.2	0.4	0.4	2.1	31.3	3.7	24.1	0.2	0.8	1.5
FKBP5	"FKBP51, FKBP54, P54, PPIase, Ptg-10"	ENSG00000096060	"FKBP prolyl isomerase 5"	Q13451	6	35573585-35728583	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 892.7;tongue: 925.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 384.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 759.3;ASC TERT1: 468.5;HHSteC: 593.0;HSkMC: 718.3;hTCEpi: 368.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009315, HPA031092, HPA031093, HPA031095"	Enhanced		Enhanced	Nucleoplasm		No	No		39000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: AB_2673734"	"unprognostic (2.09e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.72e-1)"	"unprognostic (6.30e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.18e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.22e-2)"	"unprognostic (6.90e-3)"	400.1	92.3	18.2	70.1	26.8	26.6	160.4	19.7	32.1	86.4	20.2	110.9	11.3	97.5	63.0	130.6	104.6	78.9	93.7	16.8	20.7	108.8	144.5	92.7	166.7	22.7	23.8	122.1	200.4	227.0	52.9	28.5	23.5	85.0	37.1	25.6	61.0	49.8	892.7	114.0	135.7	81.8	17.0	105.6	129.0	41.4	22.1	229.4	97.2	925.1	80.3	108.9	109.1	26.2	40.0	17.1	73.1	109.7	759.3	468.5	1.2	21.2	1.0	13.6	31.0	29.7	6.9	195.3	19.5	4.1	11.8	0.6	44.1	93.2	32.0	77.7	41.6	84.0	14.1	41.7	593.0	53.3	8.3	718.3	368.6	23.7	220.5	14.8	80.1	38.8	91.3	77.1	144.3	25.3	222.5	99.6	18.9	8.7	12.3	97.7	19.1	95.4	60.2	23.7	27.7	16.8	17.3	19.8	4.2	15.9	108.4	62.2	178.7	19.3	17.3	2.8	29.7	34.9	42.9	243.5	6.6	102.3	7.6	57.6	105.0	70.0	64.4	92.3	78.0	9.7	90.6	68.5	107.5	12.5	133.4	96.7	85.1	45.2	46.8	32.0	37.2	158.5	18.2	26.8	19.7	32.1	16.8	20.7	22.7	23.8	23.5	17.0	22.1	26.2	180.2	12.8	11.3	23.2	42.9	17.6	59.2	20.1	37.0	1.9	32.0	20.8	131.8	74.4	14.2	5.5	0.0	1.2	102.0	14.3	23.5	0.6	9.8	55.7	76.1	57.9	20.9	102.2	25.9	7.9	0.8	97.5	18.8	79.2	38.5	54.7	117.1	225.6	35.1	0.0	2.8	35.5	34.6	384.2	44.8	22.0	160.9	192.2	7.2	66.5	110.3	4.6	44.3	16.6	26.3	2.9	19.3	218.6	66.4	49.9	157.0	27.4	18.2	22.6	144.7	188.1	106.8	14.9	19.1	37.5	21.3	0.4	128.7	2.8	39.5	22.2
FLT3	"CD135, FLK2, STK1"	ENSG00000122025	"Fms related receptor tyrosine kinase 3"	P36888	13	28003274-28100592	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.3;brain: 4.9;lymphoid tissue: 6.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 24.4;Inhibitory neurons: 59.9;Kupffer cells: 29.1;Langerhans cells: 21.4;Macrophages: 16.9;monocytes: 39.5"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.8"	"Region enhanced"	"Detected in some"		"cerebellum: 4.9"	"Group enriched"	"Detected in many"	13	"myeloid DC: 68.7;plasmacytoid DC: 26.2"	"Lineage enriched"	"Detected in many"	19	"dendritic cells: 68.7"	"Group enriched"	"Detected in some"	11	"REH: 42.5;THP-1: 26.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047539			Approved	"Endoplasmic reticulum"		NA	NA		210000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 14: REH - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"		"HPA047539: AB_2680080"	"unprognostic (2.19e-3)"	"unprognostic (3.16e-3)"	"unprognostic (6.54e-3)"	"unprognostic (9.96e-2)"	"unprognostic (3.88e-1)"	"unprognostic (3.96e-7)"	"unprognostic (7.99e-3)"	"unprognostic (1.65e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.22e-1)"	0.5	0.1	0.3	3.0	0.2	5.3	1.5	4.9	0.8	0.5	0.1	0.7	0.3	0.2	0.1	0.6	0.4	1.6	0.1	0.2	0.5	1.5	0.5	0.7	6.5	1.3	0.9	0.1	2.8	0.0	0.0	0.0	1.7	0.1	0.8	0.0	0.4	0.2	0.0	0.7	1.6	0.8	0.8	5.7	0.6	0.6	0.8	4.7	0.1	0.3	3.6	1.3	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.2	0.6	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	3.6	3.4	0.0	0.8	0.0	0.2	0.0	0.0	68.7	0.0	0.0	0.0	0.1	2.0	0.0	26.2	0.0	2.7	0.3	0.2	4.9	0.8	0.2	0.5	1.3	0.9	1.7	0.8	0.8	0.8	0.0	0.0	0.0	2.3	1.5	0.3	0.0	0.0	0.0	0.0	1.5	1.0	0.4	1.5	0.0	0.0	0.0	0.0	24.4	0.0	0.0	2.7	3.7	0.3	0.1	0.2	0.0	8.2	7.4	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.7	0.1	0.5	0.0	59.9	0.0	0.0	29.1	21.4	2.3	0.0	16.9	1.8	1.9	39.5	0.0	0.0	1.5	4.2	0.1	0.0	0.0	2.2	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.2	0.6	0.0	0.6	0.0	1.7	0.0	0.0	0.0
FNBP1	"FBP17, KIAA0554"	ENSG00000187239	"Formin binding protein 1"	Q96RU3	9	129887187-130043194	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 317.7;Langerhans cells: 402.9;monocytes: 433.2;Oligodendrocytes: 522.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 137.7;JURKAT: 143.2;MOLT-4: 140.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019635, HPA019691, HPA022119, HPA067742"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"	Vesicles	"HPA019635: AB_2732423, HPA019691: AB_2670231, HPA022119: AB_2670897, HPA067742: "	"unprognostic (2.86e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.30e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.90e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (6.84e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.21e-1)"	21.8	11.9	51.2	57.8	73.7	40.6	16.4	77.4	53.4	32.5	22.2	107.3	15.0	50.0	17.0	39.4	34.8	27.8	15.1	47.0	62.5	16.4	18.4	25.4	78.1	67.6	69.1	22.1	8.1	10.7	17.7	16.3	65.8	41.4	29.6	12.6	16.3	44.1	24.1	25.9	37.6	46.8	55.9	60.9	29.6	17.3	69.9	111.0	33.4	13.2	74.3	68.4	26.8	86.6	42.5	19.3	34.9	40.8	21.0	25.8	29.5	23.7	20.2	17.6	14.7	20.3	16.2	82.9	20.4	44.5	20.8	20.7	33.0	21.6	17.6	137.7	9.8	22.8	22.8	13.8	35.8	62.3	75.1	18.7	9.3	32.6	19.5	25.6	26.1	143.2	5.4	1.1	16.4	34.0	140.1	60.8	27.5	5.7	32.6	31.9	28.3	24.1	22.1	23.0	5.5	17.6	43.3	42.9	16.5	33.3	30.0	28.3	31.9	16.6	20.7	30.5	15.0	16.4	64.4	3.8	20.0	42.2	25.2	13.2	5.1	9.6	10.8	5.6	9.3	12.7	9.7	10.3	5.8	7.7	8.9	8.6	9.3	6.0	6.5	6.9	10.9	4.5	51.2	73.7	77.4	53.4	47.0	62.5	67.6	69.1	65.8	55.9	69.9	86.6	27.2	35.3	25.2	317.7	180.4	33.1	21.3	12.8	21.6	20.2	42.5	24.6	14.8	15.7	29.8	22.0	52.1	18.6	217.2	28.3	19.6	22.6	1.7	46.2	38.8	38.3	18.1	31.3	65.6	17.3	24.5	38.8	26.5	78.7	80.4	9.2	71.0	18.4	43.6	28.6	107.8	8.7	20.3	221.2	402.9	5.5	46.6	131.1	76.5	95.5	433.2	42.8	223.5	69.4	522.1	21.8	19.8	51.6	147.9	67.8	0.2	15.0	42.3	29.5	59.2	19.9	41.0	26.5	45.4	26.7	41.1	63.9	233.7	7.1	16.2	42.3
FNIP2	"FNIPL, KIAA1450, MAPO1"	ENSG00000052795	"Folliculin interacting protein 2"	Q9P278	4	158769026-158908050	"Predicted intracellular proteins"	"DNA damage"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 288.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 3.3;myeloid DC: 2.1;non-classical monocyte: 7.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.1;monocytes: 7.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 179.0;U-266/70: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042779, HPA052758, HPA072420"	Approved		Supported	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol	"Centriolar satellite"	"HPA042779: AB_10794386, HPA052758: , HPA072420: AB_2732200"	"unprognostic (3.38e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.06e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (3.96e-11)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.10e-2)"	26.3	7.7	6.7	10.1	13.2	8.9	12.1	6.5	12.8	12.7	4.4	21.8	7.4	11.1	9.3	14.5	8.0	20.4	25.3	12.3	8.3	47.8	58.3	24.9	7.7	10.3	10.1	10.7	19.4	15.9	3.2	30.1	8.8	10.8	22.3	8.8	13.9	11.3	11.4	10.1	9.3	17.9	7.3	13.3	22.8	10.0	22.5	7.2	18.5	20.0	5.5	13.6	5.2	18.6	4.0	4.5	19.2	10.1	14.1	8.9	21.0	8.6	9.1	8.7	9.8	5.3	4.0	0.2	2.1	31.2	10.7	3.7	18.4	8.9	10.5	179.0	6.6	18.7	2.5	7.3	8.8	7.9	36.0	6.5	7.3	5.9	7.7	12.8	9.9	9.8	11.4	0.8	14.6	1.3	18.4	1.0	6.1	12.7	4.6	10.8	9.5	5.1	7.0	10.2	12.3	10.9	4.7	3.2	19.5	6.1	4.0	4.3	12.5	14.0	8.7	9.6	6.5	57.3	26.0	3.8	13.9	9.5	10.0	0.4	0.7	0.2	0.5	3.3	0.3	0.0	0.3	0.2	2.1	0.0	0.2	0.6	0.1	0.6	7.2	0.4	0.1	0.4	6.7	13.2	6.5	12.8	12.3	8.3	10.3	10.1	8.8	7.3	22.5	18.6	93.7	19.2	129.2	20.9	6.5	35.6	30.9	7.2	14.2	17.7	18.4	16.4	55.4	58.6	23.2	40.5	54.2	13.1	17.8	80.9	23.5	38.5	17.6	51.6	13.8	78.1	62.4	25.4	109.0	79.9	7.4	35.1	30.1	82.0	27.9	15.7	95.3	114.7	65.4	10.1	95.5	44.9	8.2	90.6	288.0	9.9	13.4	101.5	40.9	64.6	28.4	4.9	11.3	56.8	151.8	80.5	77.2	9.8	5.4	55.7	11.1	72.9	15.3	27.9	52.6	72.3	34.0	25.8	22.8	13.6	36.8	8.2	13.0	10.4	46.8	41.2
FOXJ2	FHX	ENSG00000065970	"Forkhead box J2"	Q9P0K8	12	8032716-8055517	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Meiosis, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008723	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA008723: AB_1078903"	"unprognostic (1.68e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (9.01e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.02e-2)"	13.8	8.3	6.6	8.7	6.7	15.5	12.3	14.3	11.9	15.5	4.6	14.8	7.3	17.7	8.0	8.8	14.4	8.1	14.7	6.7	6.6	7.3	5.9	12.1	8.3	6.3	6.2	16.8	10.0	15.4	8.5	11.0	6.1	10.6	7.7	9.3	9.5	12.8	25.2	17.5	10.1	14.7	5.1	10.8	11.3	5.8	6.2	10.7	9.9	20.6	9.1	13.5	12.3	7.0	12.4	10.3	11.1	14.0	12.6	13.8	24.3	17.5	17.8	16.7	12.4	14.8	13.3	0.2	3.2	21.3	15.4	13.2	10.0	11.7	17.8	21.6	6.8	16.4	11.8	5.1	15.8	7.4	43.9	12.2	17.2	21.7	31.5	17.4	12.1	13.0	12.2	8.0	13.7	9.6	10.5	6.6	12.6	18.4	6.8	11.2	17.2	6.0	7.0	8.2	4.6	6.3	22.0	15.1	7.6	23.1	3.5	8.8	11.0	20.3	24.8	14.5	10.7	6.4	6.8	8.1	13.1	5.9	12.3	2.5	1.4	2.2	1.5	1.1	1.9	0.8	1.5	1.7	1.8	1.5	1.7	1.5	2.7	2.8	1.5	1.7	1.2	1.2	6.6	6.7	14.3	11.9	6.7	6.6	6.3	6.2	6.1	5.1	6.2	7.0	14.1	16.0	13.1	6.2	9.1	18.9	4.5	5.5	14.8	10.7	10.4	9.1	19.9	12.8	4.0	0.0	8.4	5.5	7.7	7.1	0.0	5.9	0.4	4.0	14.0	12.8	4.9	13.7	6.1	7.5	3.1	12.0	7.7	7.2	3.8	16.1	18.9	9.5	10.1	8.4	6.4	8.4	4.1	13.2	23.0	0.9	10.5	13.9	7.2	6.5	14.2	4.0	11.3	3.0	5.7	10.3	4.4	17.0	6.7	9.8	5.0	2.4	2.9	7.5	19.7	9.9	8.4	1.4	6.4	14.2	21.5	6.2	12.3	8.1	7.4	5.3
FOXO3	"AF6q21, FKHRL1, FOXO2, FOXO3A"	ENSG00000118689	"Forkhead box O3"	O43524	6	108559835-108684774	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 15.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 94.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004074, HPA063104"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB004074: AB_2106672, HPA063104: AB_2684941"	"unprognostic (3.42e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.81e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.68e-2)"	46.7	11.4	14.7	13.4	15.1	68.5	43.1	34.0	19.6	28.1	19.3	21.7	12.4	23.5	15.3	35.4	25.4	28.2	18.6	14.3	9.8	16.3	23.1	30.3	12.8	17.4	15.5	43.0	86.9	30.2	8.6	21.3	13.3	20.0	17.0	28.7	25.1	11.5	84.1	30.6	16.9	21.1	11.5	18.8	22.2	11.9	17.1	18.5	18.0	51.4	15.8	23.2	27.4	17.0	21.6	6.8	9.1	20.4	41.2	48.4	16.1	17.0	17.7	13.5	19.9	11.9	19.5	11.7	14.8	20.0	22.3	15.0	12.1	20.8	20.4	12.9	18.3	32.5	6.2	9.8	47.4	8.6	24.8	56.0	43.2	29.3	40.4	19.8	10.3	10.2	21.8	94.5	26.9	12.2	9.4	12.6	6.1	10.1	11.6	12.1	32.4	48.7	30.7	16.5	23.4	59.9	12.7	11.8	16.6	18.1	12.1	27.7	18.3	24.9	12.9	13.8	20.6	0.9	16.8	13.5	13.4	16.2	16.4	7.8	2.8	6.1	3.2	1.5	3.8	0.8	1.7	2.6	1.7	1.7	1.4	2.0	15.6	3.7	5.3	2.7	1.9	1.1	14.7	15.1	34.0	19.6	14.3	9.8	17.4	15.5	13.3	11.5	17.1	17.0	88.2	44.8	46.0	112.6	41.2	67.7	73.3	34.4	91.6	63.4	64.1	46.9	31.6	71.4	44.4	25.8	70.9	25.4	41.4	86.9	17.6	50.4	19.9	91.2	41.8	55.6	66.9	246.9	102.7	30.9	36.9	105.8	46.9	105.6	15.2	46.2	84.6	77.7	46.4	52.2	99.9	55.0	20.3	85.2	83.3	17.7	106.6	96.6	56.9	160.2	55.9	78.9	22.6	108.6	133.2	73.3	44.2	100.4	83.3	122.2	28.3	21.1	57.7	68.6	32.9	236.6	81.6	9.1	17.8	61.1	46.5	41.2	37.6	30.6	34.5	184.2
FPR2	"ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R"	ENSG00000171049	"Formyl peptide receptor 2"	P25090	19	51752026-51770531	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 56.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.0;Hofbauer cells: 12.7;Kupffer cells: 18.8;Late spermatids: 26.8;Macrophages: 61.3;monocytes: 23.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	10	"neutrophil: 1187.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 1187.9"	"Cell line enriched"	"Detected in some"	20	"U-937: 32.7"	"Not detected"	"Not detected"							HPA029154	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA029154: AB_10602133"	"unprognostic (3.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.41e-5)"	"unprognostic (1.08e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.90e-1)"	13.6	1.2	0.3	56.1	0.6	16.6	0.6	0.3	2.6	0.5	0.9	0.8	1.0	0.5	0.1	1.8	1.8	5.9	0.9	0.3	0.3	0.4	4.9	9.4	1.9	0.6	0.5	1.5	2.3	0.3	0.2	7.6	0.9	0.4	0.5	0.1	0.5	0.3	0.3	0.4	1.3	6.7	0.3	17.2	0.7	2.4	1.2	1.6	0.7	4.2	0.8	15.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.8	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.9	32.7	0.0	3.6	122.0	5.8	0.2	122.7	0.7	0.1	0.2	0.2	16.6	0.2	0.1	0.2	1187.9	0.2	85.0	3.3	0.1	46.0	0.3	0.6	0.3	2.6	0.3	0.3	0.6	0.5	0.9	0.3	1.2	0.5	0.0	0.0	5.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	9.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	5.1	0.0	0.4	0.4	12.7	0.0	0.0	0.0	0.0	18.8	0.8	26.8	0.0	61.3	0.0	0.0	23.3	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0
G0S2		ENSG00000123689	"G0/G1 switch 2"	P27469	1	209675412-209676390	"Metabolic proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 796.7;bone marrow: 1345.4"	"Cell type enriched"	"Detected in many"	4	"Langerhans cells: 5188.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 44.5"	"Immune cell enriched"	"Detected in some"	60	"neutrophil: 549.5"	"Lineage enriched"	"Detected in many"	213	"granulocytes: 549.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 460.8;HBEC3-KT: 726.2;PC-3: 180.6;RPMI-8226: 242.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"				"unprognostic (1.67e-3)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (7.72e-4)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (3.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.04e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.32e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (7.57e-3)"	"unprognostic (1.53e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.64e-1)"	796.7	194.3	7.0	95.7	7.5	1345.4	519.5	7.4	44.5	9.2	8.2	20.9	7.6	34.3	11.7	8.6	26.8	15.7	175.9	8.8	6.8	262.6	664.6	318.4	7.6	7.4	8.6	47.5	31.0	0.8	9.5	13.8	9.1	38.3	4.0	0.6	59.8	14.8	651.4	24.3	31.7	10.9	7.9	49.3	63.8	30.1	7.8	5.9	23.7	303.4	5.4	136.2	17.3	9.7	0.0	4.3	0.0	0.0	460.8	16.1	0.3	0.7	1.4	1.9	1.8	19.3	14.8	0.0	4.1	3.4	2.5	0.0	0.0	726.2	4.4	0.7	1.2	0.0	1.5	0.6	37.5	0.2	0.1	47.8	1.6	32.4	0.0	15.8	0.0	0.0	0.2	0.0	0.2	0.0	0.2	15.7	1.3	0.0	180.6	0.0	0.0	242.8	1.7	0.3	0.9	1.4	16.3	0.0	4.0	0.0	0.2	56.7	73.6	0.0	4.9	0.2	0.1	0.0	1.1	0.1	13.1	0.1	0.0	0.0	1.0	9.1	0.0	1.1	0.4	0.1	2.5	0.1	0.3	0.3	0.0	0.0	549.5	0.0	0.2	0.0	0.0	0.4	7.0	7.5	7.4	44.5	8.8	6.8	7.4	8.6	9.1	7.9	7.8	9.7	52.3	9.6	59.5	5.9	16.1	232.4	654.8	760.7	124.1	0.6	295.2	43.3	359.1	14.3	111.6	11.0	0.0	1.8	5.0	16.6	299.3	52.3	25.3	42.7	12.0	264.5	29.3	6.9	0.9	148.2	3.6	730.2	11.7	112.0	39.1	34.7	12.1	179.4	174.2	0.0	3.1	32.6	22.4	78.2	5188.4	12.3	114.6	1060.3	327.3	2.8	30.7	23.1	1.0	11.1	0.9	736.5	42.9	71.5	10.3	416.7	41.1	304.9	42.3	0.3	32.9	56.4	60.1	52.1	1.1	35.2	161.4	4.2	33.3	7.5	52.5	513.7
GCH1	"DYT14, DYT5, DYT5a, GCH, GTPCH1"	ENSG00000131979	"GTP cyclohydrolase 1"	P30793	14	54842008-54902826	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	"Allosteric enzyme, Hydrolase"	"Disease variant, Dystonia, Parkinsonism, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.4;liver: 36.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 212.5;Hepatocytes: 94.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 11.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 23.5;Daudi: 25.0;JURKAT: 23.0;SH-SY5Y: 50.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 12.7"	HPA028612	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA028612: AB_10602135"	"unprognostic (3.77e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.97e-1)"	"prognostic favorable (8.69e-4)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (6.67e-4)"	2.4	6.0	2.1	8.1	3.0	31.4	1.8	1.1	2.0	0.4	1.5	2.4	9.4	0.4	0.2	3.5	1.2	0.4	1.9	1.9	4.8	4.6	36.7	4.1	7.0	3.5	16.1	0.5	2.6	0.9	1.8	0.3	8.4	1.5	2.4	0.1	1.7	1.0	0.4	2.2	7.5	1.1	2.4	6.9	2.8	1.2	7.8	3.8	0.8	0.2	2.0	3.3	1.4	2.0	4.7	0.6	1.3	7.1	0.0	0.0	23.5	0.0	2.0	2.4	2.9	1.4	1.0	25.0	6.9	0.2	5.8	4.0	4.9	1.5	0.1	10.9	5.2	0.6	0.3	3.1	8.4	0.0	1.9	0.3	0.7	1.2	0.1	0.0	0.7	23.0	2.8	0.0	0.0	5.0	15.1	0.3	0.4	6.5	8.2	9.6	2.8	0.0	2.9	1.6	11.6	50.9	3.3	2.4	1.6	0.4	2.9	1.5	0.3	0.1	4.0	9.9	3.8	10.5	8.4	7.8	3.1	8.4	0.0	0.0	2.6	0.2	2.8	5.3	2.1	0.7	1.0	1.5	2.8	1.9	2.5	1.3	0.3	1.8	11.1	0.1	2.1	1.2	2.1	3.0	1.1	2.0	1.9	4.8	3.5	16.1	8.4	2.4	7.8	2.0	19.2	3.2	4.8	0.7	33.4	74.6	30.9	23.6	17.6	0.0	19.4	13.2	6.5	4.3	13.6	5.5	2.1	1.9	50.9	21.8	7.9	8.7	0.5	16.8	5.8	19.8	212.5	10.1	3.8	9.4	44.3	15.3	43.8	29.3	0.0	0.3	6.8	94.6	6.1	0.0	5.9	22.7	4.1	28.0	33.3	0.6	0.3	55.8	10.6	15.9	29.5	0.7	29.9	0.5	0.8	11.0	13.6	4.9	14.4	20.5	17.1	48.6	6.9	0.4	0.0	12.5	7.5	2.2	6.7	20.8	76.1	4.2	41.8	11.9	12.2	39.0
GK	"GK1, GKD"	ENSG00000198814	"Glycerol kinase"	P32189	X	30653359-30731462	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 90.7;kidney: 107.7;liver: 79.2"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 139.2;Macrophages: 133.4;Proximal enterocytes: 144.2;Proximal tubular cells: 161.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	8	"neutrophil: 178.4"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 178.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 37.4;Hep G2: 46.4"	"Low region specificity"	"Detected in all"							HPA060687	Supported					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"			"HPA060687: AB_2684343"	"unprognostic (8.78e-3)"	"unprognostic (8.41e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.58e-2)"	"prognostic favorable (3.24e-9)"	"unprognostic (1.59e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.11e-3)"	8.8	9.8	3.1	51.5	2.8	6.6	4.8	3.7	17.2	4.8	8.4	13.0	86.6	3.6	12.3	9.6	7.7	23.8	4.8	2.3	4.1	107.7	79.2	19.7	10.6	7.2	4.2	2.6	4.5	14.0	5.4	8.2	6.8	3.6	10.9	10.3	11.2	2.2	2.6	6.3	90.7	4.4	3.6	10.1	6.2	2.9	14.5	5.4	6.6	3.1	14.5	30.2	2.7	8.0	4.5	3.5	4.5	7.7	2.7	10.4	1.8	10.6	37.4	7.6	8.6	5.8	4.1	12.6	1.7	4.1	6.9	0.3	8.5	3.5	10.1	8.2	9.6	7.5	6.6	46.4	17.2	14.2	15.4	6.3	4.9	24.2	22.3	1.9	6.0	9.6	4.0	17.3	2.1	6.2	11.0	14.6	7.5	4.9	4.0	15.0	7.1	13.1	5.7	14.8	4.8	6.1	9.4	9.4	21.5	4.5	10.6	10.1	2.3	5.5	2.3	0.3	4.9	9.1	10.7	12.5	9.5	9.1	5.6	5.0	22.8	7.9	1.7	7.2	1.3	3.1	3.1	2.2	14.2	5.6	1.8	1.9	178.4	4.8	9.1	4.2	11.5	6.2	3.1	2.8	3.7	17.2	2.3	4.1	7.2	4.2	6.8	3.6	14.5	8.0	2.0	16.0	27.4	19.6	15.8	6.9	12.3	12.6	4.6	3.2	9.4	3.9	4.3	12.8	22.5	7.3	16.7	1.2	5.6	54.7	35.2	21.9	61.5	15.1	2.7	3.8	12.1	6.3	41.5	11.1	1.1	12.4	20.9	1.7	14.5	6.9	3.6	38.1	34.8	5.0	37.2	14.7	0.0	26.6	139.2	29.9	1.2	133.4	14.2	10.3	42.6	29.1	3.1	28.6	19.6	10.6	39.9	2.2	12.4	17.0	144.2	161.1	47.7	17.7	0.0	9.2	7.0	15.3	1.7	14.7	16.9	0.8	15.7	3.7	11.0	26.8
GLUD1	"GDH, GLUD"	ENSG00000148672	"Glutamate dehydrogenase 1"	P00367	10	87050202-87094843	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 816.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 294.1;Hepatocytes: 402.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 555.0"	"Low region specificity"	"Detected in all"							"HPA042492, HPA044839, HPA061369"	Approved		Supported	Mitochondria	"Intracellular and membrane"	NA	NA		23000000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"HPA042492: AB_2678024, HPA044839: AB_2679107, HPA061369: AB_2684494"	"unprognostic (1.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.81e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.57e-3)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (1.13e-1)"	"prognostic favorable (1.44e-6)"	"unprognostic (2.29e-1)"	"unprognostic (4.23e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.27e-2)"	70.1	93.0	217.2	44.8	219.0	29.2	96.4	180.4	216.8	50.2	135.8	63.4	80.9	48.1	30.0	77.0	47.4	53.3	75.6	193.3	223.2	249.2	816.4	57.7	42.9	220.9	222.9	71.6	66.2	39.0	37.1	58.8	202.3	110.5	61.5	90.2	55.6	53.2	51.1	84.2	88.6	53.3	223.2	46.4	57.0	22.3	254.6	44.8	68.1	64.4	59.2	68.1	55.6	202.3	127.1	100.3	77.1	131.5	143.0	174.5	84.0	97.7	167.8	92.4	100.5	233.0	120.6	141.5	77.8	143.4	53.0	194.7	101.4	98.5	98.0	102.7	79.8	69.0	55.9	555.0	318.1	163.2	95.5	121.3	181.5	103.2	304.9	140.3	112.0	109.3	70.7	124.0	101.0	92.1	148.1	145.7	88.2	136.9	79.8	110.4	98.3	93.1	267.4	101.8	39.7	73.9	87.8	68.8	126.1	73.9	94.3	112.8	112.4	47.8	42.5	98.2	101.0	73.6	81.4	167.5	115.3	182.8	29.3	9.1	14.2	9.7	8.3	11.1	10.3	9.8	11.2	10.1	15.9	11.3	9.9	8.0	1.2	13.6	16.0	5.9	12.6	6.5	217.2	219.0	180.4	216.8	193.3	223.2	220.9	222.9	202.3	223.2	254.6	202.3	49.3	22.4	23.9	294.1	56.6	106.0	57.5	32.2	105.3	22.5	83.3	38.2	60.2	57.2	47.3	60.7	37.5	95.7	45.6	56.1	156.5	32.5	14.2	37.3	44.0	54.1	39.4	52.6	35.8	33.8	63.8	89.0	86.2	59.7	43.2	33.6	50.7	402.3	69.1	15.2	38.0	49.5	36.7	74.1	184.5	26.0	88.0	81.4	104.9	42.2	50.6	140.0	39.1	48.7	42.9	50.2	38.3	90.7	75.7	103.4	124.2	175.5	21.6	68.9	65.7	41.3	55.9	11.4	8.6	189.5	122.3	47.6	84.6	70.9	49.6	107.3
GNA13	"G13, MGC46138"	ENSG00000120063	"G protein subunit alpha 13"	Q14344	17	65009289-65056740	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 144.5"	"Cell type enriched"	"Detected in all"	4	"Langerhans cells: 537.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010087	Approved		Supported	Cytosol		NA	NA		320000	"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA010087: AB_10601478"	"unprognostic (2.55e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.23e-3)"	"unprognostic (8.21e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.77e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	23.7	22.5	21.3	41.5	23.9	144.5	15.8	25.0	22.5	17.6	21.3	27.7	21.0	17.9	10.5	18.2	15.9	26.5	12.6	20.2	26.6	17.6	27.0	27.1	46.8	26.9	21.7	22.6	15.3	15.8	8.3	39.3	30.1	15.1	26.2	17.2	10.4	16.1	36.8	12.1	23.3	22.9	25.4	33.5	18.0	15.4	23.7	49.9	17.9	38.6	44.6	30.5	12.3	35.2	33.3	36.9	32.6	21.6	31.8	29.5	32.2	25.3	28.7	35.0	39.7	20.7	23.0	130.0	16.1	26.6	42.0	22.5	35.0	29.4	51.5	35.4	19.5	69.0	20.7	38.7	45.7	54.2	45.5	23.9	43.8	32.2	42.0	29.1	48.6	33.6	29.7	82.3	36.9	29.3	88.9	18.8	19.4	30.2	25.7	49.0	64.8	47.2	32.0	53.3	24.5	48.8	19.7	34.8	43.8	62.1	40.7	50.0	37.9	58.4	48.8	25.0	33.2	57.3	79.4	151.4	20.1	32.2	30.4	7.3	6.0	7.6	5.6	12.5	5.7	4.5	6.8	6.8	5.2	4.0	3.9	4.4	13.8	6.8	8.5	2.1	9.7	4.0	21.3	23.9	25.0	22.5	20.2	26.6	26.9	21.7	30.1	25.4	23.7	35.2	34.5	12.8	13.0	68.9	80.9	67.8	27.8	13.1	42.1	5.3	21.0	13.0	11.7	18.6	10.1	9.2	4.2	16.6	60.5	82.2	7.9	11.8	4.5	25.3	23.6	35.4	16.8	21.2	20.7	11.6	15.1	24.3	23.9	49.9	30.4	21.9	32.5	13.8	57.4	6.7	27.3	11.6	12.2	57.9	537.6	8.0	11.5	123.8	69.4	44.0	44.1	34.4	29.9	29.1	36.7	13.4	30.7	24.0	45.9	28.3	23.5	16.4	13.8	6.1	32.9	19.2	19.9	6.7	13.6	33.7	65.9	14.0	66.5	15.4	13.7	36.2
GNAI3	87U6	ENSG00000065135	"G protein subunit alpha i3"	P08754	1	109548615-109600195	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 350.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022099, HPA042141"	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome		NA	NA		1400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 41: Macrophages - Immune response"	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022099: , HPA042141: AB_2677870"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.45e-3)"	"prognostic unfavorable (5.30e-6)"	"unprognostic (2.56e-3)"	"unprognostic (2.18e-2)"	"prognostic favorable (4.59e-4)"	"unprognostic (1.83e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavorable (4.34e-4)"	"unprognostic (7.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.66e-2)"	12.7	8.2	5.8	14.2	6.1	27.7	11.9	7.3	7.5	10.9	8.6	11.8	10.4	12.1	8.0	21.8	8.0	11.3	4.2	6.0	6.5	11.2	15.3	9.7	14.1	6.7	5.9	8.8	9.3	8.9	1.8	14.8	6.8	10.3	11.8	17.8	7.7	9.0	3.8	18.4	10.6	13.6	6.3	11.4	9.0	8.7	6.2	14.2	8.0	5.5	15.9	15.5	4.0	7.3	48.3	16.4	31.0	17.3	28.4	35.0	25.7	35.3	28.6	36.0	35.5	24.4	16.1	25.3	22.4	37.6	21.6	24.5	30.0	35.3	49.4	29.2	18.0	22.1	26.3	21.9	25.1	34.9	18.8	25.2	30.4	41.3	27.8	24.2	42.8	19.1	29.8	24.2	35.5	32.9	27.3	28.4	31.3	23.0	19.1	19.2	73.6	16.6	37.4	35.4	19.5	34.9	24.7	27.6	39.4	22.8	21.1	30.5	36.7	29.4	40.7	44.9	39.2	25.6	30.2	29.2	47.6	34.4	47.1	32.4	29.7	57.8	21.1	44.3	22.4	20.1	20.4	20.6	31.9	17.1	16.8	19.4	53.8	19.9	44.6	14.2	23.8	36.3	5.8	6.1	7.3	7.5	6.0	6.5	6.7	5.9	6.8	6.3	6.2	7.3	104.0	44.8	31.5	17.0	76.6	151.2	104.3	92.2	63.2	29.9	67.7	45.3	14.3	37.1	61.0	58.8	350.3	80.3	98.8	63.9	64.6	97.9	14.7	65.5	71.5	82.6	84.3	43.8	37.5	101.7	153.7	69.2	55.5	110.9	46.3	50.1	56.7	57.2	107.9	25.2	36.4	72.3	59.0	115.0	106.9	9.4	48.7	127.4	74.7	31.9	102.4	47.9	45.3	35.7	31.3	101.6	58.9	47.4	66.3	72.5	48.9	53.5	51.7	26.2	52.6	59.0	77.6	68.6	54.7	82.1	188.4	106.9	94.3	51.7	63.5	143.0
GPAT3	"AGPAT10, AGPAT9, HMFN0839, LPAAT-theta, MAG1, MGC11324"	ENSG00000138678	"Glycerol-3-phosphate acyltransferase 3"	Q53EU6	4	83535914-83605875	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 88.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 60.0;Early spermatids: 82.3;Macrophages: 60.5;Proximal enterocytes: 56.2;Proximal tubular cells: 67.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 182.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 157.6;GAMG: 116.4;HMC-1: 57.4;U-87 MG: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029414	Approved					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"			"HPA029414: AB_10601562"	"unprognostic (9.51e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (2.71e-9)"	"unprognostic (3.74e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (8.21e-4)"	14.0	1.0	0.9	5.7	1.1	11.9	6.5	3.9	2.7	5.5	8.9	13.7	39.9	3.7	1.2	8.3	3.6	8.6	25.3	1.0	2.8	88.4	18.1	4.2	2.0	5.5	3.4	16.1	1.2	23.2	5.0	1.5	5.5	1.6	11.1	1.2	3.5	3.6	37.6	2.6	35.6	3.5	2.0	4.7	15.2	7.4	2.7	1.7	19.8	12.5	2.1	6.0	6.3	1.8	30.6	29.6	0.0	0.4	1.5	3.7	0.6	2.4	4.3	0.6	0.6	2.2	157.6	0.0	3.2	5.9	116.4	6.8	14.3	2.8	0.5	2.1	6.7	0.0	9.2	29.7	4.2	8.9	57.4	2.0	0.2	1.1	3.5	11.5	15.0	8.5	25.1	23.7	0.6	3.1	2.3	2.2	0.7	45.6	12.5	0.3	6.7	11.6	29.8	2.0	0.7	0.0	5.8	6.1	17.3	1.6	1.2	1.6	0.7	6.9	12.3	6.9	28.9	1.1	2.2	0.0	66.4	17.6	52.2	182.5	33.2	4.0	0.6	27.8	6.0	0.1	3.5	2.0	81.4	0.1	2.5	1.2	91.1	1.6	23.6	0.3	2.3	10.4	0.9	1.1	3.9	2.7	1.0	2.8	5.5	3.4	5.5	2.0	2.7	1.8	4.8	6.4	6.8	0.0	1.3	0.0	60.0	0.0	8.0	0.8	10.2	4.1	0.0	4.3	5.0	11.0	0.0	0.4	0.8	18.6	15.6	4.8	82.3	1.0	1.1	5.4	1.2	6.1	0.0	6.8	1.3	5.5	34.7	2.4	7.6	0.8	7.5	13.2	14.8	5.0	0.0	9.9	0.0	11.3	0.0	21.7	1.2	60.5	0.0	0.0	28.7	0.1	1.0	0.0	0.0	10.4	6.7	0.7	1.2	32.4	56.2	67.4	1.5	0.3	6.6	5.8	1.7	10.6	1.9	5.2	0.0	1.0	7.3	4.9	3.6	28.9
GPR132	G2A	ENSG00000183484	"G protein-coupled receptor 132"	Q9UNW8	14	105049395-105065445	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Stress response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 8.0;lymphoid tissue: 7.8"	"Cell type enhanced"	"Detected in some"		"B-cells: 23.6;Langerhans cells: 45.5;Macrophages: 30.2;monocytes: 19.1;NK-cells: 15.5;T-cells: 20.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"HDLM-2: 26.9;Karpas-707: 26.6;THP-1: 8.2"									"HPA029694, HPA029695"	Supported					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA029694: AB_10600213, HPA029695: AB_10601984"	"unprognostic (2.71e-3)"	"prognostic favorable (3.21e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.16e-1)"	"prognostic favorable (6.44e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.35e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.18e-1)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.72e-1)"	2.1	0.7	0.9	7.0	0.7	8.0	0.9	0.7	0.9	0.9	1.0	1.3	1.0	0.6	0.4	0.8	1.6	1.4	0.8	0.8	1.0	5.4	0.5	2.7	7.7	1.6	1.1	0.3	0.7	0.3	0.5	1.5	1.2	0.8	0.9	0.3	0.9	0.3	0.5	2.6	4.3	0.8	1.0	7.8	1.7	0.3	1.2	1.9	4.6	0.6	4.5	2.4	1.1	1.3	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.5	3.5	0.6	0.0	0.0	0.7	0.0	0.0	0.0	26.9	0.3	0.6	0.1	0.0	0.1	2.1	0.5	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	26.6	0.0	0.8	0.0	2.7	0.1	0.0	0.0	2.1	0.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	8.2	0.4	0.1	0.1	0.0	0.3	0.7	2.6	0.3	0.0	2.4	0.0	9.6	6.0	5.5	6.1	7.7	5.9	4.2	4.8	5.5	5.7	4.5	4.8	5.3	4.7	5.8	9.1	3.1	3.6	5.0	0.9	0.7	0.7	0.9	0.8	1.0	1.6	1.1	1.2	1.0	1.2	1.3	0.6	0.0	1.9	0.7	23.6	1.7	0.1	1.0	0.0	0.0	0.3	0.3	0.8	0.0	0.7	1.8	0.0	0.1	12.2	0.0	1.9	0.4	0.0	2.2	0.8	0.9	0.0	4.0	0.7	0.6	0.3	0.4	1.1	5.2	12.7	0.0	0.0	0.0	3.9	0.0	0.6	0.0	0.0	7.1	45.5	0.2	0.0	30.2	5.4	7.5	19.1	0.0	15.5	0.0	0.1	1.2	0.0	0.0	11.7	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.0	1.6	0.0	20.7	0.0	0.0	0.9
GPR157	FLJ12132	ENSG00000180758	"G protein-coupled receptor 157"	Q5UAW9	1	9100305-9129102	"G-protein coupled receptors, Predicted membrane proteins"	Differentiation	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 59.6"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 268.1;monocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 31.8;SK-BR-3: 62.7;U-266/70: 30.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA028697	Uncertain		Uncertain	"Nucleoli,Nucleoli rim,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Nucleoli, Nucleoli rim"	"Plasma membrane, Cell Junctions"	"HPA028697: AB_10601810"	"unprognostic (2.83e-3)"	"unprognostic (1.13e-2)"	"unprognostic (5.91e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.13e-4)"	"unprognostic (7.11e-2)"	"unprognostic (7.52e-3)"	"unprognostic (3.60e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.04e-3)"	3.3	4.8	0.7	4.4	0.8	1.3	3.3	1.1	1.2	7.9	10.7	3.1	4.0	2.9	1.3	30.2	2.9	2.0	12.9	1.4	0.6	2.3	9.0	6.7	3.1	1.7	0.9	4.3	4.1	15.1	1.4	8.7	1.2	3.5	2.2	0.9	8.9	2.3	59.6	22.6	2.8	1.7	0.7	3.9	3.7	2.0	1.1	2.5	3.3	23.9	7.5	6.7	13.7	1.0	9.0	5.0	1.5	4.1	1.4	1.3	8.0	2.8	1.8	2.3	3.1	4.1	3.4	1.1	3.4	3.0	2.9	18.9	4.6	1.8	3.4	25.2	7.6	0.1	16.0	6.2	4.9	0.1	2.0	1.2	3.9	3.9	2.4	2.3	1.8	3.7	1.4	31.8	0.9	6.5	3.8	1.9	1.7	4.4	6.3	0.6	1.3	4.3	1.4	6.0	2.3	6.1	10.8	62.7	5.2	3.0	8.9	1.1	13.3	7.8	2.0	20.5	1.3	30.6	5.2	0.1	5.8	12.6	3.3	0.7	0.4	0.1	0.6	0.3	0.5	0.4	0.4	0.6	0.2	0.6	0.4	0.5	1.2	0.2	0.1	0.2	0.2	0.2	0.7	0.8	1.1	1.2	1.4	0.6	1.7	0.9	1.2	0.7	1.1	1.0	3.1	6.4	8.9	0.0	5.3	13.6	10.2	17.8	12.5	0.7	14.7	8.4	13.4	2.8	12.3	5.5	2.1	34.8	2.9	6.8	0.0	3.5	0.1	13.7	6.9	4.0	0.0	0.0	1.4	3.9	10.0	4.8	5.1	26.5	0.0	3.2	2.5	14.8	4.0	1.7	1.2	4.8	10.2	0.8	268.1	0.2	1.8	13.1	7.2	0.0	107.4	1.0	0.0	0.0	0.2	13.9	4.3	5.3	4.7	6.8	7.5	1.6	7.4	1.4	0.0	5.5	4.2	0.6	2.3	43.6	24.3	48.2	3.5	5.0	5.5	16.1
GPR31	"12-HETER, HETER1"	ENSG00000120436	"G protein-coupled receptor 31"	O00270	6	167155247-167157980	"G-protein coupled receptors, Predicted membrane proteins"	"Lipid metabolism"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA014014, HPA027108"	Uncertain					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"		"Cluster 41: Macrophages - Immune response"			"HPA014014: AB_1849292, HPA027108: AB_10601474"	"unprognostic (9.92e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-3)"		"unprognostic (2.20e-3)"	"unprognostic (5.95e-3)"	"unprognostic (4.03e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.86e-1)"	"unprognostic (8.10e-4)"	"unprognostic (2.45e-1)"	"unprognostic (6.01e-2)"	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR42	"FFAR3L, GPR41L, GPR42P"	ENSG00000126251	"G protein-coupled receptor 42"	O15529	19	35370929-35372962	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.9;Kupffer cells: 1.9;Macrophages: 1.2;T-cells: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044681	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"			"Cluster 41: Macrophages - Immune response"			"HPA044681: AB_2679043"											"unprognostic (1.73e-3)"			"unprognostic (1.31e-4)"				0.6	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.7	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.9	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0
GRK3	"ADRBK2, BARK2"	ENSG00000100077	"G protein-coupled receptor kinase 3"	P35626	22	25564675-25729294	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 30.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 32.2;Club cells: 16.7;Extravillous trophoblasts: 29.2;granulocytes: 18.9;Hofbauer cells: 29.3;Macrophages: 26.4;monocytes: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 4.1;eosinophil: 5.2;intermediate monocyte: 7.2;memory B-cell: 4.1;myeloid DC: 3.2;naive B-cell: 5.0;non-classical monocyte: 6.8;plasmacytoid DC: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 43.6;JURKAT: 69.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000804	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 2: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Plasma membrane"	"HPA000804: AB_1078281"	"unprognostic (1.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.89e-2)"	"prognostic favorable (1.29e-4)"	30.2	5.4	6.5	12.9	8.9	7.8	9.4	2.3	14.7	4.0	0.0	3.1	2.8	5.3	1.3	2.4	8.7	4.7	4.3	18.9	2.6	2.4	3.2	9.4	15.1	5.4	6.2	2.9	7.1	4.2	3.2	4.4	2.5	7.5	3.9	4.8	3.2	1.6	0.9	3.3	4.7	5.9	2.9	18.8	3.8	15.7	7.6	10.2	4.1	1.2	15.6	6.2	1.5	6.0	0.1	3.9	11.9	3.9	8.1	1.0	17.3	1.3	3.8	3.8	6.5	6.4	6.8	22.5	0.3	0.3	10.5	0.2	11.9	9.1	11.1	43.6	7.6	10.3	1.3	14.3	0.3	33.8	16.8	2.0	6.2	2.6	4.6	0.6	0.7	69.4	1.1	0.1	4.4	5.6	24.4	2.4	8.5	12.1	0.0	10.8	18.9	3.8	0.0	6.6	27.6	37.5	2.2	0.1	9.0	10.9	3.3	13.4	0.3	0.1	23.6	0.2	4.9	2.6	9.1	17.4	15.8	11.8	3.7	0.5	4.1	5.2	0.0	7.2	0.2	4.1	0.0	0.2	3.2	5.0	0.1	0.1	0.2	0.0	6.8	2.7	0.3	1.5	6.5	8.9	2.3	14.7	18.9	2.6	5.4	6.2	2.5	2.9	7.6	6.0	3.9	16.0	32.2	0.0	10.2	0.0	0.0	0.0	0.0	0.0	11.7	9.5	0.0	0.0	16.7	0.0	0.0	2.0	1.1	0.0	1.9	9.4	0.0	12.7	5.8	2.4	0.0	0.0	0.0	1.8	29.2	4.1	0.0	2.2	18.9	3.7	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.0	0.0	27.4	0.0	0.0	0.0	0.0	3.4	0.0	0.0	2.1	0.0	0.0	1.8	6.6	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	3.3	1.1	5.0	0.0	0.0
HLA-DMA	"D6S222E, RING6"	ENSG00000204257	"Major histocompatibility complex, class II, DM alpha"	P28067	6	32948613-32969094	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 120.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 400.4;Hofbauer cells: 354.3;Kupffer cells: 411.6;Langerhans cells: 1350.5;Macrophages: 591.4;monocytes: 332.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"classical monocyte: 3.8;intermediate monocyte: 3.8;memory B-cell: 6.3;myeloid DC: 7.2;naive B-cell: 6.4;plasmacytoid DC: 5.2"	"Group enriched"	"Detected in many"	12	"B-cells: 6.4;dendritic cells: 7.2;monocytes: 3.8"	"Group enriched"	"Detected in some"	5	"U-266/70: 30.5;U-698: 94.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012750, HPA017295"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA012750: AB_1853926, HPA017295: AB_2669575"	"unprognostic (1.69e-3)"	"unprognostic (3.52e-2)"	"unprognostic (8.03e-2)"	"prognostic favorable (4.64e-5)"	"unprognostic (3.99e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (7.01e-2)"	"unprognostic (9.69e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.14e-2)"	79.9	63.6	0.1	1.0	0.1	23.4	63.4	0.1	0.6	33.1	0.5	26.7	1.6	19.8	22.8	16.0	31.4	0.9	23.5	0.1	0.2	48.0	15.1	98.3	2.4	0.3	0.2	13.5	19.4	0.1	15.6	0.9	0.2	23.1	13.6	0.4	25.9	0.3	11.8	25.1	69.6	0.5	0.3	120.4	32.7	4.0	0.2	0.6	33.1	0.2	36.9	21.3	20.8	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	2.1	0.1	0.1	0.0	0.1	0.0	0.5	1.9	0.0	0.0	0.5	0.3	0.3	2.5	0.4	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.7	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	30.5	13.7	94.3	0.6	0.0	0.0	0.0	3.8	0.3	0.2	3.8	0.0	6.3	0.1	0.2	7.2	6.4	0.0	0.1	0.4	0.3	1.2	5.2	0.4	3.6	0.1	0.1	0.1	0.6	0.1	0.2	0.3	0.2	0.2	0.3	0.2	0.5	240.5	73.7	171.3	0.7	400.4	48.3	15.5	77.3	17.6	1.8	38.2	32.0	5.2	45.8	95.9	53.3	2.1	4.9	175.6	19.3	17.6	101.0	3.4	12.5	3.1	123.6	3.0	30.5	0.8	51.1	4.2	16.4	43.8	24.5	41.2	8.2	37.1	4.4	354.3	0.0	1.2	25.0	22.4	411.6	1350.5	5.3	16.1	591.4	80.0	14.0	332.4	4.3	33.0	1.5	1.3	26.6	46.2	18.8	68.9	19.1	267.0	47.1	77.6	1.3	19.7	5.4	15.6	4.1	4.8	7.0	41.9	4.0	44.7	4.3	42.6	60.9
HLA-DMB	"D6S221E, RING7"	ENSG00000242574	"Major histocompatibility complex, class II, DM beta"	P28068	6	32934629-32941028	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 78.8;lymphoid tissue: 101.5"	"Group enriched"	"Detected in many"	4	"B-cells: 228.5;dendritic cells: 129.4;Hofbauer cells: 274.8;Kupffer cells: 201.9;Langerhans cells: 472.8;Macrophages: 272.4;monocytes: 187.1;Proximal enterocytes: 284.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 128.8;dendritic cells: 85.3;monocytes: 73.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 14.2;Daudi: 27.6;EFO-21: 12.4;U-266/70: 7.8;U-698: 31.9"					"Low region specificity"	"Detected in all"			"HPA012298, HPA077524"	Supported		Supported	Vesicles		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA012298: AB_1853927, HPA077524: "	"unprognostic (5.34e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-2)"	"prognostic favorable (3.89e-5)"	"unprognostic (3.07e-1)"	"unprognostic (7.64e-3)"	"unprognostic (4.00e-1)"	"unprognostic (3.46e-3)"	"unprognostic (6.99e-2)"	"unprognostic (8.76e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.60e-2)"	38.3	35.9	0.1	13.2	0.2	6.9	25.7	0.3	1.0	21.6	0.1	19.9	0.0	14.6	7.4	9.3	14.6	0.1	11.1	0.0	0.6	41.9	7.8	59.9	17.6	0.3	0.4	9.5	9.1	0.0	9.2	0.8	0.2	13.1	14.9	0.5	14.7	0.0	5.3	14.3	78.8	0.0	0.9	101.5	17.6	2.2	0.1	9.9	45.9	0.0	18.8	14.4	10.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	27.6	12.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	7.8	0.4	31.9	0.0	0.1	0.0	0.5	73.2	16.7	1.2	73.8	2.6	94.0	1.0	2.9	85.0	128.8	0.7	2.4	4.7	16.2	28.1	85.3	6.7	71.4	0.1	0.2	0.3	1.0	0.0	0.6	0.3	0.4	0.2	0.9	0.1	1.1	36.8	9.6	57.0	0.7	228.5	12.0	1.0	5.4	2.2	0.2	2.5	4.7	2.6	5.7	12.7	16.5	0.0	1.7	129.4	3.3	11.7	28.8	0.5	7.5	5.4	37.2	4.2	10.3	0.8	4.4	1.6	3.8	3.1	38.5	15.2	22.7	5.7	0.5	274.8	0.0	0.6	8.5	2.0	201.9	472.8	1.5	3.4	272.4	16.0	27.2	187.1	0.5	21.6	1.0	0.1	2.5	17.8	1.9	3.8	1.3	284.8	7.4	16.8	1.1	6.6	1.6	3.1	0.6	0.7	1.1	10.9	2.7	17.6	0.9	10.3	8.7
HLA-DOA	"HLA-D0-alpha, HLA-DNA, HLA-DZA"	ENSG00000204252	"Major histocompatibility complex, class II, DO alpha"	P06340	6	33004182-33009591	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 30.3;B-cells: 61.5;dendritic cells: 20.3;Kupffer cells: 29.4;Langerhans cells: 59.0;Macrophages: 37.7;monocytes: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 17.8;naive B-cell: 21.0"	"Group enriched"	"Detected in many"	11	"B-cells: 21.0;dendritic cells: 17.8;monocytes: 6.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.9;HDLM-2: 9.1;REH: 40.5;U-698: 8.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA045038, HPA076922"	Enhanced					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 64: Macrophages - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 41: Macrophages - Immune response"			"HPA045038: AB_10959457, HPA076922: "	"unprognostic (8.02e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.94e-2)"	7.1	6.1	0.2	7.8	0.4	1.5	6.5	0.4	0.4	4.9	0.3	3.2	5.0	3.0	1.2	2.3	5.0	2.1	2.2	0.3	1.0	8.0	2.8	12.7	15.1	1.8	0.8	2.8	2.4	0.9	3.5	0.0	1.5	5.0	4.2	0.4	3.2	2.1	0.8	2.8	15.2	1.1	0.8	28.7	4.0	0.4	0.7	7.0	4.5	1.0	19.8	3.0	3.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	12.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	40.5	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.1	8.2	0.0	0.2	0.0	0.0	1.0	0.0	0.0	6.0	0.0	14.6	0.1	0.3	17.8	21.0	0.3	1.3	0.7	0.2	4.7	5.0	1.0	2.4	0.2	0.4	0.4	0.4	0.3	1.0	1.8	0.8	1.5	0.8	0.7	1.2	7.5	3.2	30.3	0.0	61.5	1.9	0.6	0.1	0.6	0.0	0.5	2.4	1.6	1.5	2.0	3.7	0.0	0.1	20.3	0.3	0.0	6.6	0.1	0.3	0.2	8.5	0.0	2.5	0.0	0.2	0.1	1.2	0.5	0.3	5.1	3.5	1.1	0.0	13.4	0.0	0.0	0.1	2.0	29.4	59.0	0.2	0.3	37.7	0.0	6.5	41.9	0.6	4.1	0.0	0.1	0.3	0.0	0.0	0.9	0.6	0.0	2.9	1.4	0.2	0.0	0.7	0.6	0.0	0.2	0.5	1.1	0.1	4.1	1.0	0.3	1.2
HLA-DPA1	HLA-DP1A	ENSG00000231389	"Major histocompatibility complex, class II, DP alpha 1"	P20036	6	33064569-33080775	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 319.9;lymphoid tissue: 359.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 1387.3;Kupffer cells: 1794.6;Langerhans cells: 8122.8;Macrophages: 2736.9;monocytes: 2940.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 81.8;intermediate monocyte: 187.4;memory B-cell: 150.4;myeloid DC: 296.0;naive B-cell: 136.5;non-classical monocyte: 124.1;plasmacytoid DC: 82.6"	"Group enriched"	"Detected in all"	7	"B-cells: 150.4;dendritic cells: 296.0;monocytes: 187.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 37.2;HDLM-2: 115.9;REH: 30.3;U-698: 26.1"									HPA017967	Enhanced		Supported	Vesicles		NA	NA		240000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA017967: AB_1853929"	"unprognostic (8.93e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.64e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.82e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.69e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.06e-1)"	180.8	108.0	2.2	33.4	2.0	12.8	138.4	2.7	3.3	76.7	2.5	72.1	20.2	55.3	8.3	43.1	63.0	13.0	62.0	2.0	3.4	99.0	36.8	319.9	51.3	4.9	2.8	24.9	28.6	5.9	58.0	3.4	4.3	64.0	16.1	2.0	59.5	16.2	29.5	66.3	174.4	14.6	4.3	359.6	52.1	13.4	3.1	30.2	76.6	7.3	51.5	58.6	60.0	4.4	0.1	0.0	0.0	0.0	0.8	1.3	1.1	0.4	0.4	0.5	0.0	0.0	4.9	37.2	5.0	0.9	7.1	0.0	0.0	0.0	0.1	115.9	2.5	6.2	0.0	0.0	0.1	0.0	11.6	1.7	0.0	2.2	0.0	0.0	0.6	0.0	0.0	3.3	0.0	0.0	0.1	0.1	0.6	0.0	0.0	30.3	0.0	4.9	0.1	0.0	0.1	0.0	0.0	0.0	2.9	0.0	0.0	1.3	2.6	7.8	0.1	0.1	0.0	5.6	0.9	26.1	12.2	0.2	4.4	2.2	81.8	6.6	21.6	187.4	5.7	150.4	9.6	23.9	296.0	136.5	3.4	15.7	3.0	20.9	124.1	82.6	29.2	136.0	2.2	2.0	2.7	3.3	2.0	3.4	4.9	2.8	4.3	4.3	3.1	4.4	621.8	83.3	404.3	0.3	1387.3	206.7	7.2	12.4	9.1	2.8	41.2	110.4	12.1	64.3	107.3	23.9	0.0	4.2	574.9	10.6	9.8	36.4	2.8	1.2	4.1	337.8	10.2	80.3	0.5	18.8	9.3	53.7	48.4	2.8	64.6	14.3	62.2	7.5	1153.8	5.0	0.9	18.2	12.2	1794.6	8122.8	11.7	18.0	2736.9	302.4	32.8	2940.3	5.1	94.7	0.0	0.1	4.7	5.4	27.4	100.2	10.6	114.0	42.7	129.2	5.0	52.6	14.7	29.8	1.3	4.8	6.0	175.2	6.8	157.8	11.5	28.6	34.4
HLA-DPB1	HLA-DP1B	ENSG00000223865	"Major histocompatibility complex, class II, DP beta 1"	P04440	6	33075990-33089696	"Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 278.7;lymphoid tissue: 409.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 1569.6;Kupffer cells: 2374.2;Langerhans cells: 12627.8;Macrophages: 2453.8;monocytes: 3754.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 285.5"	"Group enriched"	"Detected in all"	10	"B-cells: 227.8;dendritic cells: 285.5;monocytes: 137.5"	"Group enriched"	"Detected in some"	6	"HDLM-2: 65.9;REH: 26.5"									"HPA011078, HPA058509"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA		470000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Cell Junctions"	Nucleoplasm	"HPA011078: AB_1079378, HPA058509: AB_2683737"	"unprognostic (5.44e-3)"	"unprognostic (7.03e-3)"	"unprognostic (9.84e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.77e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.85e-1)"	151.6	101.3	1.0	42.0	1.0	5.8	112.8	3.3	1.3	68.2	0.9	69.4	12.4	50.2	2.9	43.9	55.7	17.2	51.1	0.8	1.8	96.1	38.6	278.7	66.7	1.8	1.3	26.2	32.4	1.0	51.5	0.8	1.8	70.3	2.5	1.5	57.2	6.4	25.1	72.3	176.5	4.7	2.1	409.4	54.1	12.8	1.0	10.9	69.5	1.3	42.2	49.2	56.5	3.0	0.0	0.0	0.1	0.0	0.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	6.2	0.2	0.0	0.1	0.0	0.0	0.0	65.9	1.9	1.5	0.0	0.0	0.0	0.0	0.5	1.4	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.9	0.0	0.0	26.5	0.1	0.3	0.3	0.0	0.9	0.0	0.0	0.3	0.1	0.4	0.0	0.1	1.8	0.1	0.2	0.0	0.0	7.2	0.3	4.4	1.1	0.0	0.0	0.5	59.6	4.0	14.8	137.5	1.8	226.6	5.1	22.2	285.5	227.8	2.3	11.9	1.6	8.2	60.3	77.5	22.7	107.8	1.0	1.0	3.3	1.3	0.8	1.8	1.8	1.3	1.8	2.1	1.0	3.0	354.8	67.3	330.7	1.3	1569.6	300.5	26.0	5.6	19.4	26.9	54.0	123.6	10.3	67.2	62.3	29.5	16.7	4.8	692.9	7.8	3.9	58.3	3.6	2.0	16.3	297.8	9.6	87.9	1.3	15.6	8.1	62.3	48.4	2.7	61.6	13.6	97.1	8.8	1099.4	8.4	1.6	13.0	10.2	2374.2	12627.8	10.1	27.4	2453.8	323.7	20.6	3754.7	43.3	203.9	2.5	0.2	7.4	10.0	21.1	50.9	28.2	154.7	60.2	54.4	21.9	46.0	21.4	47.5	1.3	7.8	6.4	233.3	9.0	200.7	3.9	23.0	51.7
HLA-DQA1	"CELIAC1, HLA-DQA"	ENSG00000196735	"Major histocompatibility complex, class II, DQ alpha 1"	P01909	6	32628179-32647062	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 333.9;lymphoid tissue: 335.8"	"Cell type enriched"	"Detected in many"	4	"Langerhans cells: 4114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 666.6"	"Group enriched"	"Detected in all"	19	"B-cells: 287.6;dendritic cells: 666.6;monocytes: 257.6"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 1419.1"									HPA012315	Enhanced					NA	NA		200000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA012315: AB_1853930"	"unprognostic (4.24e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.36e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-1)"	61.7	45.7	2.3	111.0	2.2	7.1	41.6	2.4	2.8	49.9	5.2	76.8	0.1	27.7	32.2	32.1	29.1	127.4	20.8	1.6	5.1	39.6	95.1	333.9	335.8	4.3	2.6	18.6	15.0	2.6	15.2	13.7	2.7	15.1	115.8	1.9	34.8	7.8	7.5	30.0	74.0	19.2	5.4	180.0	103.3	12.2	3.4	234.3	26.0	0.0	322.3	175.9	16.3	11.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	213.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1419.1	0.9	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	4.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	2.4	0.4	0.0	0.1	0.6	0.6	63.2	1.5	156.1	24.4	0.0	0.0	1.9	105.8	0.5	2.4	257.6	1.0	287.6	3.3	16.5	666.6	274.1	0.4	4.3	3.0	8.2	68.3	162.7	21.6	129.0	2.3	2.2	2.4	2.8	1.6	5.1	4.3	2.6	2.7	5.4	3.4	11.1	67.9	12.8	86.3	0.0	972.8	50.2	0.4	4.3	4.6	0.1	9.8	28.6	2.1	7.2	19.4	0.0	2.1	0.8	179.8	0.9	1.9	4.6	0.6	0.5	0.4	97.4	0.0	38.3	0.1	4.6	2.4	14.7	10.7	0.9	50.4	0.8	12.8	0.6	381.0	0.0	0.1	0.4	2.0	518.6	4114.3	1.3	3.1	874.3	71.2	12.2	957.1	1.0	4.1	0.0	0.2	2.1	0.1	0.0	96.1	1.5	1.8	6.5	27.3	2.5	6.6	1.2	5.3	0.0	0.7	2.5	41.6	2.1	56.0	1.2	2.7	7.6
HLA-DQA2	HLA-DXA	ENSG00000237541	"Major histocompatibility complex, class II, DQ alpha 2"	P01906	6	32741391-32747198	"Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 20.8;lymphoid tissue: 27.1"	"Cell type enriched"	"Detected in many"	4	"Langerhans cells: 1196.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 64: Macrophages - Immune response"		"Cluster 41: Macrophages - Immune response"				"unprognostic (4.06e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.85e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.48e-2)"	10.9	4.5	0.0	0.0	0.0	0.0	7.2	0.0	0.0	3.1	0.0	3.9	0.0	2.1	0.0	3.0	2.8	0.1	2.3	0.0	0.0	5.8	1.7	20.8	0.0	0.0	0.0	0.9	1.2	0.0	2.5	0.0	0.0	2.5	0.0	0.0	3.4	0.0	1.4	8.4	11.6	0.0	0.0	27.1	2.9	0.6	0.0	0.3	3.7	0.0	0.3	3.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.1	3.2	3.6	0.0	179.2	23.5	0.3	1.8	1.2	0.0	2.5	1.3	0.5	0.0	7.5	3.7	0.0	0.2	144.1	0.1	0.0	0.2	0.7	0.1	0.2	20.6	2.4	0.4	0.0	0.0	0.8	1.6	0.0	0.3	0.0	0.8	2.2	0.3	110.0	0.0	0.0	0.0	0.0	78.9	1196.5	2.0	1.2	243.1	24.9	0.0	125.3	0.0	8.2	0.0	0.0	0.2	0.0	0.0	9.5	0.0	0.0	11.2	12.4	0.0	6.6	0.7	1.2	0.1	0.3	0.1	23.3	0.4	13.8	0.0	0.0	0.7
HLA-DQB1	"CELIAC1, HLA-DQB, IDDM1"	ENSG00000179344	"Major histocompatibility complex, class II, DQ beta 1"		6	32659467-32668383	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"lung: 179.1;lymphoid tissue: 301.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 995.1;Langerhans cells: 4144.8;Macrophages: 1090.5;monocytes: 1038.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 153.5;intermediate monocyte: 142.9;memory B-cell: 159.2;myeloid DC: 386.3;naive B-cell: 169.1;plasmacytoid DC: 116.5"	"Group enriched"	"Detected in all"	6	"B-cells: 169.1;dendritic cells: 386.3;monocytes: 153.5"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 599.9"									HPA013667	Enhanced		Supported	"Golgi apparatus,Rods & Rings"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Rods & Rings"	"Golgi apparatus"	"HPA013667: AB_1853932"	"unprognostic (8.60e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (4.48e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.40e-1)"	56.6	23.9	2.2	77.8	2.2	40.0	45.3	2.7	3.1	19.9	3.0	45.8	0.2	18.9	126.9	21.3	22.2	43.6	21.6	2.0	3.6	34.3	37.1	179.1	301.8	4.7	3.8	7.4	14.3	10.6	21.3	10.1	2.9	17.1	39.0	1.7	24.2	11.9	9.6	31.8	78.0	11.2	4.6	139.3	128.0	7.0	3.1	108.2	26.3	0.0	122.3	89.9	16.9	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	93.9	2.2	0.0	0.0	19.2	0.0	19.2	0.0	599.9	13.4	0.0	0.0	0.0	0.0	0.2	7.8	0.0	3.0	0.0	0.0	0.0	0.0	2.9	0.0	1.8	0.0	7.2	0.1	0.9	0.1	0.0	0.0	0.0	0.1	0.2	0.0	1.3	0.0	0.1	1.6	1.1	1.4	0.0	3.3	10.9	0.2	0.0	0.6	0.8	0.4	68.7	2.1	66.0	47.1	0.1	0.0	0.3	153.5	27.9	12.8	142.9	6.6	159.2	6.9	20.0	386.3	169.1	0.4	6.3	11.8	10.4	41.1	116.5	41.1	217.0	2.2	2.2	2.7	3.1	2.0	3.6	4.7	3.8	2.9	4.6	3.1	5.5	162.9	41.7	181.1	0.0	995.1	89.9	8.7	23.1	31.3	5.1	16.8	32.1	3.2	27.1	40.7	18.4	10.4	1.4	188.2	10.3	7.9	38.8	16.5	4.1	1.0	135.3	22.8	37.2	0.2	20.0	3.0	18.8	41.8	5.2	38.5	7.9	25.0	2.3	422.1	0.0	0.8	24.7	12.2	487.3	4144.8	7.5	6.5	1090.5	97.8	8.4	1038.0	1.1	25.7	0.0	0.1	28.3	27.4	9.8	86.9	8.7	417.9	18.5	53.0	2.7	6.6	4.8	9.6	2.7	2.5	18.5	66.3	3.0	84.5	0.9	36.1	49.1
HLA-DQB2	HLA-DXB	ENSG00000232629	"Major histocompatibility complex, class II, DQ beta 2"	P05538	6	32756098-32763532	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 52.4"	"Cell type enriched"	"Detected in some"	33	"Langerhans cells: 1010.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073187	Enhanced					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 31: Skin - Epidermis development"		"Cluster 41: Macrophages - Immune response"			"HPA073187: "	"prognostic favorable (5.55e-4)"	"unprognostic (3.75e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.60e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.92e-2)"	4.6	1.9	0.0	0.0	0.0	0.1	3.8	0.0	0.0	3.3	0.2	1.8	0.3	0.9	0.1	7.3	1.4	0.5	1.4	0.0	0.0	2.3	0.6	14.6	0.7	0.1	0.0	0.4	0.6	0.0	1.9	0.0	0.0	1.5	1.0	0.0	2.5	0.0	0.8	52.4	6.5	0.0	0.0	12.8	1.3	0.6	0.0	0.2	2.4	0.0	0.4	1.4	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	1.3	0.0	0.0	1.1	0.8	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.1	3.2	13.0	0.0	5.9	28.4	0.0	0.1	0.0	0.0	0.4	1.7	0.4	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.2	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	2.5	0.1	0.0	0.0	2.4	0.0	0.1	0.0	0.0	6.2	1010.0	0.5	0.9	30.5	26.6	1.0	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.6	0.2	0.6	0.1	27.6	0.1	2.7	0.0	0.0	0.4
HLA-DRA	HLA-DRA1	ENSG00000204287	"Major histocompatibility complex, class II, DR alpha"	P01903	6	32439878-32445046	"Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 940.2;lymphoid tissue: 1277.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 4744.7;Kupffer cells: 4311.3;Langerhans cells: 24286.4;Macrophages: 6377.4;monocytes: 6924.4;Proximal enterocytes: 3639.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 36.2"	"Group enriched"	"Detected in all"	4	"classical monocyte: 209.3;intermediate monocyte: 408.8;memory B-cell: 379.6;naive B-cell: 418.5;non-classical monocyte: 255.2;plasmacytoid DC: 229.8"	"Group enriched"	"Detected in all"	5	"B-cells: 418.5;dendritic cells: 229.8;monocytes: 408.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 715.7;HDLM-2: 1623.6;REH: 277.1;U-266/70: 242.2;U-698: 730.2;U-87 MG: 258.0"					"Low region specificity"	"Detected in all"			"CAB002798, CAB015402, HPA050162, HPA053176"	Enhanced					NA	NA		950000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"CAB002798: , CAB015402: AB_629980, HPA050162: AB_2681037, HPA053176: AB_2682070"	"unprognostic (1.20e-3)"	"unprognostic (4.70e-3)"	"prognostic favorable (5.30e-4)"	"unprognostic (3.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.52e-2)"	510.2	294.8	3.3	304.4	3.6	1.0	370.7	3.6	36.2	176.5	3.6	175.6	117.9	124.0	260.4	129.1	145.1	61.5	128.4	3.6	3.6	290.3	95.8	940.2	1277.8	7.8	7.5	58.5	73.9	0.1	125.6	23.5	5.9	141.5	151.1	8.3	156.0	8.5	79.4	195.5	713.3	1.4	3.5	1091.9	388.0	25.6	4.0	198.8	175.5	0.0	805.5	172.8	143.3	6.0	0.8	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.5	715.7	6.3	0.0	0.0	1.5	0.0	0.0	0.0	1623.6	0.0	17.7	0.0	0.0	0.0	1.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	3.1	0.1	0.0	0.0	277.1	0.4	0.9	0.0	0.1	0.6	0.7	1.3	0.3	22.8	0.0	0.0	0.8	0.0	8.9	1.4	2.7	1.6	242.2	6.1	730.2	258.0	0.5	0.5	5.9	209.3	74.1	2.1	408.8	1.1	379.6	2.4	10.8	4.6	418.5	1.2	2.2	17.9	15.0	255.2	229.8	19.8	137.8	3.3	3.6	3.6	36.2	3.6	3.6	7.8	7.5	5.9	3.5	4.0	6.0	935.5	291.7	1070.1	0.3	4744.7	748.4	18.1	160.7	84.2	4.1	101.2	172.6	22.5	115.8	458.0	150.8	0.0	12.7	983.5	79.5	29.4	329.2	8.7	26.9	5.2	803.1	64.9	228.5	0.2	59.8	18.3	128.0	159.6	27.1	174.8	80.9	167.4	19.8	2809.0	1.7	0.2	175.0	146.5	4311.3	24286.4	25.8	30.1	6377.4	773.7	59.0	6924.4	8.4	81.4	0.0	0.1	46.3	182.5	4.5	107.5	32.9	3639.5	303.5	487.1	19.7	72.3	27.8	78.0	3.5	5.2	35.3	576.1	25.9	218.8	0.8	245.4	273.3
HLA-DRB1	HLA-DR1B	ENSG00000196126	"Major histocompatibility complex, class II, DR beta 1"	P01911	6	32578769-32589848	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 581.3;lymphoid tissue: 651.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 2149.9;Langerhans cells: 11630.1;Macrophages: 3622.3;monocytes: 3104.1;Proximal enterocytes: 1849.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 47.5"	"Immune cell enhanced"	"Detected in all"		"myeloid DC: 749.2"	"Group enriched"	"Detected in all"	9	"B-cells: 257.9;dendritic cells: 749.2;monocytes: 371.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 1181.9;HMC-1: 159.7;THP-1: 140.4;U-266/70: 150.3;U-698: 202.5;U-87 MG: 308.9"									"CAB015400, CAB034021, HPA043151"	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"CAB015400: AB_784538, CAB034021: AB_1124844, HPA043151: AB_2678342"	"unprognostic (3.69e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.56e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.28e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.53e-1)"	311.4	162.1	7.2	220.8	7.8	61.3	239.4	6.4	47.5	121.4	11.1	113.5	2.4	90.3	140.6	71.7	119.4	66.9	134.6	6.2	11.4	217.5	100.6	581.3	651.4	6.8	7.1	40.4	50.8	0.0	80.2	13.6	6.9	88.4	135.3	5.2	93.8	0.4	58.3	122.5	353.2	11.1	9.9	516.2	232.3	25.5	9.2	254.3	129.5	0.0	257.4	116.2	91.5	13.4	0.6	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	2.4	17.1	0.0	0.0	1.9	0.0	4.7	0.0	1181.9	12.9	0.1	0.5	0.0	0.0	0.4	159.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	12.3	0.0	28.5	0.4	2.3	0.4	0.0	0.0	4.4	0.4	0.1	0.0	0.0	0.1	0.2	6.5	0.0	26.7	1.5	4.8	140.4	0.1	0.0	0.9	2.1	0.7	150.3	4.4	202.5	308.9	5.8	0.5	2.5	323.0	53.7	12.2	371.3	2.2	225.4	9.0	27.2	749.2	257.9	1.1	12.2	8.9	21.0	223.8	147.6	35.4	411.8	7.2	7.8	6.4	47.5	6.2	11.4	6.8	7.1	6.9	9.9	9.2	13.4	1241.9	147.4	609.1	0.0	2149.9	173.6	14.1	78.2	51.8	2.0	96.0	150.9	30.5	90.1	277.5	141.6	0.0	3.7	484.0	92.2	25.4	272.8	4.6	23.9	4.0	721.5	36.0	120.8	0.0	73.8	7.0	77.9	131.0	21.6	124.0	47.9	179.9	5.0	1417.7	0.0	0.0	92.7	30.5	1755.3	11630.1	12.3	14.9	3622.3	217.1	0.0	3104.1	7.7	55.6	0.0	0.0	89.1	308.9	26.7	120.2	21.0	1849.6	218.2	357.1	10.7	26.3	16.6	47.9	2.4	3.6	27.2	147.9	6.8	245.6	52.5	152.2	125.5
HLA-DRB5		ENSG00000198502	"Major histocompatibility complex, class II, DR beta 5"	Q30154	6	32517353-32530287	"Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 356.2;lymphoid tissue: 423.3"	"Cell type enriched"	"Detected in many"	4	"Langerhans cells: 4068.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 61.9"	"Group enriched"	"Detected in all"	10	"B-cells: 26.1;dendritic cells: 61.9;monocytes: 35.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 641.1;HMC-1: 154.2;U-698: 189.9;U-87 MG: 238.6"									HPA043151	Supported					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA043151: AB_2678342"	"unprognostic (1.97e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.30e-2)"	"prognostic favorable (7.89e-4)"	"unprognostic (2.28e-2)"	"unprognostic (4.68e-3)"	"unprognostic (9.09e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.60e-3)"	"unprognostic (9.72e-2)"	"unprognostic (5.48e-2)"	110.0	63.0	1.0	138.9	1.4	23.0	82.6	0.9	4.2	53.8	2.9	70.1	13.1	39.7	109.8	48.6	61.0	2.5	48.0	0.9	1.9	66.6	42.6	356.2	423.3	1.2	1.3	25.4	27.9	0.0	27.2	6.6	0.9	32.6	52.9	3.0	27.6	0.0	22.3	47.9	184.7	0.2	2.3	228.4	214.2	11.8	3.2	165.8	46.1	0.0	162.8	56.2	28.9	2.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.4	0.0	0.0	0.7	0.0	0.0	0.0	641.1	6.2	0.0	0.0	0.0	0.0	0.6	154.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.2	0.2	1.3	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	6.6	0.0	0.0	56.0	0.1	3.3	0.8	1.9	0.4	41.4	0.8	189.9	238.6	1.8	0.1	0.2	28.6	3.8	0.9	35.2	0.1	23.0	0.8	2.4	61.9	26.1	0.1	1.1	0.7	2.1	20.3	13.3	4.1	51.9	1.0	1.4	0.9	4.2	0.9	1.9	1.2	1.3	0.9	2.3	3.2	2.0	467.2	16.0	84.9	0.0	632.7	104.3	3.1	9.3	23.9	0.6	9.9	15.2	9.5	88.6	35.6	14.7	4.2	1.4	140.9	17.5	1.9	2.8	2.7	1.5	1.1	285.3	1.8	72.3	0.1	8.1	2.9	30.3	75.4	2.0	60.1	1.5	88.5	3.4	475.2	0.0	0.1	35.4	12.2	516.2	4068.5	7.4	15.8	978.8	120.9	8.4	246.9	0.5	9.2	0.0	0.1	31.5	52.3	34.3	46.2	6.7	661.5	37.0	71.6	1.8	19.7	8.9	17.3	0.8	1.3	11.2	90.6	3.1	68.0	0.3	50.8	65.7
HPS5	"AIBP63, BLOC2S2, RU2"	ENSG00000110756	"HPS5 biogenesis of lysosomal organelles complex 2 subunit 2"	Q9UPZ3	11	18278668-18322198	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Albinism, Disease variant, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 35.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 96.1"	"Cancer enhanced"	"Detected in all"		"melanoma: 19.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077851	Approved		Supported	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA077851: "	"unprognostic (2.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.85e-3)"	"unprognostic (5.89e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.67e-2)"	"unprognostic (2.72e-1)"	7.4	8.4	4.4	5.8	5.5	3.7	10.5	4.7	4.5	5.1	5.9	4.8	6.1	5.0	2.8	7.3	5.1	3.9	5.9	4.0	4.6	5.4	35.7	8.6	9.2	5.6	5.0	7.1	6.8	3.6	8.5	7.1	5.9	4.8	3.3	8.9	16.3	3.5	5.5	6.3	8.1	3.9	5.2	9.0	4.6	14.8	5.4	5.9	6.0	3.1	8.3	4.9	5.5	7.4	5.9	8.5	9.0	9.1	11.9	6.6	9.8	15.3	12.6	9.9	10.4	5.3	1.8	14.1	5.8	13.3	12.4	8.3	10.6	10.1	12.1	11.8	7.7	6.9	7.1	6.7	11.2	15.2	12.4	10.6	9.9	6.1	12.9	10.0	8.0	9.0	9.1	8.0	16.1	4.8	8.1	11.0	4.5	6.8	9.3	11.8	12.9	6.0	9.6	5.3	3.0	5.9	19.2	6.8	22.8	8.9	5.1	8.8	5.9	11.3	6.1	14.8	7.1	3.4	12.0	16.1	6.2	7.8	32.4	12.3	3.6	2.9	2.1	5.4	2.6	5.3	2.6	2.2	8.3	4.4	2.5	2.6	1.0	2.8	6.0	3.2	2.6	2.5	4.4	5.5	4.7	4.5	4.0	4.6	5.6	5.0	5.9	5.2	5.4	7.4	17.2	96.1	14.6	13.1	30.8	15.6	14.2	16.2	12.5	17.5	17.4	23.0	18.2	17.2	14.7	7.3	31.3	22.2	16.0	4.7	5.9	5.2	50.9	20.7	11.2	13.4	10.7	11.6	16.7	8.4	10.6	11.8	18.3	30.0	14.5	17.8	7.9	45.1	18.1	10.1	21.0	5.0	12.2	22.7	45.0	18.6	8.4	35.8	28.4	11.2	32.3	16.1	0.0	21.1	24.0	6.2	8.5	13.2	17.4	15.2	27.1	6.5	21.1	26.1	6.6	17.1	13.1	16.2	12.6	19.6	15.3	17.4	17.8	10.5	6.0	21.8
ICOSLG	"B7-H2, B7h, B7H2, B7RP-1, B7RP1, CD275, GL50, ICOS-L, ICOSL, KIAA0653"	ENSG00000160223	"Inducible T cell costimulator ligand"	O75144	21	44217014-44240966	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, B-cell activation, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.2;brain: 33.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 28.5;Glandular and luminal cells: 22.7;Langerhans cells: 39.0;monocytes: 21.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 19.9"									"CAB026037, HPA029179, CAB079997"	Approved		Approved	"Plasma membrane,Cytoplasmic bodies"		NA	NA		130000000	"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytoplasmic bodies"		"CAB026037: , CAB079997: , HPA029179: AB_2732445"	"unprognostic (3.03e-2)"	"unprognostic (1.40e-4)"	"unprognostic (3.52e-2)"	"unprognostic (1.94e-2)"	"unprognostic (6.74e-2)"	"unprognostic (9.40e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.84e-1)"	3.1	3.6	12.1	4.9	21.8	18.2	2.6	10.7	17.9	3.9	0.2	2.1	2.5	1.9	1.4	5.4	3.4	4.1	5.2	11.7	12.4	8.3	3.3	3.1	8.0	18.7	17.9	0.8	2.1	0.7	1.4	3.1	17.1	3.3	1.8	1.4	3.0	1.4	1.5	6.6	3.8	1.3	11.0	4.3	4.9	1.4	18.2	2.6	2.3	1.8	5.5	3.2	3.5	33.3	0.5	4.6	0.2	3.9	1.0	1.5	10.4	1.0	0.9	0.5	0.3	7.9	0.6	19.9	2.9	0.5	1.8	5.8	2.7	1.6	0.3	2.0	2.0	0.6	4.0	2.3	0.9	8.7	14.1	1.4	2.6	1.2	1.3	0.3	1.1	0.7	3.3	1.7	0.3	5.2	0.4	11.4	2.7	13.2	4.8	17.1	1.3	11.6	0.8	10.3	2.0	0.1	12.9	18.2	0.4	1.4	5.1	12.2	1.1	0.6	4.4	0.4	0.4	16.4	12.2	16.2	5.8	8.0	2.5	0.3	0.3	0.2	0.1	0.3	0.1	1.8	0.3	0.1	0.2	2.4	0.3	0.4	0.3	0.2	0.2	0.7	0.1	0.2	12.1	21.8	10.7	17.9	11.7	12.4	18.7	17.9	17.1	11.0	18.2	33.3	1.2	0.0	1.5	0.3	28.5	7.5	5.8	8.4	3.4	1.7	8.7	5.8	0.6	1.5	2.4	9.2	0.0	0.4	2.0	7.9	0.0	2.0	1.9	9.8	2.1	4.6	5.3	0.8	0.0	0.7	1.1	5.6	4.6	22.7	0.0	0.2	1.4	2.8	3.7	0.0	0.0	4.5	8.2	8.8	39.0	4.0	3.1	15.6	8.8	0.0	21.0	1.2	2.1	0.0	0.5	0.8	3.8	10.9	4.7	16.0	3.6	3.5	0.6	1.2	0.0	4.5	6.1	0.1	0.2	4.7	6.5	0.5	2.9	0.3	4.5	7.9
IFNA14	"IFN-alphaH, LEIF2H"	ENSG00000228083	"Interferon alpha 14"	P01570	9	21239002-21240005	"Predicted secreted proteins"	"Antiviral defense"	Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	NA	NA						"Cluster 41: Macrophages - Immune response"			"HPA047557: AB_2680087"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IFNB1	"IFB, IFF, IFNB"	ENSG00000171855	"Interferon beta 1"	P01574	9	21077104-21077942	"Cancer-related genes, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"Hofbauer cells: 2.2;Macrophages: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA073843	Supported				"Secreted to blood"	NA	NA	3750		"Cluster 36: GdT-cells - Adaptive immune response"		"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 41: Macrophages - Immune response"			"HPA073843: "	"unprognostic (2.38e-1)"									"unprognostic (2.60e-4)"								0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
IL10	"CSIF, IL-10, IL10A, TGIF"	ENSG00000136634	"Interleukin 10"	P22301	1	206767602-206774541	"Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 6.7;lymphoid tissue: 7.7"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 28.3;Kupffer cells: 44.4;Langerhans cells: 35.5;Macrophages: 99.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"thalamus: 3.5"	"Immune cell enhanced"	"Detected in some"		"classical monocyte: 2.1;intermediate monocyte: 1.8"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.1"	"Group enriched"	"Detected in some"	11	"HMC-1: 14.6;U-266/70: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013120, HPA071391"	Approved				"Secreted to blood"	NA	NA	5670		"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"CAB013120: , HPA071391: "	"unprognostic (3.65e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	"unprognostic (4.26e-1)"	"unprognostic (8.01e-2)"	"unprognostic (4.00e-1)"	"unprognostic (4.66e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.96e-2)"	6.7	2.1	0.1	7.7	0.1	3.2	0.7	0.2	0.7	0.8	0.9	1.0	0.8	0.3	0.1	1.5	1.4	3.5	1.1	0.2	0.5	0.2	1.6	1.5	5.7	0.7	0.4	0.4	0.1	0.2	0.4	1.9	0.6	0.4	1.3	0.0	0.2	0.7	0.0	0.1	1.1	3.1	0.5	4.9	0.8	0.8	3.5	2.9	0.2	1.2	2.0	2.9	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.2	0.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.4	0.1	0.1	0.2	0.7	0.2	0.5	0.7	0.4	0.6	0.5	3.5	1.2	0.5	0.0	1.9	0.0	5.6	1.0	0.4	0.0	0.0	0.2	0.2	0.3	0.3	0.0	1.3	0.0	0.0	0.1	1.3	0.0	0.0	0.0	6.9	0.1	0.2	1.9	0.0	0.4	0.0	0.0	0.1	0.8	1.1	0.2	1.3	0.0	0.7	0.5	28.3	0.0	0.0	0.0	0.0	44.4	35.5	2.9	0.0	99.5	1.8	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.4	0.9	0.3	0.0	0.0	0.0	0.4	0.0	0.9	0.8	0.0	0.2	0.7	1.1	0.1	12.9	0.0	0.0	0.4
IL13RA1	"CD213a1, IL-13Ra, NR4"	ENSG00000131724	"Interleukin 13 receptor subunit alpha 1"	P78552	X	118727133-118794535	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 199.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 10.9;eosinophil: 12.2;myeloid DC: 17.2;neutrophil: 29.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 17.2;granulocytes: 29.2;monocytes: 10.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 181.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001587			Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		17000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles	Nucleoplasm	"HPA001587: AB_1079133"	"unprognostic (5.14e-3)"	"unprognostic (4.72e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.75e-2)"	"unprognostic (8.81e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.19e-8)"	"unprognostic (1.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.82e-2)"	"unprognostic (5.08e-2)"	51.9	34.3	15.9	40.3	16.2	7.1	41.5	18.1	17.3	27.1	20.4	52.1	48.5	31.9	26.2	53.5	35.8	39.3	20.2	14.6	22.3	33.7	120.3	48.9	25.4	26.0	20.3	37.5	22.3	22.2	15.4	32.8	24.6	22.5	61.6	25.6	34.7	27.1	31.4	20.6	60.8	40.6	22.2	29.9	35.8	16.6	19.6	16.0	29.8	55.9	34.5	31.6	27.4	24.6	31.6	37.2	17.4	48.0	39.0	113.5	33.1	63.3	86.2	29.2	37.6	21.8	55.0	0.1	111.4	86.6	84.8	29.1	19.0	26.6	32.3	181.0	16.5	5.1	30.9	55.8	23.4	0.6	13.0	104.1	23.5	40.0	48.8	87.9	61.8	0.0	16.6	3.3	41.9	44.8	0.1	8.5	16.1	57.8	38.6	0.1	43.3	0.2	43.6	32.9	6.5	6.0	102.3	35.5	24.7	22.8	22.8	28.9	79.3	56.7	26.7	99.7	50.5	0.7	16.8	0.3	125.6	16.1	24.6	0.2	10.9	12.2	0.0	2.7	0.1	2.9	0.0	0.0	17.2	2.5	0.0	0.0	29.2	0.1	1.1	2.9	0.1	2.9	15.9	16.2	18.1	17.3	14.6	22.3	26.0	20.3	24.6	22.2	19.6	24.6	36.0	70.5	48.5	1.0	20.2	17.2	37.1	17.2	18.2	2.1	32.4	26.3	11.5	37.1	46.0	29.5	16.7	8.1	2.8	61.9	9.8	36.1	38.1	25.8	34.0	58.8	93.2	4.8	0.3	98.3	31.9	38.7	38.7	27.3	0.0	13.6	78.9	149.0	41.2	0.0	2.0	138.4	16.2	124.8	140.6	7.3	24.2	120.4	21.4	73.1	199.7	43.7	2.1	0.0	6.9	87.9	27.0	18.8	1.3	42.3	70.8	25.2	49.7	11.2	32.9	14.4	26.2	7.5	28.9	37.2	12.1	9.4	2.7	7.1	29.5	30.8
IL1A	"IL-1A, IL1, IL1-ALPHA, IL1F1"	ENSG00000115008	"Interleukin 1 alpha"	P01583	2	112773925-112784493	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Cytokine, Mitogen, Pyrogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 13.3;testis: 10.4;urinary bladder: 26.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 22.6;Club cells: 9.8;Endometrial ciliated cells: 11.5;Glandular and luminal cells: 29.4;Macrophages: 30.6;Squamous epithelial cells: 9.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 22.3;urothelial cancer: 17.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HBEC3-KT: 447.6;hTCEpi: 216.2;hTERT-HME1: 283.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	10800			"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"				"unprognostic (3.41e-2)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (1.99e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.03e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (4.03e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.62e-2)"	0.5	0.0	0.3	1.3	0.4	1.0	0.4	0.5	0.4	4.8	0.2	0.3	0.1	2.5	0.8	13.3	0.1	2.3	0.0	0.4	0.5	0.0	0.0	2.3	0.3	0.9	0.8	0.0	0.0	0.4	0.2	1.5	1.0	0.1	0.2	0.1	1.2	0.4	0.0	0.8	0.1	0.0	0.7	0.3	0.1	10.4	0.5	0.3	0.2	0.0	8.7	26.0	1.3	1.2	12.5	0.0	0.5	0.0	0.1	0.0	0.2	0.4	13.5	0.0	0.2	0.5	0.8	0.0	52.5	0.0	65.9	3.6	0.0	447.6	1.7	0.1	0.1	0.1	0.7	0.2	1.0	0.2	0.1	0.0	216.2	3.8	283.4	3.4	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	4.2	0.2	0.5	0.0	0.0	0.0	0.1	55.0	0.1	0.0	1.6	0.0	0.0	0.6	0.0	0.1	1.7	1.3	0.6	0.3	0.3	0.0	0.1	0.2	5.2	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.5	0.4	0.4	0.5	0.9	0.8	1.0	0.7	0.5	1.2	0.9	6.4	1.1	0.0	2.2	1.5	0.7	22.6	1.2	0.0	0.5	0.3	0.2	0.0	9.8	0.0	0.0	0.3	0.3	0.6	0.0	4.6	8.3	11.5	2.8	0.2	0.0	0.0	0.0	0.9	0.1	0.1	0.0	29.4	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	2.0	0.0	4.8	3.8	0.0	30.6	0.0	5.6	0.0	0.0	0.0	0.0	0.1	3.5	0.0	0.0	0.4	0.3	0.0	0.0	1.9	0.0	0.0	0.0	1.1	0.1	0.1	9.4	1.0	0.0	0.4	0.1	0.2	2.4
IL1B	"IL-1B, IL1-BETA, IL1F2"	ENSG00000125538	"Interleukin 1 beta"	P01584	2	112829751-112836816	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Cytokine, Mitogen, Pyrogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 201.7;urinary bladder: 126.2"	"Group enriched"	"Detected in many"	11	"Langerhans cells: 1451.9;Macrophages: 1510.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 94.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 94.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 649.3;HBEC3-KT: 293.3;HMC-1: 235.1;hTEC/SVTERT24-B: 319.1;hTERT-RPE1: 277.0;U-87 MG: 571.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	2330		"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"				"unprognostic (1.55e-3)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (2.75e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.72e-2)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (7.49e-5)"	"unprognostic (1.29e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.01e-2)"	43.9	7.6	2.5	53.6	2.2	201.7	2.0	3.1	4.6	3.7	4.2	8.1	3.0	7.4	2.0	3.4	4.1	19.0	3.3	2.3	3.4	7.7	9.1	17.4	9.5	4.8	4.6	0.8	4.4	3.0	2.6	7.8	3.8	6.1	6.5	0.3	3.8	1.8	0.1	0.7	3.5	9.2	4.4	17.8	25.5	1.1	2.8	9.4	2.6	7.0	12.8	126.2	1.0	6.6	6.3	0.1	0.2	0.0	0.4	0.0	0.0	2.1	649.3	3.1	6.5	0.0	0.0	0.0	18.0	0.5	11.3	14.7	0.0	293.3	39.2	0.0	0.0	29.5	0.4	0.0	2.2	0.0	235.1	1.1	8.9	319.1	103.5	277.0	0.0	0.1	0.0	0.8	0.6	0.0	0.0	2.9	0.1	1.2	26.2	1.0	0.0	0.0	0.0	48.2	0.0	0.0	1.7	0.0	2.5	0.0	0.0	2.8	0.0	15.3	0.2	0.7	0.5	0.1	0.0	0.2	571.5	14.0	22.7	1.7	12.3	4.4	0.0	19.5	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	94.1	0.2	7.7	0.0	0.0	3.4	2.5	2.2	3.1	4.6	2.3	3.4	4.8	4.6	3.8	4.4	2.8	6.6	23.8	9.6	28.2	0.0	14.1	30.8	5.4	25.4	0.0	0.2	8.2	13.3	4.8	0.0	16.2	1.8	0.0	1.5	7.5	2.8	0.0	33.2	0.3	4.9	5.0	20.0	0.0	58.9	0.0	0.6	2.6	8.1	44.4	8.4	41.7	0.0	1.4	0.4	108.1	0.0	0.0	12.7	14.2	130.5	1451.9	0.7	0.0	1510.7	23.2	1.9	7.9	0.3	0.0	0.0	0.0	2.9	10.0	0.0	9.3	4.7	0.2	0.7	8.6	0.3	0.0	1.5	4.3	0.0	0.4	8.3	20.3	4.4	6.3	0.0	1.9	6.1
IL1R2	"CD121b, IL1RB"	ENSG00000115590	"Interleukin 1 receptor type 2"	P27930	2	101991960-102028544	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 90.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 495.7;Kupffer cells: 207.9;Langerhans cells: 1083.3;Macrophages: 210.8;Pancreatic endocrine cells: 211.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 16.1"	"Group enriched"	"Detected in some"	6	"cerebral cortex: 6.4;pons: 1.9"	"Immune cell enriched"	"Detected in some"	26	"neutrophil: 377.5"	"Lineage enriched"	"Detected in many"	26	"granulocytes: 377.5"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 469.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA027597, HPA027598"	Uncertain				"Secreted to blood"	NA	NA	7130000	27000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA027597: AB_10600768, HPA027598: AB_10601229"	"unprognostic (3.54e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.83e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.58e-12)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.62e-2)"	19.7	5.9	0.2	35.5	0.7	52.8	3.7	0.3	6.4	10.3	1.9	29.7	0.8	2.5	3.5	41.2	17.7	5.3	4.0	0.2	0.5	16.0	11.6	30.8	3.3	0.5	0.4	1.2	3.7	0.3	0.8	20.1	1.9	2.3	43.7	0.1	7.9	2.2	1.2	30.7	4.6	3.4	0.3	90.1	33.0	0.5	0.7	7.4	1.9	2.9	38.5	6.2	20.5	0.3	7.3	0.9	0.0	0.0	0.9	1.2	0.8	0.0	0.2	0.0	0.1	7.7	0.2	0.1	14.7	0.0	0.3	2.9	0.0	0.5	0.0	469.8	0.4	0.1	0.1	4.0	2.5	0.0	0.0	9.9	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	60.4	0.0	0.0	0.0	0.0	24.0	1.7	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.4	0.0	1.1	0.4	7.2	0.2	0.0	0.3	0.0	0.5	0.2	0.0	0.1	4.3	0.0	0.0	2.3	0.0	0.0	0.9	0.0	14.5	0.0	0.0	0.0	377.5	0.2	0.1	0.2	5.9	1.5	0.2	0.7	0.3	6.4	0.2	0.5	0.5	0.4	1.9	0.3	0.7	0.3	1.2	6.4	1.1	0.0	1.7	147.9	13.5	2.0	495.7	0.0	0.5	0.4	0.6	10.0	0.3	1.8	0.0	1.2	1.2	23.8	5.9	15.0	2.8	14.5	1.5	4.4	6.7	2.7	0.0	8.3	36.3	6.1	18.3	8.0	2.5	0.0	3.6	16.2	5.8	0.0	0.0	117.4	0.0	207.9	1083.3	4.0	0.3	210.8	32.0	0.0	3.5	0.0	0.0	0.0	0.0	211.0	26.8	0.0	1.6	20.4	0.0	0.7	2.2	0.0	6.6	0.7	3.8	0.7	2.2	38.1	84.0	27.8	2.7	0.4	26.8	14.4
IL20	"IL-20, IL10D, ZCYTO10"	ENSG00000162891	"Interleukin 20"	Q9NYY1	1	206865623-206869223	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.8;skin 1: 1.1"	"Cell type enriched"	"Detected in some"	4	"Basal keratinocytes: 69.6"	"Cancer enhanced"	"Detected in some"		"breast cancer: 3.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SiHa: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025802	Uncertain				"Secreted to blood"	NA	NA	109000			"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"			"CAB025802: "	"unprognostic (3.08e-2)"	"unprognostic (1.91e-1)"		"unprognostic (1.82e-1)"		"unprognostic (1.16e-2)"		"unprognostic (6.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.60e-1)"		"unprognostic (3.38e-2)"	"unprognostic (1.67e-1)"		"unprognostic (1.71e-1)"	1.8	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	1.1	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.6	6.6	15.1	0.0	0.0	9.4	3.7	0.1	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.3	0.1	0.3	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.1	0.0	2.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.5	0.3	0.0	9.9	0.0	0.1	0.0	0.1	7.3
IL6R	CD126	ENSG00000160712	"Interleukin 6 receptor"	P08887	1	154405193-154469450	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.3;skeletal muscle: 94.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 115.4;Hepatocytes: 108.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 88.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 224.4;U-266/84: 274.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	24800000	35000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 16: U-266 - Nucleosome"	"Cluster 41: Macrophages - Immune response"				"unprognostic (1.19e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.42e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (7.94e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.07e-1)"	11.0	5.8	6.8	25.5	8.0	16.6	5.9	7.4	11.3	7.6	4.8	14.7	15.6	8.4	2.5	7.4	12.4	9.0	6.6	6.2	6.4	14.2	58.3	16.3	27.3	10.9	8.8	8.9	8.7	1.2	8.9	6.6	9.8	6.0	9.8	1.4	3.3	2.9	94.2	6.4	19.8	8.8	10.4	19.8	10.2	3.4	10.6	9.3	2.7	26.4	22.4	9.3	5.3	10.4	3.3	5.8	0.4	0.4	3.4	5.1	0.4	3.3	2.5	2.0	1.0	0.6	3.9	0.2	7.4	4.1	12.0	1.7	1.1	17.8	1.6	62.6	1.9	0.8	2.2	13.9	0.5	9.6	5.0	3.0	10.5	1.7	26.1	0.6	2.6	0.1	0.7	24.0	0.6	1.4	0.2	16.0	1.8	1.1	13.5	0.3	0.3	53.6	10.9	4.5	0.5	0.3	1.1	36.2	59.5	4.5	3.3	224.4	2.5	3.5	3.4	3.3	2.2	43.1	274.1	0.4	4.4	61.0	5.7	7.5	29.4	28.1	0.6	18.0	1.5	1.5	15.2	1.6	36.1	0.6	14.9	5.4	88.2	1.3	8.0	13.1	21.2	15.8	6.8	8.0	7.4	11.3	6.2	6.4	10.9	8.8	9.8	10.4	10.6	10.4	3.4	115.4	82.7	18.6	11.0	37.9	72.9	8.3	13.1	0.1	7.5	7.4	9.9	25.8	33.9	1.8	0.0	0.5	16.9	38.5	0.0	4.3	35.1	34.1	5.7	10.9	7.7	3.8	5.7	1.2	1.2	26.3	25.5	48.7	61.3	1.3	3.9	108.6	42.9	0.0	5.9	6.5	14.2	41.8	79.3	14.5	0.3	63.7	24.9	44.0	76.8	3.8	4.1	3.0	3.3	7.5	8.7	0.4	41.9	58.9	60.1	15.5	29.0	0.2	0.0	28.3	19.2	0.4	1.1	7.2	29.7	1.0	17.1	0.1	15.4	17.0
INSIG1	"CL-6, MGC1405"	ENSG00000186480	"Insulin induced gene 1"	O15503	7	155297776-155310235	"Plasma proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 563.4"	"Cell type enriched"	"Detected in all"	4	"Langerhans cells: 4121.3"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 142.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"intermediate monocyte: 272.8;non-classical monocyte: 500.8"	"Lineage enriched"	"Detected in all"	6	"monocytes: 500.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 1228.9;RPMI-8226: 605.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071524			Uncertain	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA071524: "	"unprognostic (8.11e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (9.62e-4)"	"unprognostic (4.97e-2)"	79.2	37.3	25.3	35.4	36.9	45.5	37.4	47.1	39.1	25.5	58.0	29.8	53.0	19.5	31.8	40.1	17.6	31.6	21.0	30.2	40.9	45.6	563.4	43.2	30.9	61.1	51.7	24.0	111.7	17.4	18.9	34.2	62.8	62.6	26.4	40.5	70.9	11.3	9.0	42.5	35.2	20.3	36.6	19.0	61.1	34.4	36.5	40.4	12.5	12.0	25.3	36.7	23.3	86.3	158.9	29.0	76.8	48.1	200.6	265.5	41.9	12.5	179.1	36.9	242.6	18.1	225.2	104.0	35.7	98.2	282.2	83.9	53.1	92.6	43.3	32.3	155.5	28.6	51.7	0.0	99.0	49.3	448.7	165.6	50.4	281.8	25.8	27.3	49.8	202.8	53.2	1228.9	47.9	82.2	238.7	128.6	80.0	30.4	20.4	43.5	0.2	605.1	291.6	77.8	57.2	45.5	41.6	29.9	67.8	28.7	29.0	162.0	56.3	40.5	11.8	77.2	33.3	296.8	57.4	93.3	177.6	187.2	38.2	21.3	29.7	13.4	49.3	272.8	25.5	46.5	32.8	41.9	78.5	60.2	32.6	36.7	62.6	27.5	500.8	44.7	77.0	85.2	25.3	36.9	47.1	39.1	30.2	40.9	61.1	51.7	62.8	36.6	36.5	86.3	91.4	41.7	121.5	39.8	100.5	140.2	59.4	148.2	74.6	16.5	58.0	31.6	43.6	35.8	114.4	40.5	10.4	47.7	79.0	129.1	17.6	52.0	21.2	30.8	11.6	135.6	126.8	38.3	11.1	140.4	189.0	120.4	57.6	67.4	60.4	18.1	33.2	828.9	46.9	38.7	16.9	91.5	185.1	63.6	4121.3	9.7	15.8	381.0	247.3	7.5	29.6	88.7	34.0	17.1	61.8	53.6	86.6	18.4	100.1	180.4	29.1	9.4	68.3	18.1	19.7	36.3	62.0	33.6	45.0	135.8	155.3	130.4	108.2	20.6	48.0	158.5
IPMK		ENSG00000151151	"Inositol polyphosphate multikinase"	Q8NFU5	10	58191517-58267894	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 3.0;monocytes: 1.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037837, HPA057542"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA037837: AB_10670166, HPA057542: AB_2683460"	"unprognostic (4.52e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.22e-3)"	"unprognostic (6.85e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (9.96e-7)"	"unprognostic (1.79e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.27e-3)"	"unprognostic (9.02e-3)"	4.9	3.1	3.1	5.8	3.1	2.4	4.7	4.1	4.5	4.4	2.3	7.1	7.9	2.3	3.4	5.2	2.9	6.9	1.8	2.9	3.2	4.1	18.1	3.3	4.6	3.6	3.6	1.8	3.8	12.1	1.9	8.7	3.2	3.4	6.0	4.7	2.7	1.7	2.7	5.1	10.4	1.9	3.2	6.4	3.5	2.2	3.5	4.5	4.1	3.2	4.4	5.2	2.5	3.2	16.3	4.1	5.9	5.8	5.7	6.6	5.1	4.2	9.0	3.5	7.1	8.3	10.1	13.0	8.3	5.0	3.4	4.9	5.0	5.6	11.2	5.9	3.8	3.2	3.9	7.9	3.4	5.1	7.1	7.3	4.9	6.0	12.0	4.0	7.7	3.7	2.1	6.5	6.3	4.1	7.0	9.8	3.8	6.6	3.8	0.5	12.8	6.0	6.6	4.1	4.1	7.1	5.5	14.4	4.3	9.6	12.0	6.1	6.7	3.8	7.4	8.1	5.4	13.8	8.7	10.1	7.2	5.3	1.5	1.7	0.7	1.6	0.1	0.7	0.1	0.3	0.1	0.1	0.4	0.2	0.4	0.1	3.0	0.2	1.0	0.2	0.0	0.1	3.1	3.1	4.1	4.5	2.9	3.2	3.6	3.6	3.2	3.2	3.5	3.2	8.9	6.4	4.2	16.6	16.9	54.0	10.0	8.4	26.2	10.0	11.6	8.3	2.8	4.3	13.3	1.8	6.2	10.5	8.1	29.3	3.9	4.2	3.0	24.3	9.7	9.9	8.4	3.0	21.8	4.9	22.5	15.7	8.2	22.8	7.0	2.5	8.2	13.2	10.0	13.5	27.8	10.6	10.2	22.8	40.7	1.4	2.8	29.1	26.6	24.4	16.6	5.4	2.1	30.7	23.6	6.2	21.7	1.9	8.5	9.6	28.6	9.1	29.1	5.8	6.6	10.2	8.5	10.0	5.1	20.1	58.1	9.4	10.1	4.1	11.1	17.5
IRAK2		ENSG00000134070	"Interleukin 1 receptor associated kinase 2"	O43187	3	10164919-10243745	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.3"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 43.7;Oligodendrocytes: 34.3;Prostatic glandular cells: 23.4;Urothelial cells: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 33.2;BJ hTERT+: 35.2;CAPAN-2: 35.6;GAMG: 62.6;RT4: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013483, HPA050520"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"CAB013483: , HPA050520: AB_2681154"	"unprognostic (1.31e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.61e-3)"	"unprognostic (8.71e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (1.89e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (2.24e-1)"	"unprognostic (3.10e-2)"	"unprognostic (7.22e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.91e-2)"	"prognostic favorable (6.60e-5)"	6.4	3.6	4.0	6.0	3.9	23.3	4.6	3.9	8.0	2.9	1.7	2.1	2.0	2.0	0.7	7.2	1.8	4.4	1.9	3.2	5.1	3.4	10.8	10.4	3.8	5.1	4.1	1.0	1.9	1.0	1.2	2.2	5.6	3.3	1.7	1.5	3.6	1.8	17.0	5.2	5.4	1.4	3.4	4.5	3.4	1.3	4.2	3.9	3.1	4.3	11.5	16.1	4.5	8.0	2.7	7.6	0.3	1.0	8.1	6.7	33.2	2.9	35.2	4.7	4.5	3.6	35.6	0.1	0.9	4.3	62.6	0.8	0.8	9.0	6.3	2.3	2.5	0.8	1.7	9.9	3.9	0.0	1.1	4.1	1.5	17.3	22.4	12.4	9.7	0.3	1.8	10.7	5.7	0.1	0.0	1.8	0.3	4.2	7.5	1.7	0.0	0.6	10.3	49.2	0.5	0.3	3.3	0.1	0.3	0.8	0.8	1.7	10.1	10.7	0.9	6.5	7.0	3.6	11.3	2.1	22.9	4.7	1.9	0.2	1.0	0.1	5.8	0.7	6.0	4.2	1.7	3.3	1.0	3.2	1.2	3.0	2.1	7.4	0.2	0.0	0.7	2.2	4.0	3.9	3.9	8.0	3.2	5.1	5.1	4.1	5.6	3.4	4.2	8.0	3.9	0.0	4.1	1.6	8.3	8.0	20.8	9.9	5.2	0.9	1.6	1.3	2.0	0.0	6.1	0.0	0.0	0.2	3.8	1.3	0.0	9.8	4.1	4.3	2.4	12.3	0.0	0.0	6.3	4.2	0.7	4.3	7.7	16.7	0.0	0.1	0.7	4.8	3.4	0.0	7.0	0.7	4.1	2.9	43.7	1.5	0.9	20.9	5.4	13.1	1.9	2.1	7.2	7.1	34.3	15.7	0.3	0.0	7.4	23.4	2.6	1.1	1.3	0.0	0.0	4.2	2.0	0.7	0.9	4.7	7.4	1.0	3.9	0.2	0.5	30.4
IRAK3	IRAK-M	ENSG00000090376	"Interleukin 1 receptor associated kinase 3"	Q9Y616	12	66189195-66254622	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"			Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 83.3;Kupffer cells: 123.0;Macrophages: 126.3;Microglial cells: 114.3;monocytes: 96.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 12.7;classical monocyte: 23.4;intermediate monocyte: 24.2;myeloid DC: 11.5;neutrophil: 12.9;non-classical monocyte: 42.0"	"Group enriched"	"Detected in many"	12	"dendritic cells: 11.5;granulocytes: 12.9;monocytes: 42.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.9;ASC TERT1: 21.1;HEL: 22.9;HL-60: 30.8;NB-4: 25.1;THP-1: 37.3;U-937: 26.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043097	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA043097: AB_10795612"	"unprognostic (7.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (8.52e-2)"	"prognostic unfavorable (6.23e-4)"	"unprognostic (5.58e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.23e-2)"	18.7	3.8	3.7	12.4	4.1	78.1	11.6	4.1	7.5	9.3	5.4	4.6	1.3	4.0	3.0	3.8	8.0	6.9	7.9	3.2	4.7	3.5	2.8	19.0	4.1	5.6	5.7	3.2	2.5	0.9	8.9	6.8	6.5	5.3	2.8	0.4	6.2	5.6	2.6	3.4	5.6	5.4	5.0	27.5	6.9	1.8	5.6	2.7	5.0	4.6	3.9	8.4	6.6	5.1	0.0	0.0	0.4	0.0	25.9	21.1	0.0	2.9	0.0	1.5	2.3	0.0	2.2	0.0	1.4	5.3	0.0	0.0	3.2	0.0	1.3	0.0	0.0	22.9	1.4	0.0	13.4	30.8	4.0	13.5	0.1	1.2	0.0	0.0	7.6	0.0	0.0	0.0	1.0	0.0	0.0	25.1	1.3	0.0	0.0	0.0	6.4	0.0	0.1	3.3	0.1	0.0	11.6	0.0	1.2	0.1	0.1	37.3	8.2	0.0	0.0	0.0	0.0	0.9	0.2	2.2	0.0	26.8	0.0	12.7	23.4	4.3	0.0	24.2	0.0	0.1	0.0	0.0	11.5	0.7	0.0	0.0	12.9	1.8	42.0	0.1	0.6	7.3	3.7	4.1	4.1	7.5	3.2	4.7	5.6	5.7	6.5	5.0	5.6	5.1	83.3	9.6	19.4	1.3	2.3	1.5	4.8	27.5	6.2	0.3	2.5	1.8	2.8	0.0	46.9	3.7	0.0	0.2	14.8	0.5	0.0	0.6	6.4	0.5	7.5	38.5	0.0	9.7	0.4	1.2	0.4	22.3	18.3	0.5	27.3	0.5	36.4	1.2	9.4	0.0	5.6	1.1	36.7	123.0	12.1	5.3	7.2	126.3	5.4	114.3	96.9	0.2	3.1	2.0	0.6	4.9	0.1	11.3	9.1	1.6	0.0	0.2	35.1	0.1	0.0	18.1	10.2	0.8	1.8	1.2	1.3	0.3	3.5	12.5	0.7	2.5
IRS2		ENSG00000185950	"Insulin receptor substrate 2"	Q9Y4H2	13	109752695-109786583	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 51.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 38.1;LHCN-M2: 36.9;SH-SY5Y: 40.2;THP-1: 62.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016944, HPA054664"	Approved		Supported	Aggresome,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol	Aggresome	"CAB016944: , HPA054664: AB_2682563"	"unprognostic (2.87e-3)"	"unprognostic (5.73e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.28e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.24e-1)"	26.2	16.5	22.2	5.9	21.8	51.3	18.9	12.1	28.4	10.7	3.9	11.3	4.4	13.0	6.3	4.2	7.7	4.0	13.0	32.2	22.9	3.5	22.1	11.1	2.3	29.4	24.5	18.6	4.3	3.6	19.1	6.7	24.8	13.3	3.4	6.0	11.6	6.1	21.4	15.5	6.0	4.7	13.6	5.4	7.8	3.0	25.2	2.3	5.5	7.7	2.2	7.1	8.6	20.1	5.8	6.6	4.2	0.0	34.5	6.9	2.3	6.3	7.4	3.8	3.1	0.6	7.0	0.0	3.9	4.5	5.4	2.6	2.2	5.6	4.7	2.3	29.5	2.8	9.3	0.0	34.8	10.7	3.3	14.5	29.6	1.1	38.1	24.5	1.4	0.5	1.9	0.0	36.9	3.0	0.1	31.1	4.5	3.2	1.4	13.1	3.8	2.8	10.6	1.5	6.1	40.2	3.3	0.1	27.2	3.5	0.8	62.8	0.1	7.8	0.0	0.5	8.5	0.0	3.1	2.1	5.8	10.2	13.7	1.5	0.6	0.9	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	3.3	0.0	0.2	0.0	0.2	0.1	22.2	21.8	12.1	28.4	32.2	22.9	29.4	24.5	24.8	13.6	25.2	20.1	13.7	32.1	33.8	53.8	31.1	113.9	48.0	100.2	81.4	25.8	68.9	98.4	72.3	60.1	79.5	31.3	114.7	20.3	40.0	71.2	5.9	36.4	47.6	81.6	110.6	13.4	122.6	34.5	51.3	3.1	11.1	52.0	28.1	188.5	25.3	25.8	20.0	142.9	24.1	25.2	42.2	42.0	52.9	143.5	24.4	12.3	37.3	131.2	129.9	29.0	59.3	32.4	17.5	46.3	34.8	30.8	44.4	20.3	7.9	76.8	77.3	3.9	40.3	30.6	26.3	57.1	44.0	21.2	10.2	74.6	126.2	30.6	37.5	63.1	42.7	53.6
ITGAX	CD11C	ENSG00000140678	"Integrin subunit alpha X"	P20702	16	31355134-31382999	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 48.1;brain: 33.7;lung: 58.1;lymphoid tissue: 67.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 51.1;granulocytes: 74.0;Hofbauer cells: 45.1;Kupffer cells: 51.5;Langerhans cells: 77.3;Macrophages: 141.7;Microglial cells: 56.2;NK-cells: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 87.5"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 106.1"	"Not detected"	"Not detected"							"CAB004458, HPA004723, CAB072871"	Enhanced					NA	NA		50000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"CAB004458: AB_626859, CAB072871: AB_2665723, HPA004723: AB_1846231"	"unprognostic (9.75e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.59e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.20e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.34e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.95e-2)"	12.9	2.3	6.0	42.7	8.1	48.1	4.3	8.8	33.7	2.2	8.4	2.9	2.3	2.8	0.8	2.0	5.9	10.8	3.5	6.2	9.3	2.9	6.3	58.1	23.2	14.6	11.8	1.0	2.9	1.4	2.9	4.6	14.3	3.2	4.3	0.6	4.5	1.5	1.3	2.1	5.5	4.7	13.0	67.5	4.8	0.6	18.4	4.0	2.8	3.2	12.3	9.2	2.1	24.8	0.1	0.6	0.1	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.4	0.0	9.0	0.0	0.3	0.1	0.0	0.3	0.1	18.6	0.1	0.1	0.3	0.4	0.0	1.1	106.1	0.1	0.1	1.7	0.2	0.7	1.0	0.0	0.1	0.4	0.0	0.0	0.1	8.8	0.4	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	2.7	0.1	0.0	3.3	0.8	0.0	1.6	0.0	0.1	0.1	0.0	0.2	4.9	1.8	0.3	12.8	29.1	27.1	4.8	50.3	0.4	2.1	0.1	0.7	34.7	1.0	0.1	0.7	87.5	41.4	61.0	0.6	0.1	11.5	6.0	8.1	8.8	33.7	6.2	9.3	14.6	11.8	14.3	13.0	18.4	24.8	0.8	12.8	51.1	0.0	9.8	2.8	0.3	0.0	0.0	0.1	0.6	1.3	1.5	0.0	10.5	0.0	0.0	0.4	33.6	0.0	0.0	0.3	0.0	0.4	0.5	4.8	0.0	3.4	0.2	0.0	0.6	4.4	0.0	0.5	74.0	0.0	1.1	0.1	45.1	0.0	0.3	0.0	0.0	51.5	77.3	0.0	0.0	141.7	1.8	56.2	35.3	0.1	68.0	0.5	0.3	0.2	0.0	0.0	5.5	0.2	0.0	0.3	1.5	0.1	0.0	0.6	1.0	0.0	0.2	0.0	1.1	0.4	16.5	0.1	0.0	0.1
JARID2	JMJ	ENSG00000008083	"Jumonji and AT-rich interaction domain containing 2"	Q92833	6	15246069-15522042	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.8"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 195.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 34.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 73.8;SuSa: 78.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063889, CAB069890"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Mitochondria"		"CAB069890: AB_10000529, HPA063889: AB_2685143"	"unprognostic (5.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.26e-3)"	"unprognostic (7.04e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-1)"	7.3	4.7	6.7	9.2	7.1	57.8	6.0	23.6	8.7	5.3	3.7	5.0	5.7	5.0	6.7	13.7	3.9	4.4	6.4	7.5	6.2	4.1	3.6	7.2	9.0	7.1	6.8	5.7	3.5	3.6	4.4	7.1	7.8	4.5	4.6	20.0	6.4	3.3	11.8	13.4	6.8	4.1	5.2	10.6	7.0	16.0	8.0	20.0	3.8	4.3	9.8	5.8	6.8	8.2	12.4	8.5	34.0	19.6	4.1	4.0	33.5	3.5	8.3	4.5	5.5	8.8	9.4	6.5	12.3	7.1	6.8	6.3	8.0	20.1	4.1	13.0	12.4	23.3	10.6	11.6	4.6	23.9	26.3	5.7	12.3	6.6	26.2	13.4	4.7	73.8	30.5	10.8	2.7	12.6	47.6	44.6	36.4	6.1	3.8	20.9	10.4	18.6	4.2	13.0	26.2	15.0	7.3	24.9	32.1	78.1	8.7	25.0	8.5	20.6	11.4	11.5	12.3	6.9	17.8	11.7	7.0	21.9	26.6	10.1	3.8	3.2	3.4	2.4	2.9	2.5	1.6	2.1	3.1	3.4	2.1	2.9	13.2	4.9	2.7	4.4	1.4	2.1	6.7	7.1	23.6	8.7	7.5	6.2	7.1	6.8	7.8	5.2	8.0	8.2	30.1	6.4	12.8	175.3	40.7	80.4	10.7	23.0	31.9	74.2	28.3	23.1	10.5	15.7	17.1	5.5	87.6	27.0	62.9	10.0	1.9	8.2	89.2	30.7	18.0	27.1	26.8	50.9	125.9	4.4	25.0	17.6	19.9	77.5	25.3	14.8	15.7	13.8	24.0	154.8	124.4	16.4	16.2	61.3	195.0	40.8	8.7	89.5	26.6	97.4	49.1	134.0	54.6	136.7	136.6	15.6	9.3	8.6	34.9	6.8	16.6	3.8	8.7	89.7	6.6	18.1	23.6	9.4	71.1	43.4	151.6	25.2	43.2	17.4	14.7	15.4
KBTBD8	"KIAA1842, TA-KRP"	ENSG00000163376	"Kelch repeat and BTB domain containing 8"	Q8NFY9	3	66998307-67011210	"Predicted intracellular proteins"	"Translation regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.9;lymphoid tissue: 20.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 31.9;Langerhans cells: 35.2;Macrophages: 20.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 62.6;Karpas-707: 28.4;U-698: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041285, HPA069190"	Approved					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"			"HPA041285: AB_10796341, HPA069190: AB_2686101"	"unprognostic (2.62e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.70e-4)"	"unprognostic (1.99e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.93e-1)"	"unprognostic (8.14e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.26e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.54e-1)"	1.4	1.1	1.4	6.9	2.0	13.9	1.0	1.7	3.2	0.7	3.8	2.4	1.8	0.4	0.2	1.3	0.4	1.8	3.8	1.7	1.1	0.6	1.3	2.2	20.4	0.7	0.7	0.4	0.9	0.3	0.5	3.2	0.7	1.0	1.9	1.3	0.9	0.4	1.6	0.5	2.8	1.2	0.8	5.7	2.2	7.8	0.9	3.6	0.8	2.2	20.7	1.9	0.3	1.4	1.2	1.4	2.5	2.9	1.7	1.1	5.3	3.1	1.1	2.3	1.6	5.7	0.6	62.6	0.8	0.9	1.3	1.7	14.5	3.4	3.6	10.7	4.7	23.0	0.7	2.9	2.2	14.8	23.9	1.9	1.5	4.6	4.0	0.7	1.7	12.4	5.7	28.4	1.6	2.4	11.9	2.5	10.5	2.3	1.1	6.8	2.5	8.5	0.7	1.9	8.6	3.1	1.2	1.0	2.1	3.1	0.6	4.2	4.8	7.7	1.8	16.8	6.0	16.4	27.6	43.3	2.1	11.7	2.6	0.0	1.1	0.4	1.1	3.0	0.6	6.2	1.3	1.2	2.4	6.7	1.2	0.8	0.0	1.1	2.6	0.3	2.4	1.2	1.4	2.0	1.7	3.2	1.7	1.1	0.7	0.7	0.7	0.8	0.9	1.4	2.3	0.0	1.8	0.3	31.9	5.2	0.4	0.1	5.7	1.3	1.9	2.5	11.6	1.5	0.7	0.0	2.1	4.0	7.5	2.1	0.0	0.5	1.4	0.3	0.3	1.6	1.2	3.0	4.5	0.9	1.4	1.3	1.1	0.4	4.5	0.1	2.2	0.5	3.8	3.3	2.7	1.2	2.0	1.9	35.2	1.3	0.0	20.9	0.0	1.9	1.3	1.7	0.0	2.0	1.8	1.2	1.5	0.4	11.0	0.3	0.9	0.5	0.2	0.7	0.0	3.5	2.5	9.9	5.3	5.1	5.5	2.5	9.1	0.8	1.4	0.5
KCTD20	"C6orf69, dJ108K11.3, MGC14254"	ENSG00000112078	"Potassium channel tetramerization domain containing 20"	Q7Z5Y7	6	36442767-36491143	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 126.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030092	Approved		Approved	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"	"Nuclear speckles"	"HPA030092: AB_10601437"	"unprognostic (2.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.20e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.00e-3)"	"unprognostic (5.03e-3)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.63e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.05e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (9.31e-4)"	"unprognostic (2.94e-2)"	41.6	25.9	15.3	28.1	16.7	27.7	21.3	16.0	16.4	23.7	14.8	21.5	14.3	25.7	15.4	28.1	19.5	28.9	18.0	15.6	19.5	16.0	31.2	22.0	27.6	18.6	19.4	22.8	12.8	14.6	11.9	26.0	18.6	19.3	18.1	10.9	14.6	21.0	20.7	29.6	15.7	31.5	16.3	25.3	14.7	10.3	17.0	34.8	14.3	18.9	29.5	28.6	17.6	17.5	36.7	16.9	47.0	90.4	62.8	41.3	23.4	43.7	60.4	46.9	52.2	43.6	20.8	124.3	38.2	72.4	26.8	33.3	62.3	31.4	77.3	90.3	34.9	70.3	26.0	46.5	29.9	68.9	46.8	41.1	32.5	36.1	23.0	31.2	48.7	64.1	112.8	68.2	44.9	33.1	78.5	26.6	17.5	29.1	15.3	78.0	53.4	68.8	25.5	40.6	11.4	65.9	38.4	38.6	116.6	46.6	53.5	68.1	56.4	126.2	43.4	37.5	55.0	53.0	132.9	87.8	21.7	93.7	131.4	29.7	17.4	11.4	8.1	15.1	9.4	6.8	6.5	6.8	16.3	5.6	6.5	6.6	12.5	7.8	8.9	9.0	8.6	13.9	15.3	16.7	16.0	16.4	15.6	19.5	18.6	19.4	18.6	16.3	17.0	17.5	38.3	38.5	23.7	21.9	28.6	50.1	19.6	15.2	24.5	22.4	23.7	23.9	15.9	28.6	22.2	16.5	10.4	26.3	45.4	14.0	1.9	18.2	0.7	20.0	33.8	38.3	15.1	64.6	23.3	14.2	18.9	38.9	23.9	24.6	53.8	40.8	44.6	45.6	26.7	15.2	23.3	15.5	12.2	51.3	126.3	2.3	31.7	61.4	33.8	27.2	58.4	18.1	30.9	22.6	26.5	19.5	16.3	53.4	48.7	18.9	18.8	19.0	22.5	10.5	19.7	35.8	42.7	8.1	27.2	27.6	63.4	23.0	39.6	23.8	16.1	32.2
KDM6B	"JMJD3, KIAA0346"	ENSG00000132510	"Lysine demethylase 6B"	O15054	17	7834217-7854796	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Inflammatory response"	"Chromatin regulator, Dioxygenase, Oxidoreductase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 393.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 3.6;neutrophil: 8.9"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 8.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037988	Supported		Approved	"Nuclear speckles"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"		"HPA037988: AB_10672502"	"unprognostic (3.43e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.89e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.42e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (5.73e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (1.85e-1)"	33.6	13.3	3.1	20.0	2.4	35.5	12.6	12.5	22.9	12.2	3.4	15.4	14.3	14.0	3.4	13.6	17.1	15.6	17.7	3.2	4.5	14.6	15.2	27.4	8.0	4.8	3.2	29.7	17.1	7.9	21.8	6.8	3.3	14.5	4.1	6.2	12.0	6.2	12.4	16.4	17.5	5.5	1.4	20.7	17.7	16.1	5.0	16.4	15.9	8.2	4.6	19.8	12.4	6.2	4.9	7.0	12.5	19.0	4.6	3.4	16.2	3.8	5.4	2.7	2.8	9.3	3.6	11.4	4.5	3.0	3.9	12.2	5.8	5.1	1.6	4.7	4.5	5.3	6.7	6.2	13.0	7.2	15.6	5.3	8.0	6.1	5.1	7.2	4.8	11.8	8.8	4.8	1.2	7.7	10.6	6.5	6.4	4.9	3.9	11.9	2.9	3.2	5.1	7.7	6.6	21.4	4.8	11.5	10.3	7.3	6.4	8.9	2.3	4.0	7.1	7.0	5.5	5.6	1.2	3.9	5.3	4.2	8.1	3.6	0.6	1.1	0.3	0.4	0.3	0.3	0.2	0.1	0.3	0.5	0.3	0.4	8.9	0.1	0.2	0.7	0.1	0.4	3.1	2.4	12.5	22.9	3.2	4.5	4.8	3.2	3.3	1.4	5.0	6.2	135.5	25.6	33.6	6.2	158.8	214.4	122.2	30.8	156.0	45.2	113.7	70.9	10.8	42.9	32.4	7.3	31.3	15.1	127.6	47.8	1.9	28.0	29.2	88.2	67.1	80.5	79.9	8.4	9.0	25.1	15.9	85.4	73.4	181.6	178.6	44.8	34.2	22.7	23.4	38.7	10.9	62.5	18.3	50.4	393.1	10.7	16.4	219.2	56.9	4.7	25.6	13.2	9.2	5.5	1.9	58.4	49.1	13.9	70.7	99.6	53.9	9.8	20.5	17.1	19.7	181.2	83.0	20.1	19.3	138.1	188.0	52.0	104.1	22.0	46.2	86.6
KLF4	"EZF, GKLF"	ENSG00000136826	"Kruppel like factor 4"	O43474	9	107484852-107490482	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 254.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1054.7;Basal squamous epithelial cells: 832.1;Distal enterocytes: 789.2;Intestinal goblet cells: 710.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.0;non-classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 39.2;hTCEpi: 84.4;hTERT-HME1: 54.5;OE19: 47.2;U-2197: 111.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002926	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA002926: AB_1852541"	"unprognostic (2.06e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (3.93e-5)"	"unprognostic (2.55e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.13e-2)"	"unprognostic (8.32e-2)"	73.5	23.9	5.1	21.0	4.7	50.5	63.7	4.0	7.8	53.2	4.6	87.3	28.4	16.0	5.6	102.1	43.0	44.3	31.0	3.7	5.1	6.2	12.4	44.8	5.6	5.0	4.7	29.0	7.0	5.7	4.9	32.4	5.0	16.7	96.0	0.8	27.5	7.6	14.2	254.7	40.5	40.6	4.1	24.1	58.0	17.8	6.0	17.0	25.2	23.2	14.5	43.9	58.9	4.0	13.3	3.9	0.6	0.1	16.6	39.2	5.2	4.4	27.6	6.7	8.1	1.0	18.0	0.0	0.6	6.9	23.7	8.7	6.1	3.9	3.0	0.0	2.2	0.0	7.5	0.3	21.6	0.0	0.0	5.0	84.4	14.0	54.5	1.5	0.6	0.2	0.6	0.0	4.1	7.3	0.0	1.4	4.1	47.2	25.2	0.3	1.6	0.2	2.3	3.7	0.4	0.2	4.0	11.8	15.2	12.7	1.3	5.4	3.5	3.6	0.1	111.5	2.1	0.2	0.1	0.0	3.4	2.6	6.8	0.0	0.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	1.0	0.2	0.0	0.1	5.1	4.7	4.0	7.8	3.7	5.1	5.0	4.7	5.0	4.1	6.0	4.0	1054.7	12.8	41.1	0.3	32.2	436.0	284.3	143.0	832.1	0.5	206.7	205.0	70.3	35.8	71.5	1.8	8.4	49.1	15.0	789.2	1.9	24.4	263.1	154.1	216.0	336.6	123.8	4.8	0.0	38.7	75.5	463.2	537.2	297.4	54.7	4.7	216.0	4.6	89.9	0.0	0.2	710.9	83.4	232.9	282.0	163.0	143.8	401.0	206.3	16.9	36.8	2.0	0.0	0.0	0.0	49.3	540.9	60.5	38.3	187.3	198.0	2.1	46.4	2.0	39.5	463.7	130.0	21.6	15.9	639.9	674.0	107.9	26.8	63.5	332.6	236.8
KLF7	UKLF	ENSG00000118263	"Kruppel like factor 7"	O75840	2	207074137-207167267	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 95.2;Oligodendrocytes: 160.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003423, HPA030490"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA003423: , HPA030490: AB_10601922"	"unprognostic (5.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.85e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.75e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (4.26e-4)"	"unprognostic (3.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.47e-2)"	19.9	8.2	8.2	13.8	15.0	40.3	15.0	19.3	9.1	8.9	0.0	11.4	4.6	16.9	5.9	9.7	10.0	11.8	10.1	8.3	13.4	7.9	7.1	15.2	7.7	20.2	17.0	14.2	5.1	3.0	4.9	5.8	20.9	8.2	5.3	4.7	7.4	7.4	4.9	6.8	10.3	20.9	12.1	10.3	9.1	6.8	17.4	14.3	8.8	7.4	7.3	9.8	9.8	20.3	8.8	6.1	16.3	1.1	5.6	14.4	3.4	10.0	8.0	15.3	6.7	0.1	7.1	0.1	6.3	20.6	26.5	21.5	13.9	46.2	8.2	6.0	0.8	0.2	18.5	3.5	9.7	4.6	6.7	19.3	15.3	10.7	35.0	22.0	18.1	4.6	0.0	8.2	11.8	0.2	5.6	1.7	9.7	0.9	3.0	2.4	4.3	6.4	3.7	6.8	25.0	30.5	8.6	12.0	7.8	13.0	2.0	6.9	35.9	30.3	14.5	12.9	12.0	6.2	4.5	0.0	26.7	3.8	6.1	28.9	9.4	12.3	1.6	12.1	0.6	5.7	8.4	1.6	5.3	7.7	14.3	9.9	40.8	22.9	22.7	2.4	7.7	6.1	8.2	15.0	19.3	9.1	8.3	13.4	20.2	17.0	20.9	12.1	17.4	20.3	95.2	41.7	6.7	74.4	15.8	21.9	23.1	35.0	6.2	9.0	9.9	11.4	17.6	14.3	15.1	9.2	12.5	0.5	6.9	0.4	1.9	22.7	10.2	13.9	33.7	65.8	6.0	2.5	46.4	51.5	0.8	22.0	11.7	17.3	12.0	3.6	79.9	14.7	15.6	11.8	31.1	2.6	34.6	50.0	22.9	5.2	13.7	37.6	3.6	61.8	28.3	7.1	8.2	68.9	160.5	79.9	1.4	10.1	4.3	9.2	14.1	4.3	9.8	8.7	46.0	38.6	42.0	0.8	14.8	8.1	15.3	1.1	7.6	7.9	4.3	9.3
KLHL6	FLJ00029	ENSG00000172578	"Kelch like family member 6"	Q8WZ60	3	183487551-183555706	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 31.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 35.7;Endometrial ciliated cells: 28.3;granulocytes: 51.1;Hofbauer cells: 24.1;Macrophages: 33.3;Plasma cells: 63.6;Respiratory ciliated cells: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 41.3;HEL: 26.6;HMC-1: 26.7;U-266/70: 82.1;U-266/84: 45.5;U-698: 121.3"	"Low region specificity"	"Detected in all"							HPA024512	Uncertain		Approved	"Plasma membrane,Microtubules,Mitotic spindle,Centriolar satellite"		Yes	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Centriolar satellite"	"Plasma membrane, Microtubules, Mitotic spindle"	"HPA024512: AB_2131015"	"unprognostic (8.46e-2)"	"unprognostic (3.67e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.03e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (9.62e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.73e-2)"	1.5	0.7	0.7	11.8	0.8	3.5	0.9	1.0	1.0	0.8	0.7	2.5	2.5	0.6	0.2	0.6	4.8	2.1	0.7	0.6	1.4	0.4	1.0	4.2	29.3	2.6	1.4	0.3	0.6	0.2	0.2	1.9	2.0	0.5	2.3	0.1	1.3	0.1	0.2	0.1	4.8	0.7	1.5	6.3	4.1	0.2	3.1	10.0	0.6	0.3	31.0	1.8	0.3	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	21.9	0.0	26.6	0.0	0.0	0.0	7.3	26.7	0.0	0.0	0.0	0.0	0.0	4.6	0.5	0.4	18.4	0.0	0.0	8.8	4.1	0.0	0.0	0.0	14.8	0.1	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	2.5	0.0	0.1	0.0	0.1	82.1	45.5	121.3	0.0	8.0	0.0	7.8	2.8	11.8	0.6	2.2	0.7	3.6	2.4	1.0	2.0	2.4	2.9	1.8	2.4	2.2	2.7	4.6	4.2	2.6	0.7	0.8	1.0	1.0	0.6	1.4	2.6	1.4	2.0	1.5	3.1	3.7	4.0	6.4	6.5	0.7	35.7	1.1	1.7	0.6	0.6	0.6	0.3	0.4	4.8	0.0	5.4	0.0	2.1	0.2	16.6	0.2	0.0	0.1	2.0	28.3	0.5	4.6	0.0	7.6	0.3	0.0	0.3	1.7	2.0	0.8	51.1	8.1	1.1	0.2	24.1	0.0	0.3	0.0	0.0	20.7	22.4	0.8	0.3	33.3	8.8	14.0	10.1	0.3	5.2	1.0	0.3	0.0	0.1	0.0	63.6	1.2	0.0	0.4	24.4	0.7	0.0	1.8	1.5	0.3	0.4	0.1	0.6	0.5	16.8	0.0	0.2	1.2
LFNG	SCDO3	ENSG00000106003	"LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q8NES3	7	2512529-2529177	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 74.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 40.3;Enteroendocrine cells: 87.4;monocytes: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.7;OE19: 46.4;RH-30: 46.0;U-2 OS: 49.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069130	Approved		Approved	"Nuclear membrane,Golgi apparatus"	"Intracellular and membrane"	NA	NA		880000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	"Nuclear membrane"	"HPA069130: AB_2686091"	"unprognostic (4.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.52e-2)"	"prognostic favorable (6.36e-4)"	"unprognostic (1.85e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.15e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.16e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.28e-2)"	16.7	6.5	23.3	17.3	25.9	9.8	13.7	29.3	22.4	9.9	11.1	23.1	15.5	9.4	2.2	11.4	6.1	11.8	13.1	17.4	30.1	9.0	2.5	14.4	18.6	34.1	35.6	1.8	74.4	3.0	3.7	6.5	24.8	17.1	12.0	3.0	33.4	4.6	4.6	58.2	17.2	5.8	25.0	20.9	37.8	4.2	38.1	5.8	6.7	3.6	10.8	12.2	13.8	23.6	1.5	14.3	18.4	2.5	2.0	1.7	1.2	5.4	2.8	4.7	5.9	6.0	37.7	1.1	16.7	14.8	8.1	27.1	2.9	5.1	2.3	8.6	0.6	4.3	7.7	3.2	0.1	6.2	7.7	3.3	12.6	7.8	0.8	3.2	1.9	0.3	0.7	0.2	3.6	34.5	0.1	8.7	22.4	46.4	10.3	1.8	46.0	2.9	1.8	4.5	16.9	4.2	6.2	1.4	0.3	4.7	10.2	7.3	4.5	10.5	49.7	0.4	15.4	0.2	0.0	1.4	11.8	16.4	2.0	6.3	5.3	12.7	1.8	6.9	2.0	1.1	1.7	0.9	2.3	2.0	1.8	1.8	2.8	1.3	6.6	0.6	4.2	1.7	23.3	25.9	29.3	22.4	17.4	30.1	34.1	35.6	24.8	25.0	38.1	23.6	23.3	6.4	6.0	18.9	15.6	6.8	2.5	10.6	3.4	8.5	5.3	12.4	3.6	5.7	2.8	0.0	0.0	0.1	40.3	23.1	0.0	1.2	0.1	2.4	8.5	16.0	87.4	2.7	0.0	6.4	0.3	5.7	30.5	1.2	17.7	0.1	13.9	0.6	7.0	0.0	0.1	34.5	6.1	30.4	13.8	0.5	1.8	30.6	3.6	11.2	38.2	31.3	19.6	1.5	0.1	21.7	3.1	0.0	12.6	2.2	8.8	0.4	1.2	0.8	0.0	0.6	5.0	0.3	3.1	0.6	4.0	0.0	15.9	0.5	15.3	0.7
LIPN	"bA186O14.3, LIPL4"	ENSG00000204020	"Lipase family member N"	Q5VXI9	10	88759982-88779626	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	Ichthyosis	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	9	"skin 1: 26.7"	"Group enriched"	"Detected in some"	4	"Macrophages: 7.5;monocytes: 2.5"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"classical monocyte: 2.9;eosinophil: 10.3;intermediate monocyte: 7.5;neutrophil: 5.4;non-classical monocyte: 8.5"	"Group enriched"	"Detected in many"	8	"granulocytes: 10.3;monocytes: 8.5"	"Cell line enhanced"	"Detected in single"		"HL-60: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted in other tissues"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 61: Skin - Cornification"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"				"unprognostic (2.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.13e-1)"		"unprognostic (2.99e-1)"	"unprognostic (1.08e-1)"		"unprognostic (3.27e-1)"	"unprognostic (1.07e-1)"		"unprognostic (2.03e-2)"		"unprognostic (9.75e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.65e-1)"	1.3	0.3	0.0	2.8	0.0	2.8	1.7	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.4	0.6	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	26.7	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.8	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	2.9	10.3	0.0	7.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	5.4	0.0	8.5	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.0	7.5	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
LITAF	"FLJ38636, PIG7, SIMPLE, TP53I7"	ENSG00000189067	"Lipopolysaccharide induced TNF factor"	Q99732	16	11547722-11636381	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 701.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"neutrophil: 2578.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 2578.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006960	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA006960: AB_1079254"	"unprognostic (2.26e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (4.07e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.60e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.85e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.60e-1)"	139.3	43.7	53.5	165.8	81.9	207.0	95.5	79.6	70.0	121.2	70.5	121.1	46.3	100.5	77.8	62.7	108.2	114.1	63.9	52.2	63.0	182.3	107.7	192.1	112.3	94.0	79.4	67.6	64.6	56.5	39.0	71.3	92.7	105.9	116.1	63.9	116.4	83.4	36.3	71.6	57.9	93.5	77.3	119.6	70.7	10.6	77.6	68.6	116.8	37.6	123.7	214.1	83.1	109.4	79.2	157.8	89.4	43.8	13.9	11.0	90.7	100.2	309.0	93.6	139.1	62.6	206.3	39.9	126.8	86.1	108.7	95.5	40.1	186.4	88.4	304.2	45.8	2.8	117.1	310.3	212.9	12.5	12.9	35.0	320.8	79.6	210.7	84.4	0.3	2.7	25.3	149.5	1.5	75.8	1.8	183.3	146.4	104.0	0.6	12.1	19.6	228.2	79.0	110.4	22.2	68.0	172.9	219.4	183.9	136.3	122.5	66.7	0.8	38.7	65.3	23.0	24.2	59.2	140.6	100.5	45.1	95.8	225.5	508.8	149.5	284.0	459.6	130.2	277.2	174.0	284.0	412.7	178.0	173.9	318.9	381.4	2578.1	274.5	81.9	220.1	350.3	584.9	53.5	81.9	79.6	70.0	52.2	63.0	94.0	79.4	92.7	77.3	77.6	109.4	297.5	44.8	70.0	7.5	176.7	157.4	336.2	365.4	68.3	2.2	180.5	157.6	48.8	148.7	222.2	163.7	0.0	56.4	505.5	305.4	485.2	245.8	2.3	112.2	151.9	76.3	17.5	18.3	1.1	72.9	471.9	156.7	39.8	108.1	214.9	1.1	94.2	52.9	227.8	0.0	1.6	153.1	175.0	156.9	701.0	11.3	56.2	422.0	156.5	7.5	391.8	232.7	433.5	11.6	59.5	123.3	236.1	68.4	186.3	239.8	23.3	104.3	150.3	5.4	52.6	89.6	176.1	0.2	5.4	37.1	132.1	37.1	278.7	16.6	88.9	368.6
LONRF3	"FLJ22612, RNF127"	ENSG00000175556	"LON peptidase N-terminal domain and ring finger 3"	Q496Y0	X	118974614-119018355	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 16.9;Gastric mucus-secreting cells: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 3.8"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 12.2;K-562: 13.8;OE19: 15.2;PC-3: 16.0;SiHa: 14.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050422, HPA061162"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Plasma membrane"	"HPA050422: AB_2681122, HPA061162: AB_2732658"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.01e-2)"	"prognostic unfavorable (4.32e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.31e-3)"	"unprognostic (6.34e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.27e-3)"	3.3	3.3	1.2	1.9	1.1	4.5	1.4	6.6	2.8	1.5	0.0	3.5	2.3	1.9	1.2	1.4	2.0	2.4	2.3	3.3	1.0	2.8	12.7	6.4	0.8	0.9	1.9	1.6	7.0	0.7	0.9	0.8	1.0	1.9	4.3	2.8	4.8	2.4	8.8	0.7	2.0	1.5	1.5	0.6	4.0	1.7	2.0	0.3	8.2	3.9	1.0	3.6	0.7	1.1	5.0	6.9	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	6.0	0.0	3.5	0.0	12.2	0.0	1.3	0.0	0.1	0.1	3.7	6.6	11.8	6.9	3.7	5.7	0.7	0.0	0.0	0.0	0.0	2.1	1.7	0.5	13.8	0.0	0.9	5.5	0.0	2.3	0.0	15.2	16.0	0.0	3.1	0.0	4.2	2.1	0.2	0.0	14.5	0.4	11.8	0.1	0.0	4.5	0.3	0.1	0.2	0.0	7.9	1.4	6.3	0.0	3.2	5.4	3.4	0.0	0.4	0.0	2.4	0.0	3.8	0.0	1.1	0.8	0.0	0.0	0.5	0.8	0.5	0.0	0.0	0.0	0.4	0.3	1.2	1.1	6.6	2.8	3.3	1.0	0.9	1.9	1.0	1.5	2.0	1.1	2.2	6.4	13.4	7.8	0.4	1.5	16.9	0.2	1.8	3.3	0.8	1.9	4.4	0.0	6.1	1.8	0.0	0.5	5.3	11.2	1.9	3.0	1.6	4.4	6.4	3.3	1.2	0.4	1.8	4.3	0.0	8.0	17.3	13.0	6.3	0.1	2.2	4.1	2.7	1.7	6.0	4.6	0.0	4.7	7.7	1.0	0.9	9.5	3.6	9.4	0.5	3.7	2.1	3.5	0.2	5.2	8.8	1.5	1.3	7.2	1.6	1.5	0.3	0.3	0.0	9.9	2.0	2.4	4.6	1.6	0.1	0.4	2.7	0.2	3.7	12.5
LORICRIN	LOR	ENSG00000203782	"Loricrin cornified envelope precursor protein"	P23490	1	153259687-153262124	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Keratinization		"Ichthyosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"skin 1: 1842.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	11	"melanoma: 45.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	92	"HDLM-2: 35.2"									"HPA076123, HPA077266"	Enhanced					NA	NA		1800000		"Cluster 61: Skin - Cornification"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA076123: AB_2732302, HPA077266: AB_2732338"	"unprognostic (1.97e-2)"	"unprognostic (1.93e-2)"			"unprognostic (4.16e-2)"	"prognostic favorable (8.53e-4)"		"unprognostic (1.65e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.41e-1)"			"unprognostic (1.47e-1)"	"unprognostic (3.03e-1)"		"unprognostic (1.02e-2)"	1.1	0.2	0.5	0.2	0.4	0.0	24.2	0.2	0.4	0.8	0.0	0.5	0.0	0.2	0.0	0.7	0.0	0.0	0.7	0.4	0.9	0.2	0.8	0.4	0.1	0.7	0.5	0.5	0.6	0.0	0.2	0.0	0.5	0.2	0.0	0.0	1.7	0.0	10.9	1842.9	0.4	0.0	0.5	0.4	0.3	0.5	1.0	0.6	0.3	0.0	1.8	0.1	21.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.4	0.4	0.9	0.7	0.5	0.5	0.5	1.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LPAR6	"P2RY5, P2Y5"	ENSG00000139679	"Lysophosphatidic acid receptor 6"	P43657	13	48389567-48444704	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Hypotrichosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 266.1;Basal squamous epithelial cells: 327.2;Early spermatids: 334.0;Langerhans cells: 703.7;Late spermatids: 321.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 21.6;HUVEC TERT2: 35.3;MOLT-4: 20.0"	"Low region specificity"	"Detected in all"							HPA028934	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"			"HPA028934: AB_2672833"	"unprognostic (1.19e-1)"	"unprognostic (4.10e-1)"	"unprognostic (8.82e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.57e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (6.22e-4)"	"unprognostic (1.07e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (6.54e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.94e-2)"	41.0	26.5	14.5	26.8	14.7	6.1	43.0	15.2	27.1	41.9	18.3	22.1	15.0	28.7	39.5	81.8	22.2	35.5	24.9	14.0	15.8	26.2	23.2	34.6	45.6	19.0	16.4	14.9	8.7	9.7	15.9	77.7	18.0	60.7	27.6	5.8	59.7	32.2	9.0	33.9	21.7	27.1	18.2	40.2	21.6	8.1	16.7	36.4	24.3	20.8	41.1	40.8	75.1	21.0	0.1	2.1	21.6	0.1	7.0	8.6	0.2	4.5	12.7	0.9	2.5	0.0	6.4	0.0	0.1	4.9	0.0	12.7	0.6	7.2	0.4	0.0	4.3	0.2	0.2	15.9	4.6	0.1	0.1	11.5	12.4	0.5	7.0	0.0	35.3	7.0	0.0	0.3	4.2	0.0	20.0	6.3	8.6	0.4	5.9	16.9	0.0	0.2	5.9	13.1	0.0	0.1	0.0	0.1	4.5	13.2	2.2	0.1	9.1	2.4	0.0	0.2	1.1	0.0	0.0	0.0	0.7	1.1	7.8	1.3	71.9	0.3	24.6	112.0	13.6	1.2	70.0	29.4	26.0	0.5	49.3	15.6	5.9	6.9	103.6	1.1	83.9	58.2	14.5	14.7	15.2	27.1	14.0	15.8	19.0	16.4	18.0	18.2	16.7	21.0	266.1	3.2	9.7	4.9	5.8	120.6	196.3	155.7	327.2	1.7	30.5	30.5	5.8	17.2	76.2	5.5	0.0	0.8	22.2	4.9	0.0	10.4	334.0	10.1	20.7	140.1	21.4	8.8	1.8	4.1	0.8	23.6	16.8	12.8	7.6	5.8	136.0	2.9	82.9	0.0	1.8	4.9	42.7	74.0	703.7	321.7	22.7	111.9	49.8	177.1	76.4	11.3	18.6	5.0	2.0	6.7	4.1	15.8	6.3	107.1	3.0	25.5	49.4	1.5	13.1	5.4	13.3	2.5	1.7	182.7	142.9	0.8	52.3	14.0	9.6	143.5
LRRFIP1	"FLAP-1, FLIIAP1, GCF-2, HUFI-1, TRIP"	ENSG00000124831	"LRR binding FLII interacting protein 1"	Q32MZ4	2	237627587-237813682	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 322.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006979	Approved		Supported	Cytosol		NA	NA		580000	"Cluster 52: Eosinophils - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA006979: AB_1079282"	"unprognostic (2.07e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.50e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.99e-3)"	"unprognostic (8.90e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.07e-2)"	"unprognostic (7.64e-2)"	44.2	21.0	11.3	49.2	9.0	86.8	34.0	3.8	11.0	34.1	23.0	63.2	35.9	64.3	15.7	58.2	32.1	39.4	69.7	11.7	10.8	51.7	48.9	61.7	45.4	7.3	6.9	16.0	21.2	55.1	14.8	41.4	7.0	40.9	40.3	6.4	38.0	31.2	111.0	23.7	35.9	58.8	5.9	45.7	49.6	5.4	9.4	43.5	37.8	50.7	52.6	69.4	43.4	7.3	99.1	50.1	17.5	45.9	25.4	55.6	77.7	67.4	62.3	37.8	37.2	19.2	64.6	8.4	27.4	108.8	81.2	80.9	54.0	100.4	80.2	322.6	34.7	78.0	55.1	54.8	58.5	104.2	71.0	23.9	205.8	88.2	216.0	50.6	59.8	54.0	58.4	77.8	79.5	47.8	60.5	79.5	29.6	73.3	45.1	87.9	125.3	80.1	122.0	141.8	46.3	24.0	33.5	76.2	92.2	37.6	42.9	129.2	99.4	42.4	41.1	49.5	77.0	15.8	14.3	53.2	63.4	102.7	51.0	78.5	104.1	248.4	74.8	97.5	55.1	55.9	89.0	77.3	84.1	60.1	46.1	52.2	326.2	46.9	168.9	73.1	76.7	61.4	11.3	9.0	3.8	11.0	11.7	10.8	7.3	6.9	7.0	5.9	9.4	7.3	236.4	487.2	307.3	35.6	249.6	307.0	391.9	166.0	113.3	46.4	128.6	86.2	160.3	127.2	269.9	172.9	37.5	111.2	347.1	319.5	52.8	229.7	7.9	368.3	88.2	213.0	190.5	62.4	175.9	333.0	359.2	109.1	159.0	426.3	241.0	56.9	122.0	149.1	175.8	21.9	237.5	168.3	79.3	271.2	721.3	7.9	29.8	398.9	167.2	57.1	365.0	25.1	213.1	111.1	12.5	389.6	220.6	23.3	146.6	430.5	152.8	49.5	286.1	6.0	78.9	147.3	182.9	10.1	27.4	179.3	243.1	25.3	288.5	158.3	150.0	588.4
MAP2K1	"MAPKK1, MEK1, PRKMK1"	ENSG00000169032	"Mitogen-activated protein kinase kinase 1"	Q02750	15	66386837-66491544	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cardiomyopathy, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 172.5;Langerhans cells: 265.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003834, HPA026430"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		120000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"		"CAB003834: AB_562310, HPA026430: AB_1853742"	"unprognostic (4.05e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.81e-3)"	"unprognostic (5.78e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.62e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.40e-3)"	57.9	31.0	47.6	38.3	79.7	63.7	32.5	30.2	61.3	31.1	22.5	26.5	19.4	26.3	29.6	51.8	23.7	27.0	40.7	69.4	44.3	31.2	105.3	34.7	49.5	31.6	32.6	25.7	22.4	38.5	26.8	29.6	40.1	26.2	23.6	34.1	29.3	21.8	85.5	23.7	27.0	31.9	35.7	32.6	24.1	15.2	42.8	33.8	22.8	51.3	55.4	31.2	33.7	49.9	105.8	55.3	94.4	39.0	55.3	41.3	53.8	83.6	61.6	76.6	68.1	79.0	82.1	96.8	93.2	59.9	58.2	93.3	88.8	106.4	89.8	79.1	56.8	30.9	50.4	40.7	45.1	41.0	45.3	32.3	64.0	55.9	81.6	81.5	60.7	48.0	54.3	116.7	113.4	40.3	33.5	51.9	47.9	93.9	42.9	39.2	58.1	84.7	74.8	48.5	58.3	31.7	60.8	45.5	63.0	74.9	41.0	33.7	90.8	99.5	63.8	71.1	112.4	74.0	143.1	60.6	105.1	69.9	48.4	3.0	7.5	5.4	6.4	7.7	5.8	2.8	5.6	6.1	7.7	4.6	6.9	4.2	3.5	8.3	7.7	15.1	4.6	2.8	47.6	79.7	30.2	61.3	69.4	44.3	31.6	32.6	40.1	35.7	42.8	49.9	24.5	28.9	24.8	24.2	40.0	82.8	45.9	32.3	21.1	10.0	22.2	10.2	21.5	40.0	24.9	25.8	14.6	48.1	45.0	25.1	46.9	69.4	12.1	16.3	13.9	34.6	21.7	19.0	69.7	23.1	48.8	30.3	17.9	35.4	8.9	19.8	18.9	172.5	51.4	10.1	46.4	15.4	20.3	90.7	265.3	23.6	22.4	115.1	53.4	48.7	87.9	34.9	35.0	28.1	31.7	103.9	23.5	21.8	49.1	87.7	22.2	35.9	17.7	7.8	6.6	16.3	52.4	35.6	42.7	30.3	67.3	51.7	54.0	5.9	19.1	65.4
MAP3K8	"c-COT, COT, EST, ESTF, MEKK8, Tpl-2"	ENSG00000107968	"Mitogen-activated protein kinase kinase kinase 8"	P41279	10	30434021-30461833	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 332.1"	"Cell type enhanced"	"Detected in many"		"Macrophages: 225.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 44.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB005120, HPA017962"	Supported		Supported	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"CAB005120: AB_2140669, HPA017962: AB_1853776"	"unprognostic (1.91e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.07e-1)"	"unprognostic (9.29e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.04e-3)"	"unprognostic (8.23e-2)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (8.76e-7)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.98e-3)"	69.1	18.8	7.2	39.9	5.8	332.1	31.8	5.9	8.0	15.1	22.1	19.6	8.3	18.3	5.9	23.2	38.0	37.4	18.5	6.7	13.5	12.7	16.2	64.5	33.7	10.7	8.1	12.0	7.4	6.9	8.4	46.5	8.8	11.1	16.4	10.9	12.5	11.2	6.6	36.0	21.1	35.6	9.3	41.7	20.3	3.0	15.9	9.3	14.7	6.1	28.8	49.4	20.4	7.9	15.5	13.7	3.6	7.7	18.3	15.4	17.3	3.8	20.3	8.2	9.6	9.4	34.2	10.3	9.2	8.1	8.1	28.2	8.4	3.7	3.0	23.3	4.4	19.2	25.6	30.8	16.0	6.0	44.2	19.5	2.1	7.4	1.6	7.7	3.6	0.2	8.8	14.7	1.4	8.8	0.2	22.3	1.4	8.3	4.9	1.3	3.0	5.8	7.9	30.8	0.3	1.6	13.7	11.3	1.9	10.0	3.7	12.7	0.1	4.8	4.3	18.0	0.6	22.4	22.7	3.2	6.9	25.3	0.2	45.8	14.7	53.1	15.7	26.4	8.7	20.8	3.3	10.3	14.5	38.0	0.2	6.0	35.5	28.3	38.7	30.0	1.0	10.3	7.2	5.8	5.9	8.0	6.7	13.5	10.7	8.1	8.8	9.3	15.9	7.9	51.0	38.5	49.6	11.8	147.3	116.9	50.0	91.1	109.8	19.0	51.7	24.3	10.1	11.5	67.5	3.7	0.0	29.3	203.6	13.6	1.9	31.4	0.5	149.3	51.4	55.7	12.0	21.2	7.7	11.3	86.8	66.2	33.1	205.6	71.1	1.1	25.0	3.1	128.2	0.0	7.1	6.3	83.4	113.8	205.5	1.1	8.4	225.1	42.7	30.9	64.7	6.1	36.0	2.0	0.7	23.4	20.7	4.1	107.8	46.8	3.9	3.5	78.8	1.6	6.6	23.6	62.3	0.3	0.8	129.1	84.8	159.4	97.8	1.5	6.5	195.6
MAPK7	"BMK1, ERK5, PRKM7"	ENSG00000166484	"Mitogen-activated protein kinase 7"	Q13164	17	19377721-19383544	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 43.1;SuSa: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018561, HPA031031"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB018561: AB_2140544, HPA031031: AB_2673706"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (5.67e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	8.3	13.7	4.0	4.0	4.4	5.2	7.7	4.0	5.9	14.3	4.4	10.6	5.5	11.1	3.3	16.3	8.7	4.5	6.2	3.9	4.5	7.7	3.9	8.7	3.7	5.3	6.1	12.5	3.4	2.9	6.1	6.7	4.4	8.9	3.5	2.2	6.7	6.1	5.0	12.5	7.3	6.7	3.3	9.4	6.7	11.8	5.0	3.5	7.4	3.4	3.6	10.1	15.2	4.1	6.9	11.0	9.9	7.7	43.1	17.2	10.4	9.0	8.3	13.0	12.4	12.2	1.4	4.1	7.3	16.5	10.4	8.2	10.4	9.4	7.8	7.2	8.3	1.9	8.4	5.4	21.2	1.9	7.8	21.6	6.2	18.2	7.2	12.0	9.5	7.5	3.7	1.4	13.2	4.8	13.0	7.4	10.7	8.4	6.7	8.6	12.9	3.0	5.4	3.7	4.4	12.3	9.7	1.0	5.0	53.7	6.1	3.1	6.0	14.6	10.8	15.5	6.7	2.6	4.0	1.2	16.5	1.6	9.2	0.8	3.4	10.7	3.7	6.5	2.0	1.8	1.8	3.2	2.3	1.0	1.6	2.0	1.1	4.9	6.0	1.4	1.0	3.1	4.0	4.4	4.0	5.9	3.9	4.5	5.3	6.1	4.4	3.3	5.0	4.1	10.7	6.4	3.3	2.6	7.8	5.5	6.1	9.5	13.6	2.4	5.8	4.6	5.3	2.8	5.6	5.5	2.1	5.7	6.7	16.2	5.9	8.1	8.7	3.0	7.9	8.5	10.7	1.7	2.0	6.2	8.0	9.6	12.2	5.2	2.5	7.7	7.5	1.1	7.7	0.0	2.1	6.9	10.2	6.9	6.1	5.7	11.5	14.4	3.6	6.5	3.4	13.1	17.5	1.0	2.0	8.0	20.8	11.7	9.3	6.3	9.0	3.5	3.2	2.1	26.3	8.4	11.1	33.2	16.4	9.8	4.3	5.1	6.2	7.7	6.7	5.3
MARCHF1	"FLJ20668, MARCH-I, MARCH1, RNF171"	ENSG00000145416	"Membrane associated ring-CH-type finger 1"	Q8TCQ1	4	163524298-164384050	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.6;retina: 27.5"	"Group enriched"	"Detected in some"	4	"B-cells: 21.4;Hofbauer cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	94	"classical monocyte: 41.8;eosinophil: 25.5;intermediate monocyte: 41.0;memory B-cell: 42.3;myeloid DC: 44.2;naive B-cell: 35.8;non-classical monocyte: 45.4;plasmacytoid DC: 16.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 7.1;U-266/70: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014600, HPA048024"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles	"Endoplasmic reticulum, Golgi apparatus"	"HPA014600: AB_1853573, HPA048024: "	"unprognostic (7.29e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.79e-3)"	"unprognostic (9.00e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.91e-2)"	6.4	3.5	7.8	21.5	8.1	3.9	2.7	3.6	7.7	3.1	1.8	3.5	3.9	2.5	0.7	3.0	2.8	5.3	1.7	6.6	10.1	1.8	4.1	8.0	31.6	8.0	8.2	2.7	2.8	0.8	2.5	9.9	6.9	2.3	4.5	27.5	3.2	1.2	1.0	4.5	7.0	6.2	7.0	25.8	3.9	1.7	12.1	5.6	2.1	1.0	25.5	7.7	2.9	14.4	0.6	0.5	2.1	1.2	0.0	0.0	1.3	0.9	0.0	0.0	0.0	1.2	2.4	7.1	2.5	0.0	0.2	1.0	0.0	0.0	0.0	0.8	0.7	5.0	3.0	0.5	0.0	3.1	1.6	0.0	0.0	0.0	0.1	2.8	0.0	1.3	1.9	3.6	2.4	0.7	1.8	1.9	2.6	0.2	0.9	2.0	0.3	0.5	0.1	1.1	1.0	0.9	0.6	1.0	0.4	1.4	2.9	0.5	2.3	0.8	1.4	0.5	1.7	7.0	2.5	1.9	0.9	1.5	1.1	0.0	41.8	25.5	0.1	41.0	0.0	42.3	0.1	0.0	44.2	35.8	0.0	0.0	0.3	0.3	45.4	16.5	0.0	18.4	7.8	8.1	3.6	7.7	6.6	10.1	8.0	8.2	6.9	7.0	12.1	14.4	0.1	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	46.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0
MAT2A	"MATA2, MATII, SAMS2"	ENSG00000168906	"Methionine adenosyltransferase 2A"	P31153	2	85539168-85545281	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 874.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009968, HPA043028"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		1800000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB009968: AB_675710, HPA043028: AB_10960707"	"unprognostic (1.38e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (5.29e-5)"	"unprognostic (9.89e-3)"	"unprognostic (5.90e-3)"	"prognostic unfavorable (4.87e-4)"	"prognostic favorable (8.94e-4)"	"prognostic unfavorable (5.94e-5)"	"unprognostic (4.07e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.77e-2)"	270.4	277.5	184.1	153.2	226.7	98.3	136.1	199.3	235.9	173.0	152.6	193.2	141.4	165.5	236.0	166.2	200.1	209.5	189.6	191.5	207.3	203.6	115.7	168.5	121.8	226.8	219.3	211.0	874.7	165.8	284.1	122.3	208.0	196.2	146.5	248.7	137.7	120.0	278.9	141.1	155.6	127.2	194.4	116.7	225.5	132.3	219.2	102.1	388.8	112.0	127.7	262.9	168.2	289.7	175.3	253.0	290.4	181.6	195.3	236.7	171.1	213.5	195.6	219.3	232.4	208.4	569.9	404.5	137.0	261.0	178.9	264.3	369.6	318.6	279.8	207.0	271.0	242.5	408.7	181.9	355.6	364.3	259.7	215.9	315.8	237.4	164.1	278.1	211.5	230.7	277.9	309.0	505.1	149.5	334.4	398.2	193.5	148.7	320.8	350.3	275.0	264.2	328.9	271.2	227.9	209.6	193.2	183.4	354.6	145.9	156.0	192.3	207.7	267.4	160.9	149.3	260.5	189.0	161.4	290.6	175.0	447.3	143.8	9.1	24.7	8.2	22.3	26.9	32.7	19.8	25.2	23.7	23.6	18.9	23.1	20.5	2.5	27.3	22.3	16.6	24.2	24.9	184.1	226.7	199.3	235.9	191.5	207.3	226.8	219.3	208.0	194.4	219.2	289.7	150.5	48.1	83.6	122.4	104.2	143.5	217.1	47.1	206.1	73.5	116.3	134.6	6.5	82.9	57.6	71.7	68.8	36.2	126.3	60.6	19.6	59.2	75.2	28.8	49.2	83.6	83.3	87.1	56.1	58.5	40.6	121.9	106.0	47.4	84.4	83.3	45.0	44.6	67.4	26.9	60.4	65.1	26.4	118.8	141.9	25.8	72.1	165.7	67.6	26.2	64.6	58.8	27.8	28.6	95.5	53.6	48.0	83.8	78.4	66.7	73.8	138.7	35.2	89.0	111.7	298.5	231.0	54.1	56.2	168.2	118.3	38.2	102.0	51.1	70.6	88.4
MBD2		ENSG00000134046	"Methyl-CpG binding domain protein 2"	Q9UBB5	18	54151606-54224669	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 5.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037282, HPA067582, HPA067615"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB037282: AB_477234, HPA067582: AB_2685866, HPA067615: AB_2685872"	"unprognostic (4.86e-2)"	"unprognostic (7.21e-2)"	"prognostic favorable (6.49e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.04e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.19e-2)"	26.9	10.5	6.5	19.2	8.9	20.3	19.9	9.5	9.4	16.0	6.5	17.3	12.0	11.3	15.8	29.5	11.3	11.5	14.9	6.8	8.9	16.7	16.9	16.4	32.1	7.6	8.3	11.4	17.4	16.5	9.2	18.8	7.7	13.4	16.4	14.3	19.4	15.1	15.4	25.4	15.5	11.9	7.0	21.2	13.9	31.5	7.9	20.1	31.0	16.8	35.2	21.0	20.1	8.2	29.1	13.2	23.2	11.7	27.3	23.0	22.5	26.5	33.9	30.6	26.6	8.5	15.8	68.7	13.1	42.1	13.5	45.1	20.1	36.6	33.4	50.2	11.1	10.2	20.4	18.3	28.2	32.7	17.7	20.2	40.3	23.5	34.1	20.3	35.9	20.7	8.0	62.0	28.0	14.0	33.1	18.1	24.2	11.3	17.2	21.8	13.9	27.9	44.5	29.9	25.6	10.8	21.0	21.1	14.7	30.3	10.9	16.3	31.2	31.1	14.1	10.9	24.4	65.1	38.3	52.5	27.4	27.4	19.0	0.0	1.4	0.7	0.6	2.6	0.9	0.7	0.7	1.0	0.8	1.3	0.3	0.6	1.2	0.2	5.0	0.7	1.5	0.4	6.5	8.9	9.5	9.4	6.8	8.9	7.6	8.3	7.7	7.0	7.9	8.2	71.1	28.9	21.0	30.3	44.9	49.3	37.3	21.2	13.1	19.3	46.0	35.3	35.8	24.3	23.0	33.1	16.7	14.3	57.6	51.2	7.9	26.3	1.9	62.1	48.9	38.0	16.3	22.7	42.5	58.4	49.4	32.7	21.9	103.3	8.2	32.0	32.2	25.2	30.3	21.9	38.3	35.9	10.2	142.6	38.7	4.8	25.1	82.2	26.6	43.1	69.3	45.9	8.2	32.2	49.5	54.3	28.0	26.4	53.7	51.5	35.7	23.5	30.0	27.0	26.3	39.0	35.2	6.5	6.1	54.6	62.5	18.3	47.7	43.0	38.7	79.5
MBOAT4	"FKSG89, GOAT, OACT4"	ENSG00000177669	"Membrane bound O-acyltransferase domain containing 4"	Q96T53	8	30131671-30144665	"Metabolic proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 3.6;stomach 1: 3.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 3.6;Cholangiocytes: 12.8;Ductal cells: 3.1;Enteroendocrine cells: 3.5;Excitatory neurons: 2.4;Inhibitory neurons: 3.1;Oligodendrocyte precursor cells: 3.0;Oligodendrocytes: 5.4"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.7"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Hep G2: 3.1;OE19: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044509			Supported	"Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA044509: AB_2678966"	"unprognostic (4.35e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.85e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.30e-2)"	"unprognostic (7.02e-2)"	"unprognostic (4.24e-6)"	"unprognostic (9.87e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.66e-2)"	0.1	0.5	0.1	0.2	0.1	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	1.7	0.9	0.2	0.1	0.1	0.1	0.4	0.3	0.4	0.1	0.1	0.1	3.6	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.4	3.7	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.1	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.1	0.1	0.1	0.6	0.1	0.4	0.7	0.0	0.4	0.6	0.2	1.0	0.7	1.2	0.8	0.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.1	1.1	0.0	0.0	0.0	3.5	0.0	2.4	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.4	0.0	0.0	0.0	3.1	0.0	0.0	0.6	0.0	0.6	0.0	0.2	0.0	1.0	0.0	0.0	0.0	3.0	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MCL1	"BCL2L3, Mcl-1"	ENSG00000143384	"MCL1 apoptosis regulator, BCL2 family member"	Q07820	1	150560895-150579738	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 685.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 106.3"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"U-698: 4726.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002781, HPA008455, HPA031125, CAB068195"	Enhanced		Enhanced	Mitochondria		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB002781: , CAB068195: AB_2665695, HPA008455: AB_1079334, HPA031125: AB_10602026"	"unprognostic (3.82e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (7.16e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.46e-2)"	297.8	149.2	72.9	264.9	75.0	685.1	175.0	77.0	84.2	143.4	85.0	137.1	99.4	98.5	41.8	199.3	190.7	278.8	139.1	65.3	81.5	125.2	404.6	237.1	161.2	86.4	77.8	105.3	161.7	89.2	82.8	146.9	79.4	96.3	120.1	90.1	124.7	56.4	153.8	189.2	133.6	171.4	80.6	171.5	167.0	41.3	91.4	128.9	133.3	160.1	157.1	302.6	124.6	75.8	140.2	74.8	131.9	73.3	262.9	262.2	175.8	164.8	174.5	173.0	139.4	91.9	112.3	184.9	102.2	120.2	80.3	187.7	101.7	203.3	166.7	154.8	68.3	76.4	109.9	106.2	204.7	130.6	151.3	147.3	221.3	170.6	330.0	159.5	192.7	49.4	168.1	225.3	234.2	160.3	64.6	80.7	242.0	122.9	131.9	94.7	111.1	85.9	195.2	103.7	95.9	134.2	125.6	135.9	232.4	191.2	100.4	195.2	251.6	109.2	119.4	55.5	212.8	310.2	409.5	4726.7	189.5	95.1	141.9	23.3	19.8	51.8	15.0	17.4	17.4	12.6	19.0	16.6	16.6	14.0	22.8	17.6	106.3	10.6	16.2	9.4	30.1	11.2	72.9	75.0	77.0	84.2	65.3	81.5	86.4	77.8	79.4	80.6	91.4	75.8	366.0	198.7	295.5	12.4	339.2	489.2	394.7	142.6	434.2	38.7	339.3	229.9	84.8	228.8	148.8	33.1	60.5	108.6	398.5	491.8	41.1	196.4	209.2	187.5	310.8	241.9	259.6	61.8	6.5	174.7	203.4	278.4	228.3	365.7	343.8	209.0	229.2	218.8	262.7	11.8	5.5	309.0	107.8	453.6	930.9	347.0	72.7	614.2	273.9	30.0	250.6	101.2	94.7	10.1	6.8	183.4	345.1	60.9	831.8	293.4	233.1	68.9	110.3	78.0	78.9	350.3	217.4	47.4	35.4	372.2	572.0	270.4	499.8	126.0	205.7	401.1
MCOLN2	"FLJ36691, TRP-ML2, TRPML2"	ENSG00000153898	"Mucolipin 2"	Q8IZK6	1	84925583-84997113	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Innate immunity, Ion transport, Protein transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.1;lymphoid tissue: 13.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 26.3;dendritic cells: 43.6;Distal enterocytes: 31.4;Early spermatids: 53.1;Langerhans cells: 100.8;monocytes: 32.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 29.7"	"Group enriched"	"Detected in many"	14	"B-cells: 10.3;dendritic cells: 29.7;T-cells: 8.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 21.9;HAP1: 14.7;HDLM-2: 26.9;HEK 293: 13.6;THP-1: 28.5;U-698: 18.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019114	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"			"HPA019114: AB_1853645"	"unprognostic (3.02e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.38e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.12e-4)"	"unprognostic (3.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-2)"	0.7	8.8	0.2	5.3	0.2	2.9	1.0	1.0	0.4	1.1	0.7	10.2	1.7	1.0	4.0	0.7	2.6	1.6	0.4	0.3	0.1	1.1	0.7	5.4	12.9	0.4	0.1	0.5	0.8	1.1	0.6	2.6	0.3	0.7	15.1	0.1	0.8	0.2	0.2	2.1	5.5	0.6	0.1	6.7	2.1	1.5	0.3	2.3	0.5	0.2	13.1	1.6	0.7	0.5	1.5	1.6	0.0	4.0	0.8	0.2	0.3	1.0	5.5	1.6	2.0	0.0	0.1	21.9	0.5	0.0	2.6	0.1	14.7	1.8	1.5	26.9	13.6	1.9	0.4	0.0	1.3	0.0	1.8	0.3	0.0	1.3	1.0	0.1	0.0	5.1	0.0	0.0	0.3	0.5	0.3	0.0	1.6	0.0	2.9	0.0	3.3	0.0	0.1	0.2	0.9	0.0	0.1	0.2	9.2	0.2	2.4	28.5	0.1	1.3	2.1	0.0	4.2	0.0	0.0	18.5	1.2	0.0	4.0	0.1	0.3	0.0	5.9	1.1	2.1	10.3	5.0	8.9	7.1	3.7	0.6	4.5	0.2	0.4	0.2	29.7	0.2	2.6	0.2	0.2	1.0	0.4	0.3	0.1	0.4	0.1	0.3	0.1	0.3	0.5	0.4	0.0	0.6	0.0	26.3	4.5	0.4	0.1	1.2	0.0	1.1	1.8	0.5	0.0	1.3	1.8	0.0	0.1	43.6	31.4	0.0	0.1	53.1	12.3	6.0	0.4	2.4	1.3	0.9	1.4	0.1	1.5	1.5	24.5	0.0	0.1	0.7	0.0	0.7	0.0	0.5	4.5	0.0	1.3	100.8	19.6	0.0	14.4	8.8	2.8	32.3	0.0	1.0	0.0	1.4	0.4	4.7	0.0	13.8	0.6	0.0	2.3	1.5	0.0	0.0	0.7	0.3	1.6	4.3	0.0	3.3	0.3	21.8	1.6	5.4	0.1
MGAT1	"GLCNAC-TI, GLYT1, GNT-1, GnTI, MGAT"	ENSG00000131446	"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase"	P26572	5	180784780-180815652	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 280.2;Syncytiotrophoblasts: 384.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017432	Approved					NA	NA		12000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA017432: AB_1853851"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.39e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (8.65e-4)"	"unprognostic (4.15e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.00e-2)"	130.4	66.7	44.0	65.8	43.8	60.6	113.7	40.7	59.9	70.7	64.6	69.8	50.2	75.2	28.2	103.2	85.8	39.9	103.2	38.4	42.0	63.3	146.9	113.3	68.5	56.7	43.2	75.1	115.3	20.3	61.7	67.3	54.0	75.5	30.1	29.2	82.0	37.1	61.1	73.4	82.2	40.9	47.4	139.9	78.1	36.4	64.9	38.3	96.1	35.6	42.2	85.0	72.3	49.3	58.3	58.2	30.9	66.3	149.6	68.7	111.0	130.1	154.4	77.4	96.7	79.4	45.6	50.2	77.3	122.3	78.2	68.8	17.0	190.8	46.1	271.6	47.6	44.2	34.1	61.7	72.8	40.6	137.6	79.7	91.5	63.1	62.9	53.6	67.9	34.2	26.1	84.7	70.9	78.3	38.9	55.2	29.6	37.5	72.0	46.2	44.5	66.8	30.9	67.3	27.2	32.1	54.6	56.5	115.7	27.2	43.8	68.5	72.9	94.7	44.7	42.7	61.1	165.9	149.2	44.7	77.6	78.9	49.8	93.0	228.6	104.6	83.5	186.7	91.6	48.3	60.2	70.3	161.7	42.0	51.4	59.1	152.2	70.4	149.4	152.9	75.3	235.1	44.0	43.8	40.7	59.9	38.4	42.0	56.7	43.2	54.0	47.4	64.9	49.3	157.8	48.1	31.1	9.8	57.7	61.2	44.6	52.8	50.1	20.7	41.5	29.7	18.4	44.3	32.7	29.5	56.3	94.9	114.7	43.8	37.2	49.0	31.7	26.2	34.2	94.2	49.8	47.6	7.5	79.0	280.2	80.5	33.6	48.7	30.4	27.2	125.7	88.1	200.5	63.9	8.5	54.9	20.3	195.5	142.1	43.2	62.7	234.9	81.8	26.2	112.1	18.9	87.6	8.0	14.6	54.0	34.7	76.0	169.7	76.9	57.2	22.5	20.4	78.8	32.9	72.1	51.5	26.8	22.5	46.8	63.9	384.9	59.3	43.7	36.7	56.8
MIS18BP1	"C14orf106, FLJ11186, KIAA1903, KNL2, M18BP1"	ENSG00000129534	"MIS18 binding protein 1"	Q6P0N0	14	45203190-45253540	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 40.7"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 145.1;monocytes: 150.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA006504	Approved		Approved	Nucleoli,Cytosol		NA	Yes			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoli	Cytosol	"HPA006504: AB_1078317"	"unprognostic (2.12e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (3.83e-4)"	"unprognostic (4.18e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.32e-3)"	"unprognostic (3.31e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.21e-1)"	8.6	3.7	1.5	14.1	1.4	40.7	10.7	0.9	1.6	7.3	1.1	8.0	8.4	10.2	5.3	7.1	6.7	7.7	3.8	1.4	1.7	3.7	4.1	9.5	23.2	2.1	1.9	12.2	4.6	2.3	1.3	10.6	2.4	6.3	10.1	1.2	6.7	5.8	1.3	8.6	9.6	9.6	1.9	15.2	8.5	13.5	1.5	24.4	6.8	3.8	21.7	7.8	3.9	2.8	54.1	20.0	40.7	18.0	12.1	17.2	30.0	36.4	19.2	29.7	36.5	10.7	50.7	73.6	15.5	18.5	12.8	37.0	23.9	18.5	55.3	39.5	15.3	44.5	23.2	13.8	8.1	103.7	39.7	12.5	7.4	17.6	16.5	19.4	36.7	14.1	19.7	17.2	29.1	19.9	44.1	45.9	30.8	26.5	24.9	51.5	16.4	28.5	15.3	22.3	28.4	12.3	16.2	24.6	13.1	24.1	29.5	58.1	20.4	15.7	47.4	19.5	16.6	15.3	21.5	34.5	8.8	42.6	22.8	64.5	28.8	35.8	7.9	28.5	8.5	28.5	7.5	6.8	21.5	25.5	5.0	5.1	17.8	10.8	53.8	31.0	10.9	9.1	1.5	1.4	0.9	1.6	1.4	1.7	2.1	1.9	2.4	1.9	1.5	2.8	54.6	25.6	27.8	6.8	87.7	20.1	11.6	17.7	19.4	8.4	24.3	27.3	13.3	7.2	26.1	9.2	16.7	40.9	91.6	17.1	5.9	14.0	3.5	29.2	47.6	43.5	27.6	72.6	34.5	11.1	42.5	32.5	35.7	28.0	43.6	145.1	30.4	7.3	35.4	0.0	7.6	25.8	18.3	89.8	30.9	6.8	55.3	115.7	5.4	74.0	150.1	5.1	55.6	9.5	11.1	13.5	47.7	60.5	73.5	25.0	12.1	5.0	20.9	7.6	0.0	13.9	23.3	80.0	105.4	32.5	26.3	19.4	54.5	77.9	29.9	24.6
MMP19	"MMP18, RASI-1"	ENSG00000123342	"Matrix metallopeptidase 19"	Q99542	12	55835433-55842966	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins"	"Angiogenesis, Collagen degradation, Differentiation"	"Developmental protein, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 58.5"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 54.4;Fibroblasts: 52.8;Hofbauer cells: 30.8;Kupffer cells: 35.7;Langerhans cells: 100.7;Macrophages: 61.2"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"thalamus: 1.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"BEWO: 75.6"	"Region enriched"	"Detected in many"	5	"olfactory bulb: 7.2"	"Low region specificity"	"Detected in all"			HPA070804			Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA		2100000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum, Vesicles"		"HPA070804: AB_2686315"	"unprognostic (2.61e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.77e-3)"	"unprognostic (2.01e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (8.56e-9)"	"unprognostic (5.06e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.73e-2)"	"unprognostic (4.00e-2)"	58.5	3.6	0.0	11.4	0.1	0.7	18.3	0.0	0.3	10.4	0.5	7.3	1.2	20.7	0.5	2.3	17.2	25.6	8.8	0.1	0.1	5.7	2.7	25.4	2.8	0.1	0.1	11.9	7.2	0.5	0.8	10.8	0.2	3.3	3.3	0.1	3.1	2.3	0.9	5.5	8.7	8.7	0.1	27.4	9.6	0.4	1.3	2.9	4.4	0.6	6.9	9.6	6.2	0.1	1.5	0.0	0.2	0.0	7.8	12.4	75.6	10.1	10.6	3.9	4.4	0.6	0.6	0.0	0.0	12.8	0.3	0.0	0.0	3.0	4.0	0.8	0.0	0.0	0.3	0.1	6.5	0.0	0.6	12.1	0.4	1.9	2.4	6.2	0.7	0.0	0.2	0.1	11.2	0.0	0.0	0.2	0.3	0.0	0.2	0.0	2.8	0.0	1.7	4.7	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.2	15.7	2.2	5.0	0.2	0.3	0.1	0.0	0.0	8.4	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.2	0.1	1.3	0.1	2.8	0.0	4.6	0.7	1.3	7.1	0.3	1.9	0.6	0.4	0.3	0.3	0.7	11.5	3.3	0.0	4.2	18.6	0.7	0.0	0.0	0.3	0.5	2.4	20.8	1.5	0.0	0.0	0.2	0.5	54.4	52.8	1.1	1.7	2.5	0.4	3.6	0.7	30.8	0.0	0.2	0.1	0.0	35.7	100.7	0.9	5.9	61.2	12.4	1.9	22.5	0.4	0.0	0.0	0.3	0.1	0.0	5.3	1.0	0.3	0.0	0.1	1.5	1.7	0.0	3.8	7.6	0.2	0.2	1.0	4.3	18.7	0.9	0.2	0.0	0.4
MOB3A	"MOB-LAK, MOB1C, MOBKL2A, moblak"	ENSG00000172081	"MOB kinase activator 3A"	Q96BX8	19	2071036-2096673	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 74.4;Langerhans cells: 91.3;monocytes: 81.1;NK-cells: 77.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057744			Uncertain	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Intermediate filaments, Cytosol"		"HPA057744: "	"unprognostic (2.05e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.33e-6)"	"unprognostic (3.40e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.12e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.16e-2)"	"unprognostic (7.74e-3)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (5.90e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.18e-1)"	24.8	15.3	19.8	49.7	19.3	53.7	20.9	19.5	45.6	25.4	21.9	36.0	12.9	32.3	9.4	22.4	27.4	17.5	14.8	19.7	19.4	15.8	9.7	25.1	73.3	26.8	21.3	20.4	13.6	8.7	12.2	15.8	22.8	25.9	15.0	6.7	17.1	20.1	14.0	21.1	31.7	28.6	20.2	60.4	20.4	8.8	24.8	34.9	16.0	14.4	65.7	27.1	22.9	21.2	45.6	18.4	21.5	20.6	49.7	54.7	16.7	28.1	17.7	18.7	14.9	7.4	16.1	116.4	10.1	48.8	15.2	18.9	12.0	62.2	15.0	41.2	6.2	25.3	12.3	10.1	49.2	40.0	125.7	32.4	40.4	51.5	21.7	21.6	35.5	22.1	13.4	113.4	27.6	18.1	20.9	40.6	6.6	5.5	13.1	12.6	6.4	91.2	23.5	11.3	13.7	18.3	14.3	14.9	15.9	15.9	16.0	64.3	60.8	22.6	12.4	42.5	16.9	22.1	86.8	90.4	61.0	26.7	27.7	80.8	87.0	100.7	62.3	83.8	52.9	43.6	45.8	51.9	58.7	39.1	34.1	44.1	274.5	54.2	96.3	33.4	60.3	85.6	19.8	19.3	19.5	45.6	19.7	19.4	26.8	21.3	22.8	20.2	24.8	21.2	8.6	3.2	4.5	8.8	50.6	15.0	10.9	11.7	8.6	3.7	9.4	7.4	3.7	4.3	9.7	11.0	20.9	11.1	50.8	18.9	3.9	10.8	1.6	6.1	12.7	11.7	14.9	11.8	6.5	9.5	53.5	12.0	8.2	9.6	27.9	8.1	18.5	4.7	33.3	1.7	5.8	12.2	14.2	74.4	91.3	4.8	18.3	50.1	16.0	6.5	81.1	6.9	77.2	4.0	6.0	10.1	12.6	17.0	38.0	11.9	16.0	9.0	10.1	6.6	6.6	10.5	11.2	9.4	6.6	7.2	15.9	27.5	37.3	7.7	9.5	10.8
NAMPT	"PBEF, PBEF1"	ENSG00000105835	"Nicotinamide phosphoribosyltransferase"	P43490	7	106248298-106285966	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Biological rhythms, Pyridine nucleotide biosynthesis"	"Cytokine, Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 580.0;Langerhans cells: 1123.7;Macrophages: 947.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	7	"neutrophil: 279.2"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 279.2"	"Cell line enhanced"	"Detected in all"		"HHSteC: 387.5;U-87 MG: 434.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034349, HPA047776, HPA057722"	Approved		Approved	"Nuclear speckles,Cell Junctions"	"Secreted to blood"	NA	NA	2140000	1400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"	"Cell Junctions"	"CAB034349: AB_2251220, HPA047776: AB_2680151, HPA057722: "	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (8.81e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (6.83e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.44e-3)"	308.5	74.2	14.4	360.5	15.6	312.5	103.3	15.2	35.4	47.3	21.7	62.5	38.5	38.6	6.9	228.2	107.6	113.7	103.1	15.2	20.9	82.9	317.9	218.5	23.2	75.7	24.9	58.4	80.9	25.9	30.1	87.3	30.3	70.1	30.3	17.2	126.0	13.4	135.9	54.1	55.9	48.0	21.3	88.2	102.4	11.7	46.3	15.6	42.2	44.4	39.9	283.3	86.7	21.5	103.6	41.0	14.6	16.8	85.8	95.0	34.4	26.1	194.7	57.0	90.6	25.7	38.7	77.7	78.8	32.1	131.5	58.2	38.8	88.1	93.8	50.5	51.7	35.8	17.2	22.6	387.5	61.3	49.4	94.8	94.2	114.9	115.0	70.6	187.3	32.0	70.5	225.6	68.1	49.4	58.1	19.4	36.6	33.6	59.7	25.8	30.4	147.6	46.2	60.8	33.4	19.3	46.0	61.1	107.9	43.0	25.4	9.4	168.2	75.6	52.9	105.9	51.9	212.1	142.7	115.7	434.3	69.3	105.6	39.6	6.5	16.0	1.8	21.8	2.4	3.9	2.2	2.7	7.0	3.4	2.8	2.2	279.2	4.4	30.5	5.5	7.1	4.8	14.4	15.6	15.2	35.4	15.2	20.9	75.7	24.9	30.3	21.3	46.3	21.5	323.8	131.4	245.7	12.1	78.0	207.6	321.0	105.7	169.0	23.8	184.2	132.0	94.8	197.3	161.4	42.3	12.5	26.2	67.5	105.8	46.9	320.6	12.2	128.0	160.8	192.8	25.1	29.5	25.3	141.3	58.9	239.6	132.0	296.5	188.4	18.8	159.5	580.0	107.0	40.4	28.8	51.9	63.1	390.3	1123.7	6.9	40.4	947.3	161.9	46.9	102.7	22.6	9.2	12.1	22.4	138.1	49.7	31.2	93.7	364.0	112.8	50.7	94.1	30.8	26.3	264.6	185.6	30.5	65.8	98.3	207.8	25.3	110.3	38.4	79.4	334.5
NBN	"AT-V1, AT-V2, ATV, NBS, NBS1"	ENSG00000104320	Nibrin	O60934	8	89933331-90003228	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 265.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001429, CAB003836"	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Nucleoplasm	"CAB003836: AB_562172, HPA001429: AB_1854460"	"unprognostic (1.52e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.32e-3)"	"unprognostic (7.46e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (5.46e-5)"	"unprognostic (5.05e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.15e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.03e-1)"	22.5	12.4	9.2	27.8	12.8	54.0	25.4	9.3	10.0	16.9	7.4	18.3	15.1	22.3	11.4	20.0	14.5	22.5	12.1	10.2	12.5	20.7	22.3	18.1	24.3	10.7	8.6	16.9	15.5	15.4	9.0	14.1	9.9	17.5	22.5	9.8	16.6	14.9	10.0	10.3	16.0	24.2	11.0	23.4	12.7	16.4	11.0	19.0	22.7	16.2	26.4	21.8	9.6	15.0	54.8	30.1	29.3	15.6	16.5	38.7	18.9	37.9	49.5	46.6	50.8	17.2	41.8	83.8	42.2	35.5	19.1	17.7	35.7	35.7	59.8	38.0	19.7	67.7	16.8	23.6	30.8	40.0	35.2	30.5	18.3	27.2	57.9	22.8	39.5	33.9	50.6	46.6	55.3	46.9	65.6	26.0	8.5	39.5	31.4	42.3	25.3	47.0	62.8	73.8	8.1	26.6	23.5	265.1	23.1	16.3	49.8	31.4	29.2	40.9	28.0	25.5	38.0	21.2	25.0	45.5	41.3	39.4	39.1	32.4	17.7	32.9	11.9	19.7	12.7	15.2	8.5	8.8	18.9	8.9	8.1	9.0	34.4	16.1	31.5	10.4	5.9	13.1	9.2	12.8	9.3	10.0	10.2	12.5	10.7	8.6	9.9	11.0	11.0	15.0	36.9	48.1	14.2	24.5	39.8	11.9	13.5	20.4	23.9	25.4	29.7	22.9	30.3	14.3	33.7	27.6	2.1	23.0	29.3	11.2	43.0	35.1	17.6	45.4	46.9	22.9	12.1	31.7	45.0	32.0	19.7	36.3	19.9	31.2	79.7	38.3	18.9	30.6	25.9	13.5	39.9	16.9	16.2	29.2	27.1	7.2	19.0	51.1	12.4	32.8	54.7	29.4	36.0	40.7	40.3	24.7	9.9	26.4	38.8	11.6	9.9	40.5	36.4	11.2	6.6	50.3	31.7	20.2	46.0	31.5	13.5	10.8	35.3	68.7	19.4	11.0
NBPF9	AE01	ENSG00000269713	"NBPF member 9"	P0DPF3	1	149054027-149103561	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Hepatocytes: 28.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 49.5"	"Group enriched"	"Detected in all"	4	"granulocytes: 49.5;monocytes: 14.2"	"Low cell line specificity"	"Detected in all"											"HPA038748, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050"	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	Cytosol	Microtubules	"HPA038748: AB_2676188, HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: "	"unprognostic (1.25e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.90e-2)"	"unprognostic (9.42e-6)"	"unprognostic (6.23e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.63e-3)"	"unprognostic (8.80e-2)"	15.8	10.5	8.8	11.5	8.6	8.9	13.7	17.3	9.1	16.6	11.4	14.4	6.4	14.2	17.0	9.6	14.6	9.5	10.0	9.0	8.9	11.5	33.8	17.2	13.6	9.6	10.2	14.9	18.6	9.6	13.8	7.5	8.7	12.8	9.0	21.4	10.2	7.2	6.8	12.8	15.2	11.5	7.5	15.5	13.2	10.7	10.6	4.0	25.9	2.6	10.7	12.4	12.5	8.1	50.1	21.4	26.2	35.5	23.0	28.1	20.7	44.7	32.5	23.1	25.0	16.2	21.0	11.9	12.1	23.1	27.8	14.7	18.2	20.9	39.4	30.2	19.1	3.8	41.2	9.7	26.7	5.0	13.8	27.8	15.4	25.4	44.1	42.7	20.5	9.0	14.1	30.1	28.4	38.8	1.4	7.4	9.8	8.8	28.8	13.5	16.3	18.0	18.8	22.9	16.9	34.9	14.8	35.7	19.5	16.0	26.5	9.3	48.6	52.0	15.2	38.2	69.8	36.7	20.8	23.0	18.9	3.2	18.6	49.5	14.2	0.6	0.6	5.1	1.0	2.7	1.8	0.6	1.9	5.5	2.5	1.4	8.2	7.8	2.0	7.7	2.5	1.4	8.8	8.6	17.3	9.1	9.0	8.9	9.6	10.2	8.7	7.5	10.6	8.1	2.5	38.5	16.0	8.5	9.0	5.5	8.7	2.6	2.8	4.8	4.7	2.8	4.2	4.3	12.5	5.5	6.2	2.9	7.2	0.8	0.0	3.4	11.1	8.6	8.7	5.3	1.8	2.1	8.5	2.0	4.0	12.4	4.1	8.8	18.9	7.3	2.2	28.2	3.6	0.0	6.2	1.0	4.1	12.1	17.0	3.8	7.2	12.7	3.6	6.5	14.3	3.7	3.1	7.5	3.2	2.9	7.7	4.1	9.8	3.6	1.6	1.0	6.8	12.0	6.6	7.0	5.2	9.9	4.2	5.9	14.2	1.4	6.3	3.8	1.1	5.9
NDEL1	"MITAP1, NDE1L1, NDE2, NUDEL"	ENSG00000166579	"NudE neurodevelopment protein 1 like 1"	Q9GZM8	17	8413131-8490411	"Predicted intracellular proteins"	"Differentiation, Neurogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 134.5;Suprabasal keratinocytes: 136.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"granulocytes: 175.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017916	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"			"HPA017916: AB_1854337"	"unprognostic (6.34e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.35e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.70e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.77e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.95e-3)"	"unprognostic (4.66e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.73e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.63e-3)"	42.8	60.3	18.2	37.0	23.1	109.8	33.2	19.4	26.2	36.6	17.6	30.9	18.4	29.2	20.3	54.7	32.1	40.7	30.0	23.8	20.9	19.8	43.9	44.4	23.2	18.0	19.2	46.6	27.8	18.0	35.0	39.9	20.9	25.5	23.1	25.3	32.5	22.3	43.6	91.3	24.8	26.7	15.3	29.0	25.8	26.4	20.6	24.4	23.2	31.1	26.8	37.8	39.8	23.5	41.9	36.6	34.2	29.4	50.9	61.9	28.1	87.2	72.6	61.4	64.0	32.0	22.2	24.0	28.9	97.1	34.8	47.7	30.9	34.6	62.9	40.1	50.1	48.0	59.8	38.7	54.5	18.4	98.4	41.2	66.7	52.8	60.0	44.7	49.8	37.0	29.0	27.6	54.1	17.9	27.2	15.7	14.9	26.2	20.4	28.2	26.9	19.8	27.7	23.6	16.2	17.8	52.9	25.4	29.4	36.0	17.3	12.6	65.6	48.7	18.4	45.4	48.4	19.3	42.5	19.3	61.0	27.4	50.3	85.5	28.3	98.2	35.1	27.6	37.0	25.5	31.3	34.8	23.9	26.1	30.4	27.9	175.0	32.8	24.7	20.6	36.5	36.3	18.2	23.1	19.4	26.2	23.8	20.9	18.0	19.2	20.9	15.3	20.6	23.5	48.4	12.8	20.9	12.1	33.8	79.0	55.3	18.3	27.3	13.9	24.1	20.4	17.5	12.8	18.1	12.9	20.9	18.9	39.7	36.8	9.8	13.6	86.8	34.8	21.5	26.4	4.2	37.5	27.0	12.2	37.1	26.4	47.9	63.5	80.5	13.3	18.5	12.8	14.1	8.4	22.0	37.1	20.3	13.2	74.0	134.5	12.8	40.8	32.0	18.7	13.2	8.8	19.6	14.6	19.6	24.0	42.6	14.7	38.2	36.0	21.8	5.8	11.3	14.1	6.6	24.7	40.1	8.3	10.0	25.0	136.7	57.3	40.1	11.8	17.6	73.4
NFATC1	"NF-ATC, NFAT2, NFATc"	ENSG00000131196	"Nuclear factor of activated T cells 1"	O95644	18	79395856-79529325	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 50.4;Skeletal myocytes: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004513, HPA071732"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nuclear bodies"	Nucleoplasm	"CAB004513: AB_628011, HPA071732: AB_2686439"	"unprognostic (3.53e-2)"	"unprognostic (2.16e-3)"	"unprognostic (3.08e-3)"	"unprognostic (3.40e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.85e-3)"	"unprognostic (7.02e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.54e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.11e-3)"	12.8	4.6	4.8	11.7	6.0	3.9	10.6	5.6	4.1	6.0	27.9	10.1	3.0	7.7	0.9	3.0	8.0	10.0	15.5	4.3	5.4	4.8	2.7	13.6	21.2	8.3	7.2	7.2	7.0	4.1	3.4	4.1	6.4	6.4	1.5	0.5	6.4	2.9	32.7	10.6	13.2	3.2	7.5	18.7	5.4	8.5	7.2	8.3	7.7	9.3	13.5	7.1	6.1	6.4	0.0	4.0	1.9	3.6	3.3	3.6	6.9	2.4	0.3	0.6	0.3	0.3	3.6	22.0	1.5	3.2	5.6	0.4	9.9	0.0	0.8	15.3	8.0	15.4	0.9	0.1	7.3	4.9	8.2	4.3	0.0	1.2	0.1	0.0	12.2	9.0	12.5	4.5	2.4	8.4	12.8	1.7	3.5	2.9	2.6	4.0	2.5	5.0	1.8	1.6	0.0	0.0	3.2	2.6	5.6	4.2	3.2	19.7	11.4	5.0	20.9	0.0	0.3	0.1	0.1	60.2	0.0	6.6	9.3	1.8	3.4	7.5	4.0	9.1	4.2	7.6	6.2	5.5	3.1	10.0	5.2	3.7	2.9	2.1	13.6	3.0	5.0	4.7	4.8	6.0	5.6	4.1	4.3	5.4	8.3	7.2	6.4	7.5	7.2	6.4	19.4	0.0	6.0	13.4	50.4	37.2	30.0	7.0	6.2	0.1	19.2	13.5	8.4	5.7	8.1	0.0	0.0	0.3	11.8	0.1	0.0	5.7	12.1	10.6	5.4	25.2	0.0	5.9	0.2	4.0	7.2	24.3	8.6	16.1	31.8	1.2	39.3	0.6	12.3	0.0	0.2	0.0	2.0	12.6	35.4	20.3	8.4	21.9	10.6	9.4	6.9	2.5	13.4	4.0	1.3	4.9	0.0	9.8	8.9	12.0	0.0	0.5	4.4	0.1	0.0	52.1	14.2	11.4	13.2	1.5	29.7	0.5	29.4	2.1	0.1	7.7
NFE2L2	NRF2	ENSG00000116044	"Nuclear factor, erythroid 2 like 2"	Q16236	2	177227595-177392697	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002990, CAB020317, HPA043438"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB020317: , HPA002990: AB_1079476, HPA043438: AB_2678482"	"unprognostic (2.11e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.90e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.48e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.83e-1)"	"prognostic favorable (2.26e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.77e-3)"	87.0	73.6	64.8	65.4	83.9	58.9	78.3	74.9	86.7	83.2	78.7	83.4	100.1	92.6	97.2	257.0	88.5	97.7	77.6	66.5	71.6	143.5	176.6	88.5	50.4	82.0	77.5	137.3	47.3	60.4	58.4	80.4	84.5	72.7	85.8	68.2	79.7	90.5	64.4	162.3	82.9	91.8	70.4	69.0	176.9	65.2	75.7	68.2	130.4	65.9	93.8	160.7	108.7	91.8	53.1	57.3	52.2	56.4	181.4	190.2	61.7	91.8	124.9	81.4	90.5	75.9	97.9	52.8	93.8	102.8	148.4	96.9	65.1	136.7	111.5	40.8	41.1	65.9	95.9	156.3	231.2	39.3	60.6	134.0	314.5	115.5	169.3	184.4	80.9	39.7	72.7	91.4	111.8	49.8	42.3	101.9	58.8	277.2	58.9	34.0	46.5	54.6	120.9	182.1	69.0	45.0	202.9	64.8	216.6	147.8	49.1	105.0	119.9	80.4	54.5	89.5	54.7	70.1	44.7	43.1	81.6	43.3	159.4	130.6	89.3	55.4	55.2	84.3	62.9	61.8	64.0	57.0	100.4	51.9	101.2	66.8	103.2	68.1	83.0	38.8	66.6	66.0	64.8	83.9	74.9	86.7	66.5	71.6	82.0	77.5	84.5	70.4	75.7	91.8	193.3	157.0	93.5	66.3	143.3	295.8	241.8	448.4	306.7	61.3	90.0	113.7	67.9	117.2	247.0	154.5	16.7	113.2	249.1	120.7	393.2	154.5	81.4	238.1	126.9	139.6	75.6	58.0	25.3	170.8	34.5	206.6	170.7	279.9	212.7	141.5	120.0	93.2	88.1	57.2	26.6	73.5	321.4	111.6	569.9	39.0	287.7	266.0	96.0	88.1	170.6	191.4	55.6	63.8	113.0	128.3	91.8	214.0	118.8	150.5	94.9	85.0	205.9	48.4	39.5	211.8	152.4	66.1	32.1	617.9	315.4	186.2	150.6	153.5	119.6	225.2
NFIL3	"E4BP4, IL3BP1, NF-IL3A, NFIL3A"	ENSG00000165030	"Nuclear factor, interleukin 3 regulated"	Q16649	9	91409045-91423832	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 122.0;Endometrial stromal cells: 127.4;Glandular and luminal cells: 152.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 57.9;neutrophil: 26.9"	"Lineage enriched"	"Detected in many"	35	"granulocytes: 57.9"	"Cell line enhanced"	"Detected in all"		"ASC diff: 152.6;HDLM-2: 179.1;hTCEpi: 141.2;hTERT-HME1: 149.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003261	Approved		Approved	"Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nuclear bodies"		"HPA003261: AB_1079477"	"unprognostic (2.18e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (3.23e-6)"	"unprognostic (5.44e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.37e-2)"	149.8	84.1	11.1	37.5	12.1	211.2	80.2	16.5	17.0	75.6	14.0	55.3	18.1	62.0	15.0	22.9	94.0	47.5	60.9	11.9	13.8	36.2	121.6	68.7	9.4	15.7	14.6	92.6	30.3	15.9	31.6	47.4	14.7	59.9	21.8	33.6	22.9	16.4	133.5	59.5	29.3	52.5	13.2	20.0	44.1	18.5	13.7	18.2	26.7	24.9	11.6	61.2	64.9	12.9	18.3	10.7	12.8	7.1	152.6	117.9	62.1	21.3	61.1	23.8	35.8	7.4	8.9	7.9	12.9	17.8	69.5	11.7	14.9	21.4	27.1	179.1	6.4	8.7	10.2	62.2	124.4	12.1	50.8	120.3	141.2	21.5	149.2	13.5	10.8	20.2	14.3	89.6	15.8	9.2	1.3	16.1	9.8	31.3	9.7	29.3	13.9	11.7	29.5	8.7	16.0	11.8	14.9	13.2	21.5	22.6	7.4	15.8	11.6	52.0	11.5	45.2	10.9	76.3	18.9	3.5	27.8	11.3	9.4	57.9	1.6	10.3	1.2	0.7	0.6	0.4	0.0	0.3	0.9	0.1	0.1	0.2	26.9	0.1	1.0	0.6	0.0	0.6	11.1	12.1	16.5	17.0	11.9	13.8	15.7	14.6	14.7	13.2	13.7	12.9	60.1	22.4	32.4	1.3	7.8	46.1	14.7	15.2	22.2	17.7	31.7	28.6	81.8	8.6	16.4	0.0	16.7	9.6	75.6	23.7	9.8	10.5	24.1	122.0	127.4	34.3	16.1	1.3	5.1	9.8	24.9	55.0	9.7	152.6	9.5	27.5	13.9	29.4	10.6	20.2	5.6	9.5	6.1	25.3	78.0	6.4	10.8	75.4	33.8	2.8	15.4	17.8	6.2	3.5	2.9	7.8	9.1	11.7	24.3	25.6	17.7	10.0	10.3	15.5	6.6	60.2	83.8	0.8	3.9	23.3	39.5	23.1	22.6	6.8	9.6	13.1
NFKB1	"KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50"	ENSG00000109320	"Nuclear factor kappa B subunit 1"	P19838	4	102501331-102617302	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 610.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004031, HPA027305"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB004031: AB_330564, HPA027305: AB_1854429"	"unprognostic (1.06e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.03e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.76e-4)"	"unprognostic (1.84e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.92e-3)"	26.7	16.2	3.9	30.3	7.0	34.6	19.8	6.5	5.7	22.0	5.5	20.4	15.2	18.9	2.7	23.0	19.1	20.8	15.8	4.2	5.8	17.4	16.4	25.0	33.1	7.6	6.1	18.8	16.0	11.7	7.7	21.2	7.8	17.3	19.6	4.9	18.9	17.8	20.9	23.7	20.3	17.0	5.6	23.0	17.5	7.6	6.4	37.0	16.3	10.7	35.1	48.5	19.9	10.1	36.8	19.2	11.2	13.6	27.0	28.5	10.9	20.0	64.2	27.7	27.1	21.5	40.8	58.0	17.6	32.6	39.4	29.5	22.0	34.5	35.2	53.6	10.8	22.7	14.5	15.0	20.0	44.3	44.3	19.7	20.2	22.0	34.4	15.0	34.5	18.1	25.8	34.1	17.6	17.7	4.1	9.1	5.0	24.3	15.4	33.4	25.9	24.0	15.3	38.8	7.1	11.8	38.3	37.2	16.3	8.3	8.6	24.2	40.5	32.5	16.6	14.5	26.4	17.0	13.3	52.0	20.8	19.4	44.1	0.0	2.1	2.6	0.9	3.0	1.9	1.9	3.0	1.6	4.8	1.7	4.5	3.2	1.9	3.7	3.1	1.5	0.8	1.6	3.9	7.0	6.5	5.7	4.2	5.8	7.6	6.1	7.8	5.6	6.4	10.1	32.5	41.7	49.4	42.1	90.0	165.4	91.5	57.1	31.3	6.6	41.5	32.6	19.1	24.3	40.8	20.2	6.2	14.4	119.6	41.1	3.9	28.5	7.6	82.5	62.0	47.6	33.6	13.0	78.4	37.3	16.9	63.1	29.6	207.0	111.1	19.8	23.9	23.9	24.8	20.2	77.2	43.2	18.3	56.2	610.3	2.4	23.9	178.3	55.2	59.0	207.9	9.5	23.7	66.9	127.4	46.3	27.1	34.6	56.3	78.5	21.1	24.4	31.5	6.7	0.0	73.7	41.2	2.5	8.1	35.3	150.3	14.2	88.2	16.7	35.4	90.2
NFKB2	"LYT-10, NF-kB2, p105, p49/p100, p52"	ENSG00000077150	"Nuclear factor kappa B subunit 2"	Q00653	10	102394110-102402524	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 168.0;Karpas-707: 157.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008422, CAB022098, HPA023900"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol	Nucleoplasm	"CAB022098: , HPA008422: AB_1854434, HPA023900: AB_1854435"	"unprognostic (1.10e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.98e-2)"	"prognostic favorable (8.45e-5)"	"unprognostic (4.04e-1)"	"unprognostic (8.34e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (6.69e-12)"	"unprognostic (2.37e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.56e-1)"	26.5	21.0	7.6	44.4	7.4	69.3	19.6	7.1	9.2	22.9	8.5	39.1	15.5	21.6	2.3	17.7	20.4	18.5	20.6	7.2	7.2	34.6	28.2	41.0	40.7	8.5	7.5	21.4	24.1	6.1	10.8	14.7	8.0	29.0	6.8	1.1	21.3	9.1	18.4	20.0	26.5	12.2	7.5	50.6	22.7	10.0	8.4	16.9	20.1	7.6	25.7	37.0	19.1	8.0	67.9	48.6	7.7	31.7	11.1	16.6	19.3	18.5	61.0	19.6	25.9	28.6	55.2	32.9	43.5	11.9	48.8	40.9	20.5	28.2	6.8	168.0	11.2	7.0	11.7	15.9	30.1	5.1	45.5	22.0	14.6	34.1	32.3	26.5	7.8	16.1	7.6	157.8	7.4	26.4	7.1	22.7	10.3	15.7	16.6	16.8	24.5	27.0	34.3	22.1	1.7	8.2	16.2	36.7	26.3	7.2	29.3	16.4	21.2	19.0	28.9	25.4	47.0	113.1	105.0	32.6	31.1	14.8	10.9	0.0	1.3	0.0	0.7	0.9	0.7	2.6	0.8	0.7	0.7	2.1	0.8	0.8	5.6	0.8	2.1	0.6	1.1	0.5	7.6	7.4	7.1	9.2	7.2	7.2	8.5	7.5	8.0	7.5	8.4	8.0	20.8	9.6	8.8	3.3	88.3	43.5	59.3	41.2	34.7	2.2	17.1	14.5	3.1	25.8	29.9	18.4	16.7	6.3	39.0	33.3	5.9	33.2	1.1	33.7	14.4	26.1	16.3	0.4	0.1	21.0	15.8	26.0	80.0	52.0	71.8	5.5	11.7	3.7	20.9	0.0	0.1	30.4	22.4	19.4	122.9	1.7	7.5	52.5	30.2	1.9	75.1	3.9	12.3	1.5	0.7	44.9	37.4	4.9	49.1	49.3	33.2	8.6	19.9	5.3	0.0	36.4	43.6	4.7	11.1	17.5	44.6	23.1	54.6	8.8	17.9	45.6
NFKBIA	"IkappaBalpha, IKBA, MAD-3, NFKBI"	ENSG00000100906	"NFKB inhibitor alpha"	P25963	14	35401513-35404749	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction"		"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1114.7"	"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 4056.6;Langerhans cells: 4828.7;Suprabasal keratinocytes: 3420.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 391.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003815, HPA029207"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 15: RT4 - Unknown function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"CAB003815: AB_344886, HPA029207: AB_10603122"	"prognostic favorable (1.33e-5)"	"unprognostic (3.39e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.80e-2)"	281.0	171.3	75.6	150.7	78.0	1114.7	171.4	75.4	92.5	123.8	78.3	121.0	61.2	95.5	29.6	151.8	141.2	130.4	145.5	71.4	75.9	104.5	208.1	366.0	122.6	90.1	76.2	255.7	101.9	68.8	92.4	92.7	81.6	112.6	80.9	18.7	118.3	110.0	139.7	260.5	148.5	92.7	77.0	226.2	130.7	31.7	84.9	123.2	111.9	138.3	181.4	366.2	166.8	79.8	62.5	54.1	20.1	18.2	114.7	75.9	71.1	25.2	240.7	53.3	47.3	16.9	36.5	37.5	66.1	40.2	125.2	79.5	38.3	104.9	76.1	229.2	14.9	18.6	39.9	101.4	68.6	29.9	15.0	83.1	103.5	36.4	92.2	35.5	48.6	18.4	15.9	58.4	38.6	73.0	39.2	71.0	18.6	60.0	33.1	87.8	23.1	31.6	92.8	391.7	17.9	31.2	67.2	115.9	29.7	41.0	66.1	62.2	91.7	72.8	26.5	21.3	41.0	70.9	77.7	64.5	60.8	22.0	15.3	322.0	444.9	301.4	175.3	267.2	264.0	258.4	207.1	182.5	428.9	329.7	178.1	153.0	942.9	285.9	183.7	233.0	154.9	506.4	75.6	78.0	75.4	92.5	71.4	75.9	90.1	76.2	81.6	77.0	84.9	79.8	802.9	535.2	914.0	14.4	505.6	4056.6	1862.8	2061.4	1729.6	27.0	430.7	414.0	188.6	367.4	719.2	62.5	12.5	196.4	762.2	447.8	195.6	875.0	4.3	703.8	935.6	1079.8	203.5	87.8	7.1	394.8	174.9	1145.1	333.8	1440.1	906.1	68.2	313.4	147.2	791.2	48.8	5.1	453.0	634.7	491.4	4828.7	14.7	153.1	1609.0	1085.1	39.4	428.1	95.2	97.9	6.6	8.6	383.5	511.5	116.2	1039.4	1412.0	1051.6	115.9	298.2	37.4	203.8	956.9	847.2	3.3	26.4	1544.6	3420.6	660.0	838.4	91.8	346.0	1004.6
NFKBID	"IkappaBNS, IkBNS, TA-NFKBH"	ENSG00000167604	"NFKB inhibitor delta"	Q8NI38	19	35887653-35902303	"Predicted intracellular proteins, Transcription factors"	"Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 152.7;granulocytes: 90.3;Langerhans cells: 418.5;Macrophages: 89.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA054778			Uncertain	"Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol	"Nuclear bodies, Plasma membrane"	"HPA054778: "	"prognostic favorable (6.01e-4)"	"unprognostic (9.60e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.51e-2)"	"prognostic favorable (5.43e-4)"	"unprognostic (4.21e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.83e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.47e-3)"	"unprognostic (5.64e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.71e-2)"	"prognostic favorable (8.34e-6)"	4.0	1.8	0.7	4.4	0.6	15.9	2.5	2.7	1.6	1.9	2.1	2.3	1.1	1.8	0.0	2.1	3.0	2.4	1.5	0.8	1.4	2.5	1.5	5.6	4.8	1.4	0.9	3.3	2.1	0.9	4.2	0.8	1.2	2.2	0.8	0.7	1.6	0.5	0.4	2.2	4.0	0.5	1.0	5.4	2.0	0.4	1.3	5.2	3.9	0.2	3.1	2.2	2.0	1.7	3.3	3.0	0.6	2.0	0.3	0.5	1.4	2.0	2.4	2.1	1.5	0.7	2.6	4.0	1.5	2.1	1.9	1.7	2.1	1.6	0.9	2.3	0.4	2.4	4.9	0.7	0.5	2.1	7.0	0.7	1.0	3.9	0.9	0.5	0.8	1.8	0.5	2.4	0.4	2.6	1.7	2.5	0.8	0.6	0.6	0.9	0.4	0.8	1.8	1.4	1.0	0.8	2.7	2.1	0.2	0.5	0.9	2.1	0.8	3.3	3.0	1.5	1.4	1.7	0.6	4.6	1.8	4.9	0.5	0.0	0.9	1.7	1.4	0.6	1.1	3.3	0.6	1.1	0.9	5.5	1.0	0.6	3.2	1.5	1.1	1.2	1.5	0.5	0.7	0.6	2.7	1.6	0.8	1.4	1.4	0.9	1.2	1.0	1.3	1.7	11.7	0.0	11.3	2.9	152.7	29.7	14.3	12.9	34.7	8.0	10.9	7.5	1.1	5.7	5.6	1.8	20.9	1.3	58.9	5.7	0.0	2.5	0.1	27.8	6.8	21.5	3.0	1.7	4.9	1.0	2.8	11.3	2.0	80.8	90.3	3.8	9.3	0.3	39.2	0.0	3.4	5.7	2.0	31.0	418.5	0.4	1.2	89.4	19.6	2.8	40.0	1.0	13.4	1.5	0.5	2.8	2.1	1.9	38.1	13.8	9.2	1.7	3.9	9.2	0.0	3.3	6.7	0.4	1.0	20.7	33.4	1.0	45.3	2.4	6.2	10.0
NFKBIE	IKBE	ENSG00000146232	"NFKB inhibitor epsilon"	O00221	6	44258166-44265788	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002692, HPA005941, CAB010272"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010272: AB_2235977, HPA002692: AB_1079479, HPA005941: AB_1079478"	"prognostic favorable (1.72e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (4.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (1.37e-6)"	"unprognostic (2.61e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (8.07e-4)"	6.8	5.8	10.9	19.1	10.8	31.5	5.9	12.1	17.6	4.1	10.7	7.2	7.4	3.7	4.7	5.9	3.3	8.3	5.3	11.3	10.6	16.1	10.5	13.6	19.9	11.5	11.4	2.7	8.3	5.3	4.5	5.5	11.2	8.3	5.9	3.7	7.4	3.3	3.5	9.9	12.1	3.6	11.7	35.0	7.0	10.7	11.8	9.9	5.3	3.9	25.1	16.3	5.0	12.3	28.4	7.9	9.5	15.1	3.7	2.8	5.3	4.9	23.8	14.9	15.4	15.0	12.9	15.7	17.0	5.1	39.7	6.2	10.3	15.4	16.6	26.1	6.0	7.9	3.0	17.0	11.4	26.1	23.0	7.1	6.7	13.8	8.8	12.5	10.7	7.2	7.7	39.2	3.9	14.4	5.2	52.7	5.0	44.1	4.0	9.9	8.5	14.0	34.7	30.3	6.1	7.8	3.4	12.5	20.9	8.0	8.6	29.9	18.1	8.4	9.8	5.3	15.4	25.0	11.4	28.7	7.4	28.4	16.1	8.8	7.5	4.0	1.6	9.4	3.2	8.6	2.2	1.5	6.6	6.5	1.0	1.6	3.0	0.8	11.1	8.1	3.1	1.7	10.9	10.8	12.1	17.6	11.3	10.6	11.5	11.4	11.2	11.7	11.8	12.3	7.5	0.0	9.7	1.0	26.0	38.2	28.7	11.6	14.8	3.4	15.3	9.9	5.4	22.8	9.2	3.7	2.1	5.2	12.5	12.2	17.6	49.5	17.3	10.0	6.2	15.9	14.9	1.7	1.1	21.0	8.0	17.3	10.7	12.8	32.5	2.5	6.1	2.0	57.2	3.3	2.0	11.9	6.1	22.6	151.2	34.1	1.8	48.6	48.0	3.7	55.2	3.3	1.0	0.5	0.9	58.9	33.3	2.6	18.7	32.6	14.3	14.4	6.1	4.1	6.6	11.8	11.0	25.9	12.3	11.6	39.2	5.3	13.8	7.0	8.5	34.7
NFKBIZ	"FLJ34463, INAP, MAIL"	ENSG00000144802	"NFKB inhibitor zeta"	Q9BYH8	3	101827991-101861022	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 406.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 33.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 24.7;monocytes: 33.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 72.1;RPTEC TERT1: 71.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA010547, HPA075363"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"	"Cytoplasmic bodies"	"HPA010547: AB_1854442, HPA075363: AB_2686745"	"unprognostic (2.20e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.82e-2)"	"prognostic unfavorable (4.30e-8)"	"unprognostic (2.69e-1)"	"unprognostic (8.90e-2)"	"unprognostic (3.30e-1)"	"unprognostic (8.52e-3)"	57.5	12.0	2.8	44.4	5.2	406.0	31.7	4.7	6.0	13.4	19.1	24.5	52.6	36.3	3.7	26.9	64.8	51.3	23.6	3.4	4.8	29.2	52.4	48.2	27.2	6.7	4.2	19.1	27.0	3.6	12.5	22.3	5.5	26.6	30.6	8.0	80.8	7.4	4.6	45.7	23.2	54.6	6.2	26.9	30.5	3.7	6.8	18.8	24.7	10.2	22.7	71.3	18.3	5.0	6.5	5.2	3.5	4.4	9.7	16.7	5.3	26.2	72.1	11.3	10.7	6.3	7.8	12.2	32.4	7.2	34.8	20.5	2.5	11.4	29.2	35.9	2.3	11.7	10.2	3.4	14.7	0.8	0.7	11.6	17.3	30.5	13.7	27.8	8.4	0.3	2.0	24.6	16.2	8.1	0.2	6.9	6.0	2.3	15.3	1.5	15.7	1.5	71.0	42.7	1.5	1.9	4.4	5.3	29.6	7.4	6.3	4.8	10.6	18.1	18.0	6.9	8.6	20.4	7.8	8.1	32.9	2.2	2.5	11.7	5.9	1.7	1.4	13.1	1.7	2.9	2.1	1.6	3.8	4.6	6.0	4.2	24.7	0.8	33.9	6.0	1.3	2.3	2.8	5.2	4.7	6.0	3.4	4.8	6.7	4.2	5.5	6.2	6.8	5.0	199.5	86.6	266.6	10.7	91.3	281.7	61.2	123.0	103.0	9.0	108.7	105.8	20.6	84.4	143.0	66.2	2.1	19.3	98.6	157.8	0.0	213.0	4.6	116.1	221.4	135.3	73.6	21.0	23.7	132.1	41.0	214.2	277.8	291.9	381.8	17.9	82.1	65.2	56.5	10.1	20.2	69.7	59.0	150.6	291.5	1.3	20.2	318.4	71.2	16.9	79.0	25.7	12.3	17.1	79.3	127.6	115.8	0.7	128.5	88.8	91.2	5.6	117.3	8.9	19.7	218.4	131.1	0.6	2.6	136.4	251.7	25.6	134.0	19.2	111.7	70.5
NINJ1	NIN1	ENSG00000131669	"Ninjurin 1"	Q92982	9	93121496-93134251	"Predicted membrane proteins"	"Angiogenesis, Cell adhesion, Cytolysis, Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 286.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 539.9;Langerhans cells: 741.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1668.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 1668.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 197.5;MCF7: 191.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045063	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"			"HPA045063: AB_10964133"	"unprognostic (1.23e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.40e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.40e-3)"	"unprognostic (7.46e-3)"	60.9	129.8	51.0	39.9	48.9	286.9	53.0	47.9	58.7	47.6	50.2	60.1	27.0	36.5	20.2	25.7	47.6	39.2	64.0	44.2	51.9	100.4	118.0	65.0	41.5	54.5	53.2	35.9	35.0	137.7	59.2	66.6	53.3	58.9	16.5	6.1	77.3	56.2	38.0	80.4	37.6	36.0	57.6	89.9	42.5	37.6	57.2	30.5	71.4	30.0	19.6	100.5	37.9	59.2	45.0	68.2	13.2	30.0	47.4	19.1	51.6	30.2	85.9	43.5	26.7	29.5	15.5	0.6	15.0	29.7	47.6	44.8	14.7	84.6	9.4	103.3	28.7	6.8	17.2	197.5	163.7	4.8	13.8	62.5	80.9	41.1	22.5	132.4	41.3	16.3	5.0	49.6	9.9	191.1	13.9	13.8	18.7	51.9	53.0	24.6	10.3	79.0	35.0	18.6	4.3	18.4	67.3	105.4	41.9	22.0	81.9	31.3	31.1	15.8	44.6	33.2	22.9	26.2	11.4	1.0	48.2	14.8	12.1	152.9	313.3	824.9	69.8	315.4	94.5	7.8	65.0	59.3	75.9	2.4	76.5	55.1	1668.9	44.7	355.8	10.7	73.8	219.1	51.0	48.9	47.9	58.7	44.2	51.9	54.5	53.2	53.3	57.6	57.2	59.2	15.7	28.9	41.6	6.5	24.3	114.6	75.8	273.0	130.3	1.8	117.8	96.6	31.6	62.9	80.7	40.5	0.0	128.3	45.8	19.4	129.1	95.2	3.9	22.9	20.9	46.9	18.0	3.0	3.4	101.7	78.3	64.9	20.9	24.5	47.0	13.8	23.6	48.5	539.9	1.7	3.9	21.3	111.9	176.9	741.7	21.1	42.0	278.1	147.7	18.7	214.9	76.1	33.0	3.0	1.7	68.7	23.7	72.6	32.5	60.3	75.5	240.6	18.8	3.8	13.1	45.7	53.3	0.9	11.4	36.3	135.7	73.3	54.7	4.5	19.7	76.9
NKRF	"ITBA4, NRF"	ENSG00000186416	"NFKB repressing factor"	O15226	X	119588337-119606443	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001476			Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"	Nucleoli	Nucleoplasm	"HPA001476: AB_1079488"	"unprognostic (6.12e-3)"	"unprognostic (7.58e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.92e-2)"	"unprognostic (4.74e-3)"	"prognostic unfavorable (4.92e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.56e-3)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.08e-3)"	4.4	6.5	11.3	5.7	11.8	6.9	5.4	9.6	16.9	4.2	7.3	3.7	4.1	3.9	4.0	5.6	4.4	3.5	4.1	11.5	13.1	6.1	6.0	4.1	8.7	11.2	10.1	6.1	3.8	5.2	5.5	6.5	11.5	4.1	3.5	5.3	4.0	3.5	5.5	6.2	4.3	4.0	9.4	5.9	4.1	1.9	11.4	9.5	4.6	4.6	8.4	6.3	4.3	10.6	17.9	18.3	10.4	11.3	8.7	8.5	15.5	10.7	8.5	14.1	15.0	19.8	15.3	31.8	18.4	9.2	12.1	20.4	43.8	16.4	17.2	16.4	28.9	16.8	20.3	12.9	8.3	33.5	11.8	9.5	13.2	16.3	19.2	9.6	14.1	15.3	18.5	12.6	12.5	27.6	20.8	25.2	23.1	26.2	19.9	16.5	15.2	32.7	18.8	12.7	16.7	14.2	15.2	23.1	16.5	10.6	9.7	20.0	12.2	8.7	9.5	19.3	27.1	10.5	14.1	32.9	9.3	36.3	10.1	1.1	0.5	0.7	1.0	0.8	1.1	1.3	1.2	1.3	0.6	1.2	1.9	1.6	0.1	0.5	0.3	0.9	1.8	0.8	11.3	11.8	9.6	16.9	11.5	13.1	11.2	10.1	11.5	9.4	11.4	10.6	5.4	6.4	8.9	5.9	11.1	19.4	10.4	4.1	6.8	13.3	6.1	6.9	4.5	8.6	3.1	5.5	27.1	14.4	8.5	3.0	1.9	4.2	0.1	6.1	7.4	7.0	10.7	2.5	20.6	3.6	14.3	6.1	3.1	8.1	14.7	6.6	3.3	3.9	6.4	8.4	20.6	4.4	10.2	7.5	33.1	0.6	7.8	11.6	5.4	7.5	5.6	4.4	1.0	9.0	9.2	4.1	1.9	6.8	5.2	10.7	3.6	4.4	3.9	7.9	0.0	10.1	7.2	1.7	1.9	6.9	25.7	14.9	15.7	6.9	7.4	9.5
NLRP3	"AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1, DFNA34, FCAS, FCU, MWS, NALP3, PYPAF1"	ENSG00000162711	"NLR family pyrin domain containing 3"	Q96P20	1	247416156-247449108	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	Activator	"Amyloidosis, Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 53.8"	"Cell type enriched"	"Detected in many"	6	"Macrophages: 254.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 129.4"	"Group enriched"	"Detected in many"	23	"dendritic cells: 37.3;granulocytes: 129.4;monocytes: 35.6"	"Cell line enriched"	"Detected in some"	4	"THP-1: 78.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA012878	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA012878: AB_1846752"	"unprognostic (3.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.23e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.86e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.84e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.17e-4)"	"unprognostic (1.10e-1)"	"unprognostic (6.10e-2)"	8.3	1.4	1.0	10.0	0.8	53.8	3.5	0.8	1.0	1.8	0.8	1.5	0.8	0.9	0.4	2.7	1.4	6.5	1.0	0.9	1.6	0.6	2.1	4.6	2.5	2.0	1.4	0.7	1.6	0.9	0.5	3.4	2.1	0.8	1.8	0.3	0.8	0.7	0.5	0.4	2.4	4.8	1.9	4.6	1.4	0.3	1.6	1.7	1.0	0.5	1.7	6.4	0.4	3.4	7.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.9	0.2	0.4	0.0	0.3	0.0	0.3	0.0	0.5	0.0	0.0	2.2	2.9	0.5	0.0	1.3	0.2	0.0	0.0	5.3	0.0	0.0	0.0	0.5	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	13.8	0.0	0.0	0.4	0.4	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	78.4	0.1	3.2	2.5	0.0	0.2	0.0	0.0	0.0	7.2	18.9	2.4	129.4	35.6	0.2	0.6	21.7	1.7	0.0	2.9	1.2	37.3	0.1	1.1	0.7	8.6	0.0	11.5	1.8	0.1	12.2	1.0	0.8	0.8	1.0	0.9	1.6	2.0	1.4	2.1	1.9	1.6	3.4	2.2	0.0	0.5	0.3	2.6	1.0	0.1	0.0	0.6	0.3	0.6	1.1	0.6	0.0	0.0	0.0	0.0	0.7	6.0	0.0	0.0	0.0	0.3	0.1	0.5	2.3	0.0	1.7	2.6	0.0	0.4	1.2	1.5	0.1	2.5	0.2	0.4	0.3	16.2	0.0	1.2	0.2	0.0	35.4	41.4	0.2	0.0	254.2	0.0	17.8	14.5	0.7	1.0	1.0	0.4	0.1	0.0	0.4	4.0	0.0	0.0	0.2	0.0	0.4	0.0	1.0	1.1	0.4	0.4	1.3	0.6	1.4	10.2	0.1	0.0	0.0
NOCT	"Ccr4c, CCR4L, CCRN4L, NOC"	ENSG00000151014	Nocturnin	Q9UK39	4	139015781-139045939	"Predicted intracellular proteins"	"Biological rhythms"	"Hydrolase, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Glandular and luminal cells: 20.6;Syncytiotrophoblasts: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012287, HPA053714"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA012287: AB_2668640, HPA053714: AB_2682238"	"unprognostic (2.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.00e-3)"	"unprognostic (3.24e-1)"	"prognostic unfavorable (5.28e-5)"	"unprognostic (1.86e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.52e-4)"	"prognostic unfavorable (6.23e-4)"	8.2	2.0	2.8	3.2	2.6	36.3	4.5	1.7	7.1	1.4	0.0	1.8	1.2	1.6	0.5	1.9	1.0	5.5	2.9	5.0	2.9	3.6	13.9	2.9	2.1	1.5	3.4	0.6	3.0	1.7	2.2	5.6	2.6	1.0	1.6	3.4	1.6	0.5	6.5	2.2	2.2	3.0	1.4	1.7	1.7	2.2	4.4	1.9	1.5	6.1	2.6	4.9	1.3	2.9	6.5	7.1	2.9	5.7	6.6	2.7	17.2	9.4	6.9	13.7	10.0	10.3	2.8	22.7	7.4	7.3	18.4	4.5	15.8	8.9	13.7	9.5	6.1	10.3	4.4	8.7	6.2	15.3	6.0	3.2	4.4	15.4	10.4	2.7	6.3	4.3	18.6	7.0	6.6	8.0	10.0	7.8	10.1	3.0	8.1	8.5	8.6	7.7	9.4	4.3	11.3	7.3	6.0	6.8	5.6	11.2	5.0	11.2	8.7	7.7	9.4	7.2	11.8	5.9	5.5	14.0	7.0	29.8	9.9	0.8	0.5	0.3	1.0	0.6	0.5	0.4	0.4	0.5	0.2	0.7	0.3	0.6	2.7	0.6	1.6	0.6	0.3	0.1	2.8	2.6	1.7	7.1	5.0	2.9	1.5	3.4	2.6	1.4	4.4	2.9	10.9	9.6	1.1	0.0	2.8	0.0	2.7	0.0	5.7	5.6	2.7	2.5	0.0	1.5	0.6	0.0	14.6	6.1	4.7	0.6	1.9	2.3	0.7	10.4	6.3	2.6	0.0	1.7	0.0	0.2	11.8	2.9	6.1	20.6	2.5	0.8	1.1	2.6	1.5	1.7	0.0	0.4	0.0	1.6	0.0	0.1	0.9	6.9	0.0	0.0	0.1	0.6	4.1	0.0	0.0	2.5	0.0	0.0	5.5	2.5	2.6	4.0	0.7	5.2	0.0	5.4	4.3	1.0	3.9	6.5	0.0	12.0	4.3	0.8	0.2	2.3
NOTCH2NLA	"N2N, NOTCH2NL"	ENSG00000264343	"Notch 2 N-terminal like A"	Q7Z3S9	1	146146203-146229026	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Notch signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"B-cells: 1.6;dendritic cells: 2.8;Extravillous trophoblasts: 2.0;Fibroblasts: 1.2;Hofbauer cells: 2.1;Macrophages: 2.2;Plasma cells: 3.0;Smooth muscle cells: 1.4;Syncytiotrophoblasts: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											CAB004669	Uncertain				"Secreted to blood"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"			"CAB004669: AB_426149"	"unprognostic (1.54e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.28e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.83e-2)"	14.5	5.9	6.3	6.8	4.2	5.3	13.4	2.1	9.7	18.9	17.1	7.8	5.1	9.0	13.6	22.0	9.8	6.9	10.6	8.9	6.1	8.6	15.5	13.1	5.9	6.9	4.9	11.6	10.9	8.8	3.7	9.6	4.9	14.5	6.4	8.6	14.9	7.8	9.1	29.0	7.1	8.5	2.4	11.4	7.4	34.0	7.7	5.4	10.6	3.8	6.8	9.1	21.0	6.5	22.8	7.8	12.2	4.4	11.4	31.4	4.8	12.3	20.7	14.1	16.0	4.3	10.5	5.0	5.1	9.7	7.6	10.1	6.9	15.7	22.1	13.5	5.8	17.1	15.8	2.0	12.9	7.6	6.1	28.5	4.9	15.5	33.2	17.4	10.2	7.4	5.4	26.6	20.1	15.9	4.2	5.2	3.6	1.7	14.9	4.1	11.9	16.2	7.4	12.0	1.9	1.2	21.0	12.2	4.9	7.9	20.5	7.7	42.2	9.5	8.2	19.9	16.1	51.0	14.2	12.5	15.6	6.1	8.4	16.8	13.4	27.9	4.3	13.4	4.1	14.3	4.0	4.0	10.5	11.4	5.8	4.2	19.5	4.5	18.1	17.3	4.2	3.0	6.3	4.2	2.1	9.7	8.9	6.1	6.9	4.9	4.9	2.4	7.7	6.5	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0
NR4A2	"HZF-3, NOT, NURR1, RNR1, TINUR"	ENSG00000153234	"Nuclear receptor subfamily 4 group A member 2"	P43354	2	156324437-156342348	"Cancer-related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 129.3;bone marrow: 130.8;ovary: 129.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 511.7;dendritic cells: 410.4;Langerhans cells: 782.3;Macrophages: 577.5;T-cells: 465.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 16.0;HMC-1: 10.9;SK-MEL-30: 8.1;U-266/70: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000543, CAB010481"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"		"CAB010481: AB_2298676, HPA000543: AB_1854631"	"unprognostic (4.26e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.04e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.14e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.43e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.11e-1)"	40.0	129.3	4.3	24.5	44.1	130.8	15.6	36.2	8.8	18.3	5.9	9.5	2.9	15.0	1.7	11.4	28.2	32.7	36.6	15.1	3.6	19.2	20.2	18.8	6.3	3.2	9.2	129.2	9.2	8.8	54.0	5.2	2.8	25.6	18.7	5.3	19.2	15.5	11.6	12.8	7.8	14.5	0.9	4.6	19.9	5.6	2.5	9.7	15.2	7.8	1.4	50.9	14.0	6.4	0.9	1.3	0.5	1.8	3.2	0.7	0.9	1.1	5.5	0.4	1.3	0.0	3.3	0.0	1.2	0.4	0.4	1.6	2.6	0.7	0.4	1.3	1.4	1.0	16.0	0.0	0.6	0.7	10.9	0.6	1.2	0.4	0.4	2.1	0.3	0.0	1.6	1.0	1.1	1.9	0.0	0.8	2.1	1.5	0.8	0.2	0.7	3.3	0.6	0.8	2.7	0.1	2.6	4.1	8.1	0.3	0.2	1.0	0.7	2.9	0.8	0.7	0.4	14.2	1.8	0.0	5.3	1.0	7.0	1.9	1.7	2.4	1.0	0.3	0.5	0.4	0.3	0.5	1.9	0.3	0.5	0.2	6.5	0.0	0.7	0.0	0.4	0.5	4.3	44.1	36.2	8.8	15.1	3.6	3.2	9.2	2.8	0.9	2.5	6.4	70.7	25.6	124.7	7.8	511.7	218.6	25.8	87.5	298.7	11.8	120.8	160.1	11.9	17.2	58.3	71.7	50.1	4.7	410.4	35.0	0.0	13.1	36.7	209.6	33.9	111.9	206.4	12.0	5.8	9.1	6.5	164.9	103.9	349.7	349.3	4.3	45.0	6.8	125.1	0.0	0.8	95.4	42.7	161.1	782.3	37.2	4.1	577.5	241.9	5.6	7.9	1.6	3.1	4.0	2.3	11.7	41.9	0.7	203.5	49.1	25.9	0.4	54.6	33.4	13.1	63.0	169.8	1.8	3.3	230.2	213.7	9.9	465.1	34.4	57.5	29.5
NR4A3	"CHN, CSMF, MINOR, NOR1"	ENSG00000119508	"Nuclear receptor subfamily 4 group A member 3"	Q92570	9	99821855-99866891	"Cancer-related genes, Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 305.7;Langerhans cells: 417.5;Macrophages: 172.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BJ hTERT+: 24.1;HeLa: 8.0;SK-MEL-30: 18.5;U-266/70: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043360	Uncertain					NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"			"HPA043360: AB_10961186"	"prognostic favorable (5.97e-4)"	"unprognostic (6.92e-3)"	"unprognostic (5.34e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.40e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.29e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.69e-1)"	43.2	61.2	3.4	14.9	6.3	32.7	7.4	14.1	5.5	11.4	4.2	9.8	0.7	15.7	0.7	4.0	24.8	23.5	67.2	10.2	7.4	7.8	9.0	19.6	1.3	6.3	3.9	46.8	5.2	3.0	21.2	6.5	5.9	15.6	4.0	8.7	2.4	3.3	62.8	2.4	5.8	13.4	1.1	3.5	13.7	1.0	2.9	6.5	7.2	6.2	0.9	32.8	5.1	2.3	0.1	0.1	0.7	0.1	1.3	0.4	1.1	1.5	24.1	0.2	0.2	0.2	0.1	0.2	0.3	0.7	0.5	0.1	0.5	0.0	0.1	1.8	0.3	0.1	8.0	0.0	0.2	0.1	2.3	0.3	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.7	0.0	0.2	0.0	0.2	0.6	0.0	1.1	0.0	0.0	0.1	0.4	0.4	2.7	2.0	18.5	0.2	0.0	0.0	0.1	1.4	0.4	1.8	0.1	9.2	0.1	0.0	0.9	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.4	6.3	14.1	5.5	10.2	7.4	6.3	3.9	5.9	1.1	2.9	2.3	9.6	12.8	19.7	3.9	101.5	79.5	14.0	3.5	97.9	0.9	44.2	58.5	305.7	4.3	10.0	16.5	10.4	2.3	91.3	2.0	0.0	0.1	1.4	93.1	12.8	16.2	27.3	0.4	13.1	1.7	2.2	60.3	32.6	124.3	120.7	1.2	7.5	0.5	10.5	0.0	6.2	3.8	2.0	12.3	417.5	2.4	1.5	172.8	88.9	2.8	43.0	3.6	1.0	1.5	0.9	0.2	2.3	1.2	37.9	4.7	0.6	0.1	11.4	1.7	0.0	35.7	75.0	1.1	1.6	15.9	59.5	5.6	69.6	1.0	1.7	3.4
OXSR1	"KIAA1101, OSR1"	ENSG00000172939	"Oxidative stress responsive kinase 1"	O95747	3	38165089-38255484	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008237, CAB017181"	Supported		Enhanced	Cytosol		NA	NA		300000	"Cluster 38: Basophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 41: Macrophages - Immune response"	Cytosol		"CAB017181: , HPA008237: AB_1079540"	"unprognostic (2.16e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (4.05e-2)"	"unprognostic (4.44e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.99e-3)"	18.4	17.2	9.7	15.7	10.0	33.8	15.6	13.6	12.5	17.8	13.0	18.3	15.2	14.8	15.6	34.1	12.8	15.1	16.9	9.9	10.8	21.5	18.6	15.5	18.5	11.0	11.0	16.1	12.1	26.3	11.5	16.5	11.1	16.5	19.7	13.0	15.2	16.3	36.7	19.5	15.7	17.6	10.2	15.0	16.8	14.1	11.0	25.1	14.8	35.4	23.4	26.7	21.1	11.2	48.5	21.9	42.5	29.8	29.0	33.3	48.2	41.9	57.1	59.2	63.8	28.3	30.8	53.4	20.8	50.5	25.4	29.4	57.8	43.1	77.5	57.6	24.5	58.6	46.1	31.1	34.6	36.6	34.2	26.6	49.6	54.8	87.8	55.7	37.5	67.7	45.2	29.9	102.7	13.7	71.1	26.4	44.8	31.2	26.1	24.2	35.7	41.4	36.4	36.4	22.0	34.0	45.9	114.2	29.0	46.3	37.7	23.7	34.4	37.0	36.6	56.8	63.0	22.7	29.0	38.7	50.7	44.6	75.3	6.8	1.6	3.9	1.8	2.8	1.9	1.0	2.2	1.7	2.6	1.2	1.7	2.1	3.2	3.1	2.5	1.4	2.8	0.9	9.7	10.0	13.6	12.5	9.9	10.8	11.0	11.0	11.1	10.2	11.0	11.2	19.0	12.8	25.8	46.7	27.3	44.1	35.5	25.3	26.7	13.3	19.4	16.5	32.6	4.3	27.6	27.6	20.9	12.1	27.4	44.0	19.6	28.4	3.9	39.9	32.1	19.0	24.1	29.7	59.6	14.5	21.0	18.4	90.7	91.2	15.8	24.9	14.6	20.5	14.9	21.9	51.9	24.5	10.2	29.8	79.0	2.3	9.6	58.0	7.2	29.0	35.2	8.0	18.6	44.7	42.8	46.5	29.4	12.8	19.5	56.5	27.0	22.5	16.1	7.0	13.1	23.7	22.6	15.1	18.5	41.9	51.9	33.0	29.6	19.6	21.6	115.3
PABPC4	"APP-1, iPABP"	ENSG00000090621	"Poly(A) binding protein cytoplasmic 4"	Q13310	1	39560709-39576790	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 469.7;skeletal muscle: 557.5"	"Cell type enhanced"	"Detected in all"		"Kupffer cells: 460.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027301, HPA056496"	Supported		Enhanced	Cytosol		NA	NA		850000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA027301: AB_2672208, HPA056496: AB_2683153"	"unprognostic (6.81e-2)"	"unprognostic (7.01e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (1.14e-7)"	"unprognostic (2.22e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (3.00e-10)"	"unprognostic (1.87e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.08e-1)"	98.4	95.9	26.1	51.2	27.5	76.8	76.1	24.7	28.6	68.8	31.5	83.6	36.8	87.2	41.1	72.1	67.8	39.8	151.9	25.8	24.4	57.0	82.0	72.9	65.1	33.6	25.6	124.8	469.7	27.9	37.4	49.6	30.4	59.3	32.7	22.7	75.5	36.9	557.5	65.0	66.7	46.2	30.4	71.2	153.1	99.4	32.7	32.7	55.0	244.6	65.1	91.9	69.2	36.1	280.8	90.3	75.7	143.3	223.0	441.9	250.7	161.6	135.2	143.5	103.6	175.0	142.2	239.7	150.3	238.5	58.0	131.5	161.2	197.8	175.8	120.6	128.7	200.2	94.1	194.7	234.5	146.5	122.5	392.7	234.3	164.0	252.6	180.0	179.4	174.9	211.3	126.6	231.5	131.5	135.3	132.8	268.9	95.4	98.0	105.4	274.6	194.9	138.4	343.0	63.9	106.9	118.3	106.1	266.1	137.3	115.8	388.9	146.2	118.6	161.8	308.1	201.3	315.1	423.3	202.5	181.7	130.8	78.6	9.8	18.2	4.8	14.2	22.9	13.3	16.0	20.6	13.0	19.0	19.9	25.3	17.6	1.9	11.8	33.0	18.2	14.9	7.9	26.1	27.5	24.7	28.6	25.8	24.4	33.6	25.6	30.4	30.4	32.7	36.1	55.0	19.2	48.9	8.8	120.6	55.8	80.7	36.5	45.5	25.9	104.4	77.5	145.3	90.1	47.7	47.8	81.3	85.2	82.0	115.5	41.1	44.4	70.7	49.0	95.7	50.5	59.3	75.3	9.4	92.3	154.1	69.1	88.7	78.9	53.2	83.0	69.9	152.7	100.5	33.7	10.3	87.5	26.4	460.9	104.6	25.6	69.0	162.4	56.9	13.1	78.6	29.1	30.9	6.0	13.7	57.0	83.2	46.3	212.5	103.5	96.4	46.5	17.5	110.5	6.6	85.3	75.2	37.4	186.3	77.5	41.8	107.1	66.7	86.2	81.7	114.9
PAG1	"CBP, PAG"	ENSG00000076641	"Phosphoprotein membrane anchor with glycosphingolipid microdomains 1"	Q9NWQ8	8	80967810-81112068	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 169.6;granulocytes: 124.5;Melanocytes: 140.5;Microglial cells: 166.8;Sertoli cells: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 35.4;HMC-1: 45.5;SK-MEL-30: 36.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001632, HPA066527"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Plasma membrane"		"HPA001632: AB_1079557, HPA066527: AB_2685685"	"unprognostic (8.30e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.94e-3)"	3.9	3.1	3.4	9.0	3.5	12.3	2.0	14.8	4.0	1.8	4.3	9.2	7.6	1.9	2.2	1.6	1.8	7.1	4.7	2.8	3.7	1.7	4.7	14.9	14.5	4.5	4.5	1.2	14.9	0.9	2.0	16.0	4.9	2.6	8.7	5.0	3.7	2.1	1.3	4.3	9.0	3.0	4.9	9.1	4.4	0.7	5.2	10.4	1.8	2.1	14.0	4.8	2.6	5.6	0.1	0.1	4.8	0.2	8.9	8.5	0.1	2.0	15.5	1.0	1.9	0.3	0.1	35.4	0.2	0.5	7.6	1.5	0.1	1.8	0.9	0.9	4.5	20.8	0.3	0.0	9.1	3.4	45.5	4.1	1.2	8.9	8.2	0.9	0.0	6.2	0.2	0.1	14.8	0.3	12.6	0.3	0.4	8.1	1.4	9.5	2.4	0.1	1.6	7.6	1.0	1.7	0.0	0.3	36.1	0.8	1.2	3.5	0.3	1.1	0.6	0.0	1.2	5.7	1.6	12.3	9.7	11.7	8.5	13.1	1.4	2.0	2.5	6.4	6.1	2.0	6.2	4.4	1.9	1.6	4.9	3.8	2.3	1.7	14.6	4.1	7.2	2.7	3.4	3.5	14.8	4.0	2.8	3.7	4.5	4.5	4.9	4.9	5.2	5.6	6.2	0.0	12.4	40.8	37.0	31.5	3.9	5.2	0.6	39.7	2.2	2.2	15.4	10.0	14.0	3.7	0.0	0.8	39.0	169.6	0.0	4.0	3.5	0.6	4.4	10.9	3.6	3.8	57.5	6.5	26.2	24.3	8.2	1.1	124.5	97.0	12.5	10.3	27.1	63.9	60.0	23.2	6.1	73.6	26.2	2.1	2.5	79.1	140.5	166.8	40.8	34.9	19.6	82.4	75.3	2.0	62.1	7.9	38.4	7.7	109.3	0.4	0.8	3.2	124.9	32.3	37.1	0.2	3.0	3.8	22.6	2.3	78.1	11.8	27.4	13.7
PAPSS2	ATPSK2	ENSG00000198682	"3'-phosphoadenosine 5'-phosphosulfate synthase 2"	O95340	10	87659613-87747705	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 135.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 240.4;Distal enterocytes: 202.4;Hepatocytes: 111.5;Proximal enterocytes: 181.3;Theca cells: 96.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 4.0;myeloid DC: 2.1;non-classical monocyte: 7.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.1;monocytes: 7.7"	"Cell line enhanced"	"Detected in many"		"BJ: 189.8;fHDF/TERT166: 473.2;HHSteC: 196.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071224, HPA075267"	Enhanced		Approved	Mitochondria		No	No		16000	"Cluster 7: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"HPA071224: AB_2686366, HPA075267: "	"unprognostic (3.98e-3)"	"unprognostic (7.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.33e-6)"	"unprognostic (3.50e-2)"	"prognostic favorable (6.58e-4)"	"unprognostic (1.14e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (3.46e-3)"	33.3	135.2	6.3	26.6	7.0	2.0	20.9	6.2	9.5	17.8	6.2	79.9	29.5	8.5	3.1	10.2	12.4	20.7	11.6	5.8	6.2	23.8	77.0	70.4	11.0	6.9	6.6	27.5	26.1	2.1	3.0	58.5	7.5	6.7	64.3	2.3	16.4	3.4	4.7	3.5	61.8	16.7	6.8	8.5	9.2	11.7	8.0	3.0	21.3	8.7	14.8	16.6	11.5	7.2	19.9	20.0	6.4	0.3	129.4	164.8	0.3	189.8	157.7	110.4	79.9	1.0	4.1	0.1	9.8	473.2	3.5	8.5	13.9	13.3	125.2	0.2	10.0	8.8	13.4	0.1	196.5	0.2	3.8	58.7	0.3	63.7	5.2	135.6	94.2	1.4	0.0	89.4	79.2	74.1	0.1	0.7	7.4	4.8	24.1	0.4	0.1	0.4	117.5	8.7	0.9	1.6	92.5	3.3	1.1	12.6	13.5	5.3	120.0	38.2	22.5	131.5	13.9	0.3	1.0	0.3	18.3	0.2	0.2	0.0	1.1	0.0	0.0	4.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.6	0.0	7.7	0.0	0.0	0.8	6.3	7.0	6.2	9.5	5.8	6.2	6.9	6.6	7.5	6.8	8.0	7.2	49.5	240.4	38.2	3.6	2.6	2.3	0.9	18.0	1.8	0.2	11.5	4.7	4.4	8.6	13.8	9.2	0.0	0.5	0.8	202.4	13.7	6.4	1.2	2.6	18.7	23.2	12.6	5.2	22.2	30.2	0.8	36.1	15.3	11.6	0.0	20.3	36.0	111.5	11.5	0.0	27.6	26.5	4.1	29.8	50.7	0.8	17.4	51.0	1.8	30.0	5.2	1.3	0.0	21.6	1.0	19.4	46.1	5.3	3.1	2.1	181.3	9.8	3.4	0.0	13.1	1.0	20.4	1.2	0.7	1.1	1.3	1.4	1.7	96.4	74.3	1.1
PBX2	"G17, HOX12, PBX2MHC"	ENSG00000204304	"PBX homeobox 2"	P40425	6	32184733-32190202	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061478	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA061478: AB_2684535"	"unprognostic (9.73e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (8.90e-5)"	"unprognostic (4.98e-1)"	"unprognostic (2.68e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.81e-2)"	"prognostic favorable (6.84e-4)"	"unprognostic (3.84e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.27e-1)"	30.3	39.6	4.9	14.2	4.5	9.0	27.6	3.9	5.5	47.4	5.0	51.2	10.6	47.8	30.4	33.5	47.1	4.9	32.1	4.5	4.7	37.9	31.0	43.9	16.7	5.1	4.6	52.3	28.2	4.5	52.0	25.2	4.8	39.3	12.2	8.5	27.6	12.3	29.8	34.1	39.8	13.0	4.3	64.5	36.7	23.9	5.0	23.9	55.2	2.3	17.8	42.4	39.2	4.6	4.8	7.9	32.3	17.7	23.5	29.4	13.9	3.7	8.9	9.7	10.0	6.5	7.8	21.9	23.5	13.7	3.8	13.4	8.1	26.8	10.6	19.5	30.3	20.5	7.1	3.8	20.7	13.2	18.7	43.2	14.9	7.4	24.8	16.6	19.1	38.8	26.5	11.1	3.7	18.1	13.6	29.7	0.6	2.9	2.2	18.8	5.0	26.1	21.2	7.7	9.4	12.6	3.0	6.8	26.5	18.3	16.9	25.0	6.5	8.5	19.8	3.4	4.2	54.1	36.9	27.2	17.3	9.9	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.9	4.5	3.9	5.5	4.5	4.7	5.1	4.6	4.8	4.3	5.0	4.6	27.7	6.4	11.0	14.4	18.5	18.2	18.5	11.8	15.4	19.2	17.0	12.2	3.7	31.5	10.1	16.5	8.4	32.2	29.4	9.6	3.9	17.1	1.0	12.3	24.5	24.8	30.5	19.1	7.8	14.0	25.6	16.0	12.2	16.6	15.2	21.8	28.9	23.0	19.0	26.9	7.0	15.5	10.2	34.5	55.5	4.2	20.2	25.3	8.8	9.4	23.9	21.0	35.0	6.0	9.1	13.9	12.5	19.5	17.7	19.4	12.5	10.2	9.6	4.9	6.6	19.7	19.8	1.6	6.1	19.7	19.5	47.2	16.7	22.8	13.2	18.1
PDPK1	PDK1	ENSG00000140992	"3-phosphoinositide dependent protein kinase 1"	O15530	16	2537979-2603188	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004272, HPA035199"	Supported		Supported	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"CAB004272: AB_626657, HPA035199: AB_2674514"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.69e-3)"	"unprognostic (8.37e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.28e-2)"	"prognostic favorable (1.29e-14)"	"unprognostic (2.04e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.16e-1)"	11.6	13.5	15.1	12.4	25.2	16.1	11.1	10.2	20.6	10.9	1.5	15.8	17.3	11.8	13.2	13.3	14.7	9.5	15.1	19.2	5.2	17.0	12.4	13.6	15.0	10.8	6.1	14.0	19.4	27.1	11.2	12.1	11.3	13.0	14.9	15.5	17.8	12.2	18.9	14.2	19.6	12.3	3.7	13.9	13.6	14.7	7.7	16.8	15.8	19.2	14.1	11.1	10.4	12.5	13.1	16.5	20.1	13.5	20.3	16.9	21.5	21.7	13.6	18.7	15.6	16.6	15.2	21.4	14.5	20.7	15.9	20.2	24.3	15.3	17.6	39.6	17.1	11.4	23.0	27.7	17.7	19.2	29.0	15.4	27.5	20.1	13.3	17.9	17.3	19.1	22.2	17.0	22.1	27.7	19.2	13.3	12.8	24.3	15.1	39.0	20.2	19.5	18.0	11.5	31.7	16.3	27.9	31.3	11.5	12.8	29.0	23.5	21.6	20.2	20.2	20.0	18.8	22.6	23.4	33.3	9.7	13.1	17.9	5.4	7.1	8.4	4.1	8.3	3.9	4.2	3.8	5.0	5.8	3.4	4.3	4.0	12.5	5.2	8.9	8.0	1.9	4.7	15.1	25.2	10.2	20.6	19.2	5.2	10.8	6.1	11.3	3.7	7.7	12.5	17.6	16.0	19.1	45.1	32.9	26.6	20.8	25.7	26.7	60.2	30.0	22.0	33.8	40.0	23.0	11.0	54.2	47.0	35.2	41.1	13.7	23.1	14.4	35.6	23.8	19.1	21.6	28.0	46.7	23.6	27.9	23.2	23.0	45.3	7.6	18.1	22.5	46.1	26.0	74.0	41.7	29.9	10.2	55.7	51.1	30.4	31.7	37.1	21.4	31.9	43.3	42.3	25.7	37.7	44.2	31.6	24.0	44.4	27.1	30.3	50.2	44.8	41.1	44.9	46.0	30.5	30.0	46.8	36.8	38.5	34.1	104.7	25.7	24.2	31.4	27.1
PELI1		ENSG00000197329	"Pellino E3 ubiquitin protein ligase 1"	Q96FA3	2	64092652-64144420	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 228.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 224.1;Plasma cells: 318.8;Squamous epithelial cells: 208.0;Suprabasal keratinocytes: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 76.9"	"Group enriched"	"Detected in all"	4	"granulocytes: 76.9;monocytes: 23.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 58.8;U-698: 146.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Approved		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: AB_2682072"	"unprognostic (3.33e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.91e-2)"	"unprognostic (3.12e-3)"	"unprognostic (6.73e-3)"	"unprognostic (8.01e-3)"	"unprognostic (4.16e-2)"	"unprognostic (3.52e-3)"	"unprognostic (5.99e-3)"	"unprognostic (3.33e-1)"	"prognostic unfavorable (5.67e-6)"	"unprognostic (6.72e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.03e-1)"	27.6	7.9	10.2	28.1	14.4	228.5	25.7	11.9	13.5	17.9	9.2	18.6	17.6	17.3	8.6	42.9	12.7	26.1	11.8	13.8	11.2	10.6	13.5	31.0	24.7	12.2	11.2	5.5	9.3	37.9	15.8	15.6	12.2	8.9	20.1	5.1	18.9	7.7	7.1	29.7	23.2	13.9	12.6	21.8	18.1	10.7	10.9	28.3	9.7	10.0	29.0	22.4	23.7	15.6	3.6	2.8	36.5	24.6	4.2	3.2	8.3	4.8	5.4	4.3	6.8	58.8	4.1	48.3	11.3	1.7	1.6	5.8	11.1	10.5	8.6	12.2	8.9	4.4	1.7	9.5	12.4	4.8	8.3	4.2	8.1	6.4	21.6	4.5	24.3	18.2	2.7	11.7	3.7	0.3	10.6	6.9	23.8	11.1	1.7	13.2	12.6	28.1	17.7	10.8	16.7	23.3	3.6	5.5	12.9	11.3	3.0	3.3	17.5	4.0	5.7	4.0	7.1	27.0	2.8	146.7	2.1	4.3	10.9	15.0	15.6	15.0	0.9	14.1	1.7	8.5	4.8	1.9	5.4	6.6	5.6	2.5	76.9	3.0	23.2	0.5	11.6	6.6	10.2	14.4	11.9	13.5	13.8	11.2	12.2	11.2	12.2	12.6	10.9	15.6	94.5	28.9	49.2	4.6	84.4	224.1	74.6	48.2	105.9	1.7	60.9	50.3	5.7	15.7	52.0	5.5	0.0	1.7	16.9	57.9	1.9	5.3	10.6	34.6	26.4	52.1	25.7	3.4	23.4	26.7	8.6	24.5	75.4	58.7	15.2	6.3	37.5	7.5	22.8	3.3	19.1	23.4	30.5	67.6	103.7	11.2	1.5	107.0	112.1	119.9	30.6	5.5	3.1	82.9	67.9	20.9	45.9	1.9	318.8	44.7	32.7	9.6	43.6	2.0	0.0	10.1	51.9	8.4	9.6	208.0	217.5	4.0	49.4	3.2	32.4	145.8
PFKFB3		ENSG00000170525	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3"	Q16875	10	6144934-6254644	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 334.6;skeletal muscle: 621.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 153.8;Collecting duct cells: 195.0;Langerhans cells: 132.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 26.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 296.2;RPTEC TERT1: 181.8;T-47d: 192.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008266, CAB020795, HPA043889"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB020795: , HPA008266: AB_1855239, HPA043889: AB_2678717"	"unprognostic (1.61e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.89e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (1.89e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.74e-1)"	334.6	22.7	66.1	72.2	81.2	246.0	153.8	75.4	66.6	30.2	22.1	22.2	19.4	24.0	11.1	51.3	37.7	59.9	21.9	62.8	105.8	243.9	32.8	67.7	24.5	145.7	100.9	24.2	21.0	10.1	39.6	20.0	100.9	20.2	8.9	31.5	40.4	49.5	621.3	53.6	22.9	16.9	90.1	50.2	26.1	13.9	91.8	15.1	10.9	30.4	28.2	63.9	40.3	105.6	22.0	296.2	23.1	18.8	85.2	10.5	12.2	31.6	22.5	22.9	35.5	14.1	78.0	37.2	20.2	13.8	18.0	69.0	24.9	50.2	26.3	44.6	17.3	22.1	16.2	5.2	7.2	21.6	32.2	7.6	16.4	39.5	9.5	58.3	44.9	25.6	16.6	13.6	18.6	35.7	15.3	20.3	22.5	31.1	20.5	34.3	11.3	14.7	181.8	11.1	21.9	8.9	22.9	24.7	45.8	39.5	192.0	25.2	57.0	23.9	22.0	3.1	38.7	27.8	10.4	33.7	65.8	25.0	37.4	2.9	7.5	7.7	2.2	9.2	5.7	1.8	4.2	2.9	4.7	1.6	3.0	3.0	26.4	1.2	5.5	2.9	4.3	4.3	66.1	81.2	75.4	66.6	62.8	105.8	145.7	100.9	100.9	90.1	91.8	105.6	37.1	76.9	55.1	153.8	27.2	102.6	16.7	21.5	37.5	6.4	37.1	36.8	19.5	22.8	32.1	195.0	52.1	0.4	37.0	14.9	0.0	54.7	5.0	41.1	18.9	32.9	8.5	1.3	42.8	25.7	6.9	30.8	33.1	64.3	44.2	72.5	8.9	15.8	20.6	6.7	19.4	6.6	18.3	88.0	132.3	9.5	2.8	122.2	46.2	41.2	19.6	0.3	4.1	14.1	31.9	59.6	5.2	7.2	25.3	4.2	5.4	2.4	19.2	1.9	0.0	58.5	24.4	0.6	2.5	20.9	63.9	1.0	61.7	12.4	8.1	14.7
PIGA	GPI3	ENSG00000165195	"Phosphatidylinositol glycan anchor biosynthesis class A"	P37287	X	15319452-15335554	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	"Glycosyltransferase, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 83.5;Suprabasal keratinocytes: 55.0;Urothelial cells: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 22.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001174	Approved					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"			"HPA001174: AB_2666220"	"unprognostic (1.15e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.90e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.99e-3)"	"unprognostic (2.24e-2)"	"unprognostic (7.37e-3)"	"unprognostic (3.93e-3)"	"prognostic unfavorable (7.64e-4)"	"unprognostic (1.85e-3)"	"unprognostic (5.97e-3)"	"unprognostic (2.24e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.18e-2)"	2.1	2.9	2.2	2.9	2.7	9.2	3.1	2.0	3.6	2.8	0.8	3.7	1.9	3.0	3.5	5.1	2.8	3.7	2.0	1.6	1.8	3.8	4.5	6.7	3.5	2.8	2.7	2.4	4.0	3.3	0.6	3.6	2.2	2.7	3.7	4.5	4.6	1.7	1.3	1.4	2.4	2.5	2.2	2.0	2.8	2.6	2.3	4.0	4.4	1.3	4.7	10.3	1.9	5.8	14.5	8.3	9.1	5.0	2.6	2.8	7.0	3.7	5.7	7.4	7.3	9.2	6.5	6.6	2.9	2.9	9.0	5.8	14.3	11.4	12.6	6.1	9.5	5.5	11.0	5.8	4.5	8.8	2.9	3.3	8.1	10.0	16.0	2.4	5.0	5.2	6.4	7.0	5.1	9.2	9.0	3.4	4.7	5.5	8.2	3.0	12.4	10.7	5.6	9.4	6.2	9.4	6.9	6.8	14.4	8.7	6.6	7.4	4.2	6.2	2.4	14.0	7.3	5.4	7.2	9.9	9.4	5.6	7.9	22.9	3.8	4.3	2.6	6.3	3.7	3.0	4.1	2.6	3.9	2.1	3.8	2.9	5.2	1.8	8.6	2.6	4.1	2.7	2.2	2.7	2.0	3.6	1.6	1.8	2.8	2.7	2.2	2.2	2.3	5.8	6.4	19.2	83.5	6.8	7.2	29.6	41.9	10.6	13.6	3.5	13.2	10.5	6.9	5.7	20.1	3.7	0.0	6.3	7.4	8.4	11.7	7.6	5.4	30.8	9.8	7.9	10.7	9.3	2.2	5.8	10.2	12.7	17.9	45.6	33.6	3.0	3.6	4.4	8.8	3.3	2.0	5.0	2.0	8.4	43.4	4.4	3.1	18.1	28.4	2.8	3.6	4.2	4.1	1.0	7.7	8.3	5.1	3.0	5.5	32.0	2.1	6.6	19.8	3.0	13.1	10.6	16.3	2.7	3.7	35.5	55.0	28.0	11.7	2.9	6.0	62.2
PIM3		ENSG00000198355	"Pim-3 proto-oncogene, serine/threonine kinase"	Q86V86	22	49960768-49964072	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 408.4;Syncytiotrophoblasts: 389.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 20.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 163.3;SK-BR-3: 144.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068758			Supported	Cytosol		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA068758: AB_2686026"	"unprognostic (3.67e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (8.09e-4)"	"unprognostic (5.59e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.92e-3)"	"unprognostic (7.27e-3)"	97.8	48.4	25.9	31.3	31.3	114.3	80.2	32.8	38.1	49.2	26.9	55.1	23.8	40.8	12.7	80.8	54.0	25.8	68.7	25.2	32.6	113.3	92.9	107.1	28.2	40.6	36.1	35.7	73.1	21.6	51.3	21.3	38.0	87.3	10.4	3.1	93.5	22.6	112.0	116.4	51.6	9.9	30.3	80.7	118.1	33.9	35.2	19.0	54.9	35.0	13.0	71.0	68.6	39.9	26.8	17.7	11.6	21.9	9.0	6.7	65.5	16.5	26.7	19.4	14.0	29.5	22.3	47.3	20.1	4.6	39.1	22.5	22.3	12.6	6.9	35.8	92.1	19.5	46.3	36.0	41.8	42.5	36.0	12.8	41.0	11.9	20.2	10.5	63.5	31.7	27.0	163.3	5.9	60.6	21.7	76.4	24.2	28.1	27.8	100.3	19.2	57.6	10.6	20.3	41.1	28.6	32.2	144.7	109.2	10.7	19.0	56.4	16.8	12.1	51.5	19.8	27.1	82.2	56.9	41.4	30.1	24.1	33.2	0.0	4.0	0.1	2.2	4.1	2.5	4.3	5.0	4.4	3.1	7.5	4.8	1.9	20.7	1.7	5.2	7.0	5.8	2.7	25.9	31.3	32.8	38.1	25.2	32.6	40.6	36.1	38.0	30.3	35.2	39.9	120.2	64.1	85.9	6.5	107.7	227.3	236.8	79.1	96.8	31.5	99.2	67.3	32.8	121.5	72.8	80.9	2.1	56.9	79.5	57.9	84.1	50.9	5.1	114.2	76.3	167.7	97.7	10.8	10.2	54.5	346.5	69.0	202.3	170.5	69.3	16.8	98.6	45.9	69.7	62.2	6.7	101.7	81.4	41.1	408.4	4.8	32.3	134.8	108.5	6.5	35.8	14.0	11.3	6.6	20.5	71.0	94.6	11.3	95.1	298.4	58.1	88.5	40.9	16.5	26.3	39.4	57.3	26.1	37.7	95.3	204.7	389.9	90.4	11.6	79.0	266.0
PLAUR	"CD87, UPAR, URKR"	ENSG00000011422	"Plasminogen activator, urokinase receptor"	Q03405	19	43646095-43670547	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"bone marrow: 688.4"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 820.7;Langerhans cells: 1833.9;Macrophages: 864.3;Urothelial cells: 2274.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1172.3"	"Group enriched"	"Detected in all"	4	"granulocytes: 1172.3;monocytes: 550.7"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 311.7;U-251 MG: 413.1;U-87 MG: 346.9;WM-115: 346.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050843, CAB073533"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		4100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB073533: , HPA050843: AB_2681255"	"unprognostic (9.28e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.59e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.18e-3)"	"prognostic unfavorable (2.33e-5)"	"unprognostic (8.08e-3)"	"unprognostic (4.30e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (7.83e-9)"	"unprognostic (4.99e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.33e-2)"	52.1	10.4	7.5	81.7	9.8	688.4	14.5	11.2	32.4	30.9	10.3	26.7	10.0	30.2	4.8	11.6	22.8	78.1	23.0	8.1	10.4	18.2	19.8	69.5	10.6	12.2	9.8	14.9	13.6	5.4	9.1	35.9	13.3	11.5	20.1	2.8	21.7	5.8	3.6	7.8	10.6	26.2	9.7	20.4	28.4	3.1	24.8	10.2	9.5	4.7	8.6	109.7	15.8	13.8	83.9	31.0	26.1	1.9	23.4	83.3	16.2	180.7	189.6	114.6	141.4	2.4	95.1	2.4	43.0	116.9	66.8	35.2	7.0	46.4	127.9	5.3	5.3	15.8	44.7	3.9	30.6	18.8	195.2	87.4	9.0	311.7	46.5	160.6	129.0	19.1	16.4	2.2	107.7	6.1	21.0	55.3	8.7	156.1	64.7	24.0	17.4	5.6	35.9	3.8	1.3	22.2	82.0	17.4	25.0	12.6	3.2	59.4	129.7	230.0	121.1	109.8	413.1	3.0	9.0	0.6	346.9	36.0	346.5	87.7	476.5	745.5	6.8	427.9	8.3	2.7	8.9	5.7	213.6	1.4	3.2	4.0	1172.3	6.7	550.7	69.3	3.6	253.9	7.5	9.8	11.2	32.4	8.1	10.4	12.2	9.8	13.3	9.7	24.8	13.8	23.1	73.7	76.6	2.3	15.5	105.2	820.7	274.2	72.3	0.7	45.8	22.5	4.5	24.3	151.9	20.2	0.0	6.5	17.4	314.5	1.9	219.3	0.9	188.1	68.0	64.9	14.8	5.2	2.5	106.5	58.8	145.4	156.0	519.1	305.2	4.2	19.2	1.7	428.9	10.1	3.3	85.3	22.4	155.4	1833.9	2.0	6.8	864.3	72.9	5.6	52.1	1.2	4.1	1.5	0.9	558.8	435.5	4.1	14.5	479.4	12.7	2.7	52.7	0.7	6.6	38.5	90.0	1.2	4.7	202.6	63.1	13.1	33.2	3.1	29.3	2274.4
PMAIP1	"APR, NOXA"	ENSG00000141682	"Phorbol-12-myristate-13-acetate-induced protein 1"	Q13794	18	59899996-59904305	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 88.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 803.1;Endometrial ciliated cells: 463.6;Glandular and luminal cells: 529.8;Squamous epithelial cells: 474.5;Suprabasal keratinocytes: 691.2;Urothelial cells: 569.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 169.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 169.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 207.5;U-138 MG: 202.1"									HPA051063	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA051063: AB_2681330"	"unprognostic (1.35e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.88e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.26e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.12e-2)"	"unprognostic (8.47e-3)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (3.15e-6)"	"unprognostic (2.53e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.09e-1)"	2.0	0.7	2.8	8.0	2.7	88.1	3.9	2.6	5.1	6.5	3.0	2.5	3.7	5.4	0.2	13.7	2.9	8.0	0.9	2.6	2.8	2.3	2.1	3.8	14.7	2.8	2.7	0.7	1.2	14.8	16.7	13.4	3.0	3.6	3.4	2.0	3.6	1.3	1.5	24.1	3.9	1.9	2.7	4.6	2.5	3.1	3.7	12.1	2.1	1.5	14.2	17.3	7.9	2.4	26.6	17.4	5.2	1.6	8.8	69.0	19.8	125.4	84.1	71.5	70.7	1.7	32.5	104.6	17.0	23.5	207.5	38.4	21.0	11.8	70.4	33.7	154.5	19.4	26.0	4.6	87.6	67.1	28.2	28.7	30.8	93.8	48.5	26.1	24.0	46.7	26.7	17.5	24.1	2.6	53.8	20.1	151.7	2.7	32.7	54.1	28.8	39.1	41.9	24.2	39.7	32.7	6.1	3.2	71.5	56.1	5.3	54.6	90.6	202.1	54.0	10.3	141.4	2.8	0.3	92.1	16.8	37.6	48.5	169.8	16.7	103.6	10.9	26.2	9.6	33.8	5.0	6.8	12.1	25.0	4.1	5.9	53.5	6.3	32.1	10.2	25.2	15.1	2.8	2.7	2.6	5.1	2.6	2.8	2.8	2.7	3.0	2.7	3.7	2.4	29.2	32.1	25.7	0.7	175.3	803.1	316.2	236.4	415.4	0.2	111.8	82.0	4.7	12.8	129.6	3.7	2.1	120.3	125.3	141.1	0.0	54.7	0.8	463.6	48.8	48.5	133.4	5.5	0.0	67.0	14.7	32.9	168.2	529.8	31.8	11.8	7.9	0.5	89.5	0.0	0.0	146.8	181.0	37.2	363.3	1.1	0.9	140.6	74.7	7.5	142.4	0.3	34.0	0.0	0.2	100.1	123.6	1.2	63.1	265.7	94.7	0.5	101.5	0.7	0.0	10.8	32.0	0.3	19.8	474.5	691.2	315.2	117.0	19.8	122.2	569.2
PNPLA8	"IPLA2-2, IPLA2G, iPLA2gamma"	ENSG00000135241	"Patatin like phospholipase domain containing 8"	Q9NP80	7	108470417-108569666	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 236.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020083	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA020083: AB_1851849"	"unprognostic (4.48e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.61e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.49e-1)"	"prognostic favorable (1.86e-6)"	"unprognostic (3.16e-2)"	"unprognostic (3.64e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.24e-1)"	27.8	47.3	23.6	17.9	25.1	82.9	20.2	21.6	29.6	19.4	22.1	14.1	11.8	17.9	17.7	21.1	11.6	21.4	25.3	24.0	26.5	30.0	34.6	17.5	18.0	23.5	23.3	14.7	13.9	28.4	16.5	26.6	23.4	18.0	15.1	24.4	11.9	17.7	35.9	15.0	10.7	20.9	24.9	17.7	15.6	15.5	22.9	18.6	24.3	34.7	22.1	29.1	12.7	26.5	28.6	12.8	22.1	19.7	47.7	32.7	32.4	26.6	47.2	21.6	35.8	12.4	16.0	15.9	33.1	26.4	43.4	10.6	37.9	17.1	32.6	24.2	10.1	11.0	19.3	9.1	34.8	7.6	21.7	29.8	31.7	29.2	26.9	23.4	29.5	17.7	13.0	44.5	27.2	18.9	18.0	18.3	9.8	17.9	17.8	6.5	23.3	34.3	25.9	35.9	18.3	25.3	25.8	27.4	32.7	27.7	11.6	12.6	24.2	35.1	15.7	52.8	15.0	37.4	41.5	23.9	33.4	11.4	23.2	21.9	29.8	26.2	14.6	32.8	17.8	28.6	14.2	14.6	29.2	27.3	15.4	14.7	24.5	22.9	43.4	11.6	19.1	22.9	23.6	25.1	21.6	29.6	24.0	26.5	23.5	23.3	23.4	24.9	22.9	26.5	64.5	41.7	49.3	66.3	91.3	92.9	124.0	42.2	55.2	64.0	45.7	35.9	49.7	8.6	51.2	23.9	18.8	58.0	72.7	44.3	93.9	32.0	52.3	124.9	67.3	57.1	57.1	50.7	42.4	37.8	37.5	76.6	45.3	236.1	71.7	19.0	23.2	44.3	32.2	32.0	42.9	27.8	67.1	45.5	90.0	47.4	32.0	113.8	55.2	23.4	43.5	42.9	18.6	38.2	41.3	29.6	38.6	39.5	76.8	80.1	16.7	41.0	62.0	32.5	19.7	88.9	63.9	18.6	23.1	60.5	135.7	130.2	69.1	43.7	22.9	122.7
PNRC1	"B4-2, PROL2, PRR2"	ENSG00000146278	"Proline rich nuclear receptor coactivator 1"	Q12796	6	89080751-89085160	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 1848.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 212.8;hTCEpi: 234.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029839, HPA066513"	Approved		Approved	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nucleoli"		"HPA029839: AB_10601247, HPA066513: AB_2685684"	"unprognostic (9.02e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.29e-2)"	"prognostic unfavorable (6.88e-6)"	"unprognostic (8.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.09e-2)"	232.7	171.7	61.6	145.9	66.3	368.1	135.4	84.0	67.5	93.8	47.9	158.4	70.2	100.6	80.4	91.4	204.4	139.3	132.5	58.3	74.2	103.5	318.1	159.6	134.1	87.7	65.7	222.5	89.2	86.8	78.5	122.6	73.0	95.0	77.5	129.8	91.9	84.3	460.6	147.5	94.3	130.3	69.5	139.6	104.6	50.1	57.4	165.9	105.6	163.4	111.2	141.4	98.5	80.4	12.1	12.0	25.3	42.4	96.7	166.6	16.9	16.0	110.6	29.5	69.0	10.2	34.5	25.9	71.2	19.4	116.3	40.5	13.3	23.9	45.6	31.8	36.3	4.7	69.8	31.9	212.8	25.0	57.9	117.6	234.4	19.6	90.1	107.9	49.4	30.3	4.1	81.0	33.3	11.5	6.8	124.7	7.0	13.9	23.1	29.1	30.0	21.5	70.2	21.1	15.7	42.2	40.3	56.3	44.0	73.6	27.9	119.4	44.8	23.1	13.2	16.2	5.9	118.3	64.0	9.0	46.3	20.6	14.9	32.8	17.3	103.8	18.3	19.0	19.0	20.7	22.1	19.7	11.3	23.0	24.9	25.9	100.9	19.2	17.9	18.7	19.0	10.5	61.6	66.3	84.0	67.5	58.3	74.2	87.7	65.7	73.0	69.5	57.4	80.4	405.7	141.1	149.8	36.2	747.6	968.9	776.8	98.9	1286.2	130.6	412.5	381.5	188.6	230.2	65.2	90.1	50.1	235.8	662.8	158.1	234.8	203.5	103.4	528.4	655.3	356.1	248.0	284.1	10.0	238.2	78.6	720.1	225.8	955.1	164.6	153.2	238.5	207.6	229.4	72.3	15.5	200.7	34.6	452.6	1848.0	41.5	481.9	898.3	439.4	39.4	763.5	403.3	440.8	20.1	41.5	143.0	184.6	377.3	530.6	738.5	211.1	319.2	61.5	134.8	420.7	731.3	725.6	51.9	64.6	840.2	1250.8	274.5	735.8	214.3	136.9	472.8
POLR1F	"A43, RPA43, TWISTNB"	ENSG00000105849	"RNA polymerase I subunit F"	Q3B726	7	19695461-19709037	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 21.6;Cardiomyocytes: 23.1;Cytotrophoblasts: 40.3;dendritic cells: 24.9;Extravillous trophoblasts: 34.1;Hofbauer cells: 34.7;Macrophages: 16.7;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019071, HPA022416"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA019071: AB_1858465, HPA022416: AB_1858466"	"unprognostic (5.66e-3)"	"unprognostic (3.43e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (1.16e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.02e-2)"	"unprognostic (4.93e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.96e-1)"	8.6	7.9	5.8	8.0	6.4	17.2	10.2	6.1	9.2	8.9	5.6	7.3	5.6	11.9	5.1	9.5	6.6	6.2	7.8	6.2	6.8	8.0	8.7	6.3	10.5	6.1	6.8	8.8	7.5	9.1	2.7	10.8	6.1	9.7	7.0	3.2	6.1	8.9	7.1	7.6	5.3	11.8	6.6	7.8	5.8	6.2	6.5	8.6	8.7	8.3	12.9	12.2	4.6	7.6	28.0	20.9	15.1	22.6	17.1	21.1	11.7	15.7	11.8	17.9	20.7	17.2	23.9	31.0	44.6	19.6	22.7	24.6	30.9	29.2	33.3	9.9	23.7	28.8	15.9	13.3	26.2	59.4	20.0	19.2	20.3	19.7	23.4	12.1	29.7	21.3	45.0	27.2	26.1	10.1	32.9	55.3	39.3	28.9	23.4	26.3	26.0	32.6	29.7	14.2	10.9	16.4	14.3	38.3	20.0	24.6	15.5	52.5	25.0	37.0	19.8	34.5	38.4	34.4	22.8	77.5	25.0	86.9	55.5	5.7	4.5	1.4	7.9	6.0	12.0	12.5	9.4	10.5	7.0	13.0	10.7	12.6	0.4	17.4	5.9	9.0	9.3	5.8	5.8	6.4	6.1	9.2	6.2	6.8	6.1	6.8	6.1	6.6	6.5	7.6	21.6	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	40.3	24.9	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	34.1	10.3	0.0	0.0	0.0	0.0	0.0	0.0	34.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	16.6	3.0	0.0	0.0	0.0
PPIF	"Cyp-D, hCyP3"	ENSG00000108179	"Peptidylprolyl isomerase F"	P30405	10	79347469-79355334	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Necrosis"	"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 370.9;Macrophages: 160.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 75.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077416			Supported	Mitochondria		NA	NA		320000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"HPA077416: AB_2686840"	"unprognostic (2.21e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.72e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.16e-3)"	"unprognostic (3.45e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.82e-1)"	"unprognostic (9.37e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.88e-2)"	62.7	227.7	42.7	42.8	48.4	168.8	42.4	57.9	69.6	27.6	63.7	50.0	36.3	14.0	7.2	66.0	22.9	19.5	119.1	38.1	45.2	63.3	174.9	29.1	32.3	49.0	56.2	19.3	86.9	77.6	18.3	27.1	48.8	18.8	52.4	8.9	39.5	45.5	99.5	71.9	31.3	21.0	50.6	58.7	98.2	35.0	57.1	28.3	26.0	133.6	55.5	60.0	35.1	60.8	220.4	90.6	62.3	123.5	57.0	73.6	79.8	124.2	161.2	265.7	249.6	213.5	102.7	224.8	68.0	87.4	188.6	127.8	195.3	115.4	410.5	72.2	186.4	352.8	87.5	380.7	96.4	245.7	80.4	173.2	81.3	264.5	262.3	86.5	47.5	86.4	351.6	268.3	91.6	111.7	64.1	204.2	53.0	99.6	500.6	109.8	96.4	114.7	103.9	200.0	124.1	92.0	63.6	253.8	97.9	40.5	111.4	187.2	43.5	116.1	106.3	137.9	242.0	124.7	137.7	181.9	114.5	313.9	32.0	15.2	34.3	18.0	10.4	27.5	10.9	19.1	9.1	9.6	43.3	7.7	8.1	7.9	75.0	9.0	10.4	5.4	10.0	16.6	42.7	48.4	57.9	69.6	38.1	45.2	49.0	56.2	48.8	50.6	57.1	60.8	8.4	6.4	6.8	7.2	32.7	42.6	30.2	23.8	31.3	4.0	41.8	40.8	124.6	14.3	14.4	12.9	6.2	99.4	26.4	39.9	92.0	42.1	14.5	12.4	24.0	10.1	21.6	37.0	4.1	28.0	127.1	25.1	78.0	15.5	13.4	73.4	6.1	98.5	91.1	8.4	5.7	69.5	18.3	40.3	370.9	14.1	6.2	160.8	35.6	4.7	32.0	13.0	5.2	5.5	15.0	39.8	26.6	6.0	48.7	41.4	21.3	41.2	12.6	5.2	19.7	18.2	28.6	14.8	22.5	52.9	37.6	142.3	23.9	60.2	81.1	34.2
PPP1R15B	FLJ14744	ENSG00000158615	"Protein phosphatase 1 regulatory subunit 15B"	Q5SWA1	1	204403381-204411817	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Translation regulation"		"Diabetes mellitus, Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 125.7"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 171.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061088			Approved	"Golgi apparatus"		No	No			"Cluster 18: Basophils - Vesicular transport"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA061088: AB_2684426"	"unprognostic (2.91e-3)"	"unprognostic (8.61e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.37e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (8.74e-5)"	"unprognostic (9.52e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.50e-2)"	40.7	23.1	12.9	31.0	15.3	125.7	23.0	17.8	13.9	19.6	16.4	23.4	22.4	21.4	13.1	25.9	21.5	30.8	13.0	11.7	13.2	21.0	48.1	24.2	29.1	14.4	15.2	24.5	36.8	18.7	10.5	32.6	14.6	22.5	24.1	16.0	22.1	15.9	13.2	18.1	24.3	29.9	14.6	23.8	27.0	11.7	15.2	33.3	28.2	18.2	24.7	53.2	14.7	19.7	29.3	23.0	26.9	22.8	34.1	23.2	108.7	23.6	28.3	31.9	28.7	27.6	40.3	48.2	16.0	28.9	22.2	36.3	40.2	23.9	29.5	37.3	28.7	28.5	55.7	17.8	41.5	49.1	49.0	29.3	30.4	31.4	34.5	22.9	35.1	40.4	44.4	92.8	21.8	29.1	47.1	30.6	46.2	26.8	32.9	33.2	48.9	49.8	32.0	35.4	25.7	39.3	42.6	59.8	49.3	36.0	39.4	50.2	19.8	22.2	31.3	28.6	40.3	62.5	30.0	47.3	20.0	33.1	23.4	13.1	5.5	5.7	3.2	5.1	3.4	2.0	3.2	3.0	5.0	2.1	4.9	3.5	11.8	3.2	6.2	2.0	4.4	2.9	12.9	15.3	17.8	13.9	11.7	13.2	14.4	15.2	14.6	14.6	15.2	19.7	72.2	48.1	37.9	15.3	40.8	73.7	43.0	23.1	48.3	18.5	43.7	24.6	15.6	32.9	25.9	18.4	20.9	22.9	40.3	70.4	3.9	15.9	9.0	72.0	90.8	50.9	44.7	27.3	12.3	24.0	42.7	54.7	76.5	146.7	49.4	31.0	28.9	48.6	31.8	8.4	13.0	43.3	22.4	42.0	171.9	4.6	13.1	97.9	49.8	10.3	36.8	14.4	11.3	18.1	23.2	30.3	40.5	12.8	50.9	55.0	39.5	11.0	43.0	18.5	6.6	72.7	48.6	17.2	13.2	39.8	64.2	49.3	46.8	31.2	35.6	104.5
PPP1R3G		ENSG00000219607	"Protein phosphatase 1 regulatory subunit 3G"	B7ZBB8	6	5085341-5089487	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 5.9;liver: 6.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 18.5;Glandular and luminal cells: 7.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.3;PC-3: 3.9;THP-1: 14.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA056393	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA056393: AB_2683115"	"unprognostic (1.99e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.56e-3)"	"unprognostic (8.64e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.71e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.27e-1)"	2.3	3.0	2.3	0.3	2.1	0.1	1.4	1.5	2.7	2.1	0.9	2.0	0.2	1.2	1.0	1.8	1.0	0.3	5.9	2.0	1.8	0.6	6.2	0.3	0.5	2.3	2.3	0.8	0.1	0.3	0.2	0.7	1.9	1.2	0.5	0.2	0.6	1.4	0.5	1.2	0.5	0.5	1.6	2.8	0.6	0.2	2.2	0.2	0.3	0.2	0.4	2.8	2.1	1.7	0.0	0.2	0.1	0.0	1.6	1.0	0.0	0.3	0.4	0.2	0.3	0.0	0.3	0.0	3.3	0.6	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.1	0.3	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	3.9	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.5	0.0	0.0	0.3	0.0	14.6	0.0	0.0	0.0	0.8	0.5	2.0	1.7	0.0	0.6	0.0	0.1	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	2.3	2.1	1.5	2.7	2.0	1.8	2.3	2.3	1.9	1.6	2.2	1.7	4.2	0.0	0.0	0.0	0.4	0.5	0.5	0.4	0.0	0.5	0.2	0.1	18.5	0.0	0.1	3.7	0.0	0.8	0.0	1.3	0.0	0.3	0.0	1.2	2.0	1.9	1.2	0.0	0.0	0.0	0.4	3.7	0.0	7.2	0.0	1.4	2.9	0.0	4.5	0.0	0.0	0.9	0.0	4.0	4.7	0.2	0.9	1.8	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.6	1.8	3.0	1.8	0.4	0.0	2.1	0.2	0.2	0.0	2.0	2.5	0.1	0.9	0.2	0.3	0.8	0.2	0.5	1.4	1.2
PPTC7	TA-PP2C	ENSG00000196850	"Protein phosphatase targeting COQ7"	Q8NI37	12	110533245-110583318	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 140.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039335, HPA040614"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"		"HPA039335: AB_10805474, HPA040614: AB_10795526"	"unprognostic (2.44e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.43e-5)"	"prognostic unfavorable (6.76e-4)"	"unprognostic (1.09e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (5.34e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.83e-1)"	18.8	25.5	6.9	16.1	7.3	52.3	13.4	12.1	11.1	15.5	8.3	15.7	13.4	14.3	6.4	21.6	11.3	15.0	40.0	6.5	14.1	21.5	21.0	15.6	20.7	12.7	12.4	13.1	13.2	30.6	8.4	10.7	12.1	12.3	16.7	15.6	17.8	13.4	88.7	21.5	13.2	16.1	9.2	15.2	11.9	14.0	13.0	18.4	11.6	140.0	18.4	19.0	19.1	7.4	24.3	13.6	11.4	12.0	27.8	24.3	16.3	10.9	14.3	11.7	11.7	15.4	9.3	42.2	11.1	10.8	16.7	23.0	23.1	25.3	23.5	30.9	19.1	37.5	14.4	16.7	26.3	41.8	29.6	21.0	40.7	16.6	48.4	17.4	22.5	28.8	28.3	11.7	19.2	6.3	37.2	35.7	16.1	13.0	25.0	30.7	15.3	25.8	48.7	26.7	18.4	14.2	20.6	28.2	24.4	11.0	13.4	22.1	25.9	10.7	11.5	32.8	18.6	33.5	40.0	46.7	18.0	22.6	21.4	0.0	0.6	0.5	0.8	0.5	0.8	0.4	0.6	0.6	0.4	0.7	0.7	0.6	2.1	0.6	0.4	0.5	0.5	0.2	6.9	7.3	12.1	11.1	6.5	14.1	12.7	12.4	12.1	9.2	13.0	7.4	14.1	22.4	28.3	16.0	35.7	91.9	53.1	33.9	56.9	8.6	20.2	12.8	105.4	12.8	36.0	9.2	14.6	7.5	28.2	36.7	17.6	7.7	29.7	34.4	20.4	22.3	16.8	7.8	15.5	8.2	8.4	26.1	12.8	63.3	23.5	8.6	15.4	29.5	17.4	13.5	19.8	15.2	30.5	28.3	97.6	33.2	11.5	30.8	33.8	21.5	31.9	4.8	20.6	19.1	11.7	14.6	15.1	9.8	28.2	57.3	16.5	13.1	35.4	23.8	13.1	22.8	22.4	15.9	24.1	57.1	104.3	6.7	28.7	8.2	17.2	77.5
PREX1	"KIAA1415, P-REX1"	ENSG00000124126	"Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1"	Q8TCU6	20	48624252-48827999	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 52.5;brain: 78.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 87.1;dendritic cells: 84.0;Kupffer cells: 104.7;Macrophages: 76.5;Microglial cells: 95.5;NK-cells: 90.6;Oligodendrocytes: 190.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 157.9;SK-BR-3: 162.2;T-47d: 145.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001927	Supported		Supported	Vesicles,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Cytosol"		"HPA001927: AB_1079674"	"unprognostic (8.07e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.47e-2)"	"prognostic favorable (8.56e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.70e-2)"	"unprognostic (5.86e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-2)"	14.8	10.6	32.8	37.4	56.4	52.5	15.0	43.2	47.2	12.3	1.2	7.0	6.3	4.0	1.4	6.4	4.7	13.0	6.7	32.1	42.0	4.8	5.2	26.8	36.6	52.1	52.0	2.5	5.3	6.9	7.6	11.7	53.8	4.8	6.0	3.9	5.3	3.4	6.6	3.5	12.7	7.7	43.5	42.9	8.8	6.0	45.3	9.8	9.4	8.6	21.8	12.3	3.2	78.1	2.3	6.1	78.4	0.0	1.3	5.7	27.2	2.7	3.5	11.2	2.8	0.4	0.3	16.4	49.5	7.2	21.4	1.0	4.1	0.2	7.5	3.7	2.0	2.4	8.8	0.0	4.6	9.0	51.1	6.3	0.0	25.7	0.0	7.6	68.4	7.2	0.2	0.6	14.8	157.9	0.2	24.7	3.1	8.1	6.4	24.1	22.8	9.8	0.5	0.0	16.5	2.4	14.7	162.2	17.8	4.4	145.0	67.4	77.2	4.5	15.6	0.2	4.6	0.9	3.5	20.1	72.4	17.8	24.3	4.5	1.9	2.2	3.7	2.2	2.2	1.5	2.0	3.2	1.6	1.4	0.3	1.1	9.2	1.8	2.0	1.3	7.3	2.0	32.8	56.4	43.2	47.2	32.1	42.0	52.1	52.0	53.8	43.5	45.3	78.1	43.2	3.2	6.6	87.1	35.4	2.5	0.3	0.4	1.2	0.3	40.0	21.5	3.7	2.8	2.6	1.8	8.4	0.7	84.0	0.9	0.0	0.2	3.5	3.5	4.7	24.5	1.2	14.1	13.3	1.2	4.4	10.3	4.1	6.2	1.3	0.7	20.7	1.9	32.1	0.0	4.6	1.8	0.0	104.7	28.2	2.9	0.9	76.5	8.8	95.5	47.1	19.4	90.6	49.3	190.2	0.1	1.0	0.4	23.3	0.7	0.3	0.2	4.5	0.7	0.0	18.1	3.3	2.2	11.6	0.4	2.4	9.3	63.9	41.2	4.5	0.7
PRNP	"AltPrP, CD230, CJD, GSS, PRIP, PRP"	ENSG00000171867	"Prion protein"	P04156	20	4686350-4701590	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell cycle, Growth arrest"	Prion	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 412.6;Basal squamous epithelial cells: 369.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	9	"basophil: 875.9"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 875.9"	"Cell line enhanced"	"Detected in many"		"WM-115: 1039.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042754, HPA043398"	Enhanced		Approved	"Nuclear membrane,Vesicles,Cytosol"		NA	Yes		5100000	"Cluster 38: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nuclear membrane, Cytosol"	Vesicles	"HPA042754: AB_10964203, HPA043398: AB_2678461"	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.96e-4)"	"prognostic unfavorable (4.64e-4)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (7.41e-5)"	"unprognostic (7.60e-3)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.75e-2)"	"unprognostic (7.28e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.69e-2)"	87.0	92.4	283.8	52.4	308.4	83.7	106.7	255.1	385.9	135.4	415.8	184.2	37.1	125.5	59.1	79.2	79.9	110.1	197.5	315.6	244.8	132.8	79.7	79.2	59.8	262.8	260.8	163.7	41.5	62.8	83.8	66.9	270.1	146.1	70.5	178.6	60.3	148.2	64.0	95.4	47.4	140.8	265.0	75.2	61.6	68.1	302.5	47.9	89.1	74.0	60.0	124.9	83.4	292.8	226.4	141.6	41.7	64.2	329.6	199.9	36.6	363.4	527.6	175.5	177.7	50.0	171.5	40.9	79.2	727.9	391.8	508.8	45.9	498.3	326.2	31.8	39.0	0.2	19.6	193.8	402.0	72.8	16.5	177.5	711.9	701.8	583.9	257.0	152.8	28.6	22.8	142.9	205.1	45.7	28.8	46.2	33.1	99.8	266.4	33.9	110.0	38.3	88.7	40.3	49.2	7.0	98.9	144.3	554.1	56.4	30.2	38.8	224.5	282.9	127.1	158.6	296.1	63.1	129.5	132.9	226.8	51.9	1039.0	875.9	74.1	5.4	67.3	60.9	100.7	25.1	56.9	55.8	62.9	25.6	33.5	40.1	4.6	23.6	50.4	24.6	72.8	72.7	283.8	308.4	255.1	385.9	315.6	244.8	262.8	260.8	270.1	265.0	302.5	292.8	44.9	80.1	45.4	120.2	85.3	412.6	211.8	132.5	369.3	265.4	60.8	103.0	257.7	32.9	68.2	33.1	116.7	7.7	71.8	2.6	11.7	58.1	6.0	14.1	73.2	66.7	29.9	31.8	125.5	14.7	6.3	177.4	14.8	18.2	173.0	25.5	41.0	36.2	63.6	45.4	170.8	5.4	40.7	219.1	200.4	13.6	143.2	126.3	168.9	59.0	54.5	142.4	42.2	95.0	158.8	18.7	4.5	170.0	47.0	120.3	2.2	84.0	38.1	99.0	13.1	73.0	82.3	36.6	4.5	81.6	284.4	14.4	107.2	10.3	8.8	122.6
PTGS2	COX2	ENSG00000073756	"Prostaglandin-endoperoxide synthase 2"	P35354	1	186671791-186680922	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 116.7;seminal vesicle: 127.4;urinary bladder: 162.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 342.9;Fibroblasts: 270.7;granulocytes: 347.6;Langerhans cells: 305.6;Macrophages: 173.1;Urothelial cells: 151.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	16	"neutrophil: 11.7"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 11.7"	"Cell line enriched"	"Detected in many"	4	"BJ hTERT+: 405.5"	"Region enhanced"	"Detected in many"		"hippocampal formation: 15.1"	"Low region specificity"	"Detected in many"			"CAB000113, HPA001335"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum, Vesicles"		"CAB000113: , HPA001335: AB_1079712"	"unprognostic (1.36e-3)"	"unprognostic (9.97e-3)"	"unprognostic (3.97e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.96e-2)"	"unprognostic (9.50e-2)"	"unprognostic (9.03e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.07e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (8.04e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.74e-2)"	17.0	7.9	1.4	13.9	2.5	116.7	3.0	1.1	4.1	62.2	2.7	14.9	2.6	8.9	0.7	6.9	5.1	31.6	11.7	1.9	1.4	10.2	8.0	34.3	8.9	2.0	1.6	2.6	2.2	5.6	3.1	8.4	1.5	25.0	9.9	0.3	1.2	127.4	0.4	1.6	3.6	12.2	1.9	2.8	14.8	0.2	1.8	5.2	3.2	6.5	0.6	162.5	2.2	2.6	0.0	21.8	0.1	0.0	2.5	2.1	0.0	93.4	405.5	0.6	3.6	15.0	17.2	0.0	0.0	0.1	2.5	12.2	0.0	7.6	1.3	0.0	0.0	0.8	2.2	0.0	13.2	0.0	0.2	0.8	2.7	11.3	28.7	1.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	0.0	5.5	1.5	0.0	1.0	0.0	0.9	2.7	0.0	0.1	1.5	19.3	0.6	13.5	0.6	0.2	0.0	0.0	27.7	0.4	2.3	0.0	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	11.7	0.0	0.4	0.0	0.0	0.0	1.4	2.5	1.1	4.1	1.9	1.4	2.0	1.6	1.5	1.9	1.8	2.6	5.2	342.9	77.7	0.0	7.4	118.8	59.1	72.8	12.5	0.0	2.6	12.8	2.5	0.0	79.7	0.0	0.0	0.2	4.2	0.3	0.0	0.8	0.2	50.0	9.9	31.1	1.2	3.6	3.8	0.2	0.3	270.7	2.0	98.9	347.6	3.8	13.6	0.2	12.1	0.0	1.0	1.0	8.2	21.0	305.6	0.0	0.0	173.1	35.6	3.7	3.4	0.1	0.0	0.0	0.1	4.9	0.1	0.0	2.0	122.6	0.2	0.3	13.1	0.3	0.0	1.8	12.8	0.1	0.4	3.3	28.4	0.5	10.8	3.7	1.2	151.6
PTPRE	PTPE	ENSG00000132334	"Protein tyrosine phosphatase receptor type E"	P23469	10	127907103-128085855	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 46.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 256.6;Inhibitory neurons: 191.6;Langerhans cells: 307.9;Macrophages: 276.3;Oligodendrocyte precursor cells: 247.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 634.6;plasmacytoid DC: 475.9"	"Group enriched"	"Detected in all"	12	"dendritic cells: 475.9;granulocytes: 634.6;monocytes: 175.4"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 38.6;HUVEC TERT2: 41.6;NB-4: 32.5;TIME: 79.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015870, HPA021872"	Supported		Approved	"Intermediate filaments"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	"Intermediate filaments"		"HPA015870: AB_1855759, HPA021872: AB_1855760"	"unprognostic (5.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.67e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.56e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (4.08e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.59e-2)"	13.6	16.7	13.9	25.3	8.9	46.9	6.7	5.7	13.9	3.9	7.7	9.2	9.5	3.5	2.6	7.9	4.9	10.3	10.6	14.2	11.1	4.3	4.4	16.0	16.4	11.6	9.0	1.6	2.7	2.7	5.0	7.8	10.7	3.4	9.3	1.0	5.8	2.4	1.3	4.7	12.9	7.4	10.8	20.6	7.4	2.6	10.7	8.6	5.5	3.1	9.8	12.7	4.4	14.2	4.3	0.9	0.5	0.0	2.5	0.4	7.5	0.1	0.0	1.6	3.6	1.7	25.1	3.3	2.6	2.1	5.2	2.3	2.1	12.2	0.7	4.0	1.9	0.4	1.4	0.0	4.1	16.2	11.6	0.8	6.9	6.1	12.1	38.6	41.6	10.3	0.0	1.9	2.6	4.0	4.9	32.5	0.2	4.6	1.5	19.1	2.6	6.4	6.8	18.0	0.0	2.5	7.4	1.3	0.3	1.8	0.6	20.1	79.5	1.7	1.8	7.8	8.9	0.9	1.3	4.6	11.3	12.5	0.0	174.3	175.4	147.2	36.6	64.5	22.3	7.7	16.5	25.1	97.9	8.3	11.5	19.6	634.6	31.6	54.9	475.9	26.7	43.3	13.9	8.9	5.7	13.9	14.2	11.1	11.6	9.0	10.7	10.8	10.7	14.2	25.0	83.3	57.2	22.5	26.2	59.5	54.3	42.4	15.9	5.2	14.2	23.6	20.3	8.6	23.7	3.7	0.0	43.2	256.6	15.7	0.0	3.7	2.1	3.6	10.6	78.0	6.7	10.3	112.7	4.4	67.4	17.5	10.7	7.7	31.6	3.7	47.5	2.3	57.5	0.0	191.6	15.8	18.3	166.7	307.9	2.5	0.6	276.3	24.9	165.8	139.5	0.0	150.4	247.3	93.4	49.2	13.3	0.4	38.5	21.3	13.9	2.2	7.8	0.9	0.0	86.0	12.8	0.5	1.9	20.4	64.6	17.0	59.3	9.2	11.7	40.3
RAB31	Rab22B	ENSG00000168461	"RAB31, member RAS oncogene family"	Q13636	18	9708275-9862551	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 180.9;Kupffer cells: 283.8;Langerhans cells: 208.9;Macrophages: 221.6;monocytes: 193.2;Oligodendrocyte precursor cells: 184.0;Syncytiotrophoblasts: 186.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 137.9"	"Group enriched"	"Detected in many"	8	"dendritic cells: 44.9;granulocytes: 137.9;monocytes: 51.6"	"Cell line enhanced"	"Detected in many"		"GAMG: 175.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019717	Approved					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"			"HPA019717: AB_10601493"	"unprognostic (4.61e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.70e-2)"	"unprognostic (3.07e-2)"	"unprognostic (5.99e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.98e-3)"	"unprognostic (8.71e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.34e-2)"	35.0	104.8	83.1	42.2	90.5	59.7	22.2	89.1	92.6	85.2	67.7	45.8	11.1	56.2	9.4	31.8	28.8	45.6	20.9	75.9	93.1	16.3	10.5	58.9	22.4	96.6	95.1	44.2	7.0	8.6	10.0	56.5	96.8	21.3	17.7	12.6	13.7	48.7	5.4	12.9	23.7	85.8	91.5	31.3	31.7	42.6	99.3	9.8	25.9	10.5	22.6	54.5	35.2	92.1	2.7	14.4	105.0	0.2	136.7	70.5	74.6	25.4	71.0	18.2	15.8	4.1	14.4	0.1	16.6	99.7	175.3	9.9	25.9	32.6	21.1	6.5	14.6	89.3	104.4	1.8	158.0	7.4	94.2	76.5	6.6	42.1	32.5	78.0	47.4	0.0	22.2	0.4	42.6	11.9	0.1	11.5	22.2	1.2	6.3	0.1	11.5	3.7	13.9	0.3	2.0	6.8	96.4	60.7	34.7	87.5	6.9	48.4	51.9	112.9	56.4	78.3	37.5	19.4	5.7	0.1	153.7	0.1	47.1	137.9	51.6	21.3	0.1	47.2	0.1	9.8	0.2	0.1	44.9	6.7	0.1	0.1	74.4	4.3	50.2	5.2	0.2	19.5	83.1	90.5	89.1	92.6	75.9	93.1	96.6	95.1	96.8	91.5	99.3	92.1	10.0	176.3	33.3	91.4	32.4	15.8	17.7	30.8	23.3	3.2	13.2	12.6	10.6	12.8	51.2	11.0	0.0	180.9	11.0	8.7	7.9	7.9	5.4	10.2	86.0	33.1	0.0	2.5	8.1	19.6	19.0	55.5	5.6	6.2	7.6	72.9	30.0	1.9	157.0	151.4	19.6	0.6	8.2	283.8	208.9	10.9	17.7	221.6	7.2	75.9	193.2	21.5	4.1	184.0	7.0	19.4	1.4	117.4	12.0	27.3	0.0	4.0	47.0	3.9	39.5	14.0	87.3	1.7	4.2	14.5	16.1	186.6	5.1	36.3	0.3	38.8
RAB7B	"MGC16212, MGC9726"	ENSG00000276600	"RAB7B, member RAS oncogene family"	Q96AH8	1	205976740-206003461	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 52.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 13.6;Cytotrophoblasts: 29.0;Fibroblasts: 13.6;Hofbauer cells: 32.8;Squamous epithelial cells: 12.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"myeloid DC: 5.1"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 5.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 26.3;HBEC3-KT: 33.6;HL-60: 22.0;HMC-1: 89.1;hTCEpi: 38.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"				"unprognostic (4.18e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (6.99e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.23e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.13e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.82e-3)"	8.0	0.9	1.7	5.2	3.2	1.3	11.0	3.5	2.5	8.5	1.6	2.7	2.8	6.9	5.9	20.2	5.6	15.0	5.1	1.6	2.2	0.6	2.4	8.8	8.5	4.3	3.5	3.5	1.3	0.6	1.8	7.1	3.0	5.8	3.1	0.8	7.2	7.5	2.1	52.1	2.5	8.0	4.1	3.8	7.0	1.1	5.7	6.7	8.1	2.2	4.9	8.2	15.5	7.0	1.5	0.1	0.7	0.8	1.9	14.5	3.5	6.8	8.1	2.8	2.6	0.9	2.4	0.0	2.3	26.3	2.9	6.6	0.0	33.6	0.9	0.3	0.0	0.0	0.0	0.8	0.1	22.0	89.1	4.9	38.2	5.2	0.1	1.7	0.1	0.0	0.4	0.0	1.9	0.4	0.1	13.3	0.3	1.1	0.0	0.0	1.9	0.7	0.8	0.3	0.0	0.1	0.9	0.0	4.4	6.9	2.3	7.5	0.0	1.9	4.5	1.8	0.5	0.1	0.0	0.0	12.0	9.3	3.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	1.7	3.2	3.5	2.5	1.6	2.2	4.3	3.5	3.0	4.1	5.7	7.0	0.8	3.2	3.9	1.3	0.2	0.0	8.3	0.0	13.6	0.0	1.9	5.5	0.7	4.3	6.2	0.0	0.0	29.0	0.1	0.0	0.0	3.6	0.0	0.8	7.9	0.7	0.0	0.0	1.7	0.2	1.0	13.6	3.6	0.6	2.5	0.4	0.7	0.1	32.8	0.0	0.1	0.0	0.0	6.4	0.0	0.8	1.8	11.0	0.0	1.9	4.1	3.1	0.0	0.0	8.2	0.6	0.1	3.4	0.1	0.7	0.0	0.0	0.0	0.4	0.0	3.2	2.8	0.0	0.1	12.6	0.0	6.3	0.8	0.1	0.0	1.9
RAP2C	DKFZp313B211	ENSG00000123728	"RAP2C, member of RAS oncogene family"	Q9Y3L5	X	132203024-132219480	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 92.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"				"unprognostic (1.37e-2)"	"unprognostic (8.80e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (2.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.00e-1)"	16.2	16.5	8.2	19.7	8.2	52.7	11.6	7.6	11.0	11.5	7.3	12.1	17.1	92.1	30.7	16.5	18.8	13.1	13.1	7.4	8.1	21.5	46.9	14.8	26.2	9.6	8.2	11.6	12.7	7.7	5.3	20.9	8.6	11.1	14.1	5.9	11.2	12.3	24.3	15.3	14.9	55.2	8.9	20.3	14.0	7.1	9.4	20.8	9.0	16.1	25.6	15.3	12.8	8.6	20.9	17.1	24.7	27.0	20.8	33.2	35.4	23.9	30.6	23.6	23.9	15.9	25.2	31.1	36.9	27.2	21.3	15.9	23.0	24.2	30.6	54.3	20.2	23.8	19.7	24.3	31.6	39.7	31.9	26.9	27.3	26.2	27.9	24.0	26.6	17.6	19.1	29.9	26.1	33.6	23.0	32.2	16.9	22.0	22.9	16.9	18.8	31.1	31.3	14.3	4.9	26.2	13.7	17.4	26.8	38.2	28.2	22.0	20.9	23.9	13.0	48.2	44.9	28.0	24.2	29.5	26.9	38.6	21.4	6.8	3.9	10.7	4.6	8.9	5.6	4.7	5.4	4.9	4.4	3.6	5.0	5.9	8.1	6.8	14.4	2.2	6.1	3.6	8.2	8.2	7.6	11.0	7.4	8.1	9.6	8.2	8.6	8.9	9.4	8.6	13.7	9.6	9.7	8.8	39.9	32.2	16.6	11.8	17.6	5.9	13.5	7.6	20.5	8.6	8.4	22.0	4.2	33.6	45.0	25.2	76.3	10.1	0.4	14.5	13.0	15.5	5.4	9.5	4.0	13.2	37.7	17.5	20.4	17.8	13.3	8.6	16.1	46.3	24.6	8.4	4.2	9.6	20.3	37.7	53.2	2.2	20.2	36.1	32.0	13.1	24.9	22.7	29.9	7.5	6.8	20.7	17.4	15.1	28.0	16.8	20.3	18.2	11.5	6.4	6.6	13.2	14.9	4.9	3.7	29.6	32.8	74.6	34.5	14.2	11.4	21.1
RAPGEF1	"C3G, GRF2"	ENSG00000107263	"Rap guanine nucleotide exchange factor 1"	Q13905	9	131576770-131740074	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 228.6"	"Cell type enhanced"	"Detected in all"		"Horizontal cells: 131.2;Langerhans cells: 108.6;Microglial cells: 123.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006426, HPA075984"	Enhanced		Supported	Vesicles		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA006426: AB_1856070, HPA075984: AB_2686771"	"unprognostic (1.00e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (5.66e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.73e-2)"	37.3	24.0	41.4	53.9	72.6	53.2	26.8	27.0	37.1	20.4	37.9	31.9	23.9	25.6	8.0	23.6	25.5	23.7	57.8	40.8	40.2	23.0	23.0	43.3	56.1	35.8	36.9	16.3	47.8	20.1	16.4	56.4	32.3	21.5	23.4	27.5	20.2	21.4	228.6	21.9	35.3	30.4	25.6	41.9	29.1	15.9	43.8	35.1	22.7	104.8	63.1	25.8	18.2	20.2	34.5	39.4	39.1	39.6	39.1	42.0	149.2	29.0	59.0	33.0	23.6	49.0	22.1	61.9	35.6	58.8	70.7	61.4	45.1	40.5	16.4	144.6	18.6	18.3	67.2	26.2	32.8	76.1	80.4	32.2	73.0	43.3	51.0	33.1	60.4	70.8	49.7	119.1	43.4	35.7	54.0	27.0	39.6	34.1	35.2	53.0	91.0	86.8	14.9	41.1	33.0	32.9	42.5	39.8	42.3	39.0	38.1	63.1	64.4	88.1	36.7	56.4	44.7	39.8	37.3	122.0	41.9	32.0	21.6	3.1	1.2	1.6	3.4	2.2	2.0	4.9	2.3	2.3	1.4	2.9	0.5	1.5	1.3	1.3	2.4	1.6	1.8	1.6	41.4	72.6	27.0	37.1	40.8	40.2	35.8	36.9	32.3	25.6	43.8	20.2	73.5	6.4	13.8	27.1	35.6	18.7	9.3	10.9	5.2	19.5	10.8	13.5	16.2	14.3	12.3	5.5	14.6	22.7	49.7	23.3	5.9	8.2	2.6	13.0	9.4	43.0	12.1	1.7	47.5	18.6	35.3	11.8	17.9	17.8	20.3	14.0	22.5	17.4	26.4	131.2	66.6	14.9	8.2	23.9	108.6	2.5	8.7	51.6	32.0	123.7	59.8	19.7	27.8	61.3	24.7	17.1	19.1	12.0	88.0	11.7	16.8	9.2	16.7	13.4	6.6	13.4	10.3	5.1	11.8	5.6	11.4	51.7	31.0	5.8	14.0	10.8
RARA	"NR1B1, RAR"	ENSG00000131759	"Retinoic acid receptor alpha"	P10276	17	40309180-40357643	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 52.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 221.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058282, HPA071548"			Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nucleoli, Actin filaments, Cytosol"	"HPA058282: AB_2683666, HPA071548: "	"unprognostic (8.05e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.48e-3)"	"prognostic favorable (2.60e-4)"	"unprognostic (8.67e-3)"	"unprognostic (4.87e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.59e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-2)"	47.6	21.1	3.2	28.3	4.4	59.6	37.2	7.2	16.5	43.7	5.1	31.0	28.4	32.2	10.7	14.9	40.7	41.3	40.8	7.0	5.7	24.1	42.3	58.4	16.4	5.3	2.7	40.8	14.7	11.3	30.6	25.7	2.8	29.8	13.2	18.3	20.6	21.3	62.6	24.8	32.2	28.6	1.8	41.7	22.9	28.8	4.9	10.0	26.9	17.4	11.8	30.3	30.2	4.3	18.0	41.9	11.8	20.5	23.4	35.9	12.5	14.9	21.8	21.5	13.6	28.6	15.1	9.6	22.7	33.2	18.9	51.1	14.2	33.9	12.0	77.5	21.4	26.6	21.2	29.8	37.0	9.4	81.3	48.2	10.0	22.7	29.2	75.8	30.9	8.4	17.6	20.2	23.7	221.5	6.4	34.2	10.7	16.2	13.3	12.9	71.3	37.0	12.2	14.4	5.4	40.5	31.0	124.8	42.1	11.7	119.1	36.6	35.8	25.3	45.3	44.2	15.4	48.7	16.9	8.3	38.4	18.7	77.1	26.3	8.9	34.6	3.2	14.6	5.1	2.0	3.6	3.8	12.4	1.7	1.5	2.8	52.6	5.9	19.5	3.8	3.1	5.0	3.2	4.4	7.2	16.5	7.0	5.7	5.3	2.7	2.8	1.8	4.9	4.3	35.6	3.2	7.0	2.3	43.4	19.5	25.6	8.4	18.8	23.2	35.4	17.5	3.8	10.0	5.5	7.3	6.2	2.2	36.9	41.2	13.7	16.7	60.5	20.7	22.0	28.4	9.6	5.7	5.4	19.2	5.8	28.5	10.7	18.4	35.5	13.9	26.0	28.8	12.3	3.3	2.6	13.1	6.1	45.4	65.5	66.2	41.7	56.9	28.4	2.8	26.1	11.8	6.2	4.0	0.3	22.0	33.1	23.0	21.0	13.4	70.9	17.7	4.9	10.2	32.9	42.1	26.7	3.6	7.6	7.1	18.9	5.2	31.7	6.5	16.5	19.3
RASGEF1B	"FLJ31695, GPIG4"	ENSG00000138670	"RasGEF domain family member 1B"	Q0VAM2	4	81426393-82044244	"Predicted intracellular proteins, Predicted membrane proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 118.7;granulocytes: 107.0;Langerhans cells: 282.6;Macrophages: 141.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 11.9;memory B-cell: 9.7;naive B-cell: 12.4;non-classical monocyte: 20.6;plasmacytoid DC: 28.0"	"Group enriched"	"Detected in all"	5	"B-cells: 12.4;dendritic cells: 28.0;monocytes: 20.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 13.4;Daudi: 16.1;Karpas-707: 11.1;NTERA-2: 7.9;OE19: 9.2;SCLC-21H: 7.3;SuSa: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044574	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Vesicles	"HPA044574: AB_10794292"	"unprognostic (3.24e-1)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (1.49e-5)"	"unprognostic (4.42e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.43e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.88e-2)"	"prognostic favorable (4.21e-6)"	"unprognostic (4.19e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.04e-2)"	13.8	6.4	8.9	11.0	20.1	32.5	8.3	12.8	9.4	8.8	17.0	6.5	13.6	3.5	12.3	11.3	8.0	12.0	4.3	8.0	9.3	9.4	41.8	19.8	10.7	37.6	12.5	2.5	2.8	5.4	7.5	13.0	39.0	4.2	7.1	12.5	9.9	2.1	2.9	24.3	13.9	5.9	10.0	11.2	14.7	2.4	18.4	14.2	3.4	2.3	9.8	6.0	5.3	20.2	0.0	0.0	0.1	0.0	0.2	0.0	1.1	0.1	0.0	0.0	0.0	13.4	0.3	16.1	0.0	0.0	0.1	0.3	1.1	0.1	0.0	0.1	2.5	1.4	1.0	0.6	0.5	0.3	0.7	0.2	0.6	0.0	0.5	0.1	0.0	2.8	0.2	11.1	0.0	0.6	5.5	0.5	7.9	9.2	3.6	1.6	0.1	6.4	0.5	0.2	7.3	0.1	0.0	2.3	0.1	7.3	1.1	0.0	0.0	0.0	0.5	0.5	0.1	0.1	0.0	5.1	1.2	0.2	0.2	0.8	3.0	0.4	1.9	11.9	2.1	9.7	1.6	1.6	2.7	12.4	2.8	2.7	1.1	3.8	20.6	28.0	0.5	1.2	8.9	20.1	12.8	9.4	8.0	9.3	37.6	12.5	39.0	10.0	18.4	20.2	9.6	28.9	15.9	1.3	118.7	58.9	7.9	4.4	23.9	11.7	22.7	13.2	9.1	15.7	11.1	14.7	37.5	33.2	71.2	13.2	13.7	3.1	0.5	44.5	4.8	10.8	26.8	0.0	3.6	4.0	2.4	9.1	30.1	38.0	107.0	0.6	102.1	45.9	39.5	3.3	2.8	12.8	16.2	64.2	282.6	1.5	0.9	141.4	62.2	10.3	2.9	1.0	2.1	26.7	25.5	3.0	9.6	1.9	33.5	10.2	9.2	12.9	34.0	4.9	0.0	5.9	17.7	0.8	3.2	10.4	56.7	11.2	56.3	0.5	8.1	11.5
RASSF2	"CENP-34, KIAA0168"	ENSG00000101265	"Ras association domain family member 2"	P50749	20	4780023-4823608	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 217.0;retina: 162.8"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 87.1;Langerhans cells: 75.8;monocytes: 148.5;Oligodendrocytes: 106.7;Peritubular cells: 149.7;Rod photoreceptor cells: 160.3"	"Cancer enriched"	"Detected in all"	5	"glioma: 48.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 56.8;BEWO: 59.2;Daudi: 62.7;HL-60: 74.7;NB-4: 96.3;U-937: 116.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051200	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA051200: AB_2681386"	"unprognostic (6.51e-2)"	"unprognostic (3.67e-3)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (7.82e-4)"	"unprognostic (3.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.49e-1)"	"unprognostic (6.46e-2)"	16.4	9.7	76.1	47.1	135.2	91.2	6.9	155.5	113.5	27.9	40.0	8.4	5.3	25.4	22.5	10.0	22.1	15.6	4.2	68.9	94.7	4.0	5.9	25.4	58.6	217.0	148.8	7.0	3.1	1.5	5.0	9.1	186.4	7.3	9.6	162.8	3.0	9.3	1.2	4.2	14.5	38.7	135.8	32.7	7.0	20.6	120.0	19.5	4.7	5.0	73.6	20.7	4.9	197.0	0.1	14.5	34.9	56.8	0.4	0.0	59.2	3.5	10.0	0.6	0.2	3.4	0.1	62.7	5.6	3.1	1.4	0.2	5.1	0.0	0.8	22.7	2.1	41.1	0.0	0.7	0.0	74.7	40.1	0.1	0.0	1.3	0.0	1.3	23.4	7.0	0.2	24.0	0.0	0.1	11.0	96.3	7.8	0.0	1.1	17.1	3.9	23.8	0.0	29.0	0.4	2.8	0.0	1.0	1.7	7.4	0.0	47.0	0.7	1.5	7.4	0.7	4.6	0.3	5.9	37.8	0.3	116.8	0.4	85.6	61.5	101.3	7.7	50.1	14.6	24.3	12.0	10.4	46.8	16.4	7.8	6.5	139.5	8.5	59.9	30.7	11.8	42.1	76.1	135.2	155.5	113.5	68.9	94.7	217.0	148.8	186.4	135.8	120.0	197.0	5.5	0.0	8.7	7.5	49.3	4.7	0.0	0.1	0.0	39.2	4.1	1.7	1.9	1.5	1.9	0.0	27.1	3.0	43.0	0.1	1.9	1.2	6.0	3.2	19.6	18.6	0.0	6.1	1.5	0.9	5.1	10.9	1.1	1.0	54.3	4.5	11.4	1.2	27.1	6.7	1.3	0.7	0.0	87.1	75.8	25.1	33.2	64.6	8.8	26.2	148.5	19.3	7.2	33.7	106.7	0.6	0.0	149.7	14.3	1.2	0.0	0.3	0.1	160.3	0.0	9.4	3.5	0.7	1.0	0.3	2.6	1.4	20.8	0.8	0.0	2.3
RASSF3		ENSG00000153179	"Ras association domain family member 3"	Q86WH2	12	64507001-64697564	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 149.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"neutrophil: 124.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 124.1"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 145.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022664, CAB034035, HPA038469"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"		"CAB022664: , CAB034035: AB_2176848, HPA038469: AB_10671743"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.73e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.59e-2)"	33.1	22.9	13.8	43.3	9.3	17.3	14.9	7.1	9.5	19.4	33.0	106.6	21.1	23.9	15.1	36.8	13.2	29.3	44.3	7.6	9.2	6.9	10.9	32.5	37.0	11.4	20.5	19.6	13.1	3.3	4.6	39.6	13.6	33.0	42.0	1.5	35.6	48.7	45.0	6.8	26.3	60.1	11.4	47.6	34.5	13.5	22.1	15.4	6.5	13.1	33.2	50.3	14.1	13.4	28.1	30.9	9.6	18.6	10.2	14.7	58.3	11.9	61.8	15.8	18.6	22.3	28.9	43.6	24.8	8.6	19.0	12.1	29.6	12.5	19.0	35.5	11.3	28.6	13.0	25.5	27.9	30.5	19.3	10.0	10.7	36.2	26.7	46.1	68.0	20.7	15.4	21.0	18.7	26.5	20.2	19.9	21.4	65.8	18.8	32.5	30.9	18.4	20.8	33.6	21.7	22.7	20.0	3.8	145.5	23.0	17.3	19.0	98.7	12.8	15.6	13.5	13.1	19.5	22.0	28.0	15.4	26.2	37.8	19.6	16.6	12.5	13.2	17.7	11.1	14.1	19.4	14.9	9.1	10.1	19.1	20.3	124.1	12.0	17.7	8.4	22.1	2.8	13.8	9.3	7.1	9.5	7.6	9.2	11.4	20.5	13.6	11.4	22.1	13.4	30.7	3.2	15.4	4.2	32.7	16.3	15.0	5.5	2.8	0.0	12.4	13.7	56.5	30.0	8.9	5.5	0.0	35.5	39.0	67.4	0.0	12.4	0.3	14.4	4.1	31.2	26.4	16.4	8.7	21.2	19.1	14.5	20.9	28.3	6.3	4.7	20.7	4.6	24.1	0.0	16.2	15.8	2.0	69.9	149.3	0.8	2.5	55.7	48.0	49.6	72.7	2.8	32.0	3.5	4.8	24.0	14.5	14.3	9.8	25.5	13.3	1.7	3.9	0.2	13.1	9.2	27.0	0.6	19.3	5.9	11.9	19.7	30.7	1.6	20.7	21.1
RASSF5	"Maxp1, NORE1, RAPL"	ENSG00000266094	"Ras association domain family member 5"	Q8WWW0	1	206507531-206589448	"Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 109.3;lymphoid tissue: 83.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 119.3;granulocytes: 140.0;Langerhans cells: 147.7;Macrophages: 78.0;NK-cells: 118.4;T-cells: 97.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 90.9;Karpas-707: 192.6;MOLT-4: 84.1;RPMI-8226: 218.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070480	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA070480: AB_2686271"	"unprognostic (1.92e-3)"	"prognostic favorable (1.46e-4)"	"unprognostic (1.37e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.93e-1)"	"unprognostic (5.17e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.84e-2)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (1.22e-6)"	"unprognostic (3.29e-1)"	"unprognostic (5.58e-2)"	"unprognostic (4.28e-2)"	"unprognostic (6.28e-3)"	6.8	15.1	3.4	48.1	2.9	109.3	4.9	1.2	3.6	10.8	0.4	8.9	9.1	3.9	1.8	41.7	10.2	18.2	10.8	3.2	2.9	4.3	14.0	26.4	63.4	4.1	4.4	3.6	10.8	8.4	10.3	5.3	4.1	8.1	9.3	1.0	30.3	7.2	14.8	28.8	17.7	6.7	2.3	56.2	17.3	1.4	5.5	83.1	5.7	3.7	60.0	30.3	20.7	4.6	9.3	4.2	0.1	1.6	3.2	1.8	0.0	0.6	4.9	1.7	2.3	0.4	19.5	32.4	2.5	2.1	0.3	13.5	3.5	2.2	1.5	22.4	12.7	35.2	1.0	0.2	1.2	59.1	90.9	2.2	8.9	2.0	2.4	3.2	0.3	76.0	14.4	192.6	0.9	1.1	84.1	37.8	1.8	0.1	3.6	39.4	4.6	218.8	0.1	14.7	4.7	0.3	15.6	1.7	0.6	0.1	3.7	37.5	0.1	0.4	6.4	8.0	2.1	67.7	52.8	30.2	3.0	34.1	1.0	211.8	40.3	268.7	112.3	53.7	99.7	28.4	82.6	117.0	43.9	26.6	112.1	105.8	157.2	131.2	84.0	34.2	78.2	154.7	3.4	2.9	1.2	3.6	3.2	2.9	4.1	4.4	4.1	2.3	5.5	4.6	2.1	38.5	27.9	1.6	64.0	32.8	16.6	8.6	27.9	1.8	7.4	4.4	7.7	15.7	11.3	0.0	0.0	0.2	119.3	1.0	3.9	8.1	0.3	0.5	0.5	4.4	2.4	16.4	19.4	8.9	0.1	11.6	9.2	0.6	140.0	0.1	5.7	6.2	12.1	8.4	16.8	1.0	10.2	49.0	147.7	0.1	7.5	78.0	14.2	6.5	54.2	0.1	118.4	2.0	0.7	8.3	2.6	9.1	41.1	13.7	0.0	0.8	9.6	0.2	0.0	2.1	6.8	0.1	0.6	48.6	27.3	0.1	97.7	0.2	2.1	49.6
RB1	"OSRC, PPP1R130, RB"	ENSG00000139687	"RB transcriptional corepressor 1"	P06400	13	48303744-48599436	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 198.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 187.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000095, CAB016687, HPA050082"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB000095: , CAB016687: AB_1622010, HPA050082: AB_2681008"	"unprognostic (4.24e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (4.06e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.70e-1)"	20.7	18.7	8.9	22.8	9.7	19.3	17.8	12.0	13.0	18.8	10.9	15.1	14.6	15.7	21.2	21.9	13.1	17.3	17.8	8.5	10.9	18.4	14.5	18.1	30.7	13.9	10.3	11.5	9.2	20.5	6.5	24.9	13.4	15.1	17.1	12.5	16.9	15.9	19.0	23.6	15.6	18.3	11.6	24.8	16.3	12.9	9.3	34.2	22.4	21.2	30.1	19.8	10.6	15.1	29.1	15.8	40.9	44.2	19.8	22.8	18.5	56.6	45.9	57.4	48.3	13.4	49.8	37.3	12.8	37.4	31.7	39.6	53.7	44.8	86.6	53.0	20.8	68.5	29.4	22.7	21.1	59.5	62.0	12.9	27.0	37.3	47.1	47.8	40.1	90.1	23.4	29.6	66.4	13.7	187.2	29.8	20.0	65.6	17.3	79.8	41.1	43.0	59.6	27.6	2.0	41.8	55.1	27.3	46.2	36.2	29.8	76.3	32.1	35.3	23.3	43.7	51.2	13.1	3.9	0.4	18.8	36.7	48.9	23.8	14.9	8.8	6.9	19.9	5.6	30.2	5.7	6.9	15.2	29.4	4.8	5.6	20.6	5.9	20.9	16.9	7.4	7.1	8.9	9.7	12.0	13.0	8.5	10.9	13.9	10.3	13.4	11.6	9.3	15.1	59.2	3.2	19.6	75.4	97.3	28.4	23.3	27.6	63.2	17.3	26.9	21.0	18.3	14.3	19.2	31.3	29.2	7.1	50.1	17.8	15.6	19.3	28.1	40.1	36.2	46.4	17.5	50.7	99.5	11.9	9.6	22.2	29.0	40.4	12.0	25.9	35.7	17.3	77.4	18.5	98.9	20.0	8.2	105.3	198.9	13.9	26.1	104.2	26.6	152.7	93.7	20.4	22.6	101.0	98.3	17.4	10.7	28.6	69.9	24.0	15.7	23.6	25.3	19.6	19.7	28.5	32.3	33.0	21.3	72.1	38.2	4.4	38.3	21.2	16.6	18.0
RBBP8	"COM1, CtIP, RIM, SCKL2"	ENSG00000101773	"RB binding protein 8, endonuclease"	Q99708	18	22798261-23026488	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Disease variant, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 125.9;Spermatocytes: 116.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 36.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039890, HPA052946"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA039890: AB_10794756, HPA052946: AB_2681996"	"unprognostic (1.55e-3)"	"unprognostic (4.10e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (7.21e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.04e-2)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.91e-3)"	"unprognostic (2.42e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.48e-1)"	10.1	8.7	6.8	10.0	6.8	18.2	29.4	9.2	11.3	20.9	41.6	14.5	9.3	20.1	23.4	22.1	28.0	12.7	7.0	7.4	9.2	42.2	14.4	13.5	14.0	6.3	7.3	6.4	18.5	22.1	17.5	8.5	6.4	10.8	12.9	6.2	19.5	23.3	2.3	28.5	12.9	16.4	6.2	7.6	13.1	28.7	8.5	32.4	18.2	3.5	17.3	18.3	18.0	7.3	32.9	24.8	36.0	41.9	18.2	19.4	28.2	44.2	31.1	40.3	56.5	45.7	36.3	95.4	19.9	27.9	38.5	67.3	41.2	89.9	78.5	68.3	33.2	41.8	32.0	44.0	22.2	151.5	43.7	13.9	86.0	61.0	105.3	23.6	16.6	65.7	25.0	69.2	41.6	49.1	112.8	50.6	34.2	60.1	41.5	57.6	65.9	58.9	117.4	34.7	84.1	39.8	74.1	22.4	39.0	20.5	129.1	39.4	12.0	107.2	49.3	52.4	78.0	92.9	108.4	105.3	49.1	72.2	58.8	17.0	6.5	3.9	1.2	24.0	0.5	6.6	1.7	2.1	8.2	5.3	0.9	1.5	2.4	7.9	36.7	8.1	4.7	3.8	6.8	6.8	9.2	11.3	7.4	9.2	6.3	7.3	6.4	6.2	8.5	7.3	13.1	35.3	42.8	10.1	22.9	27.4	44.7	125.9	76.8	4.3	22.6	72.6	10.4	35.8	41.9	29.5	4.2	12.7	25.0	14.5	43.0	30.5	17.7	56.0	19.5	14.2	7.7	37.0	20.3	33.0	9.4	13.2	23.0	67.3	66.1	22.3	5.7	16.4	11.7	1.7	15.5	9.3	16.2	11.4	23.5	14.5	6.5	27.5	23.2	8.4	9.0	2.1	4.1	9.5	2.7	44.9	8.6	5.3	53.8	37.5	17.5	26.1	28.2	7.9	0.0	20.4	14.0	116.6	83.4	36.2	19.7	15.2	13.6	9.8	14.9	45.5
RBPJ	"CBF1, IGKJRB, IGKJRB1, KBF2, RBP-J, RBPJK, RBPSUH, SUH"	ENSG00000168214	"Recombination signal binding protein for immunoglobulin kappa J region"	Q06330	4	26163455-26435131	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Notch signaling pathway, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 422.1;Oligodendrocytes: 378.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000251, HPA060647"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA000251: , HPA060647: AB_2684337"	"unprognostic (2.68e-1)"	"unprognostic (2.71e-3)"	"unprognostic (2.61e-1)"	"prognostic favorable (2.98e-4)"	"unprognostic (3.78e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.15e-3)"	40.9	18.3	28.1	33.0	44.2	51.3	28.4	34.2	38.5	31.9	27.7	33.2	20.2	36.4	18.0	28.5	23.6	25.5	21.8	29.0	37.6	21.4	17.9	31.3	27.5	41.7	38.5	34.2	22.3	26.2	12.9	54.4	39.0	28.0	28.1	33.1	19.3	22.5	21.7	26.0	22.7	38.0	32.2	25.7	25.4	28.7	36.4	27.8	24.8	28.9	26.5	31.8	21.7	58.9	68.2	19.1	60.0	39.0	91.5	138.8	44.9	54.4	47.0	50.9	60.1	14.5	36.4	56.0	34.1	36.2	39.5	12.2	51.9	33.4	98.1	30.4	28.4	42.5	24.2	27.9	47.9	76.9	35.9	64.0	28.5	104.9	39.7	70.3	28.5	34.3	43.0	21.5	93.2	20.1	54.5	76.4	163.5	20.3	30.3	48.0	112.4	25.4	26.8	22.4	84.5	36.5	28.0	20.6	24.3	54.4	22.0	53.3	38.5	50.5	25.2	86.3	51.9	40.2	51.9	55.7	132.3	86.3	43.4	23.8	94.6	112.9	31.4	77.8	42.6	37.2	49.8	34.1	136.4	33.4	41.4	35.9	220.5	70.9	77.1	31.5	68.1	68.6	28.1	44.2	34.2	38.5	29.0	37.6	41.7	38.5	39.0	32.2	36.4	58.9	72.5	48.1	66.8	62.0	54.6	152.8	86.2	104.6	55.8	94.6	48.9	51.2	44.2	62.9	83.3	46.0	129.3	102.7	47.3	26.6	74.3	64.3	44.4	54.5	96.3	73.2	78.4	46.9	81.7	65.4	74.4	129.0	29.0	62.8	57.0	130.7	65.3	53.1	365.2	85.8	85.9	51.0	59.0	208.5	422.1	56.7	135.5	234.2	80.0	60.9	125.1	95.0	44.3	215.1	378.1	76.5	35.1	84.2	54.9	113.7	44.9	55.4	67.5	102.9	85.5	71.7	95.8	134.7	158.4	45.9	109.3	83.9	102.8	57.0	47.0	75.7
RCC2	TD-60	ENSG00000179051	"Regulator of chromosome condensation 2"	Q9P258	1	17406760-17439677	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072281	Approved					NA	NA		110000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA072281: AB_2686505"	"unprognostic (2.50e-2)"	"prognostic favorable (3.31e-4)"	"unprognostic (9.91e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (3.42e-8)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (4.03e-8)"	"unprognostic (6.81e-3)"	"unprognostic (2.09e-1)"	"unprognostic (9.44e-2)"	"unprognostic (4.41e-2)"	19.4	18.4	12.3	18.9	12.2	33.3	22.2	12.8	13.2	24.8	11.0	24.0	11.4	18.7	9.9	65.2	16.3	11.8	13.4	12.1	12.5	22.8	15.9	24.2	27.7	14.2	13.6	22.1	21.3	9.4	11.4	16.1	13.1	22.3	17.6	3.1	36.0	7.8	8.4	56.3	27.6	10.2	13.9	39.2	18.3	20.6	15.8	34.2	19.0	4.1	35.2	19.7	31.3	15.3	62.2	34.3	68.4	57.9	25.3	25.4	56.6	24.3	20.9	49.2	40.4	37.0	83.4	133.8	80.4	25.3	14.5	67.4	121.0	70.0	34.1	64.3	61.1	117.6	50.5	36.0	31.8	142.7	79.7	40.5	51.8	55.1	48.7	30.7	53.3	88.7	82.4	188.4	22.0	62.9	117.4	115.9	94.7	76.0	26.0	155.7	68.6	86.5	37.3	29.0	102.9	72.6	61.4	59.5	93.6	56.7	53.2	91.3	41.9	44.8	56.0	18.1	51.1	81.7	72.9	165.8	19.3	158.6	90.9	0.9	1.9	0.7	1.4	2.6	1.2	1.6	1.1	1.4	3.1	1.7	0.8	1.4	0.1	1.7	2.1	2.5	1.0	1.1	12.3	12.2	12.8	13.2	12.1	12.5	14.2	13.6	13.1	13.9	15.8	15.3	22.6	25.6	15.3	16.6	26.4	46.5	14.7	25.3	27.9	6.6	36.5	34.3	0.9	18.6	26.6	22.0	10.4	25.0	32.2	27.5	3.9	24.4	6.8	28.0	38.3	24.9	24.1	28.8	11.0	22.7	48.9	17.4	14.8	37.5	17.7	55.9	17.5	7.3	32.6	6.7	4.9	25.9	24.4	31.4	70.0	21.0	9.3	43.0	16.0	20.6	27.9	15.3	22.6	20.6	15.3	28.8	20.6	6.0	25.9	32.2	7.5	7.0	17.9	5.4	0.0	20.7	16.7	17.6	21.2	42.9	64.5	16.3	19.7	25.6	36.4	19.4
REL	"c-Rel, I-Rel"	ENSG00000162924	"REL proto-oncogene, NF-kB subunit"	Q04864	2	60881521-60931612	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.4"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 2061.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 61.2;U-698: 109.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB004404	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"			"CAB004404: AB_670194"	"unprognostic (2.77e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.15e-1)"	"unprognostic (5.87e-2)"	"unprognostic (4.38e-2)"	"unprognostic (4.37e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.66e-2)"	4.8	4.5	2.2	14.1	1.8	37.4	5.5	8.6	4.2	4.6	0.4	4.6	4.7	5.7	2.7	6.0	3.2	8.2	2.2	2.1	2.9	3.4	7.3	6.7	15.8	3.0	1.7	5.0	5.0	6.2	1.9	5.5	2.3	4.1	4.9	9.8	4.6	2.7	2.4	8.3	5.2	3.5	0.5	11.1	5.8	3.5	2.4	9.2	4.1	2.5	16.3	13.1	3.3	3.4	7.2	3.8	3.4	4.5	2.7	2.6	7.3	2.5	3.2	1.8	2.1	3.2	6.0	61.2	6.4	2.2	4.6	7.7	5.3	3.9	4.0	7.0	5.0	6.3	6.5	3.5	1.5	13.3	7.1	2.3	10.1	4.6	7.0	3.0	4.8	6.6	7.6	4.3	1.7	4.0	9.1	5.6	4.2	5.0	1.8	12.0	8.8	2.7	2.8	24.5	3.3	3.5	6.4	7.9	2.3	5.0	4.6	5.5	5.6	5.0	6.0	3.5	3.8	5.4	2.8	109.7	3.0	10.9	2.7	3.4	4.1	2.6	2.8	4.5	2.0	5.9	1.5	2.2	3.5	7.9	1.0	2.1	5.0	2.9	5.7	3.1	1.9	2.3	2.2	1.8	8.6	4.2	2.1	2.9	3.0	1.7	2.3	0.5	2.4	3.4	67.5	320.5	325.8	8.1	430.2	517.6	123.3	69.4	194.6	82.0	95.3	58.5	5.0	48.6	165.0	51.5	85.5	29.0	469.7	59.0	3.9	31.7	4.2	150.5	79.5	103.5	42.5	37.0	16.3	29.4	58.5	97.3	96.4	300.1	412.1	82.4	30.0	19.1	51.7	58.9	16.7	49.1	46.8	141.5	2061.4	3.4	15.5	463.9	135.2	42.2	451.1	21.3	145.2	8.5	9.2	35.1	46.6	23.7	119.5	99.7	34.3	7.7	153.1	56.2	13.1	65.9	73.9	51.5	38.4	158.0	463.1	77.6	303.7	21.3	50.1	260.6
RELT	"FLJ14993, TNFRSF19L"	ENSG00000054967	"RELT TNF receptor"	Q969Z4	11	73376399-73397474	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Receptor	"Amelogenesis imperfecta, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"bone marrow: 154.7"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 43.9;Macrophages: 43.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062824, HPA071518"			Supported	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA062824: AB_2684875, HPA071518: AB_2686408"	"unprognostic (3.49e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.80e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.87e-1)"	"unprognostic (8.42e-2)"	"unprognostic (4.13e-2)"	"prognostic unfavorable (4.07e-11)"	"unprognostic (1.64e-1)"	"unprognostic (3.07e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.69e-1)"	4.9	2.2	3.4	12.9	6.5	154.7	2.5	6.7	7.7	1.4	0.4	2.3	2.3	1.4	0.5	3.9	1.9	4.5	6.2	3.6	7.0	3.7	2.1	10.9	11.9	8.9	6.8	1.8	0.8	1.1	3.5	4.6	8.1	2.1	1.4	2.2	1.9	0.4	24.3	3.2	7.1	2.6	7.0	20.8	2.2	3.2	6.9	4.6	2.2	6.4	6.9	4.8	2.3	12.6	9.1	8.9	7.0	6.8	0.8	1.0	7.5	9.6	6.2	11.1	6.7	8.5	3.9	16.4	30.9	6.4	8.8	13.1	4.4	4.7	4.3	9.9	8.3	15.4	12.4	3.1	1.8	15.6	26.3	1.1	2.0	11.9	3.5	2.6	4.1	8.4	11.8	21.0	3.1	8.5	11.5	16.5	6.1	6.9	11.0	21.9	11.7	14.2	2.3	3.9	8.9	8.5	8.3	7.5	10.0	1.7	4.1	13.9	5.4	13.8	9.7	23.1	17.6	7.5	6.1	18.2	8.5	15.5	14.8	0.7	12.5	22.2	0.9	25.4	2.0	7.6	1.0	1.7	11.8	5.8	1.3	0.6	19.9	0.4	35.3	11.7	0.5	6.3	3.4	6.5	6.7	7.7	3.6	7.0	8.9	6.8	8.1	7.0	6.9	12.6	5.7	6.4	2.2	3.6	24.2	26.5	15.4	2.8	2.8	3.5	6.1	5.5	2.7	1.5	3.4	0.0	12.5	1.6	33.0	4.7	0.0	3.6	0.9	5.4	5.2	7.2	3.5	5.7	3.1	0.9	10.7	10.1	11.2	10.8	24.8	6.8	1.8	0.2	23.0	30.3	4.5	2.8	6.1	24.2	43.9	1.2	0.0	43.9	5.4	2.8	32.8	8.9	3.1	1.5	4.8	6.7	2.4	0.0	19.2	9.9	1.0	0.5	1.4	2.8	6.6	7.2	14.5	11.7	10.5	4.6	18.3	21.1	16.1	0.6	3.1	17.8
RFPL4A	"RFPL4, RNF210"	ENSG00000223638	"Ret finger protein like 4A"	A6NLU0	19	55759014-55763175	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.4;liver: 3.4;testis: 1.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.1;Langerhans cells: 1.4"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 9.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.1;monocytes: 9.7"	"Cell line enriched"	"Detected in some"	20	"U-2 OS: 68.4"									HPA046368	Uncertain		Approved	Centrosome,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Centrosome, Cytosol"		"HPA046368: AB_2679640"							"unprognostic (3.74e-1)"						"unprognostic (2.96e-2)"		"unprognostic (9.20e-2)"			0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	3.4	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.6	0.2	1.6	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.3	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	68.4	0.0	0.2	0.4	0.4	0.2	0.0	0.0	0.0	0.0	9.7	0.0	0.0	2.2	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	1.4	0.0	0.7	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.1	0.3	0.0	0.0	0.0	0.0
RGS1	"1R20, BL34, IER1, IR20"	ENSG00000090104	"Regulator of G protein signaling 1"	Q08116	1	192575763-192580024	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 1398.7;Hofbauer cells: 390.4;Langerhans cells: 1133.6;Macrophages: 860.4;Plasma cells: 902.4;T-cells: 748.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 25.7;T-reg: 21.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 25.7;T-cells: 21.9"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 962.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"spinal cord: 85.5"	HPA074572	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"			"HPA074572: "	"unprognostic (3.68e-3)"	"unprognostic (1.14e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.37e-1)"	"unprognostic (3.87e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (4.91e-5)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (4.01e-2)"	"unprognostic (9.90e-2)"	"unprognostic (4.56e-2)"	34.7	88.2	18.2	170.3	17.4	151.6	57.9	22.1	77.4	50.7	42.2	75.4	24.7	19.2	5.2	68.3	22.8	112.8	31.4	14.6	43.7	19.9	59.9	78.9	142.9	39.1	21.7	14.3	19.1	25.6	40.0	22.2	27.9	50.7	112.7	26.6	56.0	13.8	2.9	17.9	72.7	44.9	29.3	74.6	36.6	8.5	25.3	154.2	23.9	5.1	90.7	127.7	39.3	46.7	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	4.3	0.0	0.0	2.8	4.6	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	220.6	0.0	0.0	0.4	5.6	0.2	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	962.6	4.1	3.5	0.0	0.1	0.2	0.0	0.0	25.7	0.8	0.1	1.9	0.0	5.1	4.5	0.7	0.0	0.4	3.7	0.1	0.7	0.1	4.9	21.9	0.7	18.2	17.4	22.1	77.4	14.6	43.7	39.1	21.7	27.9	29.3	25.3	46.7	10.8	12.8	103.2	0.0	170.6	49.2	6.9	0.3	5.7	0.7	11.7	18.7	1.2	4.3	13.2	0.0	0.0	2.1	148.8	1.4	0.0	1.4	1.8	1.7	2.0	32.7	4.8	16.4	0.0	2.8	2.8	15.4	47.4	2.5	1398.7	0.0	5.3	3.8	390.4	0.0	0.0	1.6	0.0	211.2	1133.6	7.4	3.1	860.4	250.8	7.5	333.9	0.9	2.1	0.0	0.0	0.2	3.5	0.7	902.4	3.7	1.3	1.2	11.3	1.9	19.7	2.0	8.5	0.4	1.2	3.5	40.2	6.0	748.2	0.2	4.0	8.3
RHOQ	"ARHQ, RASL7A, TC10"	ENSG00000119729	"Ras homolog family member Q"	P17081	2	46541806-46584688	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 189.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 1.5;classical monocyte: 2.5;eosinophil: 4.2;intermediate monocyte: 2.7;memory B-cell: 1.7;myeloid DC: 1.6;naive B-cell: 2.4;neutrophil: 4.8;non-classical monocyte: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 164.0;ASC TERT1: 132.0;SK-MEL-30: 150.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044938			Approved	Vesicles,Cytosol		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Cytosol"		"HPA044938: AB_2679149"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.60e-5)"	"unprognostic (2.01e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.43e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.52e-2)"	96.9	35.7	34.8	30.1	40.1	12.4	64.8	38.9	41.4	59.6	43.9	67.0	11.0	53.2	67.7	18.9	59.3	26.7	196.8	34.3	44.7	44.3	22.6	56.0	23.8	40.9	44.2	40.8	28.6	50.4	29.5	28.6	38.9	50.6	13.5	27.7	32.7	36.5	162.4	28.1	35.3	38.4	39.2	42.7	32.8	10.1	36.8	9.9	39.1	181.3	19.1	62.8	44.7	43.5	12.3	12.4	21.0	28.6	164.0	132.0	3.7	32.8	84.1	16.2	24.4	6.2	4.1	28.7	34.0	58.5	52.4	5.8	20.6	9.8	29.3	10.2	15.3	8.2	9.8	20.9	81.8	8.8	10.7	118.1	17.3	20.1	22.5	39.0	19.3	3.1	12.1	44.0	35.2	8.1	6.9	17.9	20.8	8.9	14.4	5.3	34.5	10.1	23.1	22.4	15.3	50.3	11.6	16.4	150.8	32.9	9.0	20.7	13.2	50.1	44.8	49.3	14.1	48.5	17.7	28.4	73.6	22.1	18.4	1.5	2.5	4.2	0.4	2.7	0.3	1.7	0.2	0.4	1.6	2.4	0.0	0.3	4.8	0.3	1.9	0.6	0.3	0.7	34.8	40.1	38.9	41.4	34.3	44.7	40.9	44.2	38.9	39.2	36.8	43.5	27.9	57.7	22.4	65.3	38.1	22.4	31.0	18.1	11.4	21.1	30.4	22.4	189.2	14.3	22.1	20.2	10.4	14.6	32.2	1.0	17.6	21.4	30.8	22.1	90.2	23.4	6.0	2.1	12.8	32.0	3.6	82.8	4.1	24.6	12.0	12.1	17.5	12.2	44.5	121.1	27.7	5.5	8.2	90.9	77.8	11.4	35.4	90.7	42.7	68.4	55.1	52.9	15.5	52.3	41.5	22.4	0.3	42.5	42.0	41.2	0.2	30.1	18.8	24.2	46.0	54.2	82.3	2.3	4.5	6.8	19.7	25.9	17.0	10.9	1.9	31.9
RILPL2	"FLJ30380, FLJ32372, MGC7036"	ENSG00000150977	"Rab interacting lysosomal protein like 2"	Q969X0	12	123415039-123436684	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 116.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 149.8;Macrophages: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 103.8;NB-4: 235.2;THP-1: 149.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028958	Approved		Supported	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA028958: AB_10602124"	"unprognostic (1.94e-3)"	"unprognostic (3.29e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (5.24e-7)"	"unprognostic (2.62e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.74e-2)"	21.4	7.5	9.3	27.4	9.7	116.2	15.8	8.2	11.1	26.3	14.2	6.3	5.4	19.3	11.2	7.6	18.4	15.7	8.2	9.5	10.2	18.6	11.9	24.1	23.8	9.7	9.7	13.1	8.0	11.4	3.5	14.4	9.2	18.6	5.8	1.4	23.2	23.7	4.6	5.5	6.5	13.8	9.1	26.7	10.3	3.2	10.3	15.2	27.8	5.9	17.7	20.5	7.0	8.6	14.2	12.7	4.6	21.8	29.8	23.6	13.3	16.1	41.0	15.3	12.7	16.2	5.5	7.6	15.2	25.1	8.4	9.2	10.3	12.3	14.2	29.1	9.8	103.8	9.9	24.2	33.2	81.2	50.6	18.3	9.3	16.0	11.6	19.8	15.7	20.4	11.1	3.8	12.4	9.4	28.0	235.2	2.9	4.5	13.9	19.8	14.1	15.4	16.0	26.1	1.0	6.7	21.9	0.7	16.9	9.2	19.5	149.0	17.0	12.5	9.2	22.8	9.9	6.2	8.0	18.2	12.3	55.1	5.3	98.6	133.3	159.3	24.0	106.0	22.4	55.8	51.1	42.7	98.7	41.9	19.7	22.5	176.8	22.4	121.5	46.7	67.7	63.8	9.3	9.7	8.2	11.1	9.5	10.2	9.7	9.7	9.2	9.1	10.3	8.6	75.7	35.3	75.2	7.2	149.8	24.5	68.4	67.8	32.5	1.4	45.3	35.9	5.1	17.2	43.3	22.0	2.1	10.1	75.0	2.4	25.4	20.1	2.1	51.9	24.8	73.2	4.2	24.2	7.5	21.0	5.4	28.2	9.2	27.0	62.6	8.4	84.3	13.3	72.9	1.7	2.6	8.1	0.0	112.5	129.7	2.7	50.4	288.7	37.4	10.3	117.8	18.7	42.2	5.5	2.3	22.7	6.4	66.2	25.7	82.6	1.5	63.5	47.1	2.1	6.6	13.1	30.1	1.4	13.0	12.5	15.3	8.1	92.5	10.1	4.8	69.2
RIPK2	"CARD3, CARDIAK, RICK, RIP2"	ENSG00000104312	"Receptor interacting serine/threonine kinase 2"	O43353	8	89757806-89791064	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 156.1;Langerhans cells: 121.3;Macrophages: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 49.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015273, HPA016499"	Approved		Enhanced	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA015273: AB_1856299, HPA016499: AB_1856300"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (6.33e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.84e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.05e-2)"	"prognostic favorable (8.05e-4)"	4.1	1.6	4.0	5.6	4.0	8.9	5.1	4.0	5.5	4.7	3.3	2.9	1.7	5.5	2.4	3.0	2.7	9.4	4.4	4.1	5.5	3.7	5.6	6.0	6.5	4.6	4.0	2.5	4.4	4.2	1.9	4.7	5.1	5.3	2.9	1.5	5.0	2.7	0.6	4.2	2.4	5.7	5.3	4.8	2.9	2.9	3.7	2.8	4.2	1.3	6.7	9.4	2.6	6.0	17.8	6.0	3.2	4.9	7.9	10.8	5.5	19.2	36.1	10.7	13.6	4.6	9.7	14.4	28.0	11.7	7.6	4.2	8.9	6.9	20.2	8.7	8.0	11.9	2.8	5.5	22.2	4.5	5.8	8.8	5.6	15.6	49.8	11.4	11.4	0.0	5.4	4.7	10.2	3.4	0.0	9.6	1.5	8.4	14.4	3.2	4.1	7.5	26.1	8.4	0.4	3.1	4.7	12.6	10.0	4.0	12.0	5.6	10.1	6.5	6.0	11.2	9.1	8.9	4.2	8.8	16.2	0.4	4.3	13.7	6.6	23.2	3.5	12.5	4.1	7.6	5.4	4.6	8.1	4.8	4.9	5.4	5.1	4.4	14.9	2.6	1.3	4.6	4.0	4.0	4.0	5.5	4.1	5.5	4.6	4.0	5.1	5.3	3.7	6.0	19.3	35.3	18.1	25.5	29.8	57.6	33.7	13.3	16.5	2.1	17.2	8.9	5.2	4.3	22.9	3.7	0.0	13.3	32.8	2.8	5.9	80.1	6.6	82.3	23.7	15.0	0.0	9.9	12.9	60.8	45.7	27.3	9.7	156.1	43.1	7.1	6.1	3.2	41.7	3.3	9.1	5.4	24.4	32.4	121.3	2.5	7.8	105.1	19.6	15.0	42.1	12.1	8.2	15.6	12.8	50.0	2.7	6.0	22.0	59.2	2.2	10.4	11.6	0.3	13.1	19.2	19.6	7.9	12.8	14.7	48.3	83.7	30.4	7.5	8.1	49.5
RIT1	"MGC125864, MGC125865, RIBB, RIT, ROC1"	ENSG00000143622	"Ras like without CAAX 1"	Q92963	1	155897808-155911404	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 80.7"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 107.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053249	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"			"HPA053249: AB_2682089"	"unprognostic (1.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.27e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (8.64e-6)"	"unprognostic (3.80e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.19e-2)"	"unprognostic (9.22e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.33e-3)"	19.8	13.8	10.7	22.9	12.1	80.7	13.3	12.0	13.0	16.6	12.1	14.0	12.7	14.8	15.4	37.3	10.8	18.5	15.7	10.3	11.8	25.1	12.2	22.7	18.3	13.5	12.7	12.8	13.8	16.5	11.0	23.0	13.3	13.8	14.3	16.0	14.4	18.0	10.8	12.8	12.5	21.3	11.6	21.7	19.7	12.2	12.8	21.5	13.4	16.5	23.6	23.6	21.9	13.3	21.0	22.9	42.3	21.7	21.5	26.6	12.0	37.2	37.4	35.2	35.4	24.1	40.0	9.6	50.0	43.9	25.3	24.7	32.0	18.5	29.4	12.9	16.4	21.0	24.4	15.6	55.7	22.5	37.9	37.1	22.5	40.9	27.4	47.7	48.7	19.7	21.0	26.3	54.3	27.3	30.7	14.9	23.0	36.2	13.9	24.0	33.3	19.6	29.9	44.2	19.7	30.7	27.1	51.1	34.8	76.9	37.3	29.4	62.5	31.7	22.3	27.3	30.7	31.1	30.9	38.8	33.9	22.8	43.0	22.8	41.0	46.9	19.5	25.5	15.6	16.9	16.8	18.5	31.1	17.1	20.2	18.1	106.3	28.8	29.3	12.5	23.8	30.0	10.7	12.1	12.0	13.0	10.3	11.8	13.5	12.7	13.3	11.6	12.8	13.3	45.8	48.1	23.9	12.4	22.4	28.9	36.5	43.7	21.6	8.1	17.4	12.3	14.2	8.6	40.4	18.4	10.4	14.5	41.8	14.1	21.5	39.4	10.4	20.4	25.7	50.5	12.6	16.4	5.1	23.4	16.8	20.8	13.3	32.5	14.0	15.2	24.7	7.0	50.7	6.7	5.3	11.5	42.7	45.6	107.9	10.3	7.2	62.6	33.8	11.2	79.2	25.9	16.5	8.5	8.1	28.3	15.4	15.8	13.4	48.8	15.4	70.6	21.9	11.9	26.3	18.2	26.1	12.7	23.2	26.0	30.7	33.5	32.7	20.7	10.0	79.2
RLIM	"MGC15161, NY-REN-43, RNF12"	ENSG00000131263	"Ring finger protein, LIM domain interacting"	Q9NVW2	X	74582976-74614624	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018895	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA018895: AB_1856323"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (6.04e-4)"	"unprognostic (1.20e-1)"	11.3	11.8	10.6	10.4	11.7	41.2	10.5	5.9	9.9	10.0	10.0	6.8	5.9	9.5	5.6	8.7	8.4	9.6	8.8	11.2	15.1	10.0	8.3	12.1	8.9	8.5	10.3	10.6	7.5	11.7	10.3	9.8	10.3	9.8	6.6	10.7	7.4	7.1	9.6	9.4	6.1	9.3	7.3	9.3	7.4	6.5	12.6	11.0	11.7	8.6	9.5	8.5	8.0	8.2	23.7	24.2	22.8	18.7	20.1	22.5	22.4	22.4	26.0	19.9	24.4	18.9	24.4	12.8	25.4	28.6	26.7	19.9	45.9	26.7	30.1	11.7	23.9	22.7	43.2	10.7	17.4	34.6	38.6	21.7	14.4	28.2	46.5	15.6	23.3	20.9	19.9	22.9	24.6	18.1	26.0	16.8	35.0	12.9	22.5	24.3	48.0	21.5	16.1	28.6	16.4	19.5	42.3	19.0	24.5	20.4	11.2	24.9	31.0	23.4	23.1	24.8	19.6	12.0	24.6	20.3	25.5	33.1	23.2	22.8	6.0	5.9	3.1	7.5	3.1	3.0	3.9	3.8	4.9	3.3	4.2	3.8	11.5	5.3	5.6	2.6	4.8	3.2	10.6	11.7	5.9	9.9	11.2	15.1	8.5	10.3	10.3	7.3	12.6	8.2	44.8	16.0	17.0	13.4	22.4	35.8	29.6	16.1	23.3	13.8	18.3	13.5	30.5	18.6	20.4	25.8	14.6	16.3	27.6	10.3	11.7	13.7	7.9	32.3	35.3	30.1	23.2	12.8	19.2	10.7	21.5	27.7	27.0	41.0	38.0	24.6	21.0	14.8	18.2	21.9	18.9	10.6	10.2	20.7	34.1	4.4	9.9	29.1	17.8	15.9	12.7	13.2	12.3	11.1	16.4	14.8	8.5	18.8	16.3	25.5	6.8	12.0	25.2	14.6	6.6	31.1	24.1	9.7	18.2	21.6	38.8	26.3	22.0	19.0	11.4	37.2
RNASE6	"RAD1, RNaseK6, RNS6"	ENSG00000169413	"Ribonuclease A family member k6"	Q93091	14	20781268-20782467	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 110.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 108.0;dendritic cells: 221.7;Hofbauer cells: 207.9;Kupffer cells: 551.2;Langerhans cells: 198.4;Macrophages: 270.3;monocytes: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 1238.8"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	7	"RPMI-8226: 65.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA000698	Approved				"Secreted to blood"	NA	NA		2600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA000698: AB_2181340"	"unprognostic (5.04e-2)"	"unprognostic (5.21e-3)"	"unprognostic (3.59e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.85e-3)"	"unprognostic (9.62e-2)"	"unprognostic (5.60e-3)"	"unprognostic (3.46e-2)"	"unprognostic (5.54e-2)"	25.2	29.5	8.0	59.6	7.5	27.5	24.0	7.8	13.6	31.6	10.0	27.7	17.3	10.6	78.4	16.0	11.3	47.7	11.7	7.3	10.9	12.2	21.1	29.6	110.5	13.6	10.1	9.9	8.4	9.0	4.3	44.8	11.9	7.9	34.0	1.8	11.2	17.2	2.0	8.6	33.4	23.6	10.8	62.1	14.9	4.5	12.6	43.8	5.5	6.0	84.5	43.3	5.1	19.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	2.1	2.1	0.0	0.0	0.0	0.0	0.0	1.7	4.7	0.6	0.2	0.0	0.0	1.9	4.6	0.0	0.0	0.0	0.2	0.0	65.6	1.1	0.7	0.0	0.1	0.0	0.0	0.1	0.1	0.0	8.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.7	0.0	441.1	537.3	12.8	5.3	124.8	12.0	324.7	13.6	5.6	513.3	410.3	6.4	1.0	199.0	36.7	2.0	1238.8	1.1	329.8	8.0	7.5	7.8	13.6	7.3	10.9	13.6	10.1	11.9	10.8	12.6	19.5	1.6	6.4	7.5	0.0	108.0	4.5	0.2	0.0	1.8	0.0	1.4	2.8	0.6	14.3	1.2	0.0	0.0	1.1	221.7	2.6	0.0	0.0	0.8	0.1	0.0	3.8	0.0	12.0	0.0	0.0	1.6	1.4	1.1	0.2	0.0	0.0	8.6	3.3	207.9	0.0	0.0	0.5	2.0	551.2	198.4	4.8	2.8	270.3	21.4	1.9	115.8	0.0	9.2	0.0	0.0	0.0	12.6	0.7	52.4	0.2	0.4	0.5	0.2	0.4	13.1	0.6	0.6	0.1	0.7	0.6	3.8	2.2	7.8	0.0	3.4	1.2
RNF144B	"bA528A10.3, IBRDC2, P53RFP"	ENSG00000137393	"Ring finger protein 144B"	Q7Z419	6	18387350-18468870	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 634.4;Langerhans cells: 296.9;Suprabasal keratinocytes: 1501.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 71.9"	"Group enriched"	"Detected in many"	9	"dendritic cells: 18.4;granulocytes: 36.7;monocytes: 71.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 192.8;hTCEpi: 59.1;HUVEC TERT2: 55.6;TIME: 56.1;U-698: 160.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046013, HPA054127, HPA072469"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoli	Mitochondria	"CAB046013: AB_11126028, HPA054127: AB_2682391, HPA072469: "	"unprognostic (2.24e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.48e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.87e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	9.4	2.0	7.4	15.6	7.4	24.0	29.1	7.9	9.0	9.5	9.1	4.2	1.8	5.7	4.7	8.4	11.8	6.2	8.1	6.4	7.7	14.0	15.5	19.4	11.3	11.8	11.9	1.6	3.2	2.9	1.7	15.1	9.4	13.1	2.8	5.0	16.9	7.3	56.9	21.1	3.3	6.2	8.9	13.1	5.7	2.3	10.5	5.1	40.9	14.1	12.9	9.4	7.1	8.7	4.6	1.0	0.4	0.0	0.3	2.0	9.8	5.3	5.7	11.0	11.8	0.1	0.4	192.8	50.7	2.3	0.6	16.3	0.1	16.0	15.5	0.9	1.4	0.2	0.2	4.2	0.2	0.2	0.2	2.7	59.1	4.3	13.2	4.9	55.6	4.3	0.1	0.0	2.7	2.0	1.5	0.0	1.6	0.6	1.1	0.7	1.7	11.8	33.2	10.6	1.9	0.2	1.2	23.9	18.5	1.5	28.2	0.5	56.1	8.6	1.9	0.8	1.2	0.0	0.1	160.6	1.0	0.4	0.7	0.4	20.7	12.9	0.5	38.9	1.6	4.6	0.8	0.6	13.3	3.6	1.6	1.0	36.7	0.6	71.9	18.4	0.5	7.1	7.4	7.4	7.9	9.0	6.4	7.7	11.8	11.9	9.4	8.9	10.5	8.7	28.8	44.8	15.0	34.9	21.7	634.4	48.8	86.0	14.8	0.9	35.7	26.3	12.8	17.2	48.3	38.6	2.1	14.1	9.8	2.2	19.6	8.6	2.1	49.0	5.8	34.6	1.2	3.8	2.3	8.9	3.7	7.8	10.7	58.5	3.8	0.1	47.2	21.9	15.0	0.0	99.0	1.8	14.2	109.4	296.9	1.8	1.2	171.7	60.5	92.8	54.1	17.9	1.0	3.5	2.5	5.2	3.6	3.0	3.4	112.3	0.9	20.6	36.7	1.2	0.0	9.0	7.8	2.2	3.2	30.0	1501.1	1.5	4.9	0.1	2.3	42.6
RNF145	FLJ31951	ENSG00000145860	"Ring finger protein 145"	Q96MT1	5	159157409-159210053	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"B-cells: 11.4;granulocytes: 16.0;T-cells: 6.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036562	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA036562: AB_10696657"	"unprognostic (1.57e-1)"	"unprognostic (9.02e-3)"	"unprognostic (4.11e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavorable (1.64e-6)"	"unprognostic (1.35e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	27.4	39.3	13.7	39.4	15.9	20.4	28.2	16.2	16.1	24.7	18.6	26.4	12.2	21.0	30.9	53.1	16.9	48.3	18.8	15.6	19.8	19.5	15.3	73.6	38.7	11.1	13.1	29.0	12.3	47.7	19.4	52.4	11.6	25.9	29.3	33.8	25.6	32.7	9.0	22.3	16.6	27.4	14.3	29.2	26.7	12.1	20.3	26.5	33.8	13.7	48.4	68.1	24.4	14.7	65.5	63.5	95.2	115.1	98.5	43.6	18.6	51.3	88.9	46.3	74.6	22.2	52.9	22.4	89.7	45.3	87.9	83.1	75.9	67.3	80.9	92.7	27.2	47.2	68.5	18.4	42.1	31.4	43.2	27.0	118.8	43.2	63.0	64.7	46.2	53.6	47.7	83.6	44.1	1.9	36.1	9.8	41.3	20.5	32.0	47.3	41.6	44.8	61.4	22.3	34.5	63.9	51.8	54.7	86.5	64.7	38.5	28.4	49.7	51.6	47.0	41.9	92.1	18.4	27.6	20.6	60.3	38.4	113.1	3.5	2.5	16.0	3.0	2.6	3.5	11.4	4.4	3.6	1.9	5.1	5.8	4.0	9.5	2.3	2.3	2.7	6.3	1.3	13.7	15.9	16.2	16.1	15.6	19.8	11.1	13.1	11.6	14.3	20.3	14.7	34.1	112.2	244.1	25.1	62.9	122.7	102.0	90.0	73.4	106.7	97.2	77.3	12.7	65.8	114.0	36.8	58.4	2.8	55.1	98.4	19.6	75.0	28.9	27.5	37.1	75.7	54.1	67.5	89.2	114.4	24.3	45.7	52.0	36.7	69.1	30.2	127.8	19.5	45.5	114.4	74.2	41.8	32.6	115.0	240.8	39.5	46.3	69.4	65.8	52.5	153.9	56.1	47.4	40.2	38.9	108.6	53.7	51.9	38.1	123.8	16.9	10.6	65.6	53.4	46.0	25.4	46.5	19.2	34.8	81.9	99.4	10.9	69.3	19.0	72.0	163.1
RNF19B	"FLJ90005, IBRDC3"	ENSG00000116514	"Ring finger protein 19B"	Q6ZMZ0	1	32936445-32964809	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 79.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 16.9"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 16.9"	"Cell line enhanced"	"Detected in all"		"Daudi: 107.6;Karpas-707: 124.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049587, HPA063640"	Approved		Approved	Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA049587: AB_2680826, HPA063640: "	"unprognostic (2.83e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.78e-2)"	"prognostic favorable (3.39e-4)"	"prognostic unfavorable (5.41e-6)"	"unprognostic (8.78e-2)"	"unprognostic (5.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (4.39e-5)"	"unprognostic (2.58e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.23e-2)"	14.5	19.1	10.7	24.3	9.6	74.1	10.9	14.5	10.7	16.8	7.6	23.3	25.0	15.0	5.0	35.3	12.3	17.4	10.4	9.9	12.1	21.1	11.3	21.1	17.7	10.7	9.6	9.7	9.2	11.5	7.9	14.9	11.8	11.0	25.8	18.9	15.4	8.9	16.2	22.6	21.7	18.0	11.6	15.1	13.1	79.0	10.8	13.0	9.0	11.1	30.6	30.1	20.9	11.6	18.7	14.3	11.9	11.3	7.1	9.6	79.5	8.5	10.0	14.7	15.6	16.8	54.9	107.6	14.2	10.7	18.2	26.5	14.3	19.8	13.3	39.6	9.5	9.2	10.5	16.9	22.5	14.7	19.0	7.9	36.3	32.5	39.3	17.2	31.9	10.3	11.7	124.8	14.5	6.1	9.6	18.4	19.2	21.1	15.8	12.7	17.3	11.3	11.5	26.4	18.9	9.6	27.0	9.1	63.1	29.1	8.0	20.8	35.1	8.1	11.5	21.1	15.1	29.6	16.1	38.0	11.9	14.7	12.5	6.1	2.0	4.0	1.6	1.9	1.3	1.2	1.4	0.7	1.4	1.5	0.4	0.6	16.9	1.0	1.7	0.6	1.7	0.8	10.7	9.6	14.5	10.7	9.9	12.1	10.7	9.6	11.8	11.6	10.8	11.6	20.6	12.8	4.4	5.5	8.7	46.1	27.0	26.7	24.5	4.6	15.8	11.7	16.2	10.0	9.9	7.3	2.1	12.6	14.6	48.0	1.9	12.9	34.8	25.4	7.3	15.3	11.3	5.2	9.7	11.5	6.3	8.4	13.3	36.9	4.5	3.2	7.1	4.8	13.5	3.3	9.8	22.1	6.1	20.9	37.7	26.3	2.1	42.4	5.4	19.7	39.5	2.8	2.1	7.5	6.6	25.7	31.9	3.8	4.6	34.2	38.6	9.2	14.4	7.7	0.0	5.9	9.6	34.7	16.3	23.9	32.5	7.4	10.3	2.3	16.3	41.7
RP2	"NM23-H10, NME10, TBCCD2"	ENSG00000102218	"RP2 activator of ARL3 GTPase"	O75695	X	46837043-46882358	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 49.5"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 62.8;Langerhans cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000234, HPA000909"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA000234: AB_1079831, HPA000909: AB_2666140"	"unprognostic (2.26e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.79e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.76e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.79e-3)"	"unprognostic (9.75e-2)"	"unprognostic (6.15e-3)"	"unprognostic (2.96e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.28e-3)"	10.9	8.9	1.9	15.6	2.3	49.5	7.2	2.6	2.3	7.9	3.6	10.1	10.6	6.9	4.0	12.9	6.8	12.7	4.8	1.7	2.7	6.7	13.2	11.8	12.9	3.3	2.8	6.5	4.6	7.4	1.7	25.2	3.5	6.7	10.5	4.2	4.4	5.3	2.0	5.3	11.0	9.0	3.5	13.2	8.1	4.0	2.3	9.8	6.1	3.6	11.2	10.4	4.2	4.6	21.8	10.3	20.4	11.0	15.7	19.4	48.0	27.4	21.5	23.8	23.9	44.6	18.2	25.8	10.7	29.3	20.1	14.0	19.8	20.0	32.1	11.5	11.5	13.9	11.7	10.7	17.9	29.2	46.4	15.1	13.0	18.8	10.1	13.3	30.5	11.4	6.2	13.1	27.0	1.9	18.1	26.8	12.5	14.8	19.5	22.9	27.9	13.8	15.3	22.0	7.4	10.0	24.4	14.9	12.4	36.2	16.8	27.1	27.1	18.3	13.6	29.1	9.8	4.9	6.8	15.4	9.5	20.4	19.5	62.6	22.6	35.5	6.1	30.8	5.0	10.3	4.9	5.3	22.6	9.6	6.0	5.7	43.5	7.6	36.3	7.6	6.1	12.2	1.9	2.3	2.6	2.3	1.7	2.7	3.3	2.8	3.5	3.5	2.3	4.6	9.6	9.6	7.4	3.9	18.9	15.8	3.2	6.1	15.4	3.1	7.8	6.1	1.7	7.2	5.1	9.2	2.1	23.2	12.0	28.6	0.0	4.7	2.8	15.8	14.5	8.6	3.6	10.3	3.1	5.3	6.4	10.3	12.8	14.9	12.0	4.0	12.5	20.1	24.3	0.0	4.0	9.4	2.0	62.8	72.9	1.7	5.6	44.7	21.4	6.5	36.6	3.6	6.2	12.1	5.9	11.6	13.4	5.7	13.2	8.2	9.8	3.6	14.5	5.5	6.6	7.7	10.5	7.8	4.6	36.4	14.9	38.2	11.4	4.7	10.5	13.6
RRAGC	"FLJ13311, GTR2"	ENSG00000116954	"Ras related GTP binding C"	Q9HB90	1	38838198-38859772	"Disease related genes, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 224.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018247, HPA055489"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Vesicles"		"HPA018247: AB_1856475, HPA055489: AB_2682832"	"unprognostic (2.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (9.97e-9)"	"unprognostic (2.14e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-2)"	37.0	16.9	18.0	16.6	19.2	30.2	25.2	20.0	19.4	17.1	16.4	21.5	18.7	16.1	14.0	24.9	13.9	17.7	21.6	17.6	20.4	24.5	18.5	19.3	20.5	20.4	21.3	21.6	14.2	24.0	10.0	28.5	21.3	14.9	17.0	16.1	14.2	16.9	17.4	29.8	16.2	21.9	19.5	17.3	15.1	17.5	19.8	18.8	16.7	18.9	21.8	19.0	18.1	21.3	37.0	16.6	21.3	23.3	110.7	74.6	33.0	33.7	68.6	44.8	47.2	12.7	23.9	23.0	18.9	52.6	71.8	21.7	40.1	22.2	36.8	37.6	28.3	22.1	19.2	14.7	135.6	26.0	23.9	66.7	55.2	48.0	61.9	35.4	47.5	24.5	22.9	44.9	65.7	10.2	19.0	14.7	27.2	15.9	28.0	18.1	37.6	15.6	31.6	42.5	11.1	16.5	27.0	20.0	73.2	47.5	18.3	19.5	42.5	54.3	22.4	60.0	29.2	35.0	60.5	26.8	50.5	29.1	28.8	0.5	2.4	5.5	1.7	2.3	2.9	3.3	2.6	2.2	2.3	3.6	2.2	2.1	5.9	1.7	1.8	8.4	2.5	1.6	18.0	19.2	20.0	19.4	17.6	20.4	20.4	21.3	21.3	19.5	19.8	21.3	31.2	32.1	28.0	6.5	42.1	111.9	47.1	19.2	40.9	20.0	31.0	25.0	22.2	24.3	16.1	12.9	12.5	84.9	38.4	30.3	11.7	55.7	56.3	32.0	26.6	34.3	14.4	24.0	7.4	48.1	57.7	39.4	12.2	42.9	16.5	16.9	35.7	14.2	72.1	38.7	8.3	10.3	20.3	34.4	65.0	49.8	30.7	49.2	53.4	9.4	63.3	43.4	10.3	7.5	15.8	47.0	14.0	37.2	20.1	47.3	21.5	30.4	15.0	22.8	19.7	28.1	37.5	24.7	28.5	46.1	140.5	224.1	23.3	18.6	12.2	51.1
RRP12	KIAA0690	ENSG00000052749	"Ribosomal RNA processing 12 homolog"	Q5JTH9	10	97356358-97426076	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 90.9;skeletal muscle: 38.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 26.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049945, HPA074403"			Supported	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoli	"Vesicles, Plasma membrane, Cytosol"	"HPA049945: AB_2680965, HPA074403: "	"unprognostic (2.79e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.12e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (2.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.81e-2)"	"unprognostic (6.99e-3)"	8.1	10.2	2.6	9.2	3.4	90.9	5.6	1.1	7.6	5.6	2.4	4.9	6.0	7.4	3.6	8.5	7.3	7.2	11.4	3.2	2.7	6.8	5.7	6.7	6.7	4.3	4.4	6.1	16.0	9.3	10.2	4.3	4.1	6.3	3.8	3.4	8.3	4.0	38.5	10.3	4.7	6.0	0.2	7.6	6.3	10.9	3.7	4.7	5.5	9.7	6.1	9.3	5.7	4.6	38.9	50.8	13.2	28.6	10.0	11.6	28.9	24.2	14.4	24.2	18.7	55.6	35.0	42.3	30.4	15.1	21.6	48.7	36.3	28.0	16.3	23.1	44.2	32.8	19.5	43.6	16.5	51.7	41.5	12.2	38.6	59.9	54.6	27.0	13.7	23.5	47.7	27.4	14.0	50.8	35.0	33.0	57.0	20.4	34.0	38.1	18.0	42.1	16.8	21.4	17.7	37.9	19.2	18.1	24.1	10.4	43.7	26.5	18.2	16.1	27.9	36.5	76.4	55.7	52.7	48.6	23.2	64.9	17.9	0.4	11.2	6.9	2.7	13.6	3.3	3.9	1.6	2.2	6.2	4.2	2.5	2.8	26.7	1.9	16.9	5.0	1.2	6.0	2.6	3.4	1.1	7.6	3.2	2.7	4.3	4.4	4.1	0.2	3.7	4.6	8.8	35.3	31.1	5.9	18.5	23.5	14.2	5.1	25.0	5.8	12.7	9.9	11.6	7.2	21.5	14.7	41.7	5.2	7.7	10.6	0.0	8.7	7.2	17.1	10.6	10.6	21.5	7.2	15.1	8.7	7.5	13.5	27.0	20.1	41.7	12.9	3.9	8.9	11.5	5.0	9.5	13.8	4.1	12.5	7.1	4.8	3.7	30.3	7.2	2.8	12.3	1.9	3.1	5.0	4.4	8.5	6.4	2.6	31.8	17.1	3.7	6.8	24.6	12.7	0.0	19.4	6.7	10.6	20.6	22.7	19.6	9.2	11.0	13.5	11.5	13.6
RUBCNL	"C13orf18, FLJ21562, KIAA0226L, PACER"	ENSG00000102445	"Rubicon like autophagy enhancer"	Q9H714	13	46334681-46438190	"Predicted intracellular proteins"	"Autophagy, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 6.1;B-cells: 20.7;Endometrial stromal cells: 6.7;Hofbauer cells: 16.7;Macrophages: 5.2"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 17.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"memory B-cell: 161.2;naive B-cell: 155.8;neutrophil: 124.0;plasmacytoid DC: 106.2"	"Group enriched"	"Detected in many"	15	"B-cells: 161.2;dendritic cells: 106.2;granulocytes: 124.0"	"Group enriched"	"Detected in some"	4	"Daudi: 179.1;U-698: 341.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA026614	Approved		Approved	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA026614: AB_10602693"	"unprognostic (3.35e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.94e-3)"	"prognostic favorable (3.76e-5)"	"unprognostic (1.09e-2)"	"unprognostic (8.30e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.95e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.47e-2)"	"unprognostic (7.00e-3)"	4.2	1.3	3.7	18.0	3.8	14.8	4.0	3.5	4.1	6.6	2.5	11.9	3.0	3.7	1.2	1.0	3.7	4.0	1.0	3.4	6.8	1.1	2.2	5.2	41.2	6.2	4.8	0.6	0.7	0.3	2.0	4.2	6.1	1.5	16.2	3.9	3.0	2.6	10.1	2.0	13.2	3.6	4.9	20.3	2.2	15.7	6.3	22.9	1.9	1.4	40.6	7.5	1.3	5.9	0.5	0.1	3.6	0.2	0.1	0.2	0.3	0.0	0.2	0.2	0.1	7.5	0.2	179.1	1.8	0.0	0.9	0.2	0.1	0.0	0.1	0.7	0.3	0.2	0.2	0.1	0.0	0.2	0.2	4.7	0.0	0.6	0.9	0.0	0.0	8.2	0.3	0.4	0.0	0.1	1.9	1.4	1.5	0.0	1.4	62.6	0.1	6.1	0.0	0.1	3.4	0.1	0.2	0.3	4.4	10.8	0.2	53.0	0.1	0.2	1.6	0.3	0.4	0.9	37.3	341.2	1.1	0.3	0.2	0.5	4.5	0.1	0.1	8.9	0.1	161.2	0.3	0.1	5.1	155.8	0.1	0.1	124.0	3.5	7.1	106.2	0.2	7.5	3.7	3.8	3.5	4.1	3.4	6.8	6.2	4.8	6.1	4.9	6.3	5.9	0.2	3.2	6.1	0.0	20.7	0.0	0.0	0.0	0.0	0.0	2.9	3.9	0.0	0.0	2.5	0.0	0.0	0.3	0.3	0.0	0.0	1.4	0.0	1.3	6.7	0.4	0.0	0.0	0.0	1.2	0.4	1.1	0.0	2.5	2.5	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.0	0.0
SAMSN1	"HACS1, NASH1, SASH2, SH3D6B, SLy2"	ENSG00000155307	"SAM domain, SH3 domain and nuclear localization signals 1"	Q9NSI8	21	14485228-14658821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 192.9;lymphoid tissue: 80.1"	"Cell type enhanced"	"Detected in many"		"granulocytes: 1174.1;Langerhans cells: 317.9;Macrophages: 414.6;monocytes: 829.9;T-cells: 332.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 314.2"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HEL: 273.7;K-562: 331.6;Karpas-707: 137.3"	"Region enriched"	"Detected in many"	6	"olfactory bulb: 20.7"	"Low region specificity"	"Detected in all"			"HPA010645, HPA017055, HPA046639"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"	Nucleoplasm	"HPA010645: AB_1856559, HPA017055: AB_1856560, HPA046639: AB_2679732"	"unprognostic (7.62e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (4.52e-6)"	"unprognostic (9.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.68e-2)"	32.3	6.7	2.4	80.1	2.8	192.9	4.7	3.3	4.9	5.7	4.2	11.0	7.0	3.4	1.9	5.3	6.3	22.7	4.5	2.5	3.5	4.2	17.5	22.9	35.4	6.2	4.5	1.3	3.1	2.0	2.1	15.5	6.1	3.9	15.3	12.7	2.8	2.2	0.7	1.5	15.1	10.8	5.1	32.0	9.3	1.2	4.6	22.4	2.2	1.2	41.0	39.7	2.5	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.1	0.0	0.0	0.0	0.0	1.8	0.0	14.0	0.0	273.7	0.0	0.0	0.0	32.5	12.7	0.1	0.0	0.0	37.9	10.2	3.6	4.8	331.6	137.3	0.0	0.0	15.9	39.5	0.1	0.0	0.2	26.8	0.3	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	35.0	0.0	0.0	0.0	0.0	58.2	0.5	0.3	1.4	20.7	0.0	314.2	38.7	234.6	22.1	52.3	15.4	27.3	42.8	33.3	25.0	15.4	26.8	19.1	49.4	18.0	83.0	0.9	60.3	33.6	2.4	2.8	3.3	4.9	2.5	3.5	6.2	4.5	6.1	5.1	4.6	8.9	4.8	22.4	54.9	0.7	127.5	15.6	1.1	0.0	1.8	64.9	2.7	3.0	1.2	1.5	11.2	36.8	0.0	0.5	147.9	0.7	0.0	0.6	0.0	0.8	0.2	8.0	0.0	13.7	1.0	6.5	0.7	11.3	10.7	0.6	1174.1	0.1	4.6	1.8	62.0	0.0	0.8	0.8	0.0	183.7	317.9	0.4	0.6	414.6	21.4	131.2	829.9	1.6	24.7	2.5	0.6	0.7	1.1	0.0	119.3	0.5	0.0	0.5	8.0	4.7	0.0	2.2	3.7	0.1	0.2	1.2	13.2	0.5	332.8	0.1	0.9	0.9
SAP30		ENSG00000164105	"Sin3A associated protein 30"	O75446	4	173369969-173377532	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 77.2;Macrophages: 77.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 181.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022627, HPA059012"	Enhanced		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB022627: , HPA059012: AB_2683880"	"unprognostic (1.53e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.83e-2)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (4.95e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (1.54e-7)"	"unprognostic (3.97e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.21e-1)"	17.4	12.9	17.4	13.3	19.7	23.4	12.8	18.4	21.6	13.9	16.1	25.6	9.5	13.2	9.6	9.9	16.9	8.6	20.4	17.0	18.2	6.2	9.0	12.8	8.0	19.3	18.2	14.6	7.3	4.5	8.1	7.1	19.2	11.4	7.0	16.3	11.6	9.7	10.5	8.5	12.5	12.4	18.7	15.7	18.4	24.7	17.6	10.3	10.6	7.4	6.6	19.5	12.6	25.3	49.0	16.3	46.3	45.2	29.0	17.9	10.1	22.5	19.3	24.7	30.4	7.0	19.4	43.9	10.3	26.3	31.1	12.0	37.8	19.1	18.9	49.6	35.9	58.7	39.6	20.0	27.5	34.0	35.9	29.8	9.2	21.1	21.2	34.7	29.3	31.5	30.8	181.4	32.2	20.9	48.4	38.0	20.5	21.7	31.3	38.9	16.5	31.6	15.1	7.8	37.5	79.1	31.8	31.9	14.9	11.8	13.5	20.0	29.1	17.6	23.9	41.4	52.8	101.5	39.1	41.8	56.8	81.6	51.2	0.4	1.3	0.0	0.6	0.7	0.2	0.1	0.3	0.4	1.0	0.2	0.0	0.2	0.5	0.0	0.4	0.0	0.4	0.2	17.4	19.7	18.4	21.6	17.0	18.2	19.3	18.2	19.2	18.7	17.6	25.3	42.1	0.0	2.3	11.1	7.2	51.7	6.6	3.9	16.5	26.2	25.5	29.3	28.9	4.3	3.7	7.3	22.9	2.1	22.5	4.8	0.0	2.2	23.1	23.6	34.3	27.3	19.7	20.2	12.5	3.5	9.3	19.9	19.4	7.4	7.0	13.5	14.6	9.0	9.3	25.2	14.6	10.5	0.0	77.2	13.8	6.2	10.2	77.0	33.8	3.7	15.2	57.7	2.1	7.1	15.4	2.4	2.7	6.4	17.6	8.6	6.4	6.2	9.9	46.3	52.6	12.5	31.7	63.7	15.2	16.1	53.0	1.2	27.0	12.3	11.1	4.1
SDCBP	"MDA-9, SYCL"	ENSG00000137575	"Syndecan binding protein"	O00560	8	58552924-58582859	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 959.8;Melanocytes: 889.4"	"Cancer enriched"	"Detected in all"	4	"melanoma: 244.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1908.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 1908.0;monocytes: 562.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 787.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012245, HPA023840"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1300000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"CAB012245: , HPA023840: AB_1857712"	"unprognostic (2.39e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.92e-1)"	228.5	126.4	94.1	160.8	111.8	245.6	167.1	102.0	130.1	160.9	112.2	119.6	83.1	109.8	83.6	88.8	95.7	194.8	120.6	103.7	112.6	126.6	174.0	223.9	121.2	113.7	103.8	89.1	80.8	132.9	45.8	264.3	113.5	70.8	134.7	26.8	124.9	78.3	65.9	84.8	92.8	151.2	107.4	203.0	130.0	41.1	110.8	129.9	120.7	113.7	92.8	248.8	91.9	123.7	123.5	185.9	194.2	101.4	711.7	607.1	86.1	122.9	439.6	175.3	228.9	74.8	250.7	0.4	194.8	166.4	321.2	49.7	106.0	142.4	215.7	22.6	91.3	184.3	156.0	60.6	787.9	47.7	287.1	417.9	188.1	176.5	525.2	273.0	428.0	125.2	92.3	104.6	403.4	32.4	104.1	55.9	122.2	478.6	52.3	49.6	59.4	24.3	282.1	127.0	84.9	153.5	133.8	56.1	630.0	213.8	51.0	127.9	382.3	168.8	72.5	200.8	81.5	31.4	45.6	74.8	428.9	0.5	155.1	777.4	562.9	528.1	61.2	349.6	78.0	69.4	82.0	67.3	251.8	61.0	103.9	80.2	1908.0	42.6	329.1	69.9	103.0	453.2	94.1	111.8	102.0	130.1	103.7	112.6	113.7	103.8	113.5	107.4	110.8	123.7	382.7	211.5	115.9	26.8	170.3	338.7	321.2	312.5	108.1	10.8	86.7	54.6	70.6	88.6	181.3	206.0	16.7	284.3	220.2	192.9	225.0	392.9	7.8	110.9	87.0	412.7	112.3	116.6	18.5	291.6	756.8	308.1	162.1	120.5	396.9	62.9	378.3	101.9	782.5	15.2	23.7	180.3	248.2	552.1	959.8	15.9	233.9	626.0	889.4	71.2	312.4	94.3	51.5	21.6	16.3	297.9	152.9	159.9	65.1	307.4	78.4	211.2	169.8	11.1	98.6	82.7	177.4	14.8	8.4	73.3	173.2	483.0	256.2	117.0	129.2	457.6
SDE2	"C1orf55, FLJ35382"	ENSG00000143751	"SDE2 telomere maintenance homolog"	Q6IQ49	1	225982702-225999343	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028467, HPA031255, HPA031256"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA028467: AB_10599192, HPA031255: AB_10601462, HPA031256: AB_10603568"	"unprognostic (9.69e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.84e-2)"	17.4	8.5	5.5	11.3	7.0	32.9	11.8	6.4	6.6	9.0	4.8	8.3	9.0	11.8	7.8	9.6	7.4	10.5	7.7	4.9	6.0	9.2	14.6	9.2	12.4	6.9	6.6	10.2	9.6	11.1	4.4	11.8	6.6	9.8	9.1	5.1	6.7	7.3	12.7	10.8	9.0	9.8	6.6	10.4	7.7	8.3	6.1	22.8	12.5	9.6	10.6	11.6	7.8	8.4	13.1	9.3	14.9	15.9	10.2	11.3	18.5	13.7	12.9	18.4	14.0	13.7	14.7	19.2	20.9	11.6	7.2	16.5	18.9	11.9	22.2	14.7	15.3	21.1	7.9	12.7	18.6	21.0	24.6	12.5	16.9	19.6	24.6	10.3	12.8	22.6	39.3	22.6	13.7	3.8	29.5	16.6	20.8	20.2	9.8	24.4	19.1	24.9	11.1	9.2	13.3	22.0	15.6	16.9	26.3	11.9	16.6	25.4	12.7	15.6	11.0	20.3	30.4	13.4	10.3	23.4	16.1	12.9	31.5	21.8	6.3	5.9	8.0	6.4	10.8	8.0	8.1	7.8	7.1	7.0	8.1	7.7	18.5	13.5	7.9	8.1	6.7	6.9	5.5	7.0	6.4	6.6	4.9	6.0	6.9	6.6	6.6	6.6	6.1	8.4	36.0	28.9	22.6	4.2	39.9	43.6	17.2	11.2	29.0	6.2	19.8	13.6	9.4	2.8	20.1	9.2	0.0	9.6	29.3	14.3	15.6	6.5	72.8	24.8	15.1	24.8	17.4	56.2	4.7	7.1	10.2	17.8	13.3	35.9	35.5	9.7	12.8	20.6	11.1	15.2	5.0	10.8	16.2	16.4	28.8	20.4	9.9	27.0	19.6	1.9	7.4	12.6	10.3	4.5	8.6	9.7	9.4	6.4	26.6	14.2	9.5	12.7	12.7	8.9	6.6	28.8	23.9	23.9	14.4	26.5	59.1	14.2	23.2	21.0	9.9	18.2
SERPINB8	"CAP2, PI8"	ENSG00000166401	"Serpin family B member 8"	P50452	18	63970029-64019779	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 58.8"	"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 120.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB034300	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		920000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"CAB034300: AB_2186486"	"unprognostic (8.49e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.71e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (8.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.90e-1)"	10.8	9.5	2.6	15.8	3.2	30.3	9.5	3.4	3.6	9.3	3.5	8.6	6.3	4.7	1.5	30.1	4.4	18.1	5.7	2.8	3.9	9.0	37.8	12.1	13.4	5.2	4.0	4.2	7.1	2.7	3.7	7.2	4.8	4.6	9.7	2.3	10.8	3.3	3.0	58.8	8.8	7.3	4.3	7.8	7.1	2.7	4.6	6.5	5.3	2.3	18.3	23.7	17.1	4.5	24.2	4.8	4.0	28.8	13.9	19.7	2.0	75.6	72.9	46.8	46.4	1.0	10.8	0.4	27.2	45.6	23.3	38.3	0.8	48.2	66.3	33.4	0.9	0.0	8.7	2.5	32.1	120.0	10.0	19.1	41.3	63.6	20.9	30.3	51.4	5.1	0.7	13.4	32.9	2.1	2.1	13.5	1.7	3.8	23.6	1.7	10.5	2.1	21.4	27.1	2.3	2.4	15.0	2.3	28.8	3.3	0.8	45.4	79.2	71.0	15.4	8.8	31.1	5.9	1.0	0.1	72.5	69.2	63.0	2.7	44.2	2.0	7.6	34.2	6.8	7.1	6.3	4.7	53.8	9.9	3.3	5.2	12.4	4.6	18.1	28.8	8.9	11.2	2.6	3.2	3.4	3.6	2.8	3.9	5.2	4.0	4.8	4.3	4.6	4.5	6.0	3.2	8.3	0.3	9.1	41.0	25.9	38.9	5.7	0.4	5.5	3.8	1.2	8.6	25.5	0.0	0.0	4.9	13.4	12.3	0.0	30.0	1.3	7.6	3.3	8.7	1.8	3.0	1.8	19.2	5.6	8.6	8.2	16.3	4.5	0.9	7.5	9.6	15.3	0.0	1.3	3.5	12.2	24.8	35.1	1.1	0.9	35.9	16.0	1.0	29.0	1.6	5.2	1.5	2.9	42.2	10.7	0.0	3.5	13.0	8.5	2.9	12.9	0.3	0.0	12.3	9.8	1.7	2.3	18.2	48.4	31.3	8.2	1.4	5.0	33.3
SERPINB9	"CAP3, PI9"	ENSG00000170542	"Serpin family B member 9"	P50453	6	2887270-2903309	"Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 41.1;placenta: 52.3"	"Cell type enriched"	"Detected in many"	5	"Langerhans cells: 1527.7"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 46.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 225.3;SuSa: 227.6;U-698: 98.8"					"Low region specificity"	"Detected in all"			HPA030067	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		3400000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA030067: AB_2673295"	"unprognostic (6.82e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.85e-2)"	"prognostic unfavorable (1.66e-6)"	"unprognostic (9.90e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.76e-2)"	11.6	11.0	6.4	35.4	6.7	18.9	5.3	7.5	7.9	7.8	5.9	5.3	4.4	4.4	3.1	9.2	8.3	11.3	9.1	6.3	8.0	5.2	16.3	26.4	40.9	8.8	7.8	3.0	2.4	6.7	8.8	52.3	8.7	5.2	6.5	4.7	4.3	2.8	2.4	2.7	10.8	5.9	8.4	28.2	5.0	8.7	7.2	13.8	7.6	1.8	41.1	17.0	7.4	8.2	0.2	9.8	0.3	0.1	0.7	0.3	225.3	1.9	0.5	2.3	3.4	2.9	18.8	38.2	22.8	2.1	0.1	0.1	27.6	0.0	2.0	12.4	2.7	3.8	3.3	5.5	12.9	0.0	0.1	10.1	0.1	4.1	0.0	0.2	50.2	3.4	17.8	0.3	1.9	0.9	0.0	0.3	31.7	0.1	0.1	3.7	0.1	0.4	1.6	0.1	1.5	0.5	22.7	0.1	0.0	227.6	0.1	0.6	52.5	0.0	0.4	0.1	0.1	0.2	49.5	98.8	0.0	0.1	0.1	4.7	48.6	0.3	43.6	100.8	36.3	22.4	31.3	41.7	16.1	24.9	28.7	41.4	7.6	51.3	62.7	17.0	35.7	37.9	6.4	6.7	7.5	7.9	6.3	8.0	8.8	7.8	8.7	8.4	7.2	8.2	26.2	19.2	17.6	12.1	105.1	35.3	2.2	4.2	1.8	1.5	13.8	6.7	5.3	1.5	12.1	5.5	0.0	83.1	100.8	4.7	0.0	15.8	1.0	68.0	10.8	44.1	15.5	11.6	21.4	0.2	143.7	35.6	3.6	82.2	46.3	2.2	66.4	7.1	17.9	8.4	23.1	2.7	2.0	59.6	1527.7	4.9	4.4	232.6	88.9	92.8	99.8	5.3	43.3	1.0	3.2	9.3	6.0	17.7	115.7	2.5	0.1	2.4	10.4	3.0	13.1	55.3	14.6	0.4	2.2	3.8	36.9	270.2	100.6	8.1	3.4	6.9
SETDB2	"C13orf4, CLLD8, CLLL8, KMT1F"	ENSG00000136169	"SET domain bifurcated histone lysine methyltransferase 2"	Q96T68	13	49444374-49495003	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Chromatin regulator, Developmental protein, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012190, HPA071677"	Approved		Approved	Nucleoplasm		No	No			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB012190: AB_2186195, HPA071677: AB_2686430"	"unprognostic (1.77e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.74e-2)"	"unprognostic (3.44e-3)"	"unprognostic (7.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.09e-3)"	"unprognostic (7.95e-2)"	"prognostic favorable (1.92e-7)"	"unprognostic (2.83e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.85e-1)"	5.3	8.9	4.2	10.4	4.6	8.2	11.1	5.7	5.2	7.4	6.2	7.5	6.4	9.0	6.1	5.9	6.3	7.7	10.5	4.7	4.1	8.1	8.0	8.1	16.7	3.4	3.9	16.0	7.1	7.8	3.9	6.3	3.6	7.6	9.3	9.5	8.2	6.9	2.5	7.8	7.2	7.5	3.8	13.1	8.0	15.3	4.7	10.1	11.1	5.3	13.9	6.4	4.7	5.5	3.0	2.0	6.0	6.2	8.3	9.3	3.0	8.4	10.5	7.4	6.9	12.5	7.1	37.1	1.6	5.5	5.5	6.0	6.4	5.7	7.2	8.5	5.6	12.9	5.7	7.6	11.7	19.9	7.1	7.3	10.2	5.6	18.5	8.0	6.3	11.8	5.7	5.0	6.8	2.6	7.6	14.8	3.2	7.9	4.8	14.6	7.5	8.0	6.8	2.8	3.1	3.5	3.7	5.2	18.2	5.1	4.4	17.0	3.8	7.0	2.5	9.4	3.4	6.1	8.9	19.4	2.2	15.9	3.3	3.0	2.7	3.3	4.2	3.6	3.6	5.4	4.4	4.4	4.9	5.5	6.1	4.7	0.9	5.1	3.0	3.4	6.5	2.8	4.2	4.6	5.7	5.2	4.7	4.1	3.4	3.9	3.6	3.8	4.7	5.5	7.8	28.9	13.3	18.6	26.9	6.9	5.7	3.9	7.4	14.4	8.0	7.4	23.2	10.0	8.0	5.5	27.1	5.6	17.0	9.7	9.8	4.0	22.1	8.6	14.7	8.8	11.5	8.8	32.9	4.2	3.3	8.5	9.7	6.8	6.3	18.8	6.4	7.6	17.1	13.5	30.4	7.0	6.1	21.5	19.8	16.5	9.9	26.4	14.2	15.9	13.8	11.0	20.6	24.1	21.5	3.6	3.7	8.2	28.9	3.5	6.7	5.5	9.8	28.1	0.0	7.5	7.7	25.5	13.1	9.2	6.0	2.9	17.3	30.7	8.6	2.5
SFT2D3	MGC5391	ENSG00000173349	"SFT2 domain containing 3"	Q587I9	2	127701497-127705242	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.4;ASC TERT1: 4.2;BJ hTERT+: 4.2;HHSteC: 5.0;hTCEpi: 7.0;hTERT-HME1: 5.2;RPTEC TERT1: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"																					0.9	0.0	2.4	0.0	2.4	0.0	5.2	2.4	3.1	3.8	2.4	3.3	0.0	1.2	6.1	0.0	4.1	0.0	0.0	2.4	2.4	3.2	6.0	1.6	0.0	2.5	2.6	1.3	1.0	5.0	0.0	1.6	2.5	2.8	5.5	0.0	0.0	3.5	0.0	0.0	0.0	2.9	2.4	1.1	1.5	1.3	2.4	4.7	1.0	2.6	4.8	1.0	0.0	2.5	0.0	0.0	0.0	0.0	7.4	4.2	0.0	0.0	4.2	4.1	3.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	3.5	2.9	3.3	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	3.8	7.0	2.0	5.2	0.0	4.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	2.4	2.4	3.1	2.4	2.4	2.5	2.6	2.5	2.4	2.4	2.5	6.9	3.2	6.8	1.6	7.6	1.3	8.2	1.6	5.7	7.9	7.1	7.0	0.0	2.8	1.5	7.3	16.7	4.2	9.5	6.4	9.8	2.8	4.9	9.3	8.7	5.2	5.4	5.5	1.8	6.2	4.4	6.4	7.7	7.4	1.3	7.5	4.2	9.5	4.1	8.4	2.5	10.5	0.0	8.4	3.0	2.7	5.6	10.5	3.6	3.7	5.1	10.0	8.2	3.0	5.1	3.1	7.0	7.5	5.6	9.3	5.6	6.4	3.4	10.1	0.0	5.2	5.2	18.3	3.8	7.1	2.7	2.9	6.5	9.7	8.7	5.9
SGK1	SGK	ENSG00000118515	"Serum/glucocorticoid regulated kinase 1"	O00141	6	134169246-134318112	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 1007.1"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 1238.4;Proximal enterocytes: 789.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 43.4;eosinophil: 170.2;neutrophil: 91.6"	"Group enriched"	"Detected in all"	8	"granulocytes: 170.2;monocytes: 43.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 298.1;RPTEC TERT1: 469.5;SK-MEL-30: 319.7;TIME: 373.9;U-266/84: 358.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022085, CAB025148, HPA051251"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"		"CAB022085: , CAB025148: , HPA051251: AB_2681407"	"unprognostic (2.05e-2)"	"prognostic favorable (5.26e-4)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-3)"	"unprognostic (2.76e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.62e-2)"	"unprognostic (4.03e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.82e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.59e-2)"	147.5	121.5	35.8	47.4	57.3	68.9	83.2	40.0	51.4	61.1	96.9	68.4	51.4	37.0	9.5	108.4	36.5	170.0	35.8	41.2	42.7	105.2	99.3	81.8	33.6	64.5	44.9	125.8	177.1	1007.1	12.0	70.6	49.6	47.6	39.0	14.1	70.8	60.3	50.2	75.7	282.5	48.4	35.8	21.5	104.2	30.4	53.6	39.7	56.7	33.9	78.1	141.3	96.7	94.0	4.1	6.9	4.2	0.4	51.7	12.9	5.9	76.7	159.4	98.4	79.8	12.2	10.6	13.1	11.3	79.8	48.0	2.5	6.8	12.2	72.0	0.5	3.1	0.6	175.7	9.2	298.1	0.7	6.8	77.3	75.4	96.7	124.3	39.3	167.1	2.3	25.6	192.8	35.6	0.6	1.1	3.0	4.8	20.3	8.3	2.4	8.9	1.5	469.5	1.4	2.2	18.6	241.7	0.7	319.7	43.2	0.5	2.1	373.9	28.8	12.3	176.9	17.1	36.2	358.5	40.3	26.7	12.0	39.5	2.2	43.4	170.2	0.7	24.4	1.6	1.9	1.3	0.8	14.1	1.4	1.6	2.0	91.6	3.6	14.5	0.9	2.5	12.6	35.8	57.3	40.0	51.4	41.2	42.7	64.5	44.9	49.6	35.8	53.6	94.0	346.2	38.5	177.8	34.0	68.0	183.3	133.7	277.3	329.0	12.0	87.1	112.0	28.4	88.6	168.6	68.0	35.5	41.0	27.0	132.2	21.5	81.3	9.6	145.8	73.1	232.1	10.7	14.7	68.2	171.2	33.6	88.8	206.4	483.4	271.8	33.9	353.4	21.9	284.2	0.0	225.7	65.1	91.6	181.3	1238.4	7.7	15.2	492.5	268.6	58.1	29.6	4.6	2.1	270.9	377.7	36.2	123.9	15.8	92.4	51.0	789.1	124.3	61.5	29.3	13.1	43.5	102.9	38.1	10.2	348.1	116.2	579.8	46.9	48.9	36.3	123.8
SH3BP2	"CRBM, RES4-23"	ENSG00000087266	"SH3 domain binding protein 2"	P78314	4	2793071-2841098	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036789, HPA036790"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA036789: , HPA036790: AB_10671712"	"unprognostic (7.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (5.42e-6)"	"prognostic unfavorable (9.52e-4)"	"prognostic favorable (1.57e-5)"	"unprognostic (6.58e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.41e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.78e-2)"	"unprognostic (5.32e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.67e-4)"	15.3	6.8	17.2	30.0	20.6	48.2	7.9	20.1	16.6	7.0	6.8	12.3	11.4	6.8	9.8	7.1	8.9	8.7	6.7	14.4	22.3	13.1	12.1	17.0	23.2	34.0	30.5	5.8	9.6	4.8	5.0	12.8	25.2	5.3	9.1	5.2	10.4	8.3	16.9	39.7	16.0	10.5	21.5	43.9	16.7	5.2	36.1	8.4	4.7	4.8	13.3	12.3	9.7	14.8	11.2	5.2	7.4	8.7	4.6	14.6	7.2	16.8	13.0	11.1	10.9	6.9	31.6	18.0	20.5	14.2	9.7	5.6	0.3	10.5	7.5	12.2	6.8	41.4	15.2	6.1	17.1	15.4	29.1	27.7	10.5	7.1	5.9	11.8	25.7	13.7	2.5	37.2	15.0	9.6	2.7	24.3	13.3	21.6	13.3	0.6	7.4	9.9	20.1	16.1	25.4	16.4	12.8	10.7	10.3	6.8	15.7	30.8	35.4	12.1	8.9	4.2	13.8	19.5	10.6	4.3	14.1	40.2	14.4	4.1	21.0	13.6	13.8	36.5	8.2	3.0	3.8	8.8	15.9	6.9	1.9	5.0	33.8	8.3	44.6	6.7	6.9	12.1	17.2	20.6	20.1	16.6	14.4	22.3	34.0	30.5	25.2	21.5	36.1	14.8	27.6	3.2	5.8	40.5	19.5	38.1	10.0	35.3	8.6	0.8	19.8	10.0	8.3	7.2	25.3	40.5	0.0	1.3	43.7	42.5	3.9	6.3	8.5	9.7	11.0	31.3	10.2	14.9	0.4	22.0	1.2	11.3	18.3	22.0	9.5	11.6	33.9	59.0	49.3	0.0	2.7	14.2	30.5	81.5	63.3	10.8	13.7	71.9	19.6	18.7	48.9	23.7	57.7	2.5	0.5	25.3	27.1	10.1	18.1	16.1	23.7	43.7	12.3	6.4	39.5	5.2	16.0	1.9	3.7	18.6	83.4	4.2	22.0	25.5	15.4	20.1
SH3BP5	Sab	ENSG00000131370	"SH3 domain binding protein 5"	O60239	3	15254353-15341368	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 200.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 195.9;Early spermatids: 192.2;Extravillous trophoblasts: 356.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 349.3;MCF7: 118.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036445, HPA057988"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nuclear bodies"		"HPA036445: AB_10670106, HPA057988: AB_2683572"	"unprognostic (1.28e-3)"	"unprognostic (2.99e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.81e-3)"	"unprognostic (4.80e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.03e-1)"	78.3	200.5	21.2	35.2	22.7	72.6	72.0	38.4	26.1	71.1	16.0	27.4	15.7	77.5	13.5	26.9	85.6	45.7	24.1	23.3	21.0	52.8	17.3	73.2	59.9	21.4	20.0	116.2	15.9	47.9	35.7	40.8	22.4	25.0	8.4	27.4	49.9	34.1	71.7	25.6	27.0	37.3	20.8	30.9	16.1	30.9	20.9	37.4	51.1	19.1	35.7	33.0	50.6	35.1	27.4	16.5	6.4	14.1	53.1	46.8	349.3	13.6	10.9	9.3	10.4	10.8	13.4	21.3	6.2	40.8	16.1	3.6	2.9	14.2	5.9	19.5	12.8	15.7	72.3	1.9	21.9	4.4	8.6	36.9	9.3	41.6	7.9	34.2	116.0	31.3	18.4	8.5	10.3	118.1	57.6	23.2	13.6	3.5	20.6	1.1	27.2	115.6	8.8	53.5	16.8	7.8	18.6	19.2	21.7	21.6	18.1	10.9	84.3	22.8	29.5	21.9	12.0	3.3	7.6	15.2	44.7	16.3	31.5	8.1	7.8	9.1	52.9	2.5	15.9	19.1	24.1	36.1	8.9	24.3	12.9	16.6	13.9	25.4	4.6	3.9	11.1	20.4	21.2	22.7	38.4	26.1	23.3	21.0	21.4	20.0	22.4	20.8	20.9	35.1	195.9	0.0	16.3	2.3	115.2	17.0	6.0	8.2	11.4	41.3	23.5	32.1	0.7	5.7	13.9	68.0	14.6	12.5	73.7	0.6	3.9	2.7	192.2	13.1	33.0	150.7	2.4	7.0	49.5	8.7	356.3	97.5	3.6	13.7	2.5	28.1	165.0	7.0	33.1	65.6	38.4	2.5	12.2	87.2	133.3	97.8	49.0	113.1	33.8	26.2	33.3	5.1	167.9	12.5	60.6	3.2	1.1	118.5	67.1	8.5	4.7	36.2	7.5	44.4	6.6	56.8	13.4	3.0	4.5	14.2	12.1	173.2	51.5	81.6	1.4	10.2
SH3TC1	FLJ20356	ENSG00000125089	"SH3 domain and tetratricopeptide repeats 1"	Q8TE82	4	8182072-8241803	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.0"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 32.6;Kupffer cells: 33.7;Macrophages: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 17.7"	"Group enriched"	"Detected in many"	5	"B-cells: 6.8;dendritic cells: 17.7;monocytes: 12.3"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 25.8;MOLT-4: 41.8;SK-MEL-30: 26.8;U-2197: 19.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038132, HPA056807"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA038132: AB_10673041, HPA056807: AB_2683239"	"unprognostic (2.46e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.61e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.77e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.29e-2)"	8.4	3.5	4.0	8.7	4.3	4.6	5.6	4.1	5.6	2.9	5.2	2.8	0.9	2.1	0.7	8.4	3.0	5.4	3.6	3.6	7.3	19.2	9.6	9.0	9.1	10.5	6.0	1.2	6.3	0.7	2.5	3.0	8.5	4.7	1.0	1.3	4.6	2.7	1.5	2.7	4.9	2.0	9.2	14.1	6.0	0.6	8.4	28.0	4.6	0.7	4.5	4.4	5.8	11.8	3.9	6.1	0.1	0.0	0.0	0.5	4.1	0.4	0.2	0.5	0.8	3.2	2.2	5.2	5.2	0.0	0.8	2.0	0.0	12.4	0.0	14.2	0.2	0.0	6.1	5.7	4.3	0.1	0.8	0.2	15.3	0.3	9.9	0.5	25.8	3.2	0.8	7.3	0.4	4.1	41.8	3.4	0.0	2.3	5.1	3.1	0.7	1.6	0.4	1.0	0.1	3.1	1.7	0.4	26.8	1.0	0.0	1.0	14.2	0.0	3.0	19.0	0.2	0.0	1.0	4.7	0.2	1.9	4.1	0.0	9.9	1.3	0.7	8.8	0.9	4.9	1.7	1.1	7.7	6.8	0.9	0.7	0.3	0.3	12.3	17.7	2.5	4.3	4.0	4.3	4.1	5.6	3.6	7.3	10.5	6.0	8.5	9.2	8.4	11.8	12.6	0.0	5.8	1.3	18.1	0.8	10.5	6.9	0.6	1.0	0.8	1.4	3.3	4.3	4.1	25.8	0.0	2.1	18.2	2.5	7.9	3.6	0.5	0.9	0.3	12.6	1.2	3.2	0.2	5.6	3.4	1.6	32.6	2.2	17.2	0.3	27.5	8.6	22.7	23.5	0.1	2.5	14.2	33.7	16.7	1.5	0.6	35.7	0.0	17.8	15.6	13.3	7.2	0.5	0.1	9.3	4.5	0.7	17.1	8.3	0.1	17.2	2.0	0.9	0.0	0.6	1.2	0.0	0.3	2.5	0.6	3.0	11.7	2.5	1.8	15.3
SHTN1	"KIAA1598, shootin-1, shootin1"	ENSG00000187164	"Shootin 1"	A0MZ66	10	116881477-117126586	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 128.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"classical monocyte: 19.7;intermediate monocyte: 12.9;myeloid DC: 19.3;non-classical monocyte: 6.6;plasmacytoid DC: 12.9"	"Group enriched"	"Detected in many"	42	"dendritic cells: 19.3;monocytes: 19.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037942, HPA037943"	Enhanced	Approved	Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA037942: AB_2675748, HPA037943: AB_10671637"	"unprognostic (1.00e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.77e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.17e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (5.08e-6)"	1.9	4.0	63.2	4.5	94.5	0.7	4.9	42.7	54.1	2.9	10.0	4.3	4.1	2.4	4.6	3.1	2.9	3.8	1.6	46.9	73.9	4.7	7.6	6.2	2.9	77.5	70.1	3.9	12.2	8.0	6.2	3.1	69.5	4.2	5.2	10.6	6.7	1.4	0.3	5.6	4.8	2.0	48.6	4.5	5.7	6.4	79.5	2.7	7.5	0.8	2.3	2.1	2.1	128.1	24.2	13.4	1.3	2.8	0.0	0.0	12.8	2.0	5.3	4.0	7.6	15.1	15.5	0.0	4.0	7.4	11.8	12.2	10.6	8.9	4.1	0.0	11.0	0.0	14.5	8.9	1.7	4.3	3.7	0.5	7.5	4.0	7.5	10.3	9.7	6.4	6.7	0.1	2.8	9.6	0.0	0.1	5.0	4.8	8.9	0.0	17.5	5.4	10.3	3.3	14.5	5.7	16.0	23.3	13.8	15.7	18.4	3.8	17.0	1.4	9.4	0.1	11.7	2.4	0.1	0.0	7.1	0.0	7.2	0.0	19.7	0.2	0.0	12.9	0.0	0.0	0.1	0.0	19.3	0.0	0.1	0.0	0.4	0.0	6.6	12.9	0.4	5.6	63.2	94.5	42.7	54.1	46.9	73.9	77.5	70.1	69.5	48.6	79.5	128.1	1.4	76.9	35.7	0.0	2.0	0.0	18.9	0.0	15.4	92.3	31.8	15.9	4.9	35.8	23.5	23.9	62.6	42.1	24.7	10.6	21.5	46.4	7.5	43.4	10.6	5.1	17.0	1.7	0.0	53.2	30.9	11.2	36.7	81.1	2.5	23.6	1.8	50.5	37.3	48.8	0.0	15.5	0.0	83.6	0.0	11.7	11.1	77.2	0.0	0.0	90.3	13.8	1.0	0.0	0.0	46.2	42.5	5.3	0.8	25.2	21.2	58.4	18.2	59.4	13.1	18.2	5.0	22.0	39.6	20.5	0.0	20.0	3.1	28.4	15.7	15.4
SIDT2	CGI-40	ENSG00000149577	"SID1 transmembrane family member 2"	Q8NBJ9	11	117178736-117197445	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 67.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"intermediate monocyte: 83.5;non-classical monocyte: 151.0"	"Lineage enriched"	"Detected in all"	7	"monocytes: 151.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052352	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"			"HPA052352: AB_2681797"	"unprognostic (3.83e-1)"	"unprognostic (4.30e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (4.18e-5)"	"unprognostic (2.74e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.22e-3)"	40.2	25.1	23.5	21.2	28.4	12.4	36.3	27.4	27.1	32.8	19.4	28.8	44.2	30.5	16.0	15.1	31.3	18.5	31.8	24.1	23.2	20.6	40.8	36.4	23.4	37.0	29.2	60.2	113.4	13.6	35.7	22.4	33.9	48.6	23.1	14.4	31.5	21.2	25.2	32.7	42.3	20.8	29.7	34.6	75.9	28.5	29.2	10.0	31.7	12.3	20.4	26.2	20.4	48.9	8.7	8.8	10.5	15.4	34.4	30.7	34.8	14.8	19.5	9.3	8.6	25.1	32.8	8.9	23.1	39.1	11.7	9.0	10.2	11.5	7.6	13.2	12.4	6.3	15.8	17.3	17.8	5.3	15.5	38.1	12.8	12.0	12.9	28.6	19.1	11.4	12.0	19.2	22.1	18.2	7.5	6.2	4.9	45.6	6.5	5.6	7.2	25.5	12.2	9.1	3.2	7.9	15.8	38.1	2.6	11.7	30.8	6.3	11.9	12.3	7.9	8.2	3.4	13.6	5.3	9.4	7.1	10.8	9.2	0.3	14.2	0.5	1.9	83.5	1.5	18.3	1.1	1.3	11.5	21.2	1.7	1.3	1.7	1.5	151.0	6.2	1.4	9.6	23.5	28.4	27.4	27.1	24.1	23.2	37.0	29.2	33.9	29.7	29.2	48.9	12.2	6.4	12.3	11.8	24.1	67.7	25.4	4.1	4.0	13.0	11.1	13.0	7.9	4.3	4.5	11.0	6.2	9.2	6.7	16.7	0.0	4.4	7.4	11.6	22.2	12.7	11.4	8.2	7.7	9.6	33.4	19.7	61.2	11.2	2.5	43.5	16.4	25.6	16.9	18.5	8.8	32.9	2.0	54.2	29.3	11.5	13.4	30.6	19.6	7.5	13.6	6.1	7.2	12.1	16.8	8.0	9.4	13.5	6.6	20.5	40.7	1.8	6.0	12.1	19.7	46.1	18.7	5.8	4.8	4.2	42.9	32.3	9.5	38.2	13.5	15.5
SLC16A10	"MCT10, TAT1"	ENSG00000112394	"Solute carrier family 16 member 10"	Q8TF71	6	111087503-111231194	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 53.7;skeletal muscle: 41.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 32.8;Excitatory neurons: 33.9;Inhibitory neurons: 47.8;Macrophages: 33.8;Melanocytes: 44.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 4.5"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 1.7;T-reg: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 49.4;HEK 293: 20.2;RPMI-8226: 37.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016860	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Cell Junctions"		"HPA016860: AB_2189211"	"unprognostic (2.03e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.56e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.86e-3)"	"unprognostic (5.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.91e-1)"	2.9	5.5	1.4	3.0	8.6	0.8	0.8	4.2	3.4	0.6	53.7	1.2	8.5	0.5	1.4	0.8	0.8	1.5	2.3	2.0	1.2	10.0	13.5	4.6	0.9	1.1	5.0	0.9	29.7	7.9	1.0	23.7	2.8	1.3	1.8	0.7	3.1	0.2	41.2	15.3	5.0	0.3	0.2	1.8	5.3	4.2	9.6	10.9	2.7	6.0	1.3	1.9	1.2	1.1	0.9	1.0	0.4	2.2	0.1	0.1	3.1	0.0	0.2	0.8	1.2	9.0	0.4	5.2	1.4	0.3	2.5	0.1	49.4	0.1	1.0	0.1	20.2	8.2	0.7	7.4	0.1	7.6	7.4	0.0	0.0	0.1	0.0	0.2	0.0	10.9	1.4	0.2	0.1	3.6	9.8	0.8	14.6	0.2	3.2	5.4	6.8	37.2	0.0	0.5	10.7	3.3	0.2	0.7	1.8	3.6	1.8	0.9	0.1	0.1	1.8	0.5	2.5	2.6	0.1	1.5	0.3	5.8	0.8	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.2	1.7	1.5	0.3	0.1	0.0	0.1	1.6	0.1	1.4	8.6	4.2	3.4	2.0	1.2	1.1	5.0	2.8	0.2	9.6	1.1	0.4	9.6	32.8	2.0	1.5	9.7	10.7	0.0	4.6	6.9	2.0	1.3	9.1	0.0	3.1	5.5	2.1	1.9	0.7	2.1	1.9	0.2	9.0	0.4	0.8	1.4	6.6	1.7	33.9	12.5	1.8	8.9	3.6	1.3	1.3	2.5	4.2	25.4	21.4	1.7	47.8	4.8	0.0	12.4	12.4	8.2	0.0	33.8	44.4	0.0	0.7	1.6	0.0	16.6	0.3	2.0	0.9	0.0	4.8	3.9	10.9	17.7	0.7	0.7	0.0	18.5	1.0	11.6	11.2	1.2	14.8	1.2	5.8	9.2	8.5	1.2
SLC16A6	"MCT6, MCT7"	ENSG00000108932	"Solute carrier family 16 member 6"	O15403	17	68267026-68291267	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 51.0;epididymis: 33.3;retina: 31.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 22.9;Glandular and luminal cells: 27.4;Kupffer cells: 16.7;Macrophages: 21.8;Rod photoreceptor cells: 45.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 10.9;melanoma: 11.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	13	"SK-MEL-30: 481.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054459, HPA066328"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA054459: AB_2682494, HPA066328: AB_2685660"	"unprognostic (2.53e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.41e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.26e-3)"	"unprognostic (5.08e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.44e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.16e-3)"	"unprognostic (2.09e-2)"	"unprognostic (9.46e-2)"	1.5	2.7	3.0	7.2	4.8	9.7	5.8	4.3	4.3	1.6	51.0	0.7	0.5	2.6	33.3	10.9	0.9	1.3	0.9	5.0	5.2	0.7	1.4	3.0	5.3	5.1	4.2	1.5	0.5	0.1	1.7	2.3	5.3	0.6	0.8	31.0	2.2	4.2	5.0	4.5	1.2	0.8	2.4	5.7	1.0	2.3	5.2	1.6	3.5	0.7	4.7	2.1	2.6	3.2	2.1	1.8	0.6	0.8	0.4	0.6	14.2	0.8	18.0	1.7	1.2	0.7	2.5	17.6	1.4	0.0	0.2	0.6	2.5	0.0	0.7	5.4	1.3	1.4	2.2	22.3	3.2	5.7	1.1	0.8	0.2	1.0	1.0	1.7	0.8	2.5	1.1	3.8	0.0	18.1	8.5	3.6	0.2	0.1	1.0	0.1	0.4	2.4	0.8	1.5	4.2	0.3	0.8	10.7	481.5	3.8	15.0	3.5	2.7	5.9	1.1	0.5	2.0	4.2	17.5	14.6	36.0	4.6	2.6	0.8	3.1	0.2	1.8	2.7	0.8	0.4	0.6	1.4	1.9	0.0	0.4	0.8	5.4	0.4	1.4	0.3	1.5	0.9	3.0	4.8	4.3	4.3	5.0	5.2	5.1	4.2	5.3	2.4	5.2	3.2	0.6	0.0	2.5	1.6	1.8	0.3	0.2	0.1	1.2	8.2	2.5	0.9	0.8	0.0	4.0	9.2	22.9	0.4	8.4	0.0	0.0	0.0	0.7	4.7	2.5	3.2	0.0	2.7	6.7	0.0	11.5	0.9	0.5	27.4	1.3	0.1	0.7	0.3	5.6	0.0	6.2	0.0	0.0	16.7	7.0	0.3	0.0	21.8	10.6	4.7	11.1	6.2	5.2	0.5	0.8	0.0	0.0	1.9	5.0	0.2	0.0	0.3	1.6	45.1	0.0	0.8	0.3	1.7	0.7	6.7	0.4	0.4	5.3	0.4	0.1	0.2
SLC31A2	"COPT2, CTR2, hCTR2"	ENSG00000136867	"Solute carrier family 31 member 2"	O15432	9	113150976-113164140	"Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"parathyroid gland: 571.4;salivary gland: 409.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 96.4;Kupffer cells: 145.6;Macrophages: 101.3;monocytes: 84.1;Oligodendrocytes: 113.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	12	"classical monocyte: 226.0;intermediate monocyte: 331.9;myeloid DC: 134.6;neutrophil: 355.8;non-classical monocyte: 423.3"	"Group enriched"	"Detected in all"	47	"dendritic cells: 134.6;granulocytes: 355.8;monocytes: 423.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 54.4;hTCEpi: 85.0;hTERT-HME1: 57.7;LHCN-M2: 68.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014861	Approved		Approved	"Nuclear speckles,Plasma membrane,Intermediate filaments"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"	"Plasma membrane, Intermediate filaments"	"HPA014861: AB_1857098"	"unprognostic (2.26e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.81e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.89e-2)"	48.2	16.7	45.0	18.4	72.6	20.1	24.4	68.2	77.8	7.3	34.2	11.3	10.8	4.4	16.7	9.3	6.9	8.6	10.3	45.1	54.0	27.8	33.4	27.4	16.1	76.6	65.8	5.1	19.2	571.4	2.5	23.6	71.4	4.4	12.1	0.8	409.1	42.6	16.7	48.2	17.2	10.8	61.5	32.7	11.8	13.8	61.7	12.1	6.3	14.6	17.6	13.3	10.7	108.2	7.8	3.1	1.3	1.7	54.4	22.3	6.5	4.0	13.9	12.8	12.3	2.4	1.5	0.3	0.5	9.1	7.9	37.7	5.1	31.0	12.0	2.2	1.3	0.1	1.2	3.3	20.7	1.9	0.8	25.3	85.0	30.0	57.7	1.8	6.9	3.0	1.4	2.6	68.9	6.5	1.6	0.7	0.4	1.8	2.6	0.2	39.3	0.0	4.5	4.2	0.9	2.5	6.9	36.4	1.4	0.8	8.6	2.5	2.4	2.0	1.9	13.7	3.2	2.1	5.0	0.1	12.5	3.2	2.0	5.1	226.0	24.0	4.3	331.9	6.5	1.2	4.9	5.2	134.6	1.0	3.8	3.9	355.8	1.0	423.3	2.1	3.0	104.9	45.0	72.6	68.2	77.8	45.1	54.0	76.6	65.8	71.4	61.5	61.7	108.2	13.8	9.6	9.2	2.3	7.0	37.1	6.4	37.7	13.6	7.0	15.3	10.8	0.6	4.3	10.9	1.8	35.5	96.4	3.6	12.8	3.9	13.5	4.1	23.5	4.9	6.4	3.5	0.4	2.1	7.7	9.0	14.4	3.6	8.4	0.0	2.7	12.8	18.1	57.2	6.7	1.8	4.5	10.2	145.6	65.6	4.6	15.8	101.3	0.0	4.7	84.1	6.9	3.1	0.5	113.7	18.5	11.0	9.4	9.1	10.2	51.3	18.2	14.8	9.1	19.7	8.7	7.8	31.0	5.2	3.3	38.4	43.1	7.9	4.6	5.7	7.6
SNX3	Grd19	ENSG00000112335	"Sorting nexin 3"	O60493	6	108211222-108261246	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		Microphthalmia	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		270000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"				"prognostic unfavorable (4.37e-5)"	"unprognostic (1.70e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.74e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.67e-1)"	224.3	220.8	217.3	131.3	220.4	296.3	182.6	216.5	304.6	169.5	208.3	167.6	119.4	137.9	152.8	172.4	144.5	132.0	266.6	224.3	219.6	168.6	199.0	147.3	184.0	214.2	219.8	187.5	123.6	124.4	95.4	199.3	215.8	104.6	112.9	88.3	134.5	119.4	323.0	129.0	125.2	157.0	221.1	145.1	122.0	109.8	218.9	123.4	123.2	285.3	163.6	166.5	147.8	234.9	164.9	98.2	94.9	314.3	505.0	377.9	147.6	241.3	240.3	187.5	231.2	155.0	118.8	138.5	232.8	315.3	328.8	128.6	212.5	207.9	254.6	161.2	136.7	268.1	110.2	182.6	272.9	183.9	175.3	324.4	279.9	180.1	202.1	296.9	312.9	131.0	261.6	161.1	263.1	156.6	70.4	403.7	80.1	199.1	166.2	76.2	229.7	145.4	300.0	225.1	111.0	154.9	155.5	197.7	260.4	212.2	100.6	623.8	235.8	161.0	108.2	218.0	319.7	65.0	90.7	148.9	284.2	332.5	197.2	118.5	75.9	169.1	37.4	70.5	48.2	215.3	43.8	39.5	109.8	181.6	44.6	37.0	48.4	64.5	68.6	132.1	48.8	70.4	217.3	220.4	216.5	304.6	224.3	219.6	214.2	219.8	215.8	221.1	218.9	234.9	329.6	105.8	70.0	39.2	332.6	378.9	328.7	264.3	231.1	44.6	254.0	244.3	395.2	161.5	160.3	191.3	16.7	685.3	219.3	199.1	643.7	307.1	387.8	144.6	161.1	352.6	128.0	611.8	55.7	253.8	581.2	323.0	101.9	120.0	167.1	127.2	275.9	240.6	974.2	43.7	43.1	154.7	189.2	451.6	786.3	496.6	288.6	415.7	368.2	31.9	409.1	325.7	209.1	27.2	39.7	260.1	200.9	266.7	187.1	247.7	321.4	697.8	198.8	53.7	256.4	186.0	304.1	316.5	173.3	354.5	440.8	618.3	181.0	259.4	180.6	337.9
SOD2	GClnc1	ENSG00000112096	"Superoxide dismutase 2"	P04179	6	159669069-159762529	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 1083.7;skeletal muscle: 3230.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2508.2;Prostatic glandular cells: 3524.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	10	"neutrophil: 4470.5"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 4470.5"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1611.9;GAMG: 614.3;HSkMC: 688.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001814, CAB002013"	Supported		Enhanced	Mitochondria		NA	NA		55000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB002013: , HPA001814: AB_1080134"	"unprognostic (2.47e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.14e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (8.12e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.82e-1)"	324.8	245.9	66.8	522.8	43.2	1083.7	169.0	37.8	125.8	92.6	99.7	126.4	60.5	105.4	7.2	136.5	118.5	121.8	178.5	37.0	101.0	252.4	459.8	266.5	64.8	250.0	96.1	55.8	212.3	69.1	42.7	62.9	192.9	130.8	37.9	25.1	328.8	43.9	3230.1	90.0	83.7	108.4	62.5	81.4	120.4	39.6	153.1	38.2	67.2	312.6	65.0	514.9	97.9	85.4	35.8	46.3	37.3	85.1	229.0	378.7	20.5	52.7	1611.9	57.7	131.1	91.3	19.4	70.7	144.5	54.1	614.3	58.9	39.1	42.5	42.4	71.2	87.2	74.5	71.8	152.3	169.5	74.0	31.9	688.9	68.5	180.9	133.6	40.7	30.0	44.9	106.7	82.2	55.4	37.6	60.3	46.6	63.3	41.5	55.4	79.6	50.3	63.9	106.2	56.6	71.5	29.5	105.1	52.4	21.4	14.1	33.1	33.7	30.4	168.6	62.1	92.5	87.9	37.8	100.2	86.5	186.7	57.4	23.6	146.3	364.4	181.1	38.8	273.9	43.4	43.4	54.9	38.5	105.2	38.3	45.0	36.9	4470.5	19.1	445.3	14.8	87.9	340.0	66.8	43.2	37.8	125.8	37.0	101.0	250.0	96.1	192.9	62.5	153.1	85.4	303.2	201.9	746.1	13.4	99.0	684.7	1144.9	2508.2	114.4	45.6	150.2	96.6	0.0	287.4	613.3	237.3	45.9	18.3	43.8	153.9	86.1	1400.2	318.2	281.7	649.8	593.0	79.6	101.2	31.1	1389.7	51.2	1098.4	103.5	1080.1	112.3	23.1	58.9	395.0	292.0	32.0	30.1	92.7	339.7	333.3	1425.8	111.5	58.1	1031.2	521.2	15.9	339.9	50.4	35.0	8.5	12.2	581.6	111.3	65.1	101.2	3524.0	128.6	530.1	269.6	61.8	39.5	1164.0	407.3	91.7	51.4	258.7	681.8	27.2	119.4	38.3	148.1	1195.7
SRGAP2	"ARHGAP34, FNBP2, KIAA0456, SRGAP2A"	ENSG00000266028	"SLIT-ROBO Rho GTPase activating protein 2"	O75044	1	206203345-206464443	"Disease related genes, Predicted intracellular proteins"	Neurogenesis	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 114.0"	"Cell type enriched"	"Detected in many"	4	"Microglial cells: 497.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028191, HPA028196, HPA078079"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Cytosol	Nucleoplasm	"HPA028191: AB_10600309, HPA028196: AB_10601113, HPA078079: "	"unprognostic (2.57e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.67e-2)"	"unprognostic (5.20e-2)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavorable (4.61e-7)"	"unprognostic (2.70e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.18e-3)"	23.6	19.8	29.8	15.8	32.9	22.3	18.0	114.0	41.8	16.5	21.7	12.4	5.8	13.8	13.4	12.9	14.6	11.7	12.3	36.5	34.5	15.4	8.0	20.9	15.2	48.4	41.0	18.2	7.9	25.3	10.4	20.0	55.9	9.0	6.0	9.9	10.0	9.0	6.8	46.9	10.6	15.3	43.4	24.7	8.7	10.7	42.8	13.8	9.9	18.0	13.7	11.9	16.5	57.4	45.6	30.0	99.7	25.6	46.4	41.6	39.0	38.5	28.7	32.9	35.9	20.7	34.0	17.6	21.6	42.9	43.8	36.1	30.0	25.4	32.7	22.2	24.4	36.5	56.4	31.2	19.3	25.4	39.4	37.6	21.6	42.2	29.3	35.7	57.9	22.6	30.6	55.4	21.2	31.6	20.3	22.4	32.2	8.1	34.1	45.3	40.8	42.6	14.1	8.2	33.2	15.2	32.7	23.9	47.5	37.4	29.7	44.4	57.9	32.1	38.4	39.9	35.8	36.8	35.7	16.5	38.4	34.6	80.0	1.0	12.2	0.7	3.2	11.8	1.3	2.6	2.6	3.3	8.3	5.3	1.0	2.2	17.7	2.1	14.0	16.2	4.0	3.7	29.8	32.9	114.0	41.8	36.5	34.5	48.4	41.0	55.9	43.4	42.8	57.4	45.5	9.6	12.1	9.4	18.0	23.8	6.1	7.5	8.6	39.5	3.6	4.4	4.6	11.5	7.9	11.0	4.2	4.1	17.1	0.3	0.0	7.2	57.7	16.4	18.4	37.2	1.2	13.2	72.2	2.1	18.3	18.6	10.2	9.7	8.2	12.0	28.9	2.9	19.0	1.7	105.0	3.3	0.0	46.2	62.5	51.0	7.8	54.1	16.0	497.5	25.4	6.6	5.2	54.3	58.5	4.8	1.3	2.6	16.0	4.2	1.4	0.8	14.5	5.8	0.0	18.5	17.9	19.0	11.6	12.1	36.4	4.2	11.9	9.7	1.8	5.8
SRGAP2B	SRGAP2P2	ENSG00000196369	"SLIT-ROBO Rho GTPase activating protein 2B"	P0DMP2	1	144887265-145095528	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.7"	"Cell type enriched"	"Detected in many"	4	"Microglial cells: 239.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 3.6;granulocytes: 3.9;monocytes: 7.9"	"Low cell line specificity"	"Detected in all"											HPA078079			Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA078079: "	"unprognostic (1.13e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.48e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.89e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.16e-5)"	"unprognostic (3.12e-1)"	"unprognostic (5.43e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.38e-1)"	9.3	10.5	9.9	6.8	9.2	7.7	6.1	48.7	10.3	6.3	3.7	4.7	2.8	6.2	4.2	5.7	6.7	5.7	5.1	10.3	10.5	8.0	4.2	8.6	5.6	15.4	14.4	8.6	3.6	13.1	3.0	10.8	19.4	3.7	2.8	3.7	3.3	4.6	8.9	18.9	3.5	7.1	14.9	12.4	2.9	3.5	12.4	6.4	4.3	5.8	3.7	5.0	6.4	17.1	13.4	28.5	60.3	12.5	28.3	24.3	19.0	14.6	12.8	12.2	14.0	8.7	24.1	6.7	19.1	8.7	21.7	22.8	15.6	8.5	15.0	6.3	15.8	9.8	20.6	12.1	19.8	8.8	12.5	17.3	12.6	30.1	26.4	18.4	24.8	5.7	5.3	23.1	6.7	15.1	3.8	10.3	11.2	6.7	10.2	10.3	12.9	11.6	10.5	5.8	7.5	9.5	19.3	6.9	31.6	14.9	14.4	22.1	45.3	26.1	26.7	23.3	17.1	9.6	12.7	4.1	9.5	11.6	37.7	1.2	3.8	0.5	0.6	5.4	0.5	0.9	1.0	1.2	2.7	0.9	0.6	0.7	3.9	0.4	7.9	3.6	1.1	0.9	9.9	9.2	48.7	10.3	10.3	10.5	15.4	14.4	19.4	14.9	12.4	17.1	37.3	25.6	7.7	5.5	14.0	0.0	3.5	0.0	6.8	17.6	3.1	3.4	3.3	5.7	2.5	9.2	2.1	4.7	20.3	0.5	0.0	6.8	1.1	13.8	14.0	35.1	2.4	29.3	37.5	3.0	21.5	15.3	3.1	6.0	1.3	3.3	54.3	4.3	12.9	0.0	55.6	2.0	0.0	58.7	0.0	2.7	15.2	40.1	0.0	239.8	38.4	8.1	16.5	24.6	9.5	6.0	0.2	9.8	8.4	4.8	0.8	1.2	8.0	2.9	6.6	16.9	12.3	4.5	6.9	19.9	0.0	2.9	6.9	8.6	1.8	4.2
SRGAP2C	SRGAP2P1	ENSG00000171943	"SLIT-ROBO Rho GTPase activating protein 2C"	P0DJJ0	1	121184811-121392874	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 31.2"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 180.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"WM-115: 80.0"									HPA078079			Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA078079: "	"unprognostic (2.43e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.48e-6)"	"unprognostic (2.40e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.18e-4)"	"unprognostic (6.10e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.71e-7)"	"unprognostic (4.90e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.66e-2)"	8.3	6.5	11.1	3.7	13.2	7.2	5.7	31.2	12.5	5.8	3.9	6.5	2.1	5.4	2.2	4.3	5.0	4.6	5.8	11.7	11.8	7.1	4.7	7.3	4.6	16.1	12.3	6.8	2.2	13.7	3.3	8.0	17.6	3.6	2.8	3.5	3.0	4.6	2.8	15.5	3.6	6.0	16.6	10.7	3.2	1.5	12.4	4.2	3.9	10.7	3.4	4.6	5.5	21.9	11.1	14.1	30.7	6.8	23.1	20.1	16.8	12.3	9.8	10.2	13.2	0.2	11.0	7.0	10.8	16.8	7.3	5.9	11.0	8.9	13.4	9.2	11.2	10.0	24.5	11.1	13.3	6.8	11.4	15.2	8.9	13.1	16.6	11.6	24.5	4.3	9.3	12.8	7.6	6.6	4.3	8.6	9.7	3.5	6.7	6.2	35.9	6.2	9.7	6.5	5.9	3.8	21.2	7.5	38.6	15.8	9.5	19.8	21.9	19.1	18.7	28.9	18.1	7.3	5.6	4.2	16.7	13.7	80.0	0.3	3.4	0.6	1.1	2.8	0.7	0.9	1.3	1.2	2.5	0.9	0.6	0.8	3.2	0.6	5.3	2.4	1.3	0.9	11.1	13.2	31.2	12.5	11.7	11.8	16.1	12.3	17.6	16.6	12.4	21.9	39.9	54.5	11.5	5.2	14.4	0.0	5.6	0.0	6.2	14.2	5.8	6.7	4.3	15.7	5.0	11.0	2.1	5.5	15.5	1.2	1.9	10.9	1.0	11.7	15.4	34.6	2.4	29.7	42.0	5.0	24.8	15.9	5.1	6.4	6.3	7.8	55.3	8.7	19.9	0.0	62.6	2.7	0.0	64.2	0.0	2.1	19.6	41.6	0.0	180.8	39.6	8.4	18.6	35.2	27.4	7.2	1.4	25.6	10.7	5.0	0.5	1.0	8.7	4.3	32.9	20.2	14.5	10.1	10.8	12.5	0.0	2.5	12.6	7.0	2.0	4.5
SRGN	"PPG, PRG, PRG1"	ENSG00000122862	Serglycin	P10124	10	69088103-69104805	"Plasma proteins, Predicted secreted proteins"	"Apoptosis, Biomineralization"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"bone marrow: 8096.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 2922.2;granulocytes: 2343.1;Kupffer cells: 1789.9;Langerhans cells: 6618.2;Macrophages: 3639.1;monocytes: 3188.2;Plasma cells: 1740.9;T-cells: 2235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 5714.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 5714.1"	"Cell line enhanced"	"Detected in many"		"HL-60: 4442.1;NB-4: 2549.7;THP-1: 4346.8;TIME: 2609.1;U-937: 3546.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000759	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	NA	NA		100000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA000759: AB_1079675"	"unprognostic (3.61e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.80e-2)"	"unprognostic (9.82e-2)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.08e-2)"	404.6	114.9	48.8	799.8	50.5	8096.7	136.4	55.5	99.6	93.2	70.1	101.8	77.9	63.5	25.9	91.0	96.8	316.4	111.9	48.2	67.8	98.3	239.4	347.3	437.2	82.4	59.3	30.7	68.4	131.6	62.1	355.6	67.8	58.9	118.9	15.5	40.1	57.4	37.5	18.9	111.4	219.4	65.5	362.8	95.0	18.3	64.7	228.9	72.7	117.1	314.6	508.3	46.1	71.0	5.3	43.0	0.2	0.4	768.1	749.7	1.2	94.9	63.9	235.1	283.5	0.1	18.2	9.1	117.4	4.1	134.4	1.1	0.0	20.6	799.9	535.7	0.4	87.1	29.8	0.3	312.7	4442.1	914.9	306.8	1.1	641.5	39.2	223.8	1227.8	13.3	82.5	419.9	1239.9	0.2	18.7	2549.7	0.7	0.1	84.6	2.4	2.3	446.7	0.6	6.0	0.3	0.8	2.3	0.6	16.0	0.0	2.2	4346.8	2609.1	187.9	12.9	3.8	20.1	486.4	508.4	57.3	112.2	3546.9	1.2	2349.8	1105.3	2730.6	474.9	774.6	313.4	73.5	228.5	362.8	583.0	39.0	125.5	268.4	5714.1	962.8	693.6	631.9	392.6	1590.5	48.8	50.5	55.5	99.6	48.2	67.8	82.4	59.3	67.8	65.5	64.7	71.0	1081.4	112.2	198.1	0.7	592.0	175.9	12.5	38.3	8.6	1.1	16.0	28.2	21.2	21.5	57.5	33.1	0.0	10.2	2922.2	2.9	0.0	4.2	4.1	4.6	15.0	566.8	1.8	277.8	0.2	9.8	10.2	87.9	70.3	6.6	2343.1	0.4	636.1	22.1	847.1	0.0	0.5	1.7	0.0	1789.9	6618.2	8.4	7.5	3639.1	556.7	80.6	3188.2	1.4	1292.5	0.0	0.2	1.3	1.2	18.0	1740.9	12.2	0.3	4.7	45.6	5.0	72.3	22.8	97.5	0.9	2.2	8.7	141.8	14.2	2235.9	1.2	5.5	18.1
ST8SIA4	"PST, PST1, SIAT8D"	ENSG00000113532	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4"	Q92187	5	100806933-100903282	"Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.0"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 73.3;Kupffer cells: 92.4;Langerhans cells: 149.3;Microglial cells: 101.2;monocytes: 97.5;Plasma cells: 73.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 91.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 41.1;HDLM-2: 69.3;Karpas-707: 57.2;NB-4: 27.9;RPMI-8226: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051126, HPA053995"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		980000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA051126: AB_2681352, HPA053995: AB_2682336"	"unprognostic (2.25e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (7.80e-7)"	"unprognostic (6.07e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.23e-2)"	5.8	1.9	2.2	14.0	2.4	7.6	2.2	1.6	2.4	1.9	2.5	3.3	3.2	1.6	0.5	1.1	1.8	5.0	2.3	1.8	4.5	0.7	2.6	5.7	12.3	4.8	3.6	0.5	0.8	1.0	0.6	11.1	5.2	1.3	4.2	0.6	1.2	0.8	0.8	0.8	4.5	2.8	2.7	11.8	3.0	0.4	4.3	9.5	2.0	1.7	10.3	5.5	1.1	4.5	0.0	6.1	41.1	0.0	2.6	3.9	1.0	0.0	0.0	0.0	0.3	0.0	0.0	3.3	0.1	0.0	1.0	0.1	1.0	0.1	0.1	69.3	0.0	2.5	0.4	0.0	0.0	13.0	5.0	3.2	0.0	0.1	0.1	5.3	7.7	10.1	0.0	57.2	2.4	0.6	18.6	27.9	0.3	0.0	0.3	10.3	0.7	44.8	0.2	0.0	0.9	0.0	0.0	0.0	0.1	0.2	0.0	11.6	2.7	0.4	0.2	0.0	0.6	18.6	20.3	3.9	1.0	15.8	5.1	58.0	18.5	22.9	13.1	21.7	9.9	11.1	8.7	11.1	12.2	9.9	5.4	10.1	91.7	10.6	24.0	3.7	17.4	12.2	2.2	2.4	1.6	2.4	1.8	4.5	4.8	3.6	5.2	2.7	4.3	4.5	35.8	6.4	14.1	1.6	49.7	8.3	0.4	2.1	2.2	0.6	0.9	0.9	2.3	1.5	10.1	0.0	0.0	9.4	44.0	0.0	1.9	0.2	0.2	0.9	1.6	28.4	0.0	8.2	6.8	0.0	42.4	5.0	1.1	0.3	24.1	0.1	7.1	0.1	22.6	0.0	73.3	0.2	4.1	92.4	149.3	0.7	0.0	57.5	14.2	101.2	97.5	3.2	34.0	4.5	1.6	0.0	0.0	0.4	73.8	0.2	0.0	0.3	16.6	0.9	13.1	1.2	3.7	0.5	0.8	0.4	5.5	19.2	37.7	0.7	0.0	0.5
STX11		ENSG00000135604	"Syntaxin 11"	O75558	6	144150517-144191939	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 25.1;bone marrow: 56.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 85.0;granulocytes: 90.3;Langerhans cells: 271.6;Macrophages: 158.0;monocytes: 85.5;Suprabasal keratinocytes: 154.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	7	"basophil: 22.6;classical monocyte: 68.4;eosinophil: 43.5;intermediate monocyte: 81.1;myeloid DC: 25.4;neutrophil: 81.7;non-classical monocyte: 87.0"	"Group enriched"	"Detected in all"	8	"dendritic cells: 25.4;granulocytes: 81.7;monocytes: 87.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 17.2;Karpas-707: 10.1;RH-30: 6.9;TIME: 8.3;U-266/70: 11.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA007992	Approved					NA	NA		1100000	"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA007992: AB_1857620"	"unprognostic (1.30e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.62e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.47e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.91e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.07e-1)"	25.1	4.4	0.6	5.8	0.6	56.5	14.5	0.6	1.1	1.9	0.7	2.8	1.0	1.4	0.3	5.1	2.6	2.1	7.3	0.7	0.8	3.6	3.1	21.3	5.5	1.0	0.7	0.9	1.1	0.6	2.1	2.4	0.9	1.3	0.9	0.2	2.1	0.3	2.5	8.2	3.3	1.9	0.8	14.1	2.0	1.1	0.9	1.8	7.5	0.9	3.5	4.0	3.2	1.1	0.4	0.1	0.1	3.9	0.2	0.3	0.6	0.4	0.3	0.4	0.7	0.1	0.4	0.1	0.4	0.6	0.7	0.6	0.0	0.1	0.2	17.2	0.6	3.0	0.6	0.1	1.0	0.9	0.5	0.0	0.0	0.2	0.1	0.2	4.3	0.8	0.1	10.1	0.5	0.2	0.4	0.9	0.0	0.0	0.3	0.1	6.9	0.6	0.0	1.9	0.2	0.1	1.2	0.1	1.7	0.3	0.1	3.8	8.3	0.2	1.0	0.4	0.3	11.6	4.6	0.1	0.2	2.1	0.4	22.6	68.4	43.5	6.0	81.1	3.8	1.4	2.7	5.1	25.4	2.4	1.0	3.0	81.7	3.2	87.0	2.7	8.3	43.9	0.6	0.6	0.6	1.1	0.7	0.8	1.0	0.7	0.9	0.8	0.9	1.1	41.9	54.5	10.7	0.0	16.6	85.0	11.3	6.3	3.4	0.0	11.1	4.6	4.5	4.3	6.6	1.8	0.0	0.9	38.1	0.1	0.0	6.4	0.4	3.7	0.7	23.7	3.5	6.1	0.1	2.6	5.7	11.2	0.5	5.0	90.3	0.2	8.2	1.4	30.1	0.0	0.1	0.4	2.0	73.7	271.6	1.2	0.6	158.0	44.4	2.8	85.5	0.0	21.6	0.0	0.1	6.1	3.3	0.0	63.1	14.4	0.0	0.1	10.7	0.1	0.0	46.6	9.7	3.0	3.8	11.2	154.6	28.0	36.6	3.2	0.6	33.3
STX4	"p35-2, STX4A"	ENSG00000103496	"Syntaxin 4"	Q12846	16	31032889-31042975	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 149.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001330	Approved		Enhanced	"Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"HPA001330: AB_1080167"	"unprognostic (2.31e-3)"	"prognostic favorable (3.65e-4)"	"unprognostic (3.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.75e-3)"	"unprognostic (5.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (2.88e-9)"	"unprognostic (6.90e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.26e-2)"	38.3	44.0	33.1	34.2	36.2	22.3	33.9	37.4	36.4	36.3	32.3	37.5	38.3	31.4	24.4	35.8	29.8	27.7	39.8	33.2	37.8	33.5	35.8	36.2	31.1	38.0	36.6	30.4	27.7	38.4	23.2	32.3	37.7	29.9	28.6	8.5	29.9	26.5	45.8	44.3	35.9	31.6	36.1	43.7	32.4	14.9	36.2	28.4	29.5	33.8	37.1	38.1	32.6	39.0	51.9	70.6	16.0	36.1	51.1	52.1	33.8	47.7	79.2	47.5	48.7	22.1	53.2	35.4	58.9	80.8	54.4	36.6	15.2	52.6	45.6	60.3	43.8	25.3	48.7	59.7	58.3	29.2	80.1	50.2	36.1	82.1	61.1	58.5	64.3	22.3	29.9	38.6	84.9	80.3	28.0	44.8	33.1	36.9	36.7	24.0	47.1	46.1	45.9	38.7	13.1	24.6	40.6	41.1	17.4	20.7	33.7	38.7	74.4	48.3	21.8	55.8	26.6	41.2	37.0	14.6	73.3	46.4	29.7	21.3	21.7	27.3	17.6	23.8	15.4	12.7	14.7	17.9	18.8	17.5	11.0	14.2	23.0	24.6	21.9	11.1	9.0	11.2	33.1	36.2	37.4	36.4	33.2	37.8	38.0	36.6	37.7	36.1	36.2	39.0	34.9	44.8	22.7	7.8	32.6	65.1	34.6	56.3	31.9	7.4	22.3	20.6	23.6	48.6	35.2	22.0	12.5	31.1	35.9	69.7	29.4	60.6	12.9	22.1	26.6	46.0	25.7	11.1	4.8	67.7	35.7	51.7	43.3	29.0	60.3	42.1	33.9	20.0	89.5	5.0	3.6	39.5	38.7	49.6	149.9	15.7	38.5	83.2	30.2	2.8	51.7	24.1	42.2	3.0	16.0	73.4	58.5	35.3	23.0	61.6	77.7	50.8	31.3	6.9	39.5	40.6	36.4	9.4	6.7	27.0	65.1	33.1	35.4	39.0	47.9	36.2
STXBP3	UNC-18C	ENSG00000116266	"Syntaxin binding protein 3"	O00186	1	108746674-108809523	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 206.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027225	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA027225: AB_1857627"	"unprognostic (3.14e-3)"	"unprognostic (4.33e-2)"	"unprognostic (7.18e-3)"	"unprognostic (4.88e-2)"	"unprognostic (6.54e-2)"	"unprognostic (9.78e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.55e-2)"	23.2	24.3	28.7	27.0	38.6	23.9	27.6	37.9	41.6	24.7	23.8	28.5	26.1	27.1	25.6	25.1	19.6	28.0	20.5	26.9	32.8	40.3	25.0	23.1	27.9	39.5	35.2	20.9	28.1	42.0	14.2	28.1	39.7	23.8	29.1	34.4	21.6	19.4	19.3	27.2	33.4	24.1	35.6	26.1	25.2	16.3	32.2	31.6	37.1	24.0	25.3	31.1	21.5	50.2	47.1	18.1	30.6	16.1	36.3	35.1	42.9	42.9	38.9	27.9	28.2	16.8	18.3	41.7	28.4	34.7	25.8	27.4	20.9	25.3	38.8	46.7	28.9	34.5	23.8	21.9	28.7	54.2	56.0	27.4	34.5	31.5	34.0	34.8	35.2	26.2	26.0	39.3	39.0	31.7	34.8	42.9	32.6	30.9	28.4	28.4	45.1	22.8	45.7	38.4	18.4	16.9	52.3	49.6	64.6	27.6	20.1	49.9	40.2	36.3	21.4	50.8	37.1	26.3	24.8	34.1	65.2	41.0	56.4	62.7	17.1	42.7	14.2	20.8	18.4	11.3	16.6	14.5	16.6	10.8	14.0	13.7	48.1	17.9	24.9	7.7	20.4	11.9	28.7	38.6	37.9	41.6	26.9	32.8	39.5	35.2	39.7	35.6	32.2	50.2	35.9	12.8	25.2	59.1	25.6	44.0	37.4	32.5	14.2	38.2	21.8	20.2	36.4	32.9	34.5	20.2	20.9	43.7	38.7	46.5	45.0	38.1	7.3	33.6	29.3	32.9	21.0	22.7	30.0	27.4	35.4	36.2	16.8	33.9	69.7	18.7	15.4	16.1	31.5	26.9	31.4	28.3	24.4	45.5	44.2	5.4	33.5	41.7	39.2	48.7	57.3	40.5	41.2	68.9	206.2	34.5	27.3	31.6	20.0	32.9	30.4	47.5	28.7	19.3	19.7	34.2	33.6	26.4	24.7	16.1	40.3	95.5	36.7	29.6	26.8	44.8
SUSD6	KIAA0247	ENSG00000100647	"Sushi domain containing 6"	Q92537	14	69611596-69715144	"Predicted membrane proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030464	Uncertain		Approved	"Nucleoplasm,Intermediate filaments"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Intermediate filaments"	"HPA030464: AB_10601128"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.58e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.10e-2)"	"unprognostic (6.70e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.10e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.34e-1)"	25.3	19.3	12.0	32.9	12.4	67.2	22.2	26.7	11.6	16.2	13.1	20.9	25.4	13.0	43.1	31.8	21.0	27.5	15.6	13.5	12.8	22.2	12.2	37.1	30.4	24.5	14.5	13.5	22.1	16.6	14.4	17.0	15.3	17.8	19.0	15.6	29.7	16.7	12.3	27.3	32.8	19.7	18.2	33.6	20.9	10.7	14.2	21.7	22.4	11.5	36.2	21.7	18.1	15.5	19.4	4.9	7.0	6.4	14.0	10.2	12.8	10.7	22.6	6.0	5.8	5.9	16.7	22.6	11.8	13.5	4.8	26.4	4.0	22.1	5.6	38.9	3.0	18.4	4.1	9.8	22.6	3.0	45.6	16.6	21.5	10.1	18.7	6.5	12.4	6.9	5.7	19.6	8.4	9.5	4.5	8.1	1.4	11.3	5.0	7.7	6.2	9.1	11.5	9.8	3.0	4.7	8.8	25.4	4.0	5.1	10.4	8.3	19.4	13.8	8.1	8.8	4.4	13.5	3.2	15.7	8.9	10.3	7.4	16.3	11.6	12.3	5.5	10.2	5.5	5.3	4.8	3.4	7.6	5.0	4.6	3.4	33.0	4.1	13.7	4.3	4.6	8.8	12.0	12.4	26.7	11.6	13.5	12.8	24.5	14.5	15.3	18.2	14.2	15.5	45.6	12.8	30.0	22.2	24.6	0.0	36.0	0.0	23.3	16.7	44.2	21.5	14.0	21.5	11.2	18.4	20.9	4.3	32.9	44.3	7.9	26.7	1.0	34.7	13.3	32.8	7.3	13.9	34.6	24.6	1.7	13.1	18.8	28.4	8.8	9.7	17.9	15.9	23.5	15.2	21.1	21.9	0.0	67.4	0.0	5.1	5.3	44.3	0.0	107.7	31.6	4.3	16.5	22.1	28.4	38.7	20.4	6.8	15.1	43.0	74.1	15.2	10.9	23.7	26.3	18.3	19.0	8.4	15.4	19.7	0.0	9.2	21.2	7.6	8.5	54.6
SYN1	MRX50	ENSG00000008056	"Synapsin I"	P17600	X	47571901-47619857	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 271.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 27.1;Excitatory neurons: 37.3;Horizontal cells: 28.6;Inhibitory neurons: 34.1"	"Cancer enriched"	"Detected in many"	4	"glioma: 11.2"	"Group enriched"	"Detected in many"	5	"amygdala: 81.4;basal ganglia: 127.5;cerebral cortex: 271.3;hippocampal formation: 118.3;white matter: 150.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 9.0;HHSteC: 8.1;NTERA-2: 17.4;SCLC-21H: 30.2;SH-SY5Y: 7.9;SuSa: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000397, CAB021929"	Enhanced					NA	NA		48000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 41: Macrophages - Immune response"			"CAB021929: , HPA000397: AB_1080146"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.48e-3)"	"unprognostic (3.05e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.31e-1)"	"unprognostic (3.49e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.64e-4)"	"unprognostic (2.73e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.95e-3)"	"unprognostic (5.27e-2)"	3.9	11.0	81.4	3.5	127.5	2.0	0.9	9.0	271.3	1.2	0.0	3.7	0.6	1.3	1.4	0.7	1.9	2.6	15.3	118.3	30.7	2.2	3.0	2.9	0.4	28.5	2.3	2.9	2.2	0.7	35.7	4.4	12.7	2.3	1.8	44.0	1.2	1.7	1.9	1.3	1.8	1.7	0.0	1.1	1.9	2.6	9.9	0.9	0.5	3.8	0.7	4.1	1.6	150.4	0.0	0.0	5.0	0.7	0.2	1.0	0.0	0.9	0.2	1.4	0.4	0.0	0.0	0.0	1.6	0.1	1.6	9.0	0.5	0.0	0.4	0.6	0.1	0.5	0.0	0.0	8.1	0.0	2.1	1.9	0.0	1.5	0.3	0.0	0.1	0.7	0.6	0.3	0.2	0.2	0.3	0.3	17.4	0.0	0.1	0.1	0.1	0.3	0.0	0.0	30.2	7.9	0.0	0.1	0.1	7.2	2.2	0.0	0.2	0.0	0.9	0.1	0.1	0.2	0.1	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.4	127.5	9.0	271.3	118.3	30.7	28.5	2.3	12.7	0.0	9.9	150.4	0.2	0.0	0.0	5.5	0.0	0.9	0.6	0.6	0.6	27.1	0.2	0.1	3.7	1.5	0.1	0.0	10.4	0.1	0.0	0.4	0.0	0.1	0.2	0.0	0.6	0.4	4.2	0.8	37.3	0.7	0.0	2.7	1.1	0.1	0.0	1.6	3.3	1.5	0.2	28.6	34.1	0.3	2.0	1.6	3.4	1.0	2.8	5.1	0.0	7.5	4.7	6.4	0.0	10.6	5.1	0.6	0.2	3.4	0.0	1.2	0.0	0.1	0.1	7.3	6.6	0.8	2.1	3.6	2.1	0.0	0.6	0.0	0.1	3.2	0.5	0.3
TAF13	"TAF2K, TAFII18"	ENSG00000197780	"TATA-box binding protein associated factor 13"	Q15543	1	109062486-109076003	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Suprabasal keratinocytes: 82.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044492	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Nucleoli	"HPA044492: AB_10962871"	"unprognostic (8.54e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (8.74e-6)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.61e-3)"	"unprognostic (7.22e-3)"	37.0	17.5	22.5	23.3	24.2	49.7	22.4	23.8	26.3	25.5	14.8	26.4	16.1	21.1	21.9	33.9	12.2	27.3	30.5	19.9	24.7	34.4	32.0	18.3	15.0	25.0	24.5	7.0	17.0	25.7	8.7	33.4	25.7	25.2	27.7	9.2	15.1	17.2	66.9	18.9	17.0	34.9	28.9	12.8	20.9	17.0	27.8	12.9	28.0	48.4	24.3	34.7	9.2	25.6	74.5	19.3	28.7	42.0	80.7	75.2	47.6	172.3	72.5	68.7	69.0	30.6	16.4	28.1	64.2	115.6	40.8	30.7	50.9	62.2	102.8	48.6	11.5	28.5	43.0	31.9	63.8	50.7	41.5	67.5	73.0	115.4	62.3	36.8	59.6	25.8	55.5	26.7	93.9	42.8	26.7	13.6	57.6	34.4	39.2	20.7	51.7	11.5	80.0	63.6	29.8	37.2	84.6	54.2	63.7	50.8	18.5	35.5	78.5	112.7	43.1	80.3	95.5	32.4	88.5	36.9	119.8	26.2	171.2	2.0	2.3	2.0	0.8	1.7	0.7	0.7	0.5	0.8	0.8	0.6	0.5	0.8	4.0	0.2	1.6	1.5	1.3	0.5	22.5	24.2	23.8	26.3	19.9	24.7	25.0	24.5	25.7	28.9	27.8	25.6	46.4	19.2	24.6	1.0	10.3	70.2	10.7	12.3	8.6	5.5	14.7	10.2	63.6	10.0	20.3	7.3	0.0	16.7	21.2	35.6	13.7	16.2	55.2	29.4	24.0	21.4	31.8	9.3	4.5	20.9	30.1	20.9	11.7	48.8	14.5	5.1	25.7	37.9	18.2	6.7	3.8	30.2	18.3	28.3	37.6	6.6	9.3	26.5	14.2	1.9	14.5	13.8	5.2	3.0	3.6	31.8	21.7	12.8	9.8	21.9	25.4	31.1	16.8	7.5	6.6	23.6	20.1	10.8	18.2	10.7	82.3	54.9	13.8	6.8	17.9	29.0
TANK	"I-TRAF, TRAF2"	ENSG00000136560	"TRAF family member associated NFKB activator"	Q92844	2	161136908-161236230	"Predicted intracellular proteins"	"DNA damage, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB010345, HPA037675, HPA037676"	Approved		Supported	Nucleoli,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	Cytosol	Nucleoli	"CAB010345: AB_2199871, HPA037675: AB_2675600, HPA037676: AB_2675601"	"unprognostic (1.14e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.98e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (2.78e-6)"	"unprognostic (2.13e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.30e-2)"	42.9	36.2	20.9	46.2	23.6	84.2	57.7	22.1	24.7	30.5	25.3	32.4	28.0	30.7	27.0	29.8	35.0	43.0	27.1	20.1	24.1	29.1	66.5	39.7	52.8	24.0	25.5	30.8	22.9	27.8	19.7	36.9	23.5	24.6	35.8	32.1	26.6	24.7	52.3	26.7	29.1	32.5	21.4	43.2	30.2	22.3	21.9	42.1	36.4	43.3	51.4	49.0	25.0	25.1	39.2	24.5	31.7	36.3	91.3	124.9	45.2	58.0	86.4	39.3	57.7	30.8	50.5	53.1	38.7	67.6	28.2	27.5	19.2	43.4	59.5	126.6	20.5	29.8	22.5	79.1	72.4	51.1	32.2	98.3	66.6	59.6	46.6	73.5	101.7	32.0	30.5	68.7	77.7	29.3	31.4	50.7	18.2	40.9	21.5	17.9	45.5	35.2	86.3	62.1	26.4	30.7	37.4	40.6	60.4	43.2	17.5	64.9	108.2	50.4	29.3	25.7	34.0	46.6	46.1	80.9	66.9	40.3	40.8	122.2	71.4	97.1	36.0	78.5	55.9	63.8	58.8	53.1	66.5	66.7	39.9	39.6	189.4	42.4	94.0	43.4	100.7	55.0	20.9	23.6	22.1	24.7	20.1	24.1	24.0	25.5	23.5	21.4	21.9	25.1	34.7	57.7	79.6	82.3	108.9	59.9	106.3	82.7	21.6	32.7	73.0	71.5	27.3	42.9	69.2	46.0	12.5	43.1	54.8	50.4	60.7	58.8	18.0	47.2	42.3	46.7	47.4	63.8	49.9	40.5	82.9	67.8	28.5	52.4	59.5	17.0	28.2	58.1	45.6	21.9	60.9	29.3	71.2	71.5	194.0	10.0	52.8	106.8	72.9	120.9	177.7	33.5	40.2	63.3	87.4	56.0	43.9	26.4	57.1	81.8	34.4	46.5	66.2	37.4	26.3	52.1	40.3	54.3	33.9	29.3	60.9	134.9	109.3	33.0	32.2	158.4
TASL	"CXorf21, FLJ11577"	ENSG00000120280	"TLR adaptor interacting with endolysosomal SLC15A4"	Q9HAI6	X	30558809-30577766	"Disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.5;lymphoid tissue: 10.9"	"Cell type enriched"	"Detected in some"	5	"Hofbauer cells: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	7	"THP-1: 166.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001185	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Vesicles	"HPA001185: AB_1078591"	"unprognostic (1.37e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.47e-2)"	"unprognostic (5.25e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.43e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.66e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.23e-2)"	1.8	1.8	0.6	10.9	0.6	19.5	2.1	0.7	1.0	1.1	1.1	3.5	4.7	0.6	0.4	1.6	0.8	3.9	0.6	0.7	0.6	1.1	2.4	4.7	10.5	1.3	1.1	0.3	0.3	0.7	0.3	2.9	1.3	1.0	3.4	0.2	1.0	0.6	0.1	0.7	3.0	2.2	0.9	9.8	3.6	0.3	1.5	5.8	0.6	0.4	10.2	4.1	0.3	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.2	0.0	0.0	13.8	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	21.5	0.0	0.0	0.0	20.5	0.0	21.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	166.0	0.0	0.0	0.0	0.0	0.1	15.0	1.6	7.5	0.0	23.9	0.0	8.6	21.9	24.1	1.6	19.8	0.3	23.0	2.0	1.1	25.3	23.6	1.8	1.3	30.6	7.1	44.4	45.9	3.4	8.0	0.6	0.6	0.7	1.0	0.7	0.6	1.3	1.1	1.3	0.9	1.5	2.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
TBC1D8	"AD3, GRAMD8, HBLP1, VRP"	ENSG00000204634	"TBC1 domain family member 8"	O95759	2	101007228-101252866	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 30.1;non-classical monocyte: 38.2"	"Lineage enriched"	"Detected in many"	5	"monocytes: 38.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 82.9;ASC TERT1: 57.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015211, HPA037496"	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nuclear speckles"		"CAB015211: , HPA037496: AB_2675507"	"unprognostic (1.82e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (4.25e-3)"	"unprognostic (3.98e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.73e-2)"	"unprognostic (7.98e-3)"	17.3	6.3	4.7	8.9	4.4	12.7	21.8	8.7	5.0	14.4	8.3	9.0	7.1	10.6	7.8	15.4	19.9	18.1	38.6	5.1	6.3	17.0	24.8	23.2	7.2	6.8	5.3	8.4	34.3	17.5	13.0	3.1	6.7	44.0	6.0	6.5	19.0	30.3	83.7	28.1	28.7	6.9	4.3	14.5	27.2	18.1	5.9	6.4	9.6	79.7	6.8	13.1	17.5	4.1	5.1	30.1	2.6	8.6	82.9	57.8	24.4	3.1	51.8	2.1	2.6	10.8	8.0	2.6	27.1	2.3	42.5	15.5	5.0	23.5	1.4	1.5	4.6	1.5	11.1	37.7	5.7	0.3	26.0	27.4	21.8	2.8	21.6	1.7	30.2	4.5	0.7	2.6	2.7	13.3	2.8	15.8	6.7	3.6	32.3	6.4	7.5	0.6	17.0	32.3	18.7	9.2	4.2	7.4	10.8	4.0	2.1	23.1	26.0	1.3	4.5	4.4	2.1	5.0	0.4	0.2	10.9	7.7	8.0	0.0	9.7	0.4	0.2	30.1	0.3	0.4	0.3	0.2	5.0	1.5	0.6	0.4	0.3	0.0	38.2	7.2	0.2	4.1	4.7	4.4	8.7	5.0	5.1	6.3	6.8	5.3	6.7	4.3	5.9	4.1	4.3	3.2	4.6	10.7	2.8	4.1	38.3	7.2	23.9	6.4	15.0	3.9	12.2	18.6	14.4	5.5	4.2	4.6	4.8	1.1	0.0	8.2	6.0	42.6	4.7	9.8	3.0	0.8	43.5	3.0	2.8	4.3	31.6	23.7	7.0	0.9	11.7	5.6	3.7	1.7	42.8	2.2	10.2	13.8	17.7	10.9	3.1	27.7	5.4	22.5	28.1	1.0	0.0	23.6	6.5	2.6	2.4	1.9	1.4	35.0	4.8	1.2	31.9	3.7	6.6	24.7	4.3	3.6	4.0	29.8	6.3	3.4	1.6	2.7	1.1	29.7
TBX19	"dj747L4.1, TPIT"	ENSG00000143178	"T-box transcription factor 19"	O60806	1	168280877-168314426	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"pituitary gland: 50.2"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 8.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 5.5;HDLM-2: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005800, HPA072686"	Enhanced		Approved	"Nuclear speckles"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"		"HPA005800: AB_1080219, HPA072686: AB_2732209"	"unprognostic (2.47e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.76e-4)"	"unprognostic (1.43e-2)"	"unprognostic (3.09e-2)"	"unprognostic (8.36e-2)"	"unprognostic (7.14e-7)"	"unprognostic (1.83e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (8.57e-2)"	"unprognostic (6.63e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.05e-2)"	1.8	0.8	1.0	0.8	1.2	0.7	1.8	0.8	1.3	2.9	1.0	2.5	0.8	5.0	0.8	1.6	2.7	1.2	1.1	1.1	2.0	1.8	1.1	2.4	1.7	1.5	1.1	3.7	1.1	0.5	50.2	0.6	1.2	2.2	1.0	0.4	1.8	1.0	0.8	2.5	1.6	2.1	1.0	2.3	1.1	1.0	1.5	1.6	1.3	0.8	1.1	1.5	2.1	1.2	1.0	0.0	0.8	3.1	1.4	0.6	1.0	1.6	0.9	0.5	0.8	1.4	1.0	0.8	1.7	0.6	0.8	5.5	0.4	0.4	0.8	5.1	0.7	0.1	1.1	0.4	1.5	1.6	2.0	1.2	1.4	0.2	0.8	1.3	0.7	0.3	1.1	1.3	0.7	0.2	0.8	1.3	0.2	3.3	0.5	1.3	0.4	0.3	1.2	0.4	1.1	1.6	0.9	0.7	1.0	1.3	0.2	1.3	1.2	0.5	1.3	1.1	1.7	1.0	0.8	0.6	0.1	0.4	1.6	0.2	0.7	0.4	1.1	0.5	0.5	0.4	0.8	0.7	0.7	0.5	0.5	0.5	1.0	0.9	1.0	2.4	0.8	0.6	1.0	1.2	0.8	1.3	1.1	2.0	1.5	1.1	1.2	1.0	1.5	1.2	1.4	0.0	0.5	2.3	1.4	2.7	1.3	1.2	2.2	0.0	3.1	3.0	0.4	0.0	0.6	0.0	0.0	0.1	6.1	2.6	0.0	0.6	0.6	3.2	1.8	2.5	1.2	0.8	0.7	0.4	0.4	2.5	0.0	5.6	4.5	1.8	0.4	0.7	1.3	0.0	0.5	0.9	2.0	2.8	8.9	0.7	3.4	4.2	0.0	6.5	3.9	0.4	6.2	0.5	3.1	1.9	0.6	2.6	1.1	4.3	0.7	0.6	1.2	0.0	0.0	0.7	0.9	1.0	1.1	1.9	3.3	0.1	1.6	0.9	0.9	2.7
TCHH	THH	ENSG00000159450	Trichohyalin	Q07283	1	152106317-152115454	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"skin 1: 41.4"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 26.2;Langerhans cells: 9.5;Macrophages: 21.8;Spermatocytes: 22.6;Spermatogonia: 29.1"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.6;SCLC-21H: 1.1;THP-1: 2.0"	"Low region specificity"	"Detected in many"							HPA028375	Approved					NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"			"HPA028375: AB_10601722"	"unprognostic (7.70e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.12e-5)"	"unprognostic (2.03e-1)"	"unprognostic (6.55e-2)"	"unprognostic (5.90e-6)"	"unprognostic (5.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.71e-2)"	"unprognostic (9.28e-7)"	0.7	0.1	0.1	0.1	0.1	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.3	0.2	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	41.4	0.2	0.0	0.0	2.2	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.7	0.0	0.0	3.6	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.1	1.0	0.1	0.1	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.3	0.0	0.0	0.3	2.0	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.3	0.2	0.2	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.5	6.4	0.1	0.5	2.8	0.5	1.2	2.5	2.0	0.0	0.3	1.8	0.0	0.6	0.0	0.3	0.0	0.0	0.2	1.4	0.2	3.5	1.8	0.0	0.5	0.2	7.5	0.9	0.0	0.8	0.0	0.1	2.5	0.0	0.6	0.0	0.5	0.5	0.0	26.2	9.5	0.2	0.3	21.8	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.0	1.3	0.0	0.0	0.7	0.0	0.0	3.2	1.4	22.6	29.1	1.0	2.4	5.2	0.8	0.1	0.0	0.1
TCOF1	"TCS, treacle"	ENSG00000070814	"Treacle ribosome biogenesis factor 1"	Q13428	5	150357629-150400308	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 104.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033199, HPA038237, HPA038238"	Enhanced		Enhanced	"Nucleoli fibrillar center"		NA	NA		18000	"Cluster 15: NK-cells - Transcription"	"Cluster 65: Brain - Ion transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center"		"CAB033199: AB_1130042, HPA038237: AB_10670660, HPA038238: AB_10671524"	"unprognostic (7.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.18e-3)"	"unprognostic (9.40e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.26e-8)"	"unprognostic (1.71e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (2.62e-5)"	"unprognostic (1.21e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.41e-1)"	13.0	10.8	44.2	14.5	43.8	13.9	13.5	43.4	104.8	15.4	40.1	20.4	7.3	16.7	7.4	16.6	14.8	6.5	14.9	43.3	42.2	14.8	9.5	12.5	18.3	44.3	43.6	15.7	14.8	9.9	11.0	10.3	44.5	15.7	8.7	9.6	12.1	10.8	21.4	16.6	15.3	11.7	40.9	18.8	14.3	14.5	45.0	20.5	12.6	9.7	16.2	19.7	14.1	48.9	78.3	85.0	42.7	80.3	16.2	21.4	115.1	59.4	24.5	81.1	80.9	211.5	59.3	113.1	53.2	21.9	92.6	88.2	93.0	107.4	57.4	59.9	100.8	54.9	55.6	80.8	17.4	91.5	40.7	18.0	24.8	94.1	71.4	20.1	36.1	59.2	80.2	32.8	27.7	70.7	100.4	67.4	128.8	35.3	80.4	91.4	67.4	64.8	19.5	54.3	58.0	59.7	68.5	111.0	55.2	66.8	49.7	36.1	35.0	59.3	73.5	71.8	113.4	40.6	55.6	123.4	46.6	78.2	54.1	1.6	2.2	1.1	3.8	2.0	4.8	4.6	3.6	3.8	2.1	4.2	3.1	3.4	1.4	8.3	2.1	2.2	2.4	3.2	44.2	43.8	43.4	104.8	43.3	42.2	44.3	43.6	44.5	40.9	45.0	48.9	18.5	9.6	22.4	7.8	41.7	40.0	21.1	14.5	15.9	25.4	13.6	12.7	17.9	11.5	10.4	11.0	41.7	21.7	29.7	24.0	5.9	19.6	8.4	13.2	17.3	24.4	18.7	23.3	7.4	23.4	41.0	20.1	18.3	17.6	23.5	29.1	12.8	10.0	28.8	21.9	6.4	18.8	16.2	27.9	53.3	6.8	19.0	40.0	12.4	2.8	27.8	9.7	33.0	3.0	8.9	15.2	8.4	15.8	26.1	37.8	15.1	6.3	10.1	25.6	26.3	20.3	17.7	27.6	34.1	22.7	39.1	8.9	26.3	20.1	32.0	19.3
TCTN3	"C10orf61, DKFZP564D116, JBTS18, TECT3"	ENSG00000119977	"Tectonic family member 3"	Q6NUS6	10	95659823-95694143	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026987	Approved		Approved	Microtubules	"Intracellular and membrane"	NA	NA		4400000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 41: Macrophages - Immune response"	Microtubules		"HPA026987: AB_10600911"	"unprognostic (1.58e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.78e-2)"	"prognostic favorable (5.77e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.03e-2)"	"unprognostic (9.25e-3)"	"unprognostic (3.78e-3)"	"unprognostic (7.29e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.30e-3)"	"unprognostic (1.59e-1)"	21.3	25.3	8.6	15.7	9.0	5.1	25.2	9.1	11.3	26.3	24.0	22.1	17.6	24.8	65.0	17.0	35.4	22.7	18.4	8.8	9.8	32.5	26.8	19.4	14.3	9.7	9.5	30.6	27.1	69.9	22.8	26.9	9.5	25.6	25.6	22.2	25.4	27.7	9.5	20.5	15.4	26.8	9.2	17.3	19.1	19.4	9.6	14.0	70.6	11.5	18.0	23.9	18.6	9.2	34.0	54.1	44.1	89.3	93.6	74.6	25.7	45.3	94.8	46.9	55.3	35.4	57.3	31.3	40.1	60.4	49.8	46.7	43.9	54.5	56.5	33.6	36.4	10.9	21.6	49.2	46.9	37.4	22.8	65.2	49.2	46.6	72.4	88.0	80.7	27.7	21.0	40.3	63.4	32.5	23.4	27.9	12.1	49.7	38.1	25.3	33.9	38.3	67.8	23.3	11.5	24.5	37.7	18.5	52.6	40.8	71.0	35.1	37.9	35.6	24.9	23.9	49.5	18.9	37.9	20.7	57.5	47.1	19.0	6.8	14.2	4.9	25.8	21.9	32.0	28.3	23.1	25.2	45.2	19.4	24.2	20.0	1.6	26.8	24.3	23.6	22.2	21.3	8.6	9.0	9.1	11.3	8.8	9.8	9.7	9.5	9.5	9.2	9.6	9.2	14.8	19.2	16.2	16.6	29.3	14.4	23.7	33.8	31.3	24.0	18.2	15.0	8.5	27.1	20.3	31.3	37.5	50.3	18.8	20.2	7.9	27.2	18.6	25.5	25.7	20.4	13.8	11.6	17.3	20.3	44.2	27.3	11.7	18.3	8.2	29.8	21.4	16.8	28.5	25.2	17.7	12.5	26.4	14.1	59.1	14.1	20.8	18.7	16.0	16.9	14.8	36.7	15.5	20.6	13.7	14.1	12.7	25.2	35.9	19.8	16.2	16.1	27.5	44.4	13.1	23.9	19.8	39.8	34.1	15.3	11.5	31.5	23.0	34.2	23.7	14.6
TES	"DKFZP586B2022, TESS-2, TESTIN"	ENSG00000135269	"Testin LIM domain protein"	Q9UGI8	7	116210506-116258783	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 197.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 386.6;Glandular and luminal cells: 283.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 230.0;hTCEpi: 263.6;SK-BR-3: 267.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015269, HPA018123"	Approved		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites,Cytosol"		NA	NA		34000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	"Focal adhesion sites, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA015269: AB_1857899, HPA018123: AB_1857900"	"unprognostic (9.81e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.01e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.84e-3)"	"unprognostic (4.81e-3)"	"unprognostic (8.81e-3)"	"unprognostic (6.19e-3)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.60e-2)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.86e-1)"	29.3	7.2	2.7	54.4	2.7	44.1	32.2	3.4	3.6	29.0	10.0	134.7	41.1	105.9	21.7	58.2	45.2	37.4	14.7	2.3	2.9	19.3	10.1	41.0	49.6	6.4	3.5	7.3	20.8	15.3	5.7	25.6	3.4	55.2	69.0	13.4	34.2	197.1	5.1	23.2	47.5	147.6	3.2	30.0	52.1	39.9	4.3	33.5	66.4	8.9	51.3	87.1	41.1	3.0	115.9	24.0	27.0	0.2	11.7	29.7	62.3	58.9	28.9	10.9	10.6	60.4	126.2	0.0	230.0	41.7	1.3	116.9	14.4	87.3	26.4	57.3	46.0	11.5	53.1	30.5	69.9	53.6	0.2	66.4	263.6	37.7	95.0	74.9	31.1	0.0	11.9	39.5	3.0	24.4	0.2	0.7	17.8	134.0	67.4	0.2	0.4	46.0	110.9	44.0	12.4	113.4	85.5	267.1	68.2	77.6	0.3	21.5	52.3	0.6	1.5	86.2	0.7	92.6	48.9	1.3	7.4	27.2	89.3	274.7	79.2	221.5	150.2	132.1	144.7	104.6	113.4	137.6	86.9	95.5	111.0	127.6	41.6	205.1	170.5	20.7	130.4	162.8	2.7	2.7	3.4	3.6	2.3	2.9	6.4	3.5	3.4	3.2	4.3	3.0	40.8	243.6	47.0	0.0	60.4	200.4	196.2	64.8	60.3	2.2	62.2	57.0	16.1	47.1	81.7	36.8	12.5	23.2	121.3	140.8	21.5	110.7	386.6	176.7	29.9	49.0	50.6	17.7	0.1	112.3	78.1	23.6	84.1	283.9	18.9	54.1	25.7	11.9	15.4	1.7	0.1	100.7	34.6	58.0	119.0	112.5	1.8	78.0	28.4	10.3	77.6	24.7	201.8	0.0	0.3	196.8	112.1	0.4	76.3	102.4	65.3	13.6	68.1	13.9	6.6	9.0	42.3	19.1	10.6	55.9	122.7	29.1	79.2	8.8	79.7	135.9
TESK1		ENSG00000107140	"Testis associated actin remodelling kinase 1"	Q15569	9	35605262-35610041	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"				"unprognostic (5.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.04e-2)"	"unprognostic (8.76e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-3)"	40.2	44.7	24.4	11.2	22.0	6.1	33.5	17.9	25.9	22.6	14.8	29.9	13.3	25.7	11.1	12.8	18.7	13.0	19.2	22.0	21.3	18.0	13.8	19.9	11.9	20.6	24.2	15.9	16.0	16.8	26.6	9.1	21.8	22.4	8.5	6.7	17.4	19.8	69.2	19.1	18.9	17.1	18.2	16.2	22.2	57.0	28.1	10.4	19.0	27.6	8.5	27.9	16.0	20.4	17.0	16.0	10.7	16.9	42.5	17.5	12.1	19.7	17.3	17.8	11.3	9.3	4.8	30.9	10.3	19.7	47.1	5.8	6.8	14.1	3.4	20.0	9.2	4.6	14.1	8.4	24.4	4.0	14.6	17.2	21.8	13.9	19.0	18.9	12.6	15.3	5.3	11.3	18.0	19.1	7.9	18.4	6.2	16.1	18.6	12.9	6.6	7.3	13.1	8.0	8.8	10.3	11.2	13.0	8.1	7.3	15.9	5.7	11.1	39.2	16.2	27.9	12.0	6.0	10.2	11.2	28.2	4.6	9.1	0.0	0.6	0.1	1.1	0.1	1.0	0.3	0.4	1.8	0.8	0.2	0.5	0.5	0.0	0.9	0.3	0.8	0.1	0.7	24.4	22.0	17.9	25.9	22.0	21.3	20.6	24.2	21.8	18.2	28.1	20.4	13.4	6.4	7.7	9.1	8.9	14.4	6.3	5.9	4.6	10.9	13.9	11.0	1.9	7.2	4.2	7.3	8.4	3.8	20.0	19.9	1.9	6.6	35.1	5.6	9.2	9.7	9.5	1.7	6.5	10.4	8.6	9.0	18.8	11.2	1.3	10.1	10.8	8.4	13.9	13.5	8.5	14.8	0.0	7.8	22.4	34.9	12.2	19.3	14.2	2.8	6.3	12.6	20.6	4.5	6.8	10.2	11.0	14.3	10.7	19.2	13.4	7.8	4.2	15.3	6.6	10.1	10.9	14.8	10.0	4.7	13.9	3.3	11.8	5.4	7.3	9.7
TET2	"FLJ20032, KIAA1546"	ENSG00000168769	"Tet methylcytosine dioxygenase 2"	Q6N021	4	105145875-105279816	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 112.6;Oligodendrocytes: 128.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 55.5"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 55.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043135	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA043135: AB_10794177"	"unprognostic (6.83e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.70e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.15e-2)"	"unprognostic (7.84e-2)"	4.3	3.1	2.9	10.1	4.4	22.4	5.4	2.5	2.7	6.3	5.8	5.2	6.1	7.2	6.0	7.7	4.9	5.0	3.3	2.1	4.6	4.1	4.2	5.4	5.6	5.3	4.4	4.3	3.7	4.6	1.8	10.2	5.3	4.4	5.9	6.6	4.7	3.3	2.8	11.0	6.0	5.7	2.9	7.2	5.3	1.3	4.1	5.4	4.2	5.2	7.0	5.5	4.5	5.6	5.1	3.1	10.9	11.1	2.1	3.7	4.2	3.1	4.8	4.8	4.7	3.1	6.4	0.5	4.0	4.0	2.1	4.9	9.3	6.1	5.3	6.7	2.9	7.0	6.5	1.6	4.9	15.5	11.8	3.8	7.9	4.5	5.6	8.6	6.4	4.1	7.7	13.6	4.4	3.1	2.5	4.7	2.5	6.2	2.2	8.4	4.7	1.0	4.7	9.4	7.5	5.9	4.2	9.1	0.8	5.9	4.5	11.8	9.1	7.8	6.7	2.1	5.3	9.5	6.8	6.8	4.8	3.8	7.2	30.1	13.6	14.7	3.9	10.4	1.6	5.3	2.3	2.2	10.2	6.3	1.9	2.9	55.5	5.9	13.6	8.9	3.1	3.3	2.9	4.4	2.5	2.7	2.1	4.6	5.3	4.4	5.3	2.9	4.1	5.6	24.5	25.6	29.1	58.8	28.3	14.4	11.0	14.2	12.5	22.8	15.6	13.6	27.9	5.7	23.9	9.2	16.7	23.1	34.1	19.0	7.9	7.0	0.4	22.1	38.3	20.3	23.3	10.9	48.4	7.5	5.7	18.0	21.4	33.2	27.8	15.5	13.6	8.5	14.5	35.3	89.7	15.8	32.6	48.8	93.3	0.9	8.1	98.3	5.4	90.9	48.1	5.8	34.0	112.6	128.3	8.2	18.7	7.2	22.5	12.1	16.3	2.8	22.3	24.3	13.1	47.0	21.7	0.2	1.3	28.4	35.9	34.2	18.9	24.7	14.0	27.5
TFE3	"bHLHe33, TFEA"	ENSG00000068323	"Transcription factor binding to IGHM enhancer 3"	P19532	X	49028726-49043410	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 12.5"	"Group enriched"	"Detected in many"	4	"granulocytes: 12.5;monocytes: 6.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023881	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"		"HPA023881: AB_1857931"	"unprognostic (2.68e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (6.03e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (2.19e-8)"	"unprognostic (1.93e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.19e-2)"	"unprognostic (6.25e-1)"	31.3	23.6	27.8	16.8	27.3	24.1	22.9	25.8	26.9	24.1	23.3	23.6	10.8	24.7	21.1	15.6	26.2	18.5	17.2	25.7	29.4	15.1	12.6	29.2	11.8	37.2	30.9	25.8	12.4	25.1	18.4	20.8	28.7	17.2	11.5	14.8	13.4	28.3	17.0	20.5	14.7	24.7	27.5	22.5	16.8	5.9	32.2	10.7	20.0	14.0	13.2	25.0	20.5	25.6	32.8	41.5	14.6	44.6	48.6	45.1	12.5	40.6	55.8	49.7	38.2	23.3	26.8	10.2	18.0	65.7	48.6	25.5	25.4	40.2	44.8	24.4	11.8	8.3	39.6	26.2	69.0	10.0	28.3	38.5	32.3	64.4	50.1	47.8	26.3	8.4	19.8	55.9	49.2	20.6	7.5	17.2	36.3	11.0	34.1	11.9	22.2	26.6	43.1	18.0	12.4	12.4	44.8	19.0	17.9	52.5	27.6	15.0	48.5	47.1	48.7	48.0	27.3	30.1	29.7	8.0	56.1	14.0	33.2	0.0	4.8	1.8	0.6	4.7	1.1	0.5	0.9	0.5	2.2	1.0	0.6	0.5	12.5	0.4	6.3	0.5	1.3	2.6	27.8	27.3	25.8	26.9	25.7	29.4	37.2	30.9	28.7	27.5	32.2	25.6	13.8	16.0	8.8	13.7	9.8	19.8	19.7	11.2	30.1	6.8	10.9	9.4	8.1	15.7	11.8	20.2	4.2	16.0	4.4	14.3	9.8	17.7	0.7	10.9	15.3	17.5	12.5	5.2	7.5	15.8	9.4	20.2	14.3	14.8	5.7	12.0	10.8	15.0	22.3	18.5	7.2	8.2	0.0	21.7	29.4	2.2	27.4	20.5	8.8	11.2	15.5	12.0	4.1	6.0	7.7	21.4	13.7	24.5	12.9	20.2	10.6	12.1	7.0	5.6	13.1	18.5	14.3	2.2	0.8	18.9	22.0	37.1	8.6	13.9	7.5	19.6
THAP2	DKFZP564I0422	ENSG00000173451	"THAP domain containing 2"	Q9H0W7	12	71664301-71680644	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 367.4;Late spermatids: 183.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA039790	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Nucleoplasm	"HPA039790: AB_10795157"	"unprognostic (5.62e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.51e-4)"	"unprognostic (1.24e-4)"	"unprognostic (7.00e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.13e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.80e-2)"	16.1	26.1	5.7	9.1	7.1	14.8	4.2	11.6	9.2	4.8	3.1	4.1	5.7	6.3	17.0	6.5	4.6	8.6	5.2	5.5	6.3	5.6	4.4	4.7	7.9	6.7	6.0	8.6	3.8	3.4	11.1	6.8	6.6	4.7	5.7	11.3	4.7	4.1	5.0	5.7	4.3	4.4	6.9	5.1	6.4	18.2	5.7	5.4	4.6	5.7	7.1	28.2	4.1	10.8	3.9	4.9	11.2	8.6	8.2	7.2	5.6	6.0	5.5	5.7	4.8	5.1	5.1	2.7	4.0	4.0	6.9	6.8	10.9	3.4	7.4	11.5	6.0	7.8	8.6	8.0	7.4	4.8	3.4	5.1	15.1	5.4	12.0	11.9	9.0	13.2	5.7	5.6	7.9	1.3	3.9	4.7	5.7	7.9	8.2	5.5	3.8	13.3	7.1	6.0	7.9	12.4	6.6	3.8	5.8	7.8	7.1	5.4	4.0	5.9	2.8	5.1	4.1	6.9	9.4	6.2	3.4	5.7	3.6	1.4	2.2	2.2	3.7	3.0	6.0	4.1	5.1	3.6	3.0	4.8	8.1	5.5	1.9	6.4	3.7	1.4	5.5	2.1	5.7	7.1	11.6	9.2	5.5	6.3	6.7	6.0	6.6	6.9	5.7	10.8	15.1	0.0	11.0	11.1	36.2	19.6	27.7	13.7	20.5	11.5	9.9	13.6	12.4	4.3	7.9	3.7	4.2	4.0	24.4	8.1	9.8	7.7	367.4	12.2	13.5	10.6	5.4	3.4	14.8	5.4	7.3	47.1	12.8	20.2	58.3	9.4	6.1	4.3	12.3	13.5	20.8	8.1	2.0	11.3	93.2	183.7	11.5	75.2	78.2	5.6	9.9	10.2	9.2	14.1	24.3	7.0	9.4	5.7	44.3	16.7	15.6	19.2	10.5	7.5	0.0	22.2	64.1	26.1	7.2	44.8	29.5	3.0	20.0	6.7	9.5	25.7
THBD	CD141	ENSG00000178726	Thrombomodulin	P07204	20	23045633-23049672	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor	"Disease variant, Hemolytic uremic syndrome, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 254.3;Endothelial cells: 200.6;Langerhans cells: 138.1;Leydig cells: 130.8;Macrophages: 130.9;Peritubular cells: 259.2;Squamous epithelial cells: 237.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 24.6"	"Group enriched"	"Detected in many"	7	"dendritic cells: 10.8;granulocytes: 24.6;monocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.3;CAPAN-2: 39.2;EFO-21: 33.5;HaCaT: 33.1;hTCEpi: 42.6;OE19: 29.8;THP-1: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002425, HPA002982"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA	5550000	1300000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"		"CAB002425: AB_563497, HPA002982: AB_1078444"	"unprognostic (1.96e-1)"	"unprognostic (2.93e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.81e-3)"	"unprognostic (4.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.35e-3)"	"unprognostic (3.01e-2)"	"unprognostic (7.58e-3)"	"unprognostic (9.71e-2)"	65.4	11.4	2.0	19.6	1.8	15.5	25.5	1.6	3.2	16.7	3.4	16.5	5.5	12.6	3.1	36.8	27.5	26.5	31.0	2.4	3.0	19.7	9.7	56.7	14.5	4.1	2.7	6.9	13.2	9.9	20.4	28.5	2.8	8.0	5.9	0.2	10.8	4.6	40.7	71.4	20.0	15.6	3.0	43.6	30.8	7.6	8.5	5.1	35.5	17.5	8.0	20.8	21.0	2.4	11.5	9.9	0.3	0.0	24.3	1.4	0.2	0.2	0.0	0.0	0.0	0.0	39.2	0.0	33.5	3.4	1.7	33.1	0.0	1.8	0.0	0.0	0.1	0.1	1.0	0.0	4.7	0.0	0.2	1.1	42.6	0.7	2.8	23.0	11.0	0.0	4.2	0.0	0.9	0.8	0.0	4.2	0.1	29.8	1.6	0.0	0.0	4.9	0.2	16.2	0.7	0.0	9.4	1.2	17.4	2.9	0.0	24.8	21.7	0.1	0.6	3.2	0.0	0.0	0.0	0.0	2.0	5.8	0.8	0.0	4.1	0.0	0.0	9.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	24.6	2.0	8.7	10.8	0.0	2.0	2.0	1.8	1.6	3.2	2.4	3.0	4.1	2.7	2.8	3.0	8.5	2.4	254.3	22.4	21.4	0.0	2.0	34.3	10.4	9.5	23.3	0.1	3.9	5.3	16.8	1.5	21.3	0.0	0.0	3.2	16.9	0.0	0.0	1.8	0.9	1.9	1.8	200.6	0.0	2.7	0.3	0.2	37.1	46.1	2.6	7.2	7.6	0.2	65.3	0.8	14.9	0.0	0.7	0.4	4.1	32.4	138.1	4.9	130.8	130.9	16.0	1.0	8.1	0.0	0.0	0.0	0.0	9.0	0.0	259.2	2.3	4.5	0.0	0.3	2.5	0.0	6.6	51.4	39.0	0.2	1.0	237.3	98.6	42.4	3.2	2.8	0.1	58.2
THBS1	"THBS, THBS-1, TSP, TSP-1, TSP1"	ENSG00000137801	"Thrombospondin 1"	P07996	15	39581079-39599466	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, Unfolded protein response"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 279.5;Granulosa cells: 228.3;Macrophages: 598.0;Smooth muscle cells: 283.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 15.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 2610.2;HUVEC TERT2: 2494.4;LHCN-M2: 1863.4;TIME: 3552.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 20.6"	"CAB033678, HPA059756"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA	16000000000	1400000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB033678: AB_793044, HPA059756: AB_2684121"	"unprognostic (1.72e-2)"	"unprognostic (9.55e-3)"	"unprognostic (7.49e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (8.47e-5)"	"prognostic unfavorable (8.50e-4)"	"unprognostic (1.00e-1)"	"unprognostic (9.25e-3)"	"unprognostic (1.48e-3)"	364.3	72.5	1.7	394.0	3.7	114.7	95.1	2.1	11.3	66.7	27.3	166.4	24.8	161.3	3.5	49.1	142.6	275.2	98.3	2.2	2.1	70.9	129.4	309.2	32.3	10.8	4.4	76.3	69.1	7.0	26.8	99.0	10.8	89.8	85.6	0.4	137.3	12.0	16.2	35.4	83.5	243.6	0.9	79.8	150.5	2.2	14.3	12.0	34.0	4.3	7.1	396.3	36.2	2.1	171.9	62.7	49.0	17.8	199.4	233.9	0.7	1025.7	861.6	283.6	185.5	185.0	135.7	1.0	348.4	2610.2	54.4	621.0	2.2	516.1	145.0	43.4	0.5	46.6	35.0	46.9	44.4	0.3	13.2	524.9	37.2	237.2	535.1	1123.6	2494.4	1.6	1.5	1.7	1863.4	14.7	0.8	3.6	8.9	17.7	20.3	0.7	125.7	1.3	430.6	472.6	0.6	0.4	300.7	16.4	18.5	60.8	178.6	3.3	3552.9	972.6	221.0	1141.1	1146.6	2.4	1.8	2.0	33.0	0.8	1064.4	0.3	8.7	15.7	0.7	0.8	2.7	0.0	0.4	0.5	0.5	0.1	0.1	0.1	1.5	7.8	0.1	0.4	0.0	10.5	1.7	3.7	2.1	11.3	2.2	2.1	10.8	4.4	10.8	0.9	14.3	2.1	19.0	25.6	19.6	0.7	4.9	95.7	131.2	37.6	181.6	0.1	66.8	69.8	48.7	18.6	19.9	69.9	6.2	1.9	8.2	144.5	0.0	52.1	0.2	64.9	127.7	79.2	3.6	0.0	0.9	127.5	2.5	279.5	15.8	38.2	162.7	228.3	44.6	7.4	6.3	0.0	1.3	46.4	48.8	105.9	97.9	0.3	1.8	598.0	39.2	13.1	5.9	0.1	3.1	0.0	0.1	183.9	55.1	0.4	5.9	79.2	8.5	48.3	11.9	1.5	6.6	59.0	283.8	0.2	0.3	51.8	51.0	2.1	19.5	10.8	67.8	42.1
TIFAB		ENSG00000255833	"TIFA inhibitor"	Q6ZNK6	5	135444226-135452351	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.6"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 8.0;Early spermatids: 4.2;Hofbauer cells: 4.0;Langerhans cells: 17.6;Late spermatids: 9.2;monocytes: 4.6"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 0.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"myeloid DC: 4.5;plasmacytoid DC: 13.9"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 13.9"	"Cell line enriched"	"Detected in some"	5	"THP-1: 9.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049372	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA049372: AB_2680733"	"unprognostic (1.33e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-5)"	"unprognostic (3.87e-1)"	"unprognostic (3.25e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.01e-2)"	0.1	0.0	0.0	3.7	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.9	1.0	0.1	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.5	5.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.2	0.0	0.0	0.9	1.0	0.2	0.0	2.6	0.7	0.3	0.0	1.9	0.0	0.0	4.9	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	17.6	9.2	0.0	2.2	0.0	0.0	4.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TLR2	"CD282, TIL4"	ENSG00000137462	"Toll like receptor 2"	O60603	4	153684070-153706260	"CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 69.9;lymphoid tissue: 51.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 77.3;Kupffer cells: 117.2;Langerhans cells: 35.7;Macrophages: 101.8;Microglial cells: 33.7;monocytes: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 199.6;intermediate monocyte: 178.9;myeloid DC: 121.3;neutrophil: 457.8;non-classical monocyte: 121.5"	"Group enriched"	"Detected in all"	49	"dendritic cells: 121.3;granulocytes: 457.8;monocytes: 199.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 11.6;HSkMC: 12.5;hTCEpi: 12.7;NB-4: 11.4;RPTEC TERT1: 13.3;RT4: 16.3;THP-1: 62.0;U-937: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060231, HPA071546"			Supported	Nucleoplasm,Mitochondria		No	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Mitochondria"		"HPA060231: , HPA071546: "	"unprognostic (4.15e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.93e-3)"	26.8	11.8	4.3	51.7	4.4	69.9	12.5	4.6	7.5	7.9	7.6	4.6	3.9	3.3	11.8	5.4	8.2	16.3	6.1	4.0	5.3	5.1	11.3	39.9	8.8	9.5	5.9	2.5	8.8	3.4	4.0	11.4	7.9	4.7	3.3	1.5	17.2	12.3	1.7	3.5	4.9	11.7	7.1	35.9	5.2	1.9	7.4	3.6	3.4	3.7	15.4	23.6	4.0	10.1	7.1	0.1	0.3	0.0	1.0	2.9	0.0	0.0	0.5	0.5	0.8	3.3	0.4	0.0	0.8	0.0	0.0	6.4	0.6	0.4	0.3	0.1	0.1	0.2	0.0	0.8	0.1	11.6	0.9	12.5	12.7	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.1	0.1	0.0	11.4	0.7	0.0	2.7	0.3	0.0	0.0	13.3	16.3	0.0	0.3	0.7	0.1	3.3	0.4	0.0	62.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	11.3	1.7	48.4	199.6	1.8	0.3	178.9	0.5	0.4	1.1	0.3	121.3	1.2	1.3	0.2	457.8	5.3	121.5	1.1	0.2	76.2	4.3	4.4	4.6	7.5	4.0	5.3	9.5	5.9	7.9	7.1	7.4	10.1	1.7	6.4	77.3	0.7	1.1	1.1	1.2	18.4	1.2	0.0	9.7	2.2	1.3	2.8	19.5	3.7	0.0	0.2	0.6	0.2	0.0	5.0	0.3	1.6	0.5	2.6	0.0	3.6	0.1	3.8	0.2	1.9	2.6	4.9	3.8	0.5	1.4	1.8	17.4	0.0	0.5	0.3	0.0	117.2	35.7	1.3	0.6	101.8	1.8	33.7	68.4	0.4	1.0	1.0	0.1	3.1	0.0	0.4	1.4	3.4	1.5	1.0	7.5	0.3	13.1	0.6	5.1	0.2	1.0	1.9	1.1	0.1	2.3	0.5	0.5	2.0
TNFAIP3	"A20, OTUD7C"	ENSG00000118503	"TNF alpha induced protein 3"	P21580	6	137867214-137883312	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Ubl conjugation pathway"	"DNA-binding, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 519.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 774.9;Endometrial ciliated cells: 605.2;Glandular and luminal cells: 1498.3;Macrophages: 596.6;Suprabasal keratinocytes: 745.7;T-cells: 624.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 106.5;Karpas-707: 161.3;REH: 151.5;U-266/84: 131.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002116	Approved		Approved	Centrosome,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Centrosome, Cytosol"		"HPA002116: AB_1858162"	"unprognostic (5.50e-3)"	"unprognostic (9.98e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.01e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.01e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (6.06e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	57.0	15.6	4.4	114.6	3.8	519.5	23.3	2.9	23.9	27.5	12.0	22.6	21.4	31.3	5.2	26.6	23.4	47.8	23.0	3.2	2.8	13.8	27.4	56.2	76.8	6.1	3.9	73.2	25.8	25.8	7.5	28.9	6.7	17.3	24.7	19.1	16.1	10.3	8.6	50.5	30.7	33.5	6.6	46.1	22.8	8.3	9.5	71.1	11.7	3.8	55.7	171.1	14.6	6.2	32.6	4.8	1.8	2.8	10.1	16.9	7.8	18.8	67.6	4.8	5.7	34.9	8.8	7.3	43.1	20.0	106.5	22.6	1.1	50.4	8.9	46.8	2.2	7.5	19.8	21.1	11.2	10.3	12.8	15.6	7.3	56.4	53.6	5.6	2.9	21.2	17.4	161.3	8.4	1.8	56.2	41.4	1.5	2.1	1.4	151.5	39.4	6.1	14.8	15.1	0.7	0.3	3.6	5.3	16.9	7.0	3.4	11.7	14.8	46.9	6.8	46.0	9.6	48.7	131.4	14.0	16.9	13.1	6.1	7.3	12.6	9.6	19.6	9.3	27.9	7.4	19.4	18.0	14.3	7.8	13.1	10.1	13.6	11.1	5.1	26.2	19.2	14.8	4.4	3.8	2.9	23.9	3.2	2.8	6.1	3.9	6.7	6.6	9.5	6.2	71.8	38.5	76.3	2.0	94.5	774.9	150.2	102.1	384.7	1.1	29.0	42.3	4.6	25.8	53.7	0.0	29.2	8.1	395.5	53.9	1.9	60.0	2.6	605.2	365.9	114.8	11.9	5.2	0.1	26.9	104.8	110.1	111.1	1498.3	255.9	2.3	48.5	13.5	45.7	0.0	0.3	38.6	67.1	125.2	461.8	3.2	6.8	596.6	129.9	8.4	59.1	1.7	14.4	2.0	0.3	30.5	29.5	6.0	331.4	170.2	37.3	3.1	84.3	13.3	6.6	29.0	94.9	2.7	2.2	367.9	745.7	23.1	624.2	14.9	20.9	78.1
TNFRSF1B	"CD120b, p75, TNF-R-II, TNF-R75, TNFBR, TNFR2, TNFR80"	ENSG00000028137	"TNF receptor superfamily member 1B"	P20333	1	12166991-12209228	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 68.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 268.7;Kupffer cells: 200.5;Langerhans cells: 288.0;Macrophages: 230.2;monocytes: 175.3;T-cells: 138.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 387.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 34.0;K-562: 45.7;THP-1: 51.8;U-87 MG: 30.8;U-937: 37.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA004796	Approved				"Secreted to blood"	NA	NA	3230000	8100000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA004796: AB_1078436"	"unprognostic (4.45e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.62e-2)"	"unprognostic (3.82e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.28e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (8.35e-5)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.10e-1)"	45.6	5.4	3.9	68.4	3.8	52.1	34.7	4.8	17.9	14.3	5.6	12.8	16.8	11.6	0.4	5.5	14.6	15.6	10.9	3.7	9.0	7.5	15.7	32.0	32.1	18.3	7.2	6.3	5.9	2.3	4.5	35.8	10.6	6.4	10.8	0.8	6.5	2.6	10.7	7.8	23.9	16.8	9.0	53.3	16.4	2.2	8.9	12.7	7.6	6.3	21.3	28.9	8.8	14.1	0.0	0.3	4.1	0.0	9.6	13.5	8.9	1.1	2.0	4.0	4.3	1.8	34.0	0.2	0.6	3.9	5.6	0.0	0.8	0.0	2.2	14.5	0.0	0.0	0.2	0.0	25.2	0.3	3.8	14.8	0.0	13.0	0.0	7.2	19.6	0.2	45.7	6.4	1.5	0.0	0.0	8.1	0.2	4.9	1.4	1.2	0.4	25.9	0.0	0.8	0.0	0.1	0.6	0.4	1.4	6.4	0.0	51.8	7.8	5.3	0.2	27.0	0.0	1.9	0.0	0.0	30.8	37.0	1.4	0.6	127.1	18.2	48.4	260.5	26.5	13.5	34.4	40.5	71.7	8.4	9.8	15.5	138.0	13.4	387.1	15.1	70.9	150.4	3.9	3.8	4.8	17.9	3.7	9.0	18.3	7.2	10.6	9.0	8.9	14.1	99.4	9.6	15.9	0.7	42.8	16.8	3.9	1.0	1.2	0.2	3.2	4.1	3.6	5.7	6.5	3.7	0.0	0.9	268.7	12.8	0.0	0.5	0.6	1.7	5.1	46.0	0.0	7.4	0.2	0.6	6.3	13.2	12.8	4.9	2.5	1.4	31.1	17.0	72.6	0.0	0.2	3.0	0.0	200.5	288.0	1.2	2.1	230.2	16.0	30.9	175.3	0.3	109.2	0.0	0.1	0.7	4.2	0.4	72.5	8.0	25.8	0.4	1.5	1.2	32.9	6.8	9.8	0.0	0.9	0.7	10.5	30.1	138.4	1.9	4.8	8.8
TOMM40L	"FLJ12770, TOMM40B"	ENSG00000158882	"Translocase of outer mitochondrial membrane 40 like"	Q969M1	1	161225939-161230746	"Predicted intracellular proteins"	"Ion transport, Protein transport, Transport"	Porin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 51.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051304	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 41: Macrophages - Immune response"			"HPA051304: AB_2681432"	"unprognostic (1.18e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.65e-2)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (8.46e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.89e-2)"	"prognostic favorable (7.80e-4)"	"unprognostic (2.29e-1)"	"unprognostic (8.71e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.14e-1)"	8.5	7.1	11.4	7.2	12.2	14.9	6.7	10.4	17.0	5.3	7.1	11.8	13.9	7.5	2.7	10.1	5.3	4.0	24.3	11.7	9.6	9.9	17.5	7.7	6.7	11.1	11.0	3.6	3.8	15.0	5.8	6.0	11.1	6.4	10.7	11.1	5.8	8.8	23.2	7.2	11.9	8.5	10.5	7.8	8.0	2.2	12.8	7.2	5.7	51.4	7.5	8.6	6.1	11.7	7.6	7.2	11.8	12.9	19.2	10.1	9.1	11.2	13.7	21.6	18.6	41.7	9.8	22.5	13.4	14.9	8.0	9.9	22.6	22.3	12.4	18.9	15.5	21.2	10.5	21.0	8.5	40.8	34.0	11.0	14.0	24.0	12.9	11.0	24.8	23.4	30.0	18.7	15.3	12.3	16.5	6.0	12.9	17.2	20.4	18.7	8.6	21.3	16.2	16.2	28.2	11.8	10.7	30.1	9.9	12.6	23.0	30.9	19.1	11.2	7.7	9.7	16.5	16.5	15.0	16.1	11.6	24.6	11.8	2.5	1.6	1.4	1.0	1.9	1.4	0.8	0.7	1.3	3.0	0.5	0.7	1.7	0.7	1.9	1.5	3.4	1.6	1.5	11.4	12.2	10.4	17.0	11.7	9.6	11.1	11.0	11.1	10.5	12.8	11.7	4.1	0.0	3.3	2.3	3.5	0.5	1.4	1.6	3.4	6.0	2.9	2.3	4.0	1.5	1.7	1.8	6.2	2.4	2.8	8.7	7.9	4.0	4.1	0.7	2.3	4.1	7.7	3.4	5.3	7.8	3.2	3.3	3.6	1.3	3.8	2.2	1.4	7.4	9.7	5.0	5.9	2.6	4.1	5.0	2.7	1.9	2.1	14.8	0.0	1.9	5.6	2.4	4.1	2.0	1.6	4.6	4.1	0.7	4.6	1.1	11.4	5.1	1.2	9.7	0.0	2.2	5.2	0.9	1.8	5.2	1.7	0.8	3.8	3.6	7.0	1.4
TOP1		ENSG00000198900	"DNA topoisomerase I"	P11387	20	41028822-41124487	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 801.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009058, HPA019039"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	Yes		7600	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nucleoli fibrillar center"	"CAB009058: AB_2303554, HPA019039: AB_1858187"	"unprognostic (1.46e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.92e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (5.86e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.51e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.14e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	37.9	36.7	17.4	49.9	18.6	74.9	27.9	21.8	25.1	26.9	25.3	36.9	42.6	27.9	34.4	36.7	22.4	37.2	19.1	18.0	18.9	39.0	47.5	40.0	59.9	18.5	18.4	24.3	28.6	26.7	22.4	50.2	18.1	31.8	37.3	25.5	26.7	24.2	21.3	26.5	42.6	23.9	18.7	38.5	36.5	18.9	18.8	58.9	37.6	20.2	60.6	42.7	28.8	19.2	105.2	71.7	131.4	108.2	52.2	61.8	129.8	92.6	81.0	105.0	94.8	190.5	127.6	296.4	96.4	48.5	112.3	98.9	159.1	147.2	153.0	64.9	81.6	378.6	54.9	139.0	135.4	165.1	124.0	69.8	76.4	102.4	166.8	94.0	111.5	98.1	167.8	98.7	120.9	233.2	235.3	119.7	106.3	104.1	131.6	197.7	123.1	157.7	121.4	95.2	108.6	75.4	145.4	88.3	95.0	94.2	98.6	146.4	109.9	84.7	71.3	78.8	100.9	62.7	75.6	338.3	113.7	91.1	82.0	12.6	9.9	16.8	6.6	10.3	8.3	10.5	7.3	7.0	9.5	10.1	7.7	6.9	19.1	6.3	13.2	18.8	9.0	5.4	17.4	18.6	21.8	25.1	18.0	18.9	18.5	18.4	18.1	18.7	18.8	19.2	116.9	118.6	201.5	66.0	117.6	245.9	338.0	90.3	153.7	98.2	90.5	75.7	49.7	78.6	170.3	99.3	60.5	192.1	137.1	194.1	74.3	94.4	10.0	151.3	167.4	115.1	91.8	486.5	86.9	65.8	175.4	121.4	84.1	259.2	78.6	119.1	67.1	131.7	99.2	72.3	77.4	126.9	69.2	101.2	109.1	12.8	59.7	151.6	72.9	74.9	95.4	88.0	78.2	87.4	90.7	119.2	169.8	69.6	234.1	162.3	94.1	136.2	68.3	87.0	85.5	135.5	130.8	116.8	54.6	129.4	214.2	801.5	111.5	123.7	117.8	237.7
TP53BP2	"53BP2, ASPP2, PPP1R13A"	ENSG00000143514	"Tumor protein p53 binding protein 2"	Q13625	1	223779893-223845954	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 152.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021603, HPA050429"	Supported		Enhanced	"Cell Junctions,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Cell Junctions, Cytosol"		"HPA021603: AB_1844384, HPA050429: AB_2681124"	"unprognostic (1.29e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.99e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.83e-1)"	11.7	8.5	35.3	12.2	37.2	49.8	9.5	34.7	39.4	11.4	35.6	9.9	8.5	12.6	10.0	16.8	10.1	18.4	12.2	33.0	34.4	9.7	14.9	18.4	12.8	34.9	35.8	13.8	12.0	15.8	7.1	8.9	33.2	8.9	9.9	38.0	12.4	8.1	13.0	13.0	10.0	11.1	33.5	9.3	12.4	11.2	37.4	15.8	20.7	11.2	13.1	16.6	11.7	35.8	32.8	16.2	42.9	27.3	15.0	14.5	27.3	20.6	29.3	29.4	25.1	33.6	19.2	0.0	17.5	17.3	21.3	21.9	33.9	12.3	39.3	62.9	33.2	43.1	15.2	11.5	30.3	36.0	28.9	17.5	13.3	27.2	27.7	22.1	17.7	23.6	55.7	31.7	24.8	9.5	27.5	22.2	37.0	19.7	15.6	36.0	44.7	3.7	26.5	20.4	36.9	47.6	22.8	27.9	29.9	27.9	15.8	48.6	20.7	30.0	21.1	32.7	39.2	15.4	17.3	26.4	18.1	23.9	35.0	4.8	1.2	0.8	0.9	1.3	1.2	0.9	1.1	1.8	1.3	0.8	1.1	0.8	1.4	3.3	1.0	0.8	0.8	1.0	35.3	37.2	34.7	39.4	33.0	34.4	34.9	35.8	33.2	33.5	37.4	35.8	18.2	48.1	22.7	76.4	23.7	17.2	41.6	7.2	21.1	8.1	12.6	8.0	20.3	18.6	28.3	7.3	52.1	10.3	24.2	13.0	1.9	20.4	1.1	45.0	42.2	19.1	14.9	54.3	1.7	10.7	5.9	22.6	21.9	152.0	48.8	14.1	8.6	10.7	9.8	0.0	5.3	8.7	14.2	14.1	44.4	2.4	10.5	41.7	8.8	23.4	9.6	10.0	7.2	27.2	29.0	21.4	7.3	8.6	27.4	30.9	6.7	5.5	15.6	45.5	0.0	41.2	26.3	12.3	20.1	21.1	11.6	4.8	38.8	31.4	10.2	40.6
TPRA1	"FLJ32197, GPR175, TMEM227, TPRA40"	ENSG00000163870	"Transmembrane protein adipocyte associated 1"	Q86W33	3	127571232-127598267	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 179.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019784	Approved		Approved	Vesicles		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 31: Skin - Epidermis development"	"Cluster 18: U-2197 - ECM organization"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA019784: AB_2670266"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.66e-2)"	"unprognostic (6.91e-3)"	"unprognostic (9.74e-2)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (3.46e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.28e-2)"	23.9	29.7	22.4	11.7	23.3	26.5	24.5	23.4	26.2	35.8	25.9	25.8	16.9	28.8	12.5	26.4	28.1	16.5	24.7	22.3	23.3	26.8	37.0	24.9	13.9	22.9	23.4	27.8	26.7	29.0	21.7	20.8	23.0	28.8	11.3	8.0	26.4	16.2	26.8	42.9	21.2	17.2	22.7	25.0	25.8	16.3	24.2	11.5	27.0	19.8	13.0	28.5	28.8	22.7	40.0	31.2	12.9	27.3	51.4	28.6	42.1	20.5	34.2	24.7	22.2	22.1	30.9	36.7	37.6	38.4	77.2	43.6	22.6	34.8	12.9	20.0	15.0	21.4	46.0	20.7	56.6	13.3	44.7	28.8	28.8	16.4	42.8	51.2	18.0	24.5	14.0	36.7	30.4	39.8	18.5	43.4	19.3	25.5	23.4	31.9	17.0	37.0	29.6	19.1	24.6	9.5	37.7	57.7	35.1	10.4	27.3	42.3	28.7	29.6	13.1	60.0	13.2	25.0	21.0	34.4	31.9	38.8	22.4	3.8	12.9	11.5	6.4	9.4	8.6	6.6	7.4	9.5	12.7	6.4	5.6	6.8	7.0	6.6	8.4	9.7	7.2	6.5	22.4	23.3	23.4	26.2	22.3	23.3	22.9	23.4	23.0	22.7	24.2	22.7	15.7	22.4	7.0	13.1	11.7	50.0	20.5	18.8	24.5	7.8	16.3	17.9	11.8	11.5	16.5	25.8	4.2	56.9	8.4	18.2	5.9	29.1	2.7	23.5	18.0	22.8	17.4	46.5	9.3	19.6	43.3	22.9	17.9	27.5	17.8	13.9	21.8	21.7	32.9	5.0	9.7	18.7	18.3	16.0	179.7	2.4	33.5	32.0	30.2	5.6	52.3	11.2	20.6	6.6	8.1	31.4	17.6	19.5	17.9	37.5	37.5	13.1	12.4	8.9	13.1	13.2	18.3	8.4	17.9	19.1	54.4	68.1	12.6	12.7	20.7	23.5
TREM1	"CD354, TREM-1"	ENSG00000124731	"Triggering receptor expressed on myeloid cells 1"	Q9NP99	6	41267926-41286682	"CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 96.0;lung: 65.3;lymphoid tissue: 44.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 26.1;Hofbauer cells: 25.1;Kupffer cells: 35.5;Langerhans cells: 21.5;Late spermatids: 20.6;Macrophages: 104.2;monocytes: 19.9"	"Cancer enhanced"	"Detected in many"		"lung cancer: 9.6"	"Region enhanced"	"Detected in some"		"cerebral cortex: 8.5"	"Immune cell enriched"	"Detected in many"	7	"neutrophil: 615.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 615.1"	"Group enriched"	"Detected in some"	4	"SuSa: 6.2;U-87 MG: 24.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005563, HPA053612"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA005563: AB_1858259, HPA053612: "	"unprognostic (6.41e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.97e-2)"	"unprognostic (5.73e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.24e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.18e-7)"	"unprognostic (6.32e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.26e-2)"	20.4	1.4	0.4	44.1	0.4	96.0	1.2	0.4	8.5	0.8	2.3	0.9	0.4	2.2	0.0	1.5	3.9	9.9	3.8	0.4	0.6	1.1	6.9	65.3	0.4	0.9	0.7	0.5	3.9	1.1	2.4	7.7	1.9	0.7	0.3	0.6	1.2	0.5	0.5	0.2	1.0	8.4	0.6	11.1	0.8	0.3	2.6	3.1	0.7	2.6	1.3	12.6	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.3	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	1.6	0.0	0.1	82.7	2.3	0.0	20.7	0.1	0.6	0.1	0.0	32.8	1.5	0.2	0.0	615.1	0.2	10.1	0.7	0.0	32.5	0.4	0.4	0.4	8.5	0.4	0.6	0.9	0.7	1.9	0.6	2.6	0.9	0.0	6.4	26.1	0.0	1.8	0.4	0.4	5.4	0.0	0.0	0.1	0.1	0.3	2.8	12.4	0.0	0.0	0.4	0.3	0.1	0.0	0.3	12.1	0.3	1.8	3.8	0.0	0.0	0.0	0.2	1.1	2.5	1.1	0.1	6.3	0.0	0.7	0.5	25.1	0.0	0.0	0.0	2.0	35.5	21.5	20.6	0.0	104.2	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.2	0.0	0.3	13.3	0.1	0.0	0.8	2.8	0.0	0.1	0.0	0.1	14.6	2.0	0.0	0.0	0.1
TREML4	TLT4	ENSG00000188056	"Triggering receptor expressed on myeloid cells like 4"	Q6UXN2	6	41228339-41238882	"Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"choroid plexus: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"eosinophil: 4.5;neutrophil: 8.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.1"	"Cell line enriched"	"Detected in single"	6	"HEL: 1.1"	"Not detected"	"Not detected"							HPA065044	Uncertain		Approved	"Plasma membrane"	"Secreted - unknown location"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"HPA065044: AB_2685411"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.58e-2)"		"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.03e-1)"		"unprognostic (5.50e-2)"	"unprognostic (9.50e-3)"		"unprognostic (1.18e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.21e-2)"	0.0	0.0	0.0	0.3	0.2	0.7	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	4.5	0.0	0.4	0.0	0.1	0.0	0.0	0.5	0.9	0.0	0.0	8.1	0.0	0.4	0.7	0.0	0.4	0.0	0.2	0.0	0.4	0.1	0.2	0.2	0.1	0.1	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPAN33	"MGC50844, Penumbra"	ENSG00000158457	"Tetraspanin 33"	Q86UF1	7	129144707-129169699	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 64.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 27.8;Langerhans cells: 84.0;Macrophages: 32.0;monocytes: 44.8;Peritubular cells: 32.7;Proximal tubular cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.1;naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.2;HEL: 38.2;U-266/70: 48.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020357	Enhanced		Approved	Microtubules		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Microtubules		"HPA020357: AB_1858410"	"unprognostic (3.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.66e-1)"	"prognostic favorable (8.88e-4)"	"unprognostic (1.67e-1)"	"prognostic favorable (8.74e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.16e-2)"	3.2	4.4	8.2	9.1	8.0	3.9	3.0	6.9	7.2	2.0	5.4	6.4	3.6	1.5	10.9	3.9	2.1	3.1	8.6	6.8	11.9	64.8	28.2	5.0	16.3	10.8	13.4	2.4	21.2	11.1	19.9	3.8	12.2	7.4	3.4	1.3	18.8	7.0	13.0	7.6	12.3	2.2	11.0	16.9	6.2	11.4	14.1	6.7	8.4	4.4	14.4	7.9	3.8	10.0	1.5	4.3	1.0	23.2	0.0	0.0	0.9	0.0	0.2	0.5	0.1	0.7	2.1	18.4	1.8	0.4	12.9	1.7	12.3	4.0	0.5	18.7	14.0	38.2	0.8	8.2	0.9	5.5	0.8	0.9	3.8	0.2	1.2	0.0	0.5	9.4	0.4	2.6	0.0	4.6	11.5	0.1	8.5	0.8	4.5	3.9	0.5	0.4	1.4	5.0	5.8	6.9	2.3	0.7	13.6	5.3	4.7	2.4	0.1	0.1	1.8	1.9	0.6	48.8	5.8	8.1	0.4	18.4	2.7	0.0	0.3	0.0	0.0	0.7	0.0	1.1	0.0	0.0	0.6	1.3	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.4	8.2	8.0	6.9	7.2	6.8	11.9	10.8	13.4	12.2	11.0	14.1	10.0	0.9	0.0	0.6	3.3	27.8	2.5	0.7	0.8	0.6	3.5	10.5	9.8	6.2	0.0	0.2	5.5	4.2	0.1	7.6	0.7	13.7	2.2	2.5	2.7	0.5	1.4	3.5	5.2	3.6	8.7	0.2	6.7	0.0	1.6	0.0	1.4	0.4	15.8	8.4	0.0	1.7	0.6	0.0	23.6	84.0	4.2	2.8	32.0	1.8	3.7	44.8	8.4	0.0	3.5	0.1	2.4	1.1	32.7	1.3	1.9	1.0	59.2	2.2	1.7	0.0	11.3	1.0	0.8	4.1	0.4	3.0	0.1	2.2	8.4	0.4	1.3
UPF2	"DKFZP434D222, KIAA1408, RENT2, smg-3"	ENSG00000151461	"UPF2 regulator of nonsense mediated mRNA decay"	Q9HAU5	10	11920022-12043170	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067008			Supported	"Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	Cytosol	"Cytoplasmic bodies"	"HPA067008: AB_2685762"	"unprognostic (1.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (6.13e-4)"	"unprognostic (5.48e-2)"	"unprognostic (5.68e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.01e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.48e-2)"	12.8	8.1	12.4	14.1	13.7	21.0	12.7	15.8	15.1	12.0	12.5	16.2	10.0	14.9	10.7	10.9	11.0	8.9	10.6	12.5	13.6	10.9	16.7	10.4	18.9	11.8	12.2	16.2	13.7	14.8	7.9	14.1	11.6	13.5	12.9	14.8	11.1	12.2	22.0	12.9	11.4	12.1	11.9	14.8	11.3	19.5	12.7	21.5	12.8	21.4	17.7	13.4	11.8	13.2	35.9	22.3	18.8	23.5	14.0	17.9	21.2	27.5	12.7	19.2	23.0	21.2	28.6	51.4	9.1	23.0	15.8	29.4	27.2	24.9	27.4	32.5	15.7	61.6	18.2	19.4	15.8	28.1	39.8	13.5	19.0	24.3	16.4	18.2	23.8	27.1	37.1	25.7	22.2	17.7	34.8	16.4	18.0	27.1	11.8	30.4	22.5	25.3	18.2	14.2	12.1	13.0	21.6	23.1	23.8	18.7	27.9	37.1	25.5	15.0	31.4	31.1	21.1	23.4	19.8	41.4	24.0	26.9	12.1	13.7	4.2	10.2	4.3	4.2	4.2	10.7	4.9	4.5	3.0	10.6	5.4	4.5	29.5	5.4	2.9	11.5	3.8	1.8	12.4	13.7	15.8	15.1	12.5	13.6	11.8	12.2	11.6	11.9	12.7	13.2	74.8	25.6	34.6	32.0	133.3	71.9	35.0	46.9	64.3	66.3	53.8	38.6	69.6	52.9	39.4	49.7	102.2	47.0	79.6	97.7	39.2	47.7	70.1	99.3	86.2	62.6	66.3	108.4	36.1	44.8	51.7	48.2	58.1	88.7	58.9	71.8	64.2	89.5	41.1	52.2	31.6	90.2	48.8	71.4	125.3	116.9	86.3	56.0	53.4	31.9	89.0	45.5	98.9	37.2	45.4	53.7	78.9	59.0	121.2	38.7	70.6	34.1	41.5	97.2	98.6	54.3	60.1	182.9	149.8	47.3	81.8	56.5	73.6	35.9	65.5	36.3
USP12	USP12L1	ENSG00000152484	"Ubiquitin specific peptidase 12"	O75317	13	27066156-27171811	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007288, HPA059492"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA007288: AB_1080531, HPA059492: "	"unprognostic (6.72e-3)"	"unprognostic (2.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"unprognostic (8.38e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.73e-1)"	20.4	13.6	21.0	20.9	22.0	75.7	15.3	21.6	26.7	13.1	15.5	35.6	18.2	13.2	15.1	17.0	13.5	17.9	14.4	23.7	22.2	24.8	34.9	23.6	29.4	18.9	24.8	14.7	15.3	16.5	13.8	17.7	19.5	14.0	25.5	38.0	10.2	12.1	13.1	24.0	24.3	18.6	21.0	17.2	17.7	15.5	22.2	12.2	16.1	15.9	26.4	21.8	13.5	21.8	24.9	15.3	28.6	14.9	18.8	23.8	10.2	34.1	23.9	18.5	13.7	27.7	37.8	35.1	16.6	27.0	44.9	15.0	18.9	19.8	39.4	57.0	16.1	54.3	19.2	19.6	23.6	31.8	36.5	14.9	28.3	21.0	23.9	23.4	43.3	23.8	18.4	16.5	38.9	14.4	19.6	42.0	20.5	31.5	26.7	22.1	36.5	8.3	36.3	17.3	31.5	19.0	29.3	24.2	28.2	35.5	11.4	30.4	51.6	19.3	18.6	41.6	31.4	12.6	15.0	24.6	32.4	18.5	22.0	0.0	0.5	2.2	0.5	0.5	0.9	1.2	0.9	0.8	0.6	1.6	0.6	0.6	0.5	0.9	0.8	1.1	1.4	0.4	21.0	22.0	21.6	26.7	23.7	22.2	18.9	24.8	19.5	21.0	22.2	21.8	54.2	28.9	29.9	19.6	42.1	91.6	29.4	7.0	34.7	23.8	30.6	24.0	23.4	17.2	9.1	23.9	39.6	15.4	26.5	47.0	29.4	12.8	19.2	29.1	26.4	42.0	20.9	60.6	37.0	16.3	7.0	34.2	23.9	68.9	13.3	15.7	21.4	23.3	14.0	28.6	29.0	27.5	10.2	20.8	153.8	10.7	7.8	47.8	39.2	42.2	33.6	13.8	9.2	43.7	65.0	24.4	37.4	6.4	37.1	34.0	34.3	21.3	12.2	32.1	32.9	114.7	42.8	2.7	12.9	23.1	79.0	10.9	27.2	9.3	24.1	40.6
VEGFA	"VEGF, VEGF-A, VPF"	ENSG00000112715	"Vascular endothelial growth factor A"	P15692	6	43770184-43786487	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 349.4;Muller glia cells: 265.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 79.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 398.9;U-87 MG: 628.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005429, CAB039240, HPA069116, CAB069907"	Supported				"Secreted to blood"	NA	NA	562000	57000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"			"CAB005429: AB_2212984, CAB039240: , CAB069907: AB_10001947, HPA069116: AB_2686089"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (4.35e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (2.34e-5)"	"unprognostic (5.10e-2)"	"unprognostic (5.27e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.73e-4)"	155.8	52.7	17.6	36.5	20.3	45.5	92.4	34.2	28.2	45.2	46.8	32.6	50.9	104.0	10.5	61.3	40.9	80.1	208.3	22.8	25.1	116.9	217.3	94.1	9.3	27.0	38.5	25.0	68.1	105.0	22.3	46.2	26.8	120.3	21.4	229.1	32.1	17.8	221.2	44.2	44.6	57.1	19.6	70.1	63.9	5.3	32.0	5.6	270.9	150.9	9.5	122.3	61.7	24.9	76.5	13.4	12.5	71.8	21.0	32.9	84.2	45.6	81.1	29.7	58.4	43.1	9.9	24.9	35.5	27.7	305.4	30.6	34.0	92.0	52.0	27.4	10.4	19.0	17.8	29.2	220.3	20.8	40.4	58.0	178.6	290.6	286.2	398.9	7.7	21.0	35.7	121.7	109.4	31.3	2.3	28.3	7.9	221.2	19.2	2.3	12.0	60.5	114.8	62.9	22.3	46.8	65.6	44.4	162.0	16.1	17.3	75.1	10.4	122.6	32.9	179.2	76.1	68.8	43.6	49.1	628.6	47.9	43.8	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	20.3	34.2	28.2	22.8	25.1	27.0	38.5	26.8	19.6	32.0	24.9	63.6	349.4	84.7	121.5	9.8	70.5	51.2	76.8	60.3	37.8	67.0	57.1	164.7	77.2	85.7	22.0	31.3	1.3	11.6	92.9	1.9	54.7	0.0	38.4	59.1	29.0	27.4	21.3	12.1	40.8	6.3	69.7	124.4	121.2	112.0	111.7	17.5	116.0	13.9	180.0	17.0	71.8	12.2	16.2	199.0	0.3	1.8	144.1	28.4	10.3	11.3	265.8	0.0	124.1	1.8	86.0	47.1	3.4	15.9	119.4	61.9	20.5	11.4	43.9	0.0	42.1	79.1	1.1	1.9	82.0	78.3	7.9	11.4	17.4	51.0	137.5
VENTX	"HPX42B, VENTX2"	ENSG00000151650	"VENT homeobox"	O95231	10	133237855-133241928	"Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Kupffer cells: 6.2;Langerhans cells: 7.9;Macrophages: 7.8;monocytes: 5.0"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 30.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"dendritic cells: 1.8;granulocytes: 1.9;monocytes: 3.2"	"Group enriched"	"Detected in some"	10	"NB-4: 18.2;NTERA-2: 10.9"									HPA050955	Uncertain		Uncertain	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center"	Cytosol	"HPA050955: AB_2681288"	"unprognostic (9.41e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.26e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.00e-3)"	"unprognostic (3.70e-4)"	"unprognostic (4.22e-1)"	"unprognostic (2.51e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.48e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.14e-1)"	4.8	2.3	1.6	3.6	1.1	2.8	1.9	1.6	1.5	1.5	1.9	1.9	0.4	1.6	0.5	0.5	1.8	1.5	1.5	1.5	1.5	1.7	0.5	3.8	0.5	1.9	1.7	1.5	1.2	0.5	1.4	0.5	1.5	1.3	0.4	0.2	1.3	0.8	0.9	1.2	1.0	1.2	0.9	5.7	0.9	1.0	2.5	0.2	0.8	0.1	0.4	1.4	1.0	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	18.2	10.9	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	1.9	2.6	0.3	0.1	3.2	0.0	0.3	0.1	0.0	1.8	0.2	0.1	0.1	0.9	0.3	2.4	0.1	0.0	0.7	1.6	1.1	1.6	1.5	1.5	1.5	1.9	1.7	1.5	0.9	2.5	1.8	0.0	0.0	1.1	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.2	7.9	0.2	0.0	7.8	0.0	0.0	5.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0
VIM		ENSG00000026025	Vimentin	P08670	10	17228241-17237593	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 4879.0;Langerhans cells: 4893.1;Leydig cells: 5013.2;Muller glia cells: 8977.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18287.8;fHDF/TERT166: 10084.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000080, HPA001762, CAB058687"	Enhanced		Supported	"Intermediate filaments"		NA	NA		35000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	"Intermediate filaments"		"CAB000080: AB_2304493, CAB058687: AB_2665570, HPA001762: AB_1080568"	"unprognostic (1.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.87e-2)"	"prognostic favorable (9.75e-6)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (8.69e-8)"	"unprognostic (1.87e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.47e-3)"	3467.6	423.1	349.3	610.6	369.5	1455.5	2362.8	289.1	527.4	1816.3	568.1	923.2	218.4	1226.5	400.0	451.5	1458.7	960.2	1364.3	337.5	404.6	473.6	192.8	1133.2	806.2	667.4	328.2	3690.8	370.0	224.8	574.5	1030.0	443.7	570.0	400.8	731.0	628.5	551.8	363.7	1126.8	674.7	1109.3	414.6	819.9	522.8	251.7	472.7	412.2	1391.1	555.8	744.7	983.5	1366.6	425.5	21.2	1119.0	1981.0	3180.7	6407.4	18287.8	3.0	5238.5	3458.9	3859.2	3421.5	8.5	70.4	2.9	273.2	10084.4	1804.7	8.4	283.8	147.0	3734.1	3567.5	387.2	563.2	523.5	0.3	1967.3	301.1	222.8	6746.8	6.5	5712.0	3213.4	9020.8	6366.3	372.4	889.3	1575.4	6939.5	4.5	736.6	911.2	632.4	1.4	1394.0	564.8	2745.9	95.7	3925.3	0.8	8.1	946.6	1.4	6.9	5447.5	1133.1	8.6	341.8	5459.0	3819.8	1644.5	3244.7	6311.5	1754.4	953.7	130.4	5775.4	28.9	3726.3	667.8	751.8	215.2	219.5	469.3	278.7	176.3	357.0	285.0	866.0	117.5	217.1	217.2	409.3	99.2	471.2	342.3	481.5	615.4	349.3	369.5	289.1	527.4	337.5	404.6	667.4	328.2	443.7	414.6	472.7	425.5	3211.7	157.0	349.4	53.5	605.8	725.8	21.6	361.2	58.1	74.2	108.8	539.1	109.5	94.4	157.3	108.5	50.1	22.1	1110.1	9.1	5.9	198.8	58.1	922.9	2314.1	2923.2	309.1	236.5	0.4	569.0	45.8	3443.0	101.4	693.7	2776.4	4879.0	2195.6	19.2	3541.4	33.7	0.3	1.8	16.2	2841.2	4893.1	131.6	5013.2	3177.8	3082.5	85.3	3893.1	8977.0	259.5	1.0	0.4	525.9	1.5	2336.6	2097.2	79.5	3.1	181.6	90.7	284.1	1420.0	3171.9	3714.2	55.1	27.5	39.4	473.0	52.7	1566.3	1791.1	6.2	28.9
WARS1	"IFI53, IFP53, WARS"	ENSG00000140105	"Tryptophanyl-tRNA synthetase 1"	P23381	14	100333790-100376805	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 324.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 66.4;Cytotrophoblasts: 16.5;Endothelial cells: 38.5;Hofbauer cells: 43.1;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 1345.3;non-classical monocyte: 1608.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 908.5;SK-MEL-30: 1012.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005573, HPA018944"	Enhanced		Enhanced	Cytosol		No	No		49000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA005573: AB_2667366, HPA018944: AB_2669986"	"unprognostic (5.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.26e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (4.84e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.92e-3)"	100.7	67.9	40.3	185.6	44.4	70.5	65.4	40.1	45.5	35.9	45.2	67.8	44.8	39.6	70.3	54.4	50.8	48.7	157.6	44.2	56.0	83.6	47.9	207.5	139.0	72.0	52.6	21.2	47.5	39.2	63.4	324.4	65.3	49.1	72.0	37.8	49.5	38.3	74.7	28.4	67.7	76.2	47.6	110.6	70.1	67.7	55.0	61.7	159.9	67.0	86.2	107.7	30.7	44.9	91.2	85.7	54.6	319.1	78.7	110.7	87.3	117.4	220.7	232.1	301.4	57.4	80.2	101.7	105.5	277.4	59.7	151.1	158.8	130.3	153.1	154.4	48.3	64.1	60.9	72.3	908.5	184.9	101.6	126.9	186.9	141.3	290.1	74.5	225.0	66.1	202.8	255.0	107.5	178.0	64.3	87.1	55.4	94.1	152.2	51.4	86.5	64.9	119.3	80.8	145.7	84.9	69.4	58.7	1012.4	70.5	153.6	234.7	153.1	25.7	58.9	269.2	61.3	446.4	277.1	191.9	295.0	144.2	205.5	96.5	471.7	610.4	41.5	1345.3	38.4	71.4	34.5	38.4	337.9	68.0	24.8	28.6	170.9	44.5	1608.2	54.7	44.8	672.7	40.3	44.4	40.1	45.5	44.2	56.0	72.0	52.6	65.3	47.6	55.0	44.9	66.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	16.5	3.7	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	11.5	5.5	0.0	0.0	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	16.6	0.5	0.0	0.0	0.0
WDFY4	"C10orf64, Em:AC060234.3, FLJ45748, KIAA1607"	ENSG00000128815	"WDFY family member 4"	Q6ZS81	10	48684876-48982956	"Predicted intracellular proteins, Predicted membrane proteins"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.7;lymphoid tissue: 28.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 44.7;dendritic cells: 29.9;Early spermatids: 47.2;Langerhans cells: 30.6;Macrophages: 24.6;Microglial cells: 81.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 14.3;myeloid DC: 11.3;naive B-cell: 21.2;neutrophil: 10.2;plasmacytoid DC: 32.5"	"Group enriched"	"Detected in many"	7	"B-cells: 21.2;dendritic cells: 32.5;granulocytes: 10.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 61.0;HDLM-2: 56.3;HL-60: 21.5;THP-1: 18.9;U-698: 25.6;U-937: 25.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040634	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA040634: AB_10795491"	"unprognostic (6.20e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.38e-4)"	"unprognostic (9.41e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.15e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.64e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.76e-2)"	1.9	0.7	3.2	12.1	3.4	11.7	1.4	4.2	4.8	1.1	3.2	1.9	1.5	0.8	1.9	1.4	0.7	3.2	0.6	3.2	4.2	0.8	1.3	5.2	28.5	6.0	4.9	0.6	1.0	0.4	0.3	1.2	6.2	0.8	1.9	0.1	1.3	0.6	0.7	2.6	7.4	1.7	5.9	17.3	2.3	3.7	6.3	12.3	0.6	0.4	23.9	3.1	0.3	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	56.3	0.0	6.5	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	6.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	25.6	0.0	25.0	0.0	0.0	3.0	0.0	0.0	2.8	0.0	14.3	0.0	0.1	11.3	21.2	0.0	0.0	10.2	0.0	1.3	32.5	0.0	1.1	3.2	3.4	4.2	4.8	3.2	4.2	6.0	4.9	6.2	5.9	6.3	9.3	0.2	0.0	1.1	2.0	44.7	0.4	0.1	0.0	0.0	0.0	0.1	0.4	1.3	0.0	0.6	1.8	0.0	0.1	29.9	0.0	1.9	0.0	47.2	0.0	0.1	0.3	0.0	0.4	0.7	0.0	0.2	1.1	0.0	0.0	5.7	0.0	0.0	0.0	13.0	0.0	0.4	0.1	0.0	12.9	30.6	17.7	0.3	24.6	1.8	81.5	16.4	0.0	0.0	1.0	0.5	0.0	0.0	0.4	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.2	2.9	0.5	0.2	0.3	0.3	1.5	0.0	0.3	0.1
WSB1	"DKFZp564A122, DKFZp564B0482, SWIP1"	ENSG00000109046	"WD repeat and SOCS box containing 1"	Q9Y6I7	17	27294076-27315926	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003293	Approved		Approved	Mitochondria		NA	Yes			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 19: Lung - Lung function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"HPA003293: AB_1858863"	"unprognostic (1.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (4.07e-5)"	"unprognostic (2.59e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.74e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.02e-7)"	"unprognostic (1.44e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.74e-2)"	41.9	22.1	14.1	45.9	35.7	48.7	35.7	22.9	26.9	47.0	5.2	40.7	28.6	49.4	24.6	27.7	45.9	39.6	32.5	14.1	35.9	29.0	15.6	58.3	34.5	38.7	22.7	47.7	29.6	19.0	23.8	75.0	40.6	27.6	30.9	76.0	27.4	32.1	23.0	23.2	33.7	44.8	17.0	69.9	32.7	21.6	33.2	24.8	28.8	16.1	35.2	32.8	39.1	80.0	30.8	21.3	65.3	37.5	40.3	49.7	69.7	26.6	37.9	20.6	39.6	32.0	12.2	30.6	29.6	36.6	26.2	28.4	40.0	19.6	30.9	85.3	33.1	48.7	41.9	32.7	75.7	34.1	69.2	60.2	26.3	30.1	18.4	31.5	83.1	31.7	49.8	28.6	36.9	19.4	44.4	38.4	19.4	17.1	17.3	35.5	35.9	18.5	31.1	24.6	20.9	28.8	27.8	27.3	36.7	77.8	22.1	44.5	46.5	25.3	19.2	34.8	26.4	12.8	34.9	31.2	23.9	26.8	23.4	75.0	41.1	71.5	21.6	70.3	26.1	22.1	18.1	24.2	65.5	25.3	17.0	19.7	37.1	21.4	82.5	21.5	30.2	26.4	14.1	35.7	22.9	26.9	14.1	35.9	38.7	22.7	40.6	17.0	33.2	80.0	300.4	221.2	476.1	189.7	245.4	249.2	185.6	138.4	253.8	91.9	186.7	147.7	67.5	144.4	194.2	239.1	348.2	360.7	183.2	222.7	27.4	124.9	153.0	201.2	187.6	254.9	194.4	148.1	229.5	65.1	217.2	284.6	190.6	301.5	163.5	436.3	316.6	43.3	228.2	82.4	267.8	191.5	162.8	412.6	288.9	26.6	141.4	358.9	197.5	206.1	153.2	170.5	112.3	349.3	658.2	76.7	185.4	122.6	144.9	196.3	178.7	30.7	137.5	381.4	124.9	243.8	221.9	119.6	104.8	202.2	280.3	714.5	183.9	98.5	133.6	148.9
XCR1	"CCXCR1, GPR5"	ENSG00000173578	"X-C motif chemokine receptor 1"	P46094	3	46017007-46027487	"G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.2"	"Cell type enriched"	"Detected in some"	5	"Langerhans cells: 10.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"myeloid DC: 3.8"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 3.8"	"Cell line enhanced"	"Detected in some"		"HEL: 1.6;Karpas-707: 2.5;RT4: 2.0;U-266/84: 2.2;U-87 MG: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013169	Uncertain					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA013169: AB_1846211"	"unprognostic (3.49e-3)"	"unprognostic (4.23e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.91e-3)"	"unprognostic (7.91e-2)"	"unprognostic (8.53e-6)"	"unprognostic (3.89e-6)"	"unprognostic (9.27e-3)"	"unprognostic (4.41e-3)"	"unprognostic (3.40e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.80e-1)"	0.9	0.1	0.1	3.8	0.2	3.0	0.6	0.8	0.7	0.7	0.5	1.1	1.7	0.5	4.5	1.9	0.5	3.0	0.5	0.5	0.1	0.3	1.1	1.4	11.2	0.3	0.1	0.9	0.1	0.1	0.0	4.3	0.3	0.6	1.1	0.6	0.2	0.6	0.1	2.7	1.7	1.5	0.0	7.2	1.2	0.4	0.3	8.8	0.5	0.4	4.6	1.6	0.2	0.7	0.0	0.8	0.3	0.0	0.0	0.0	0.7	0.3	0.8	0.0	0.0	0.7	0.0	0.7	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.4	0.0	0.0	0.4	0.3	0.5	2.5	0.0	0.8	0.4	0.0	0.0	0.4	0.0	0.3	0.0	0.3	0.3	2.0	0.1	0.0	0.0	0.2	0.0	0.7	0.2	0.0	0.0	0.4	0.9	0.2	0.1	1.2	2.2	0.7	1.7	0.0	0.2	0.7	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	3.8	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.3	0.1	0.2	0.8	0.7	0.5	0.1	0.3	0.1	0.3	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.8	10.2	1.5	0.0	2.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0
ZEB2	"KIAA0569, SIP-1, SIP1, ZFHX1B"	ENSG00000169554	"Zinc finger E-box binding homeobox 2"	O60315	2	144364364-144521057	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease variant, Epilepsy, Hirschsprung disease, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 363.7"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 662.9;Inhibitory neurons: 539.3;Oligodendrocytes: 1489.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 154.0;THP-1: 181.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003456	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA003456: AB_10603840"	"unprognostic (1.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.77e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (6.04e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.32e-2)"	61.3	45.2	185.6	56.8	258.3	127.5	29.5	138.3	165.5	52.4	3.0	24.5	21.9	29.6	9.6	27.9	20.3	43.9	45.7	132.5	155.4	18.2	23.3	41.2	43.2	238.3	214.5	70.5	5.7	6.7	3.3	62.1	222.8	18.5	29.9	35.5	9.6	22.7	20.8	12.8	25.9	33.3	183.2	69.4	18.0	16.2	249.6	10.6	13.3	18.8	24.2	46.6	24.1	363.7	1.6	2.0	83.4	0.1	98.9	49.7	0.3	35.1	35.1	38.5	37.1	0.0	0.8	6.6	0.1	37.4	10.6	0.4	14.5	0.1	47.6	37.6	11.2	154.0	6.3	0.2	23.0	26.4	113.2	42.1	0.9	48.9	22.9	33.7	29.4	0.0	43.0	4.1	45.2	0.2	0.4	79.9	12.3	0.0	1.9	44.1	63.5	0.2	0.4	0.6	0.7	22.1	4.2	0.2	97.3	27.5	0.2	181.4	45.9	42.9	0.7	87.5	11.0	47.1	0.3	7.5	66.7	78.4	122.6	27.8	47.7	12.2	21.0	42.6	1.9	9.2	2.7	10.7	27.0	9.4	1.9	7.7	15.2	7.3	43.9	21.5	0.6	19.0	185.6	258.3	138.3	165.5	132.5	155.4	238.3	214.5	222.8	183.2	249.6	363.7	32.6	6.4	19.2	121.8	92.4	24.9	1.2	0.6	3.4	158.6	2.2	4.3	71.0	1.5	10.1	5.5	4.2	1.7	426.2	0.1	1.9	0.7	2.2	2.1	84.7	29.2	0.0	127.0	228.2	0.8	2.0	123.0	13.3	2.5	157.5	99.3	79.2	4.6	144.5	662.9	539.3	0.0	0.0	435.0	276.3	7.2	120.5	435.0	103.2	343.8	233.6	69.3	223.5	381.0	1489.6	0.2	1.1	66.5	132.3	1.8	0.0	10.3	4.0	11.9	184.1	185.0	198.7	2.9	11.3	3.4	19.6	4.7	136.7	108.8	0.4	2.2
ZFAND5	"ZA20D2, ZFAND5A, ZNF216"	ENSG00000107372	"Zinc finger AN1-type containing 5"	O76080	9	72351413-72365235	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 591.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 450.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018129, HPA077824"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA018129: AB_1859012, HPA077824: "	"unprognostic (1.97e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.91e-1)"	"prognostic favorable (4.43e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.85e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.86e-2)"	"unprognostic (7.03e-2)"	312.2	187.7	99.9	55.3	112.7	145.7	150.0	105.5	136.0	97.6	70.9	88.1	39.4	91.0	115.7	99.8	120.6	87.3	117.7	103.9	107.8	114.9	204.7	108.5	46.9	93.9	113.3	250.4	73.6	69.1	138.8	79.2	105.6	76.8	49.2	50.7	69.8	121.4	591.1	75.4	69.0	94.9	100.5	60.4	95.5	88.5	105.9	52.3	79.2	273.9	59.1	108.9	87.1	110.8	115.9	113.0	138.8	59.4	156.5	77.3	104.3	131.9	178.9	71.1	55.1	14.5	112.6	60.4	81.3	194.5	105.2	122.4	305.1	50.4	103.4	450.1	43.1	53.5	57.7	70.1	120.4	74.7	71.1	99.0	87.6	72.7	79.2	156.3	122.1	60.4	49.8	82.1	82.6	31.3	96.3	38.8	178.9	107.2	74.3	74.1	72.4	70.5	218.4	109.3	101.2	86.4	85.2	91.2	117.2	142.1	42.1	64.3	97.1	57.4	71.7	104.7	90.9	113.9	110.3	38.1	77.2	49.1	146.3	39.0	35.9	37.3	11.2	52.1	12.0	17.0	14.6	14.1	33.6	15.1	13.2	12.2	27.7	19.2	81.6	6.2	11.2	23.9	99.9	112.7	105.5	136.0	103.9	107.8	93.9	113.3	105.6	100.5	105.9	110.8	370.7	176.3	192.1	102.8	125.8	339.2	573.2	130.6	376.7	93.9	267.0	207.1	322.6	92.9	132.6	132.4	75.0	145.1	118.6	213.3	148.7	145.8	91.8	257.1	291.9	195.3	136.7	155.6	45.7	142.6	164.8	270.8	145.2	527.6	109.2	116.1	97.5	308.3	198.0	40.4	38.6	119.8	126.1	290.6	320.1	44.5	118.4	470.1	208.1	31.9	268.8	84.2	53.5	38.7	67.2	185.9	221.3	93.3	149.3	329.9	87.2	127.1	109.2	70.6	85.5	674.9	285.2	148.7	116.4	298.1	291.2	226.3	165.5	102.9	109.4	528.2
ZNF267	HZF2	ENSG00000185947	"Zinc finger protein 267"	Q14586	16	31873807-31917357	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 131.1;Macrophages: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA003866	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA003866: AB_1080698"	"unprognostic (2.73e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.84e-2)"	"unprognostic (6.24e-2)"	"unprognostic (5.60e-3)"	"unprognostic (8.64e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (1.58e-6)"	"unprognostic (2.34e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.95e-1)"	"unprognostic (8.21e-2)"	6.3	3.7	3.2	18.6	3.8	27.4	7.3	3.4	11.6	5.5	5.4	6.1	7.1	6.7	3.1	7.1	6.0	10.0	4.4	2.9	4.4	5.0	6.6	9.3	17.9	4.6	4.4	6.2	4.8	4.5	2.3	10.0	4.8	5.2	7.1	2.5	5.3	3.9	6.1	4.0	5.9	5.9	4.2	13.2	6.8	9.8	6.4	11.4	5.9	6.6	18.4	13.6	4.4	5.5	8.8	10.0	8.8	7.0	6.2	7.2	26.9	7.0	11.7	9.6	14.7	17.9	13.7	15.6	12.6	5.7	9.6	11.3	14.4	11.4	18.5	23.6	12.1	15.8	5.6	16.1	5.6	17.0	35.3	10.3	7.7	13.6	9.7	7.0	14.0	11.8	25.9	35.9	13.2	12.2	11.4	11.3	8.2	6.8	5.8	11.4	24.8	13.7	10.9	38.8	2.8	4.3	10.8	9.6	10.3	15.3	5.7	23.6	16.8	9.3	8.5	8.2	12.0	20.1	12.3	15.7	12.3	13.6	5.7	36.6	24.0	33.4	12.4	23.4	18.6	21.2	16.2	12.5	18.8	15.9	12.6	15.2	75.3	16.5	27.5	11.3	20.3	12.3	3.2	3.8	3.4	11.6	2.9	4.4	4.6	4.4	4.8	4.2	6.4	5.5	23.7	9.6	8.0	3.6	37.0	31.9	39.6	15.2	13.1	4.5	12.3	12.2	5.6	8.6	14.0	3.7	0.0	14.1	27.2	5.4	7.9	19.1	23.3	34.8	10.3	33.5	7.7	10.9	7.1	20.0	10.4	17.2	13.7	31.4	60.3	5.4	7.5	2.8	21.5	11.8	3.7	7.0	14.2	25.3	131.1	8.8	5.9	82.2	14.2	15.0	68.5	5.0	22.6	9.5	7.7	49.7	8.0	3.4	19.9	30.1	4.2	12.4	26.2	3.9	0.0	10.8	12.2	20.7	29.6	33.1	25.6	8.3	47.6	5.9	5.6	48.9
ZNF281	ZBP-99	ENSG00000162702	"Zinc finger protein 281"	Q9Y2X9	1	200404940-200410056	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 33.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051228	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA051228: AB_2681396"	"unprognostic (3.13e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.50e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.23e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.71e-3)"	"unprognostic (8.30e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (1.26e-2)"	"unprognostic (4.86e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.83e-1)"	7.7	3.3	6.3	10.7	12.0	33.5	7.9	10.8	9.8	6.9	4.2	4.6	5.4	7.0	3.9	3.2	4.3	10.1	4.2	7.1	7.6	7.1	21.6	7.5	11.3	8.8	8.9	5.7	5.7	5.6	2.6	8.9	8.3	4.7	4.3	10.7	5.5	4.3	5.7	2.7	4.1	9.0	7.0	9.7	5.1	9.6	8.6	12.6	5.1	7.9	11.7	7.9	2.0	20.7	19.9	19.8	27.2	12.5	10.8	14.5	22.2	21.0	33.3	21.0	19.6	19.7	15.7	29.0	11.6	24.2	24.4	13.4	29.6	19.7	24.9	30.6	17.5	23.6	15.6	20.4	11.6	21.3	12.9	14.1	21.9	22.6	24.5	26.2	19.1	15.6	33.9	4.6	21.5	9.8	22.5	13.8	61.1	6.3	17.1	20.6	18.8	17.2	21.7	10.3	9.2	24.4	21.1	13.8	18.6	42.4	27.0	15.4	25.7	38.1	28.2	8.7	22.3	16.8	17.8	37.0	20.2	16.8	20.5	15.2	8.1	30.3	9.9	8.5	9.7	10.7	8.3	10.4	8.0	9.1	13.6	11.9	38.1	8.1	8.3	8.3	10.9	3.4	6.3	12.0	10.8	9.8	7.1	7.6	8.8	8.9	8.3	7.0	8.6	20.7	30.2	64.1	40.3	7.2	35.1	48.2	26.2	24.0	37.5	55.1	46.3	26.9	14.5	28.6	25.9	27.6	29.2	15.4	24.6	13.8	13.7	22.1	2.6	21.6	37.1	38.9	26.8	22.9	16.0	10.5	31.0	21.2	11.2	41.4	6.3	16.3	30.0	76.9	19.6	18.5	19.6	11.4	8.2	52.1	25.8	3.6	9.9	43.5	23.2	15.0	30.6	15.5	26.8	22.6	59.4	17.8	13.3	7.9	31.7	25.4	10.9	20.3	20.5	37.0	13.1	21.1	32.9	50.1	42.4	18.9	22.7	12.3	29.5	14.2	12.9	20.4